data_2k8y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k8y _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.405 ' SD ' ' HG2' ' A' ' 91' ' ' GLU . 24.3 mmt . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.9 mt -101.39 103.56 15.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.1 mp -109.72 121.39 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -131.81 145.46 51.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.78 0.832 . . . . 0.0 109.084 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.38 124.63 8.18 Favored Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.2 tt -130.68 138.89 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 122.801 0.44 . . . . 0.0 109.869 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -129.3 124.14 33.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.839 0.855 . . . . 0.0 108.798 -172.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.41 2.36 56.64 Favored Glycine 0 N--CA 1.467 0.762 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.997 -170.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -74.44 98.17 3.25 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 123.792 0.837 . . . . 0.0 111.188 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.531 ' HA ' ' HB2' ' A' ' 83' ' ' ASP . 70.7 mtp180 -73.81 107.36 6.0 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.956 0.502 . . . . 0.0 110.616 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.468 HD12 HG12 ' A' ' 86' ' ' VAL . 49.6 mm -69.49 122.96 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.891 0.877 . . . . 0.0 110.79 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.27 165.64 18.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.519 0.728 . . . . 0.0 109.352 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -73.2 -17.0 61.41 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.39 -31.62 68.93 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.503 0.721 . . . . 0.0 111.795 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.482 HD11 HD12 ' A' ' 29' ' ' ILE . 16.0 pt -52.13 -28.35 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -90.11 -20.07 23.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.55 0.34 . . . . 0.0 111.303 -176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -76.81 -12.46 59.98 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.503 0.721 . . . . 0.0 111.83 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.469 HD22 HD12 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -81.0 -8.59 59.81 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.679 0.391 . . . . 0.0 111.776 176.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.48 19.08 17.16 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.403 ' HB2' HD13 ' A' ' 23' ' ' LEU . 98.5 mt -81.66 174.74 11.09 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.493 0.646 . . . . 0.0 110.394 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -90.18 96.49 10.69 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.228 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -147.68 157.59 43.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.702 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.557 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -138.26 147.1 43.3 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 167.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.482 HD12 HD11 ' A' ' 20' ' ' ILE . 35.6 mt -132.29 121.6 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.519 ' HB3' HE22 ' A' ' 28' ' ' GLN . 4.2 pp -121.57 177.8 5.08 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.437 ' HB3' HG22 ' A' ' 34' ' ' VAL . 38.6 t-20 -75.71 119.46 19.76 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.654 0.782 . . . . 0.0 110.038 -173.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.42 -1.52 41.81 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.558 ' HA ' ' NZ ' ' A' ' 118' ' ' LYS . 37.8 t70 -79.67 -32.41 41.52 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.495 0.188 . . . . 0.0 110.522 176.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 31' ' ' ASN . 27.7 m -98.75 -2.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.873 0.869 . . . . 0.0 112.538 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.439 HG12 HD21 ' A' ' 112' ' ' LEU . 10.5 p -78.69 139.96 17.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.1 -72.25 0.33 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 40.3 p -147.15 -177.35 5.63 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.823 0.849 . . . . 0.0 110.401 176.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -52.03 -39.77 60.06 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.168 167.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.42 ' HD2' HD12 ' A' ' 42' ' ' LEU . 22.9 tptm -56.07 -29.94 61.25 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.676 0.79 . . . . 0.0 111.504 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.533 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.6 t-80 -68.44 -50.85 49.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.425 0.69 . . . . 0.0 111.015 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.407 HG13 HG12 ' A' ' 89' ' ' ILE . 93.0 t -68.37 -54.75 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.49 ' HA ' HD13 ' A' ' 45' ' ' ILE . 4.2 pp -56.16 -33.16 64.96 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.664 0.786 . . . . 0.0 111.835 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.534 ' HE2' ' HB2' ' A' ' 143' ' ' ALA . 79.5 t60 -62.45 -45.28 93.78 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.061 173.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.17 87.51 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.383 0.673 . . . . 0.0 111.367 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.558 HG12 HD11 ' A' ' 62' ' ' ILE . 48.2 mt -56.96 -48.53 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.965 0.906 . . . . 0.0 109.815 170.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.548 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 62.1 t30 -64.95 -30.36 71.34 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.388 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 10.2 mm-40 -68.66 -39.96 80.39 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.952 0.501 . . . . 0.0 109.824 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -66.99 -26.33 66.75 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.464 0.706 . . . . 0.0 112.352 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 46' ' ' ASN . 10.1 mtmp? -78.92 -31.94 45.44 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.631 0.372 . . . . 0.0 111.847 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.498 HG23 ' HG2' ' A' ' 51' ' ' LYS . 8.6 t -95.26 -45.17 7.28 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.68 0.392 . . . . 0.0 111.954 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.629 ' HB2' HH22 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -121.13 120.04 34.12 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.002 0.921 . . . . 0.0 109.183 -175.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -103.84 99.66 17.08 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 123.016 0.526 . . . . 0.0 110.229 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.61 -81.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.858 2.372 . . . . 0.0 113.935 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.4 pt -150.67 11.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.813 0.845 . . . . 0.0 111.83 -168.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.58 160.54 27.54 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -169.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -68.59 -50.14 53.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.783 0.833 . . . . 0.0 111.125 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -146.08 171.44 14.89 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.56 0.744 . . . . 0.0 110.197 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.93 -58.7 6.92 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.855 0.862 . . . . 0.0 111.897 -174.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.557 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 91.4 m95 -63.85 -33.81 76.53 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.756 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.8 mmm -73.53 -18.98 61.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.827 0.451 . . . . 0.0 110.674 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.595 ' HG2' HH11 ' A' ' 65' ' ' ARG . 22.3 tt0 -77.68 -38.84 46.65 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.072 0.949 . . . . 0.0 110.984 173.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.558 HD11 HG12 ' A' ' 45' ' ' ILE . 82.8 mt -55.0 -53.51 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.673 0.789 . . . . 0.0 111.27 -177.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.45 ' O ' HD13 ' A' ' 79' ' ' ILE . 4.3 pp -52.74 -31.29 37.23 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.189 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 61' ' ' GLU . 1.9 m -78.78 -32.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 112.005 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.629 HH22 ' HB2' ' A' ' 51' ' ' LYS . 11.8 mmm-85 -68.12 -45.14 74.5 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 122.954 0.502 . . . . 0.0 110.866 -175.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.41 -20.15 64.19 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.892 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -97.14 12.65 32.0 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.28 41.9 7.24 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 118.349 0.522 . . . . 0.0 113.481 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 57.37 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.193 1.797 . . . . 0.0 111.152 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -121.18 -160.97 0.88 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.328 1.051 . . . . 0.0 109.354 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -120.7 162.01 20.44 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.64 -49.97 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.264 1.026 . . . . 0.0 112.137 -170.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.444 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 33.6 m170 -61.45 -55.21 33.81 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.751 0.657 . . . . 0.0 110.623 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.41 -56.61 16.92 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.055 0.847 . . . . 0.0 111.789 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 -30.4 69.35 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.5 mt -68.22 -38.38 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.49 0.316 . . . . 0.0 111.012 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 73' ' ' HIS . 60.4 mttm -68.9 -45.66 70.35 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.529 HG23 HG23 ' A' ' 79' ' ' ILE . 59.4 mt -71.22 -66.11 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.206 1.003 . . . . 0.0 111.373 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.529 HG23 HG23 ' A' ' 78' ' ' ILE . 29.8 pt -122.7 26.83 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.64 179.75 48.69 Favored Glycine 0 N--CA 1.48 1.596 0 CA-C-N 118.821 0.737 . . . . 0.0 113.402 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.1 144.37 47.03 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.779 0.432 . . . . 0.0 111.323 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -151.28 149.24 29.15 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 15' ' ' ARG . 6.2 p-10 -65.79 151.33 46.87 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.459 0.572 . . . . 0.0 111.559 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.61 -118.36 6.08 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.481 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.443 HD21 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -85.27 103.78 14.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.468 HG12 HD12 ' A' ' 16' ' ' ILE . 1.1 p -137.72 156.07 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.116 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.2 t -106.85 122.87 47.27 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.504 1.122 . . . . 0.0 109.388 -170.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -95.68 128.6 42.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 28' ' ' GLN . 7.7 mt -120.27 117.92 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.671 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 42.3 t -145.91 161.94 38.89 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.874 0.369 . . . . 0.0 111.712 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.405 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 43.6 mt-10 -91.89 -47.91 7.06 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.591 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -111.7 136.3 51.12 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.171 0.588 . . . . 0.0 110.362 -171.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -57.63 -27.39 62.75 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.517 0.727 . . . . 0.0 112.403 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.79 -42.71 69.99 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.671 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 60.5 m -65.75 -37.58 86.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.749 0.82 . . . . 0.0 111.466 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -61.85 -43.1 99.53 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -62.37 -40.96 98.16 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 123.893 0.745 . . . . 0.0 110.055 177.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 34.5 mmtp -57.35 -51.82 67.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.454 0.702 . . . . 0.0 110.58 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.469 HD12 HD22 ' A' ' 23' ' ' LEU . 43.8 mm -66.15 -44.31 91.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.372 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.97 -40.31 29.93 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.499 1.119 . . . . 0.0 112.955 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 22.6 mm-40 -59.58 -46.86 87.68 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.509 0.506 . . . . 0.0 111.66 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.403 ' HB2' HG21 ' A' ' 20' ' ' ILE . 3.1 mm? -73.82 -36.43 64.95 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.465 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 20.3 pt -80.35 -47.71 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 118.639 0.654 . . . . 0.0 110.995 -173.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.07 95.17 0.02 OUTLIER Glycine 0 C--N 1.349 1.276 0 O-C-N 123.602 0.564 . . . . 0.0 113.517 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -158.11 -169.4 21.65 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -109.66 135.14 51.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.434 0.617 . . . . 0.0 109.728 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.7 mm -78.43 122.39 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -144.14 96.5 2.89 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -67.42 -17.12 64.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.578 0.751 . . . . 0.0 111.758 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.0 t -60.04 -26.66 66.31 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.12 -22.12 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.21 0.529 . . . . 0.0 110.252 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.439 HD21 HG12 ' A' ' 35' ' ' VAL . 56.2 mt -103.02 17.43 24.09 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.455 1.102 . . . . 0.0 111.953 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -113.44 -1.97 14.04 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 120.176 1.353 . . . . 0.0 112.942 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.25 0.3 OUTLIER 76.97 139.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 124.812 1.245 . . . . 0.0 113.313 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -154.24 -173.38 4.55 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.851 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.12 -34.12 70.75 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -64.05 -47.09 81.52 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.624 0.37 . . . . 0.0 111.733 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.558 ' NZ ' ' HA ' ' A' ' 33' ' ' ASP . 4.8 mptp? -62.16 -34.18 75.91 Favored 'General case' 0 C--O 1.209 -1.049 0 O-C-N 123.46 0.475 . . . . 0.0 109.826 173.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.24 -51.9 65.89 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.66 0.6 . . . . 0.0 111.148 -172.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -70.45 -39.12 74.52 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -72.78 -33.06 66.05 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 122.108 -0.37 . . . . 0.0 110.833 177.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.456 HG21 ' HD2' ' A' ' 126' ' ' PHE . 6.3 mt -61.09 -38.65 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.656 0.782 . . . . 0.0 110.805 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 7.8 ptp180 -73.9 -23.86 59.62 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.025 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.545 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 13.0 tp10 -64.11 -58.53 6.37 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 170.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -35.9 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 118.68 0.673 . . . . 0.0 112.777 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.456 ' HD2' HG21 ' A' ' 122' ' ' ILE . 22.9 m-85 -87.99 -30.89 19.67 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 119.126 -0.464 . . . . 0.0 111.77 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.545 ' HE3' ' HA ' ' A' ' 124' ' ' GLU . 21.4 mmtp 59.05 76.09 0.37 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.046 0.938 . . . . 0.0 111.744 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.506 HG12 ' HD3' ' A' ' 141' ' ' LYS . 25.6 mt . . . . . 0 C--O 1.242 0.673 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.77 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 44.9 t30 . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 120.685 0.279 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.07 -26.25 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.527 1.131 . . . . 0.0 112.288 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.04 -46.67 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.484 0.659 . . . . 0.0 109.745 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.72 -40.61 88.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.855 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -67.95 -38.27 82.62 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.595 0.559 . . . . 0.0 112.344 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.432 ' HA ' HD11 ' A' ' 128' ' ' ILE . 14.4 p -70.15 -42.79 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' A' ' 40' ' ' HIS . 9.6 mp -62.09 -42.99 99.78 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 122.77 0.428 . . . . 0.0 111.692 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -57.1 -44.5 83.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.528 0.331 . . . . 0.0 111.626 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.506 ' HD3' HG12 ' A' ' 128' ' ' ILE . 8.4 ttpt -71.97 -46.87 55.8 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.185 0.303 . . . . 0.0 111.202 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.0 pt -75.84 -33.72 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.401 -171.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.534 ' HB2' ' HE2' ' A' ' 43' ' ' HIS . . . . . . . . 0 C--O 1.246 0.876 0 C-N-CA 123.585 0.754 . . . . 0.0 112.823 -173.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.496 ' HG2' HG21 ' A' ' 45' ' ' ILE . 1.5 mpt? . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.3 mt -106.08 103.43 15.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.4 mm -107.71 122.99 62.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.69 144.86 51.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.751 0.705 . . . . 0.0 110.627 -173.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' N ' HD12 ' A' ' 112' ' ' LEU . . . -104.85 127.47 9.07 Favored Glycine 0 CA--C 1.502 -0.78 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 tt -141.64 145.71 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.072 0.549 . . . . 0.0 110.679 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -123.22 130.78 53.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.581 1.152 . . . . 0.0 109.616 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.15 7.73 69.7 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.839 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.12 94.76 1.16 Allowed 'General case' 0 C--N 1.349 0.547 0 C-N-CA 123.938 0.895 . . . . 0.0 111.131 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' A' ' 83' ' ' ASP . 51.0 mtt180 -73.07 103.44 3.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.123 0.569 . . . . 0.0 109.803 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.99 108.93 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.701 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.417 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -114.08 165.56 12.51 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.597 0.759 . . . . 0.0 110.604 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -71.49 -16.4 62.35 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.89 -36.74 84.24 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 118.251 0.478 . . . . 0.0 111.671 -173.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.454 ' HA ' HD13 ' A' ' 102' ' ' LEU . 18.1 pt -50.47 -20.83 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -93.14 -26.55 17.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.422 0.689 . . . . 0.0 111.233 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -72.72 -16.92 61.66 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.641 0.776 . . . . 0.0 112.149 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.486 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -80.89 -10.21 59.74 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.883 0.473 . . . . 0.0 111.817 179.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.46 21.31 26.91 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 116.37 1.308 . . . . 0.0 116.37 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.486 ' HB2' HD13 ' A' ' 23' ' ' LEU . 92.4 mt -87.34 176.52 7.49 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.244 0.618 . . . . 0.0 111.468 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB3' ' HZ2' ' A' ' 59' ' ' TRP . 2.9 mptp? -85.69 98.33 10.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.859 0.864 . . . . 0.0 109.758 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -146.97 160.58 42.18 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.114 0.566 . . . . 0.0 110.331 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -144.39 149.71 36.55 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 161.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.1 mt -131.29 127.22 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 pp -125.64 173.22 9.14 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.197 0.599 . . . . 0.0 109.979 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 33' ' ' ASP . 61.3 t30 -77.03 138.8 39.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.353 0.661 . . . . 0.0 110.738 -171.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.579 ' HA ' ' SG ' ' A' ' 87' ' ' CYS . . . -80.37 0.1 34.57 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.533 ' HB3' HD21 ' A' ' 121' ' ' LEU . 21.4 m-20 -82.75 -23.1 34.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.257 0.623 . . . . 0.0 111.128 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.608 HG23 ' HB ' ' A' ' 79' ' ' ILE . 32.5 m -113.97 -3.73 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.692 0.797 . . . . 0.0 111.718 -171.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -59.41 -32.71 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.734 0.814 . . . . 0.0 112.38 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 59.79 -84.61 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.447 1.099 . . . . 0.0 109.372 -170.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 40.9 p -139.14 174.41 10.54 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.92 0.888 . . . . 0.0 109.353 171.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.91 -45.23 50.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.05 165.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -51.5 -34.41 35.84 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.335 1.054 . . . . 0.0 112.592 -178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.547 ' HA ' HD11 ' A' ' 139' ' ' LEU . 11.2 t-80 -66.55 -54.53 22.73 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.696 0.623 . . . . 0.0 111.028 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -70.69 -47.78 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 122.696 0.399 . . . . 0.0 112.074 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.45 -30.39 69.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.191 0.596 . . . . 0.0 111.556 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.447 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 71.2 t60 -61.6 -46.74 88.57 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 169.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.462 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . . . -61.86 -44.99 95.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.959 0.504 . . . . 0.0 111.407 -176.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.505 HG23 ' HE3' ' A' ' 49' ' ' LYS . 36.0 mt -65.98 -49.77 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.322 1.049 . . . . 0.0 111.081 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -51.6 -47.42 63.61 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.291 1.036 . . . . 0.0 110.991 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 17.9 mm100 -66.77 -35.48 80.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.327 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.09 63.25 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 122.672 0.389 . . . . 0.0 111.545 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.505 ' HE3' HG23 ' A' ' 45' ' ' ILE . 98.4 mttt -86.31 -36.92 19.01 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.439 0.696 . . . . 0.0 112.06 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 47' ' ' GLN . 10.3 t -88.14 -37.28 16.31 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.909 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 47' ' ' GLN . 39.6 mtmt -85.53 157.54 20.39 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.683 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -102.64 103.31 31.57 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.18 177.43 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 124.154 3.236 . . . . 0.0 115.466 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.31 5.02 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.266 165.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.59 179.29 2.17 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.524 1.13 . . . . 0.0 111.749 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -62.33 -47.66 83.27 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.029 0.532 . . . . 0.0 110.326 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.4 m -157.85 -172.81 4.08 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.239 1.015 . . . . 0.0 110.185 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -62.01 -59.3 5.29 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.635 1.174 . . . . 0.0 112.919 -176.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.453 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 87.8 m95 -63.42 -28.71 70.16 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 120.753 0.311 . . . . 0.0 110.848 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.6 mmt -74.81 -21.22 59.42 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.687 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -75.84 -43.05 47.76 Favored 'General case' 0 C--O 1.209 -1.039 0 C-N-CA 122.398 0.279 . . . . 0.0 110.373 170.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.44 HD11 HG12 ' A' ' 45' ' ' ILE . 86.8 mt -56.47 -39.28 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.676 0.79 . . . . 0.0 112.173 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.06 -30.91 67.19 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.333 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -83.17 -29.05 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.337 -0.852 . . . . 0.0 110.922 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.462 ' HD2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.2 -45.75 62.71 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.548 1.139 . . . . 0.0 109.937 -172.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.22 -24.65 67.4 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.488 0.715 . . . . 0.0 112.031 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.2 p -100.18 23.67 9.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.241 0.616 . . . . 0.0 110.568 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.07 -88.54 1.54 Allowed Glycine 0 C--N 1.36 1.913 0 O-C-N 122.182 -0.324 . . . . 0.0 113.442 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.15 121.35 1.02 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -173.25 163.59 4.62 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 124.691 1.244 . . . . 0.0 109.053 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -57.39 149.69 20.06 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.136 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.32 -41.04 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.708 1.203 . . . . 0.0 111.845 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -57.21 -49.77 74.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.395 0.678 . . . . 0.0 111.096 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.501 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 49.9 mm-40 -57.0 -48.73 77.75 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.621 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.42 -36.81 83.53 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.666 0.786 . . . . 0.0 112.824 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.51 -37.55 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.041 0.536 . . . . 0.0 110.891 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 74' ' ' GLU . 53.2 mtmt -67.72 -48.65 65.91 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.798 0.333 . . . . 0.0 110.205 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.485 HG22 ' HB ' ' A' ' 125' ' ' ILE . 78.0 mt -74.21 -65.18 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.649 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.608 ' HB ' HG23 ' A' ' 34' ' ' VAL . 7.7 pt -109.41 14.3 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.61 168.55 46.07 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 119.433 1.015 . . . . 0.0 112.423 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.98 121.74 26.41 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.832 0.453 . . . . 0.0 111.323 -175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -116.95 162.36 17.89 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 165.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 15' ' ' ARG . 7.5 p-10 -65.35 153.91 39.83 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.293 0.637 . . . . 0.0 112.158 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.57 -119.46 5.81 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.358 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.454 HD21 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -87.45 104.6 16.61 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.8 p -136.92 168.74 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.562 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 32' ' ' ALA . 88.3 m -122.45 123.64 41.77 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.389 1.075 . . . . 0.0 110.238 -175.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.428 HD21 ' HB ' ' A' ' 99' ' ' ILE . 11.4 tp -102.91 125.5 49.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.281 0.632 . . . . 0.0 109.625 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mt -108.3 132.74 55.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.632 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.7 t -155.37 154.72 32.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.157 0.503 . . . . 0.0 111.225 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -87.17 -40.44 14.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.923 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.55 137.94 51.99 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.11 0.964 . . . . 0.0 110.482 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.64 -35.93 81.34 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.74 -26.64 57.64 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.779 0.718 . . . . 0.0 110.348 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 96.9 m -67.88 -42.58 81.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.228 0.611 . . . . 0.0 111.167 165.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -56.97 -49.65 75.08 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.998 0.919 . . . . 0.0 110.817 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 76.7 ttt180 -65.27 -36.95 85.69 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 123.569 0.543 . . . . 0.0 110.441 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -56.2 -40.32 73.83 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.771 0.428 . . . . 0.0 111.674 176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.466 HD11 HD21 ' A' ' 23' ' ' LEU . 29.1 mm -69.47 -45.83 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -53.69 -40.3 65.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.561 1.145 . . . . 0.0 112.564 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 70.7 mm-40 -59.47 -47.23 86.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.27 0.628 . . . . 0.0 110.847 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 20' ' ' ILE . 57.5 mt -72.75 -38.39 67.38 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.3 pt -74.63 -37.74 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 118.366 0.53 . . . . 0.0 110.768 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.98 93.41 0.03 OUTLIER Glycine 0 C--N 1.351 1.402 0 O-C-N 123.623 0.577 . . . . 0.0 114.312 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.27 -167.65 22.02 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -113.33 140.65 47.85 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.79 123.24 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.18 95.35 4.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.15 -42.03 85.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.898 0.479 . . . . 0.0 111.463 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.0 p -54.21 -29.91 48.01 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.6 p -67.32 -24.03 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 CA-C-N 118.565 0.621 . . . . 0.0 110.941 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 37' ' ' THR . 81.2 mt -86.28 -19.41 29.93 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.748 0.819 . . . . 0.0 112.009 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -93.37 -1.83 55.42 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 118.462 -0.78 . . . . 0.0 113.038 -165.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.26 0.5 OUTLIER 78.83 133.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 124.557 1.143 . . . . 0.0 112.89 -178.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 117' ' ' ASP . 4.4 p-10 -146.79 168.33 21.66 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.506 167.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.5 -34.13 76.26 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.906 0.482 . . . . 0.0 111.829 -169.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.42 ' HB2' ' ND2' ' A' ' 115' ' ' ASN . 14.2 m-20 -59.7 -48.95 79.65 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.928 0.491 . . . . 0.0 111.469 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -67.29 -27.25 67.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.448 0.468 . . . . 0.0 110.741 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.457 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 30.3 tt0 -72.62 -44.98 61.24 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.017 0.527 . . . . 0.0 110.998 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -73.69 -40.53 63.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.655 0.782 . . . . 0.0 109.993 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 33' ' ' ASP . 62.5 tp -53.78 -53.77 47.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.262 1.425 . . . . 0.0 112.317 170.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.1 mt -53.25 -30.64 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.621 1.169 . . . . 0.0 111.755 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.0 ttp85 -72.24 -33.62 67.67 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.045 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.72 -56.09 13.89 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 173.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.485 ' HB ' HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -74.24 -36.24 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -90.38 -33.39 16.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 119.447 -0.311 . . . . 0.0 111.706 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.621 ' HB3' ' HZ2' ' A' ' 127' ' ' LYS . 3.0 mmmp? 63.78 72.38 0.47 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.043 0.937 . . . . 0.0 111.765 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.548 HG22 ' HB3' ' A' ' 137' ' ' ARG . 9.2 mt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.2 t30 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.457 ' HB ' ' HG3' ' A' ' 119' ' ' GLU . 7.2 p -54.59 -34.19 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.369 1.068 . . . . 0.0 113.652 -176.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.4 t -71.41 -45.74 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.349 0.595 . . . . 0.0 109.759 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 40.3 mt-10 -68.52 -34.33 75.68 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.182 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.548 ' HB3' HG22 ' A' ' 128' ' ' ILE . 52.7 mtm180 -72.22 -39.05 68.8 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.863 0.865 . . . . 0.0 112.073 -176.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.04 -33.94 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.547 HD11 ' HA ' ' A' ' 40' ' ' HIS . 4.6 mp -62.98 -39.57 95.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.218 0.607 . . . . 0.0 111.148 173.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 35.0 mm-40 -59.66 -47.29 86.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 117.775 0.261 . . . . 0.0 111.009 173.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -63.87 -48.4 76.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.112 0.565 . . . . 0.0 111.973 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.6 pt -76.68 -25.33 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.746 0 C-N-CA 122.235 0.214 . . . . 0.0 110.54 173.293 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.539 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 76.2 mt -85.96 104.78 13.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.5 mm -101.19 120.82 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -127.27 146.92 50.26 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.19 140.42 14.86 Favored Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.478 HG21 HG13 ' A' ' 86' ' ' VAL . 10.1 tt -143.01 124.9 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.777 0.799 . . . . 0.0 111.081 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -90.11 133.2 35.01 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.196 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.45 8.76 80.32 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.832 174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.04 100.76 0.23 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.033 0.933 . . . . 0.0 111.085 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -74.0 103.23 4.41 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.491 HD13 HG11 ' A' ' 86' ' ' VAL . 50.3 mm -74.05 114.91 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.354 0.597 . . . . 0.0 110.207 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.448 ' ND2' HG21 ' A' ' 20' ' ' ILE . 2.5 p-10 -103.92 134.63 46.89 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -74.08 -1.7 21.28 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.793 0.437 . . . . 0.0 111.779 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -75.68 -20.32 58.51 Favored 'General case' 0 C--O 1.217 -0.606 0 C-N-CA 124.414 1.086 . . . . 0.0 111.027 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.448 HG21 ' ND2' ' A' ' 17' ' ' ASN . 9.4 pt -49.77 -22.36 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -83.52 -0.1 48.81 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -71.4 -28.04 63.74 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.123 0.569 . . . . 0.0 112.005 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.65 -6.69 57.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.679 0.791 . . . . 0.0 111.512 -176.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.46 14.89 9.86 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.556 ' HB2' HD13 ' A' ' 23' ' ' LEU . 95.8 mt -74.73 157.77 34.69 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.159 0.584 . . . . 0.0 110.461 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -82.67 102.51 11.54 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.273 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -149.49 160.31 43.57 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.77 1.228 . . . . 0.0 108.823 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.485 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -142.22 150.43 40.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 173.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.7 mt -134.4 125.1 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.48 HD23 HG22 ' A' ' 41' ' ' VAL . 4.2 pp -118.97 172.47 7.53 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 47.6 t30 -87.93 131.34 34.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.52 1.128 . . . . 0.0 111.133 -167.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . . . -83.6 -3.84 58.04 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.671 ' HB3' HD21 ' A' ' 121' ' ' LEU . 76.9 m-20 -63.74 -44.82 92.38 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.358 0.599 . . . . 0.0 109.817 171.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.06 -1.95 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.871 -166.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 32' ' ' ALA . 9.9 p -85.71 129.87 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.78 -68.13 0.57 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 113' ' ' GLU . 30.8 p -128.85 166.59 18.77 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.465 1.106 . . . . 0.0 108.431 169.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -22.26 34.17 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.59 0.356 . . . . 0.0 111.493 169.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.13 -30.31 66.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.266 1.026 . . . . 0.0 112.081 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.535 ' HA ' HD12 ' A' ' 139' ' ' LEU . 12.2 t-80 -61.23 -44.82 96.65 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.806 0.842 . . . . 0.0 110.377 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG22 HD23 ' A' ' 30' ' ' LEU . 40.4 t -65.76 -54.13 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.708 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 45' ' ' ILE . 3.2 pp -63.55 -32.12 73.49 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -61.03 -37.48 82.73 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.196 0.999 . . . . 0.0 110.886 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.79 -35.36 67.38 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.079 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 42' ' ' LEU . 53.4 mt -63.56 -47.07 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.461 0.704 . . . . 0.0 110.914 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -57.83 -37.26 73.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.776 0.831 . . . . 0.0 111.01 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.455 ' HA ' HG23 ' A' ' 50' ' ' THR . 79.7 mm-40 -67.56 -40.12 84.92 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.499 174.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.31 -27.6 68.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.979 0.512 . . . . 0.0 111.629 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -79.13 -34.3 43.48 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.978 0.511 . . . . 0.0 111.591 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 47' ' ' GLN . 11.8 t -87.48 -28.23 22.18 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.436 0.294 . . . . 0.0 110.894 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -98.8 135.26 40.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.671 0.788 . . . . 0.0 111.547 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HZ3' ' HB2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -76.13 105.5 2.28 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 162.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.402 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 41.1 Cg_endo -64.73 166.2 18.68 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.795 2.33 . . . . 0.0 114.801 -161.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 mm -108.7 -5.15 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 173.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.01 -179.5 6.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.048 1.339 . . . . 0.0 111.472 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HB2' ' HG2' ' A' ' 60' ' ' MET . 75.6 mmtt -73.22 -25.02 60.58 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.513 0.725 . . . . 0.0 112.262 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.68 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 29.0 t -165.28 -178.69 5.16 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.479 0.711 . . . . 0.0 110.327 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -57.48 -54.57 45.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.687 1.195 . . . . 0.0 111.42 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.485 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 86.5 m95 -62.14 -32.48 73.09 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.828 0.851 . . . . 0.0 111.58 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.68 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.1 mpt? -72.99 -26.47 61.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.876 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.582 ' HA ' HG22 ' A' ' 64' ' ' VAL . 19.8 tp10 -74.67 -31.59 61.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.282 0.233 . . . . 0.0 110.587 175.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.488 HD11 HG12 ' A' ' 45' ' ' ILE . 66.8 mt -61.52 -47.63 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.017 0.527 . . . . 0.0 110.183 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' O ' HD13 ' A' ' 79' ' ' ILE . 4.1 pp -71.9 -34.33 69.03 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.699 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.582 HG22 ' HA ' ' A' ' 61' ' ' GLU . 23.5 m -76.98 -34.05 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 118.783 0.72 . . . . 0.0 111.558 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.424 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 5.3 tpp180 -68.95 -46.48 68.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.757 0.423 . . . . 0.0 111.11 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.7 -18.95 64.35 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 123.458 0.474 . . . . 0.0 112.157 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.8 p -90.03 18.88 5.35 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.431 0.692 . . . . 0.0 112.501 175.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 142' ' ' ILE . . . 95.29 26.22 12.66 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.385 -0.675 . . . . 0.0 113.193 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 57.78 97.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.837 1.255 . . . . 0.0 109.869 -174.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -137.84 -158.11 0.83 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.725 0.81 . . . . 0.0 110.862 -168.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -120.66 164.61 16.26 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.653 1.181 . . . . 0.0 108.985 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.435 HG13 ' HG2' ' A' ' 56' ' ' LYS . 51.4 mm -47.41 -47.6 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 125.659 1.583 . . . . 0.0 112.99 -171.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 m170 -56.74 -53.37 58.52 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.856 0.863 . . . . 0.0 111.572 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.38 -58.06 10.1 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 123.519 0.512 . . . . 0.0 110.75 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.61 -54.99 34.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.428 1.091 . . . . 0.0 113.844 -170.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.3 mt -63.68 -31.24 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.49 0.716 . . . . 0.0 112.117 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.69 -39.62 19.94 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.1 mt -76.73 -66.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.83 0.452 . . . . 0.0 110.626 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 63' ' ' LEU . 9.0 pt -104.8 8.76 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.519 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 31' ' ' ASN . . . -81.83 173.95 53.8 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 119.364 0.984 . . . . 0.0 111.853 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.11 137.67 58.31 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.97 156.64 37.81 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -53.66 151.3 6.22 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.84 -115.51 5.18 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.123 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -85.5 108.55 17.97 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.491 HG11 HD13 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -135.1 171.25 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.337 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.408 ' SG ' HG12 ' A' ' 35' ' ' VAL . 61.0 m -131.64 121.46 24.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.841 1.256 . . . . 0.0 108.823 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.46 HD11 ' HB ' ' A' ' 99' ' ' ILE . 4.8 tt -99.47 128.77 45.6 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -174.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 28' ' ' GLN . 22.0 mt -113.75 114.28 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.735 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 20.8 p -138.26 156.88 47.25 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.836 0.454 . . . . 0.0 110.568 -176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.34 -51.98 15.52 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.866 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -128.75 158.39 38.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.121 0.968 . . . . 0.0 110.068 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.87 -16.15 62.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.885 0.874 . . . . 0.0 112.266 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.58 -46.59 37.73 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.0 m -61.56 -40.4 94.57 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 123.738 0.815 . . . . 0.0 110.505 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.735 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 19.4 t80 -56.74 -51.46 68.78 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 123.819 0.699 . . . . 0.0 110.84 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -61.39 -42.72 99.17 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.822 0.701 . . . . 0.0 111.005 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -57.58 -50.14 74.09 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.654 0.596 . . . . 0.0 110.899 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.46 ' HB ' HD11 ' A' ' 88' ' ' LEU . 45.8 mm -69.82 -45.45 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.835 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -54.01 -45.7 71.57 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.257 1.423 . . . . 0.0 113.2 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.95 -30.34 68.76 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 119.463 -0.303 . . . . 0.0 111.667 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.24 -46.03 71.62 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.932 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.1 pt -75.62 -41.01 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 118.103 0.41 . . . . 0.0 110.799 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.56 109.11 0.09 OUTLIER Glycine 0 C--N 1.345 1.072 0 O-C-N 123.347 0.405 . . . . 0.0 113.706 170.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.44 -171.88 44.63 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -105.25 147.46 28.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.238 0.615 . . . . 0.0 109.568 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.36 129.29 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.248 0.619 . . . . 0.0 109.561 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -132.77 100.84 5.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.289 1.036 . . . . 0.0 108.906 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -69.88 -33.18 71.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.896 0.478 . . . . 0.0 111.622 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 113' ' ' GLU . 18.4 m -50.6 -36.82 36.81 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 32' ' ' ALA . 16.2 m -66.64 -22.52 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.8 mt -100.75 17.83 20.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.808 0.843 . . . . 0.0 111.856 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.576 ' HA ' HG23 ' A' ' 37' ' ' THR . 7.4 pt-20 -134.79 8.06 3.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 78.71 131.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.202 1.001 . . . . 0.0 111.615 173.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.469 ' ND2' ' HB2' ' A' ' 117' ' ' ASP . 4.0 p-10 -156.87 174.44 15.5 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.219 1.407 . . . . 0.0 107.915 172.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -69.4 -32.23 71.09 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.469 ' HB2' ' ND2' ' A' ' 115' ' ' ASN . 2.2 m-20 -57.34 -50.68 72.19 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.541 0.736 . . . . 0.0 110.352 171.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -40.98 76.86 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.124 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HG3' HG22 ' A' ' 134' ' ' VAL . 42.5 tt0 -72.32 -49.19 36.31 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.404 0.682 . . . . 0.0 112.485 -162.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -70.16 -36.95 75.06 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.678 0.752 . . . . 0.0 110.741 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 33' ' ' ASP . 37.4 tp -59.64 -47.8 84.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.778 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.5 mt -63.5 -38.04 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.289 1.035 . . . . 0.0 110.645 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.2 ptp180 -74.36 -26.51 60.17 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 118.983 -0.532 . . . . 0.0 110.086 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -71.47 -57.49 4.38 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -31.27 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 119.014 0.825 . . . . 0.0 112.487 -172.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -92.5 -33.59 14.42 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 119.593 -0.241 . . . . 0.0 111.553 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 12.4 mmmm 66.13 82.53 0.18 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.971 0.908 . . . . 0.0 112.419 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.517 HG21 ' HB3' ' A' ' 137' ' ' ARG . 36.9 mt . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 54.0 t30 . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 120.847 0.356 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' A' ' 119' ' ' GLU . 84.2 t -64.19 -29.4 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.152 1.381 . . . . 0.0 112.324 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.8 -49.75 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.213 0.605 . . . . 0.0 110.469 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.99 -32.1 73.66 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.097 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.517 ' HB3' HG21 ' A' ' 128' ' ' ILE . 8.5 mmm180 -76.01 -35.48 59.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.115 0.566 . . . . 0.0 112.205 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.51 -41.33 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.823 -0.548 . . . . 0.0 110.973 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 40' ' ' HIS . 5.5 mp -57.12 -40.16 76.54 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.508 1.123 . . . . 0.0 112.786 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.37 -35.52 68.5 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.024 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -64.96 -46.08 83.05 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.426 0.69 . . . . 0.0 111.281 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.5 pt -72.48 -8.48 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.403 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.561 0 C-N-CA 124.386 1.074 . . . . 0.0 111.267 171.497 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.506 ' SD ' ' HB2' ' A' ' 42' ' ' LEU . 2.0 mpt? . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -103.55 104.94 17.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mm -111.83 120.31 61.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.421 HH21 HG21 ' A' ' 107' ' ' ILE . 28.0 mmm180 -133.18 145.33 50.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.876 0.471 . . . . 0.0 109.869 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.586 ' H ' HD12 ' A' ' 112' ' ' LEU . . . -107.14 118.04 5.46 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.3 tt -124.28 124.97 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.566 0.746 . . . . 0.0 111.165 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -85.11 137.74 32.85 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.156 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.29 79.51 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.211 172.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.25 109.98 4.98 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.833 0.853 . . . . 0.0 111.815 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -76.76 103.15 6.57 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.442 HD11 HG13 ' A' ' 86' ' ' VAL . 50.9 mm -70.69 93.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.511 ' ND2' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -102.01 153.59 19.75 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.625 -177.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -68.53 -13.26 62.21 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.39 -36.75 79.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.656 0.782 . . . . 0.0 112.013 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.511 HG22 ' ND2' ' A' ' 17' ' ' ASN . 6.9 pt -56.72 -22.62 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -87.25 -16.78 34.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 118.231 0.469 . . . . 0.0 111.368 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -75.31 -19.52 59.61 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.381 0.673 . . . . 0.0 112.093 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -82.65 -9.76 59.23 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.944 0.498 . . . . 0.0 111.765 -177.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.73 8.39 2.85 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.5 ' HB2' HD13 ' A' ' 23' ' ' LEU . 86.2 mt -68.57 168.69 12.44 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.977 0.888 . . . . 0.0 112.131 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -77.78 92.21 4.18 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.09 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -148.81 162.3 40.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.984 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.624 ' HB3' HD11 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -146.1 159.82 42.76 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 164.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.4 HG12 HD13 ' A' ' 88' ' ' LEU . 11.8 mt -134.08 129.68 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 121.704 -0.623 . . . . 0.0 109.39 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.419 HD22 HD12 ' A' ' 89' ' ' ILE . 2.7 pt? -119.84 179.7 4.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.072 0.949 . . . . 0.0 108.456 172.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.406 ' HB3' HG22 ' A' ' 34' ' ' VAL . 51.0 t-20 -74.51 143.16 44.68 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 87' ' ' CYS . . . -68.87 -49.67 56.28 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.038 0.447 . . . . 0.0 110.585 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' HB3' HD23 ' A' ' 121' ' ' LEU . 40.9 m-20 -52.38 -16.66 0.92 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.426 HG23 ' HB ' ' A' ' 79' ' ' ILE . 24.9 m -110.82 2.09 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.585 0.754 . . . . 0.0 111.906 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.13 -30.74 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.201 0.6 . . . . 0.0 111.95 -171.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 114' ' ' ILE . . . 58.29 -84.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.34 1.056 . . . . 0.0 109.35 -166.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 16.8 p -127.07 161.69 27.83 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.939 0.896 . . . . 0.0 111.081 172.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -53.56 -40.68 65.79 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.379 163.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.496 ' HD2' HD11 ' A' ' 42' ' ' LEU . 50.8 tptt -56.19 -35.76 67.61 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 124.994 1.318 . . . . 0.0 111.554 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -63.02 -52.6 62.27 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.889 0.743 . . . . 0.0 111.28 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 45' ' ' ILE . 40.4 t -72.66 -42.49 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 119.427 -0.321 . . . . 0.0 111.85 -175.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HB2' ' SD ' ' A' ' 6' ' ' MET . 4.1 pp -64.6 -29.52 70.53 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.015 0.371 . . . . 0.0 111.209 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -62.6 -40.22 96.23 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.019 0.928 . . . . 0.0 110.546 169.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.27 82.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.571 0.748 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.476 ' HA ' HG12 ' A' ' 62' ' ' ILE . 41.7 mt -65.49 -45.8 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.099 0.96 . . . . 0.0 110.709 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -51.69 -48.77 63.37 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.568 1.147 . . . . 0.0 110.366 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -64.6 -31.82 73.21 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.987 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.46 -21.78 48.54 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.914 0.485 . . . . 0.0 112.025 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HE3' HG21 ' A' ' 45' ' ' ILE . 96.7 mttt -82.0 -31.75 30.91 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.973 0.509 . . . . 0.0 111.622 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.463 HG22 ' HG2' ' A' ' 51' ' ' LYS . 9.7 t -100.31 -35.98 9.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HG2' HG22 ' A' ' 50' ' ' THR . 10.9 mmpt? -119.63 153.57 35.31 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.275 0.63 . . . . 0.0 111.877 -176.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.86 124.74 9.48 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.506 1.122 . . . . 0.0 109.766 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -90.57 -115.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 123.85 3.034 . . . . 0.0 110.468 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 mm -123.63 35.26 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.516 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . . . -85.83 156.54 20.52 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.878 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' HG2' HG13 ' A' ' 72' ' ' ILE . 74.3 mmtt -62.23 -53.83 49.56 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.207 0.603 . . . . 0.0 111.945 -171.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.531 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 10.6 t -156.33 -176.94 6.23 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.039 0.536 . . . . 0.0 109.678 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -58.55 -60.33 3.97 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.407 1.083 . . . . 0.0 113.244 -173.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.511 ' CE3' ' HB2' ' A' ' 28' ' ' GLN . 92.1 m95 -66.16 -23.5 66.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.747 0.419 . . . . 0.0 112.044 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.531 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.5 mpt? -77.19 -26.09 52.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.864 0.866 . . . . 0.0 110.599 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.516 ' HG2' ' HB3' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -74.92 -41.26 60.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.967 0.907 . . . . 0.0 109.389 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 45' ' ' ILE . 81.8 mt -61.54 -39.46 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.726 0.811 . . . . 0.0 112.455 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 pp -72.65 -33.47 66.62 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.007 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 ' NH1' ' A' ' 70' ' ' ARG . 25.0 m -77.07 -27.0 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.973 -0.454 . . . . 0.0 111.949 174.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 35.4 mmt180 -64.56 -62.76 1.39 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.205 0.602 . . . . 0.0 110.442 172.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.79 -27.72 68.23 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.608 0.763 . . . . 0.0 112.695 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 p -79.57 -59.07 2.89 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.37 6.6 29.16 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.722 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -78.83 -25.13 44.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.498 1.119 . . . . 0.0 111.763 -172.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.412 ' NH1' HG22 ' A' ' 64' ' ' VAL . 1.1 mpt_? 66.58 -10.61 0.27 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -173.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -99.45 118.5 36.2 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.94 0.896 . . . . 0.0 109.125 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.546 HG13 ' HG2' ' A' ' 56' ' ' LYS . 24.8 mm -53.45 -59.73 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.264 1.025 . . . . 0.0 112.353 -172.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -61.76 -45.14 95.17 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.152 0.907 . . . . 0.0 110.589 -172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -58.02 -47.86 81.79 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.858 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.92 80.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.52 0.728 . . . . 0.0 112.397 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.9 mt -68.08 -33.79 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.185 0.594 . . . . 0.0 111.035 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -68.71 -49.33 59.76 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.804 0.335 . . . . 0.0 110.698 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.547 HG21 ' HB ' ' A' ' 125' ' ' ILE . 74.2 mt -64.8 -64.22 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 124.004 0.922 . . . . 0.0 111.15 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.426 ' HB ' HG23 ' A' ' 34' ' ' VAL . 24.0 pt -110.4 15.36 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -172.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.58 173.29 44.16 Favored Glycine 0 N--CA 1.479 1.52 0 CA-C-N 120.389 1.449 . . . . 0.0 113.21 -174.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.44 146.59 32.68 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.189 0.595 . . . . 0.0 111.39 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -153.18 155.53 36.84 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.417 1.087 . . . . 0.0 108.104 171.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.25 151.98 44.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.927 0.491 . . . . 0.0 111.433 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.79 -120.78 7.01 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.205 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -79.61 105.89 11.24 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -135.74 164.53 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.647 -177.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 43.7 t -125.55 121.25 33.12 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.371 1.068 . . . . 0.0 108.959 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.4 HD13 HG12 ' A' ' 29' ' ' ILE . 10.0 tp -102.35 125.75 49.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.853 0.861 . . . . 0.0 109.865 -171.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 28' ' ' GLN . 68.4 mt -99.79 128.52 51.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 113.698 -1.592 . . . . 0.0 107.521 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 35.1 t -150.32 149.19 29.78 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 111.589 177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -86.02 -41.67 14.63 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.59 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -119.78 146.69 45.44 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.195 0.598 . . . . 0.0 110.994 -174.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -54.79 -38.31 67.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.71 0.804 . . . . 0.0 112.613 172.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -69.75 -46.51 65.7 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.515 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 28.7 m -61.21 -35.21 76.57 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.005 0.922 . . . . 0.0 110.948 178.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -63.83 -46.76 83.62 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.404 0.682 . . . . 0.0 110.152 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.58 -34.71 78.41 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.759 0.662 . . . . 0.0 110.574 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.79 -45.9 80.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.464 0.706 . . . . 0.0 111.638 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.456 HD11 HD22 ' A' ' 23' ' ' LEU . 40.2 mm -71.39 -46.72 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 122.43 -0.169 . . . . 0.0 110.766 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -54.76 -33.81 61.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.161 1.384 . . . . 0.0 112.086 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.8 -50.46 70.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.864 0.866 . . . . 0.0 111.769 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.67 -25.84 49.84 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.7 pt -80.24 -50.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 118.584 0.629 . . . . 0.0 109.575 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.92 124.43 0.05 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 123.443 0.464 . . . . 0.0 113.796 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.43 -153.15 20.59 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 117.028 0.414 . . . . 0.0 112.159 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -123.91 143.79 50.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.938 0.895 . . . . 0.0 109.164 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.421 HG21 HH21 ' A' ' 9' ' ' ARG . 49.3 mm -86.89 136.73 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -135.66 108.97 7.8 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.15 -25.22 66.86 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.541 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.2 m -46.54 -39.68 11.36 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' A' ' 32' ' ' ALA . 12.6 p -71.29 -41.62 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-O 120.846 0.355 . . . . 0.0 110.399 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 37' ' ' THR . 86.3 mt -67.78 -31.17 70.88 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.551 1.141 . . . . 0.0 112.623 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.3 1.54 54.48 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 118.15 -0.929 . . . . 0.0 112.924 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 36' ' ' ALA 0.253 1.5 mm 73.07 127.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.29 0 CA-C-N 119.296 0.953 . . . . 0.0 113.094 177.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.411 HD22 ' HD3' ' A' ' 118' ' ' LYS . 6.3 p30 -147.89 -176.68 5.36 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.024 1.329 . . . . 0.0 108.584 173.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -57.42 -49.61 75.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.493 0.717 . . . . 0.0 112.142 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.8 -51.39 69.93 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.53 1.132 . . . . 0.0 112.466 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.411 ' HD3' HD22 ' A' ' 115' ' ' ASN . 4.3 mptp? -70.6 -37.23 73.86 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.849 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -71.38 -39.22 71.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.976 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -72.2 -42.89 65.29 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.866 0.466 . . . . 0.0 112.046 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 33' ' ' ASP . 0.7 OUTLIER -66.14 -34.1 77.28 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.464 HG21 ' HD2' ' A' ' 126' ' ' PHE . 13.5 mt -58.33 -30.02 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.948 0.899 . . . . 0.0 110.782 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -69.44 -36.79 76.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 118.839 -0.6 . . . . 0.0 109.534 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.13 -55.71 30.5 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.547 ' HB ' HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -75.57 -45.07 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 118.863 0.756 . . . . 0.0 112.693 -178.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.567 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 21.7 m-30 -81.87 -33.1 30.75 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HB3' ' HZ2' ' A' ' 127' ' ' LYS . 3.7 mmmp? 63.6 76.32 0.36 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.151 0.98 . . . . 0.0 112.318 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 137' ' ' ARG . 2.5 mt . . . . . 0 C--O 1.245 0.822 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.657 0.265 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.45 -16.53 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.083 0.553 . . . . 0.0 112.445 -171.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.457 ' O ' HD12 ' A' ' 139' ' ' LEU . 86.6 t -68.63 -49.29 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -174.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -52.75 -45.54 67.07 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.495 174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.63 ' HB3' HG23 ' A' ' 128' ' ' ILE . 37.4 mmt180 -73.55 -38.85 65.09 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 113.693 -1.594 . . . . 0.0 112.346 -168.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.55 -41.15 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 123.181 0.301 . . . . 0.0 110.485 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 135' ' ' VAL . 9.9 mp -55.74 -44.16 77.32 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.741 0.816 . . . . 0.0 110.509 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -74.33 -37.94 63.41 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 123.887 0.742 . . . . 0.0 111.929 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.629 ' HD3' HG12 ' A' ' 128' ' ' ILE . 16.5 ttpp -66.25 -40.01 89.91 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.086 0.47 . . . . 0.0 111.537 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 22.2 pt -73.29 -18.92 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.017 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.875 0 C-N-CA 124.3 1.04 . . . . 0.0 110.801 174.045 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 121.523 0.678 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 72.5 mt -98.75 103.81 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 108.359 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.57 122.28 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.7 mmt-85 -127.84 150.9 49.64 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.79 0.836 . . . . 0.0 109.723 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.31 126.26 8.67 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 tt -132.63 132.68 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.416 0.627 . . . . 0.0 110.452 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -107.83 133.68 51.86 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.27 1.028 . . . . 0.0 109.955 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.79 -6.27 79.62 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.534 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.57 112.77 2.12 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.112 0.965 . . . . 0.0 112.826 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -73.28 108.52 6.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.469 0.708 . . . . 0.0 110.288 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 86' ' ' VAL . 49.4 mm -70.76 94.17 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.272 1.034 . . . . 0.0 109.837 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.45 150.38 20.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.002 177.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -82.26 -4.57 57.39 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.974 0.51 . . . . 0.0 111.23 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -65.94 -40.09 91.07 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.076 0.95 . . . . 0.0 111.154 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.8 pt -70.62 -7.87 9.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.767 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -93.46 -34.32 13.46 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.226 0.921 . . . . 0.0 110.998 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -86.28 0.67 53.31 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.74 -3.94 55.04 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.365 0.666 . . . . 0.0 112.213 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.96 -11.8 2.43 Favored Glycine 0 CA--C 1.54 1.595 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 95' ' ' THR . 85.2 mt -64.42 159.8 20.54 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.273 1.037 . . . . 0.0 112.217 -176.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -86.58 100.71 12.61 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.884 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -149.03 162.55 39.71 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.496 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.43 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 24.7 tt0 -139.02 145.55 39.76 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 166.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.0 mt -130.02 126.45 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 pp -122.39 174.28 7.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.068 0.947 . . . . 0.0 108.688 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -82.07 135.41 35.33 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.93 3.41 42.06 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.412 ' HA ' ' HZ2' ' A' ' 118' ' ' LYS . 4.4 m-20 -84.28 -34.66 23.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.271 0.629 . . . . 0.0 110.195 174.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.511 HG23 HG21 ' A' ' 79' ' ' ILE . 14.8 p -93.88 -4.47 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 123.934 0.894 . . . . 0.0 111.229 -172.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.549 HG13 ' SG ' ' A' ' 87' ' ' CYS . 8.6 p -96.41 134.42 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.59 -64.09 1.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.1 p -135.24 168.89 18.34 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.465 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HB3' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -56.6 -23.96 44.39 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 168.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.655 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 39.1 ttmt -63.02 -28.68 70.26 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 122.717 0.407 . . . . 0.0 111.947 174.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.488 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.8 t-80 -59.3 -44.82 92.5 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.853 0.461 . . . . 0.0 110.021 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.04 -52.14 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.742 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.655 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 3.8 pp -65.57 -36.42 83.71 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.764 0.256 . . . . 0.0 111.648 -171.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.45 ' CG ' ' HG ' ' A' ' 139' ' ' LEU . 57.5 t60 -57.68 -41.31 81.35 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.181 0.592 . . . . 0.0 110.71 169.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.29 -34.42 77.35 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.647 0.592 . . . . 0.0 111.13 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 42' ' ' LEU . 62.9 mt -65.78 -46.08 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.925 0.89 . . . . 0.0 110.641 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -59.39 -46.93 87.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.424 0.69 . . . . 0.0 110.247 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.423 ' HB3' ' HE ' ' A' ' 65' ' ' ARG . 29.7 mm-40 -61.68 -36.14 80.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.448 1.099 . . . . 0.0 111.166 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.15 95.92 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.565 0.746 . . . . 0.0 111.859 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -76.96 -20.35 56.22 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.538 HG22 ' HG2' ' A' ' 51' ' ' LYS . 5.1 t -105.25 -38.8 6.4 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.757 0.423 . . . . 0.0 110.757 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 50' ' ' THR . 45.2 mmtm -114.52 136.2 53.29 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.591 0.756 . . . . 0.0 110.602 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.515 ' HD3' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -109.56 116.53 54.35 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.856 -178.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.19 -142.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.126 2.551 . . . . 0.0 110.593 168.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.55 41.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 72' ' ' ILE . . . -77.68 150.94 34.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.534 -174.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -84.96 -23.14 28.89 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.85 0.86 . . . . 0.0 111.15 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -161.07 173.83 14.61 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.054 0.941 . . . . 0.0 109.399 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -66.89 -44.32 81.17 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.693 0.797 . . . . 0.0 111.177 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.43 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 94.0 m95 -76.39 -18.9 58.63 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.409 0.283 . . . . 0.0 111.589 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.5 mmt -79.15 -25.45 42.88 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.002 0.521 . . . . 0.0 110.779 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 29.8 tt0 -76.03 -37.59 58.2 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.177 0.991 . . . . 0.0 111.544 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.44 HD12 HG12 ' A' ' 45' ' ' ILE . 78.6 mt -68.25 -39.9 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.129 0.572 . . . . 0.0 111.33 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.06 -34.68 68.93 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 123.214 0.321 . . . . 0.0 111.466 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 m -74.34 -35.48 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 121.971 -0.456 . . . . 0.0 110.745 175.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 47' ' ' GLN . 16.7 tpt85 -68.42 -42.56 78.75 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.161 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.01 66.57 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.451 0.7 . . . . 0.0 111.573 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -82.93 -5.32 59.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.578 0.751 . . . . 0.0 111.947 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.9 -73.46 2.12 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -44.32 136.49 4.03 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.326 1.45 . . . . 0.0 112.365 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -96.59 5.86 49.89 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.941 0.896 . . . . 0.0 111.482 -165.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.48 126.21 43.94 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.707 1.203 . . . . 0.0 110.997 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 55' ' ' ALA . 1.7 mp -53.12 -59.15 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 124.957 1.303 . . . . 0.0 112.55 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.486 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 63.0 m80 -60.36 -46.79 88.68 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.781 0.676 . . . . 0.0 110.702 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -57.2 -51.83 67.77 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.415 1.072 . . . . 0.0 111.187 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.62 72.33 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.376 0.671 . . . . 0.0 112.681 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.55 -32.6 55.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 122.918 0.487 . . . . 0.0 111.217 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 73' ' ' HIS . 32.6 mmtp -70.14 -49.38 51.28 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 175.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 52.6 mt -68.82 -67.56 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.095 0.958 . . . . 0.0 111.881 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.511 HG21 HG23 ' A' ' 34' ' ' VAL . 6.9 pt -103.85 8.91 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.92 168.59 54.75 Favored Glycine 0 C--N 1.352 1.459 0 CA-C-N 119.457 1.026 . . . . 0.0 113.11 -171.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.86 144.82 48.93 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.54 0.736 . . . . 0.0 112.755 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -147.1 151.51 36.96 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -58.77 149.94 25.1 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 119.659 1.118 . . . . 0.0 112.062 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.78 -114.52 4.39 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.083 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -89.2 109.05 19.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.136 0.575 . . . . 0.0 110.223 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.454 HG23 HD11 ' A' ' 16' ' ' ILE . 4.2 m -137.44 175.11 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.749 0.82 . . . . 0.0 112.034 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.549 ' SG ' HG13 ' A' ' 35' ' ' VAL . 57.9 m -122.82 120.88 34.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.411 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.2 tp -104.1 120.19 40.56 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.765 0.793 . . . . 0.0 109.344 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 12.1 mt -119.12 129.48 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.074 -170.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.539 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 47.9 t -157.69 164.48 37.12 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -78.27 -53.11 7.67 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.357 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -119.86 149.84 41.43 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.193 0.597 . . . . 0.0 110.18 -173.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.14 -35.67 69.79 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.382 1.073 . . . . 0.0 113.143 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 12.8 pt-20 -73.67 -40.68 63.49 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.539 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 34.9 m -66.07 -36.24 82.68 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.137 0.575 . . . . 0.0 110.938 176.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.16 -47.36 83.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.308 0.643 . . . . 0.0 109.383 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -67.46 -34.97 78.26 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.927 -175.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 30.6 mmmt -63.52 -36.66 84.51 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.39 0.676 . . . . 0.0 111.698 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.1 mm -76.25 -44.68 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 N-CA-C 110.464 -0.198 . . . . 0.0 110.464 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.46 -45.02 76.94 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.962 1.305 . . . . 0.0 113.221 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.662 ' HG3' HD21 ' A' ' 102' ' ' LEU . 8.0 pt-20 -62.35 -35.75 80.08 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.475 0.484 . . . . 0.0 111.959 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.662 HD21 ' HG3' ' A' ' 101' ' ' GLU . 3.5 mm? -75.83 -39.15 57.28 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 119.102 -0.475 . . . . 0.0 112.012 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.3 pt -74.73 -42.94 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 118.604 0.638 . . . . 0.0 110.639 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.27 113.81 0.06 OUTLIER Glycine 0 C--N 1.35 1.308 0 O-C-N 123.545 0.528 . . . . 0.0 113.838 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.83 -162.74 29.31 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -116.92 134.98 54.08 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.56 0.744 . . . . 0.0 109.974 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.8 mm -75.43 123.67 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -143.03 95.94 2.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.099 1.36 . . . . 0.0 107.694 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.4 -18.55 63.77 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.8 0.44 . . . . 0.0 112.157 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.5 m -57.38 -25.34 59.35 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -70.71 -25.23 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 CA-C-O 120.893 0.378 . . . . 0.0 110.159 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 38' ' ' LYS . 38.6 mt -107.81 16.52 23.49 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.634 1.174 . . . . 0.0 112.051 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -103.69 -4.91 23.12 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 119.743 1.156 . . . . 0.0 112.428 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.482 HD12 HG13 ' A' ' 134' ' ' VAL 0.294 0.5 OUTLIER 93.57 123.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.803 2.041 . . . . 0.0 109.401 -176.43 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.555 ' HB2' ' HD3' ' A' ' 118' ' ' LYS . 3.7 m-80 -139.58 157.59 45.55 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 124.525 1.13 . . . . 0.0 108.328 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.72 -38.56 91.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.412 0.685 . . . . 0.0 110.733 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.79 -48.56 80.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.126 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 115' ' ' ASN . 4.2 mptp? -63.02 -42.18 99.74 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.83 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.436 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 29.1 tt0 -65.61 -44.17 87.38 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.757 -166.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -69.38 -39.02 78.25 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.54 -33.05 62.65 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 119.485 -0.293 . . . . 0.0 110.718 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.1 mt -59.14 -41.89 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.88 0.872 . . . . 0.0 110.538 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -74.53 -23.41 58.8 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.611 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -65.92 -57.65 7.37 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -78.36 -24.61 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 119.262 0.937 . . . . 0.0 112.977 -175.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -97.1 -32.42 11.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.15 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 57.88 79.11 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.062 0.945 . . . . 0.0 111.2 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.415 HD22 ' HB ' ' A' ' 135' ' ' VAL . 10.5 t30 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.482 HG13 HD12 ' A' ' 114' ' ' ILE . 3.8 p -69.73 -15.86 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.124 0.57 . . . . 0.0 112.453 -171.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.415 ' HB ' HD22 ' A' ' 133' ' ' ASN . 21.4 t -70.34 -53.13 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -56.57 -39.37 73.38 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.41 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -68.17 -42.21 80.34 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.451 -173.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.9 p -76.23 -37.83 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 122.817 0.447 . . . . 0.0 110.892 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.5 mp -60.46 -37.24 80.38 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.015 0.926 . . . . 0.0 111.388 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -73.23 -40.96 64.25 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.499 0.499 . . . . 0.0 111.618 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -72.61 -29.54 63.58 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.396 0.278 . . . . 0.0 111.438 -171.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 22.2 pt -84.75 -18.55 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.212 0 C-N-CA 123.008 0.523 . . . . 0.0 110.334 172.554 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.9 mt -93.01 102.17 13.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.4 mm -112.69 118.92 59.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -135.08 149.05 50.01 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.26 151.52 17.9 Favored Glycine 0 C--O 1.239 0.42 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.91 127.65 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.61 0.719 . . . . 0.0 112.874 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.488 ' HA ' HD21 ' A' ' 85' ' ' ASN . 11.5 ptp85 -91.72 133.17 35.84 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.823 1.249 . . . . 0.0 110.31 175.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.94 24.37 72.11 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.192 -0.458 . . . . 0.0 114.101 170.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.485 ' HB2' ' HB ' ' A' ' 103' ' ' ILE . . . -80.21 111.79 16.91 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.673 0.789 . . . . 0.0 110.974 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 110.17 8.42 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.02 92.41 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.72 0.771 . . . . 0.0 109.34 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.487 ' ND2' HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -105.01 148.58 26.58 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.486 -176.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -56.53 -24.41 46.53 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.4 -34.17 76.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.394 0.678 . . . . 0.0 112.38 -172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.602 HG22 HG23 ' A' ' 103' ' ' ILE . 7.2 pt -62.66 -15.14 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -106.82 -17.85 14.09 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 118.525 0.602 . . . . 0.0 109.845 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -69.39 -25.44 64.15 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.08 0.952 . . . . 0.0 111.16 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -76.57 -8.94 58.21 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.196 -174.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.11 17.22 9.92 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 116.737 1.455 . . . . 0.0 116.737 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.472 ' HB2' HD12 ' A' ' 23' ' ' LEU . 93.3 mt -81.93 170.5 15.55 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.426 0.69 . . . . 0.0 110.833 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -84.58 99.41 10.74 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.643 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -149.9 162.25 40.69 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.852 0.861 . . . . 0.0 109.421 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -140.09 145.89 38.21 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.6 mt -130.98 127.48 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 172.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -120.31 176.63 5.37 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' HG12 ' A' ' 34' ' ' VAL . 44.4 t30 -81.17 138.07 35.87 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB1' ' HB ' ' A' ' 111' ' ' VAL . . . -83.74 -2.45 56.3 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.509 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 61.3 m-20 -89.87 -30.22 18.05 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 122.854 0.462 . . . . 0.0 110.387 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.484 HG21 HG13 ' A' ' 125' ' ' ILE . 9.4 p -87.52 -16.29 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 123.309 0.644 . . . . 0.0 111.234 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.523 HG22 ' HD1' ' A' ' 40' ' ' HIS . 13.4 p -93.86 136.13 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.77 -66.93 0.64 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.681 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.4 p -138.49 167.78 21.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.595 1.158 . . . . 0.0 109.362 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.452 ' HB3' HD11 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -58.26 -22.94 54.43 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 174.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.443 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 87.4 tttt -58.95 -34.68 72.04 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.021 0.528 . . . . 0.0 111.677 174.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.523 ' HD1' HG22 ' A' ' 35' ' ' VAL . 18.1 t-80 -60.58 -44.57 96.07 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.204 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.57 -52.83 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.036 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.443 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 4.1 pp -64.57 -28.37 69.59 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -172.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.431 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 79.4 t60 -68.63 -33.48 74.09 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.226 0.61 . . . . 0.0 110.985 171.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 -40.82 69.58 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.024 0.53 . . . . 0.0 110.914 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.511 HG12 HD12 ' A' ' 62' ' ' ILE . 55.9 mt -61.3 -43.79 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.163 0.985 . . . . 0.0 109.915 172.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.419 ' O ' HG22 ' A' ' 50' ' ' THR . 25.8 t-20 -53.13 -48.39 67.93 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.634 1.173 . . . . 0.0 110.69 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 26.7 mm-40 -63.82 -34.62 78.34 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.231 0.957 . . . . 0.0 110.583 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . . . -73.35 -25.66 60.69 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HZ1' ' HB3' ' A' ' 49' ' ' LYS . 8.7 mtpm? -83.71 -46.19 12.55 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.376 0.67 . . . . 0.0 111.23 -176.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.494 HG21 ' HG3' ' A' ' 51' ' ' LYS . 15.1 t -93.9 -32.35 13.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.75 0.42 . . . . 0.0 111.827 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.494 ' HG3' HG21 ' A' ' 50' ' ' THR . 42.3 mtpt -109.51 160.97 15.78 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.925 0.49 . . . . 0.0 111.239 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -142.36 98.82 5.95 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 124.066 0.947 . . . . 0.0 110.248 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 54' ' ' ILE . 14.4 Cg_exo -68.41 -119.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.549 2.832 . . . . 0.0 112.036 169.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.44 ' H ' ' HB2' ' A' ' 53' ' ' PRO . 30.3 mt -132.99 34.73 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.39 158.59 23.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.548 -175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -60.24 -60.37 3.92 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.9 0.88 . . . . 0.0 112.416 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.535 ' HB2' ' SD ' ' A' ' 60' ' ' MET . 70.0 m -148.65 179.17 8.03 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.512 0.725 . . . . 0.0 109.818 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.402 ' O ' HG13 ' A' ' 62' ' ' ILE . 58.1 t80 -53.56 -56.97 12.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.324 1.049 . . . . 0.0 111.852 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.453 ' HZ3' HG23 ' A' ' 89' ' ' ILE . 75.7 m95 -65.54 -35.18 80.09 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.491 0.716 . . . . 0.0 111.473 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 57' ' ' SER . 1.1 mpt? -76.34 -19.81 57.85 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 22.9 tt0 -78.53 -38.94 39.37 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.442 0.697 . . . . 0.0 110.627 173.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.511 HD12 HG12 ' A' ' 45' ' ' ILE . 90.2 mt -57.01 -41.28 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.491 0.716 . . . . 0.0 111.036 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.0 -32.88 67.63 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.21 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.669 HG22 ' HE ' ' A' ' 65' ' ' ARG . 12.0 m -78.38 -34.21 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 121.771 -0.581 . . . . 0.0 111.729 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.669 ' HE ' HG22 ' A' ' 64' ' ' VAL . 5.8 mmp_? -70.39 -38.98 74.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.651 0.38 . . . . 0.0 110.919 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.81 68.84 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.34 0.656 . . . . 0.0 112.199 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.0 p -92.44 -3.53 55.08 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.764 0.426 . . . . 0.0 111.933 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.48 16.04 48.52 Favored Glycine 0 C--N 1.358 1.77 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -170.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.589 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.7 tp-100 -105.76 151.57 24.29 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.5 ptt-85 -85.19 -27.2 26.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.072 0.549 . . . . 0.0 111.361 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.589 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 5.8 mm-40 -90.04 125.45 35.41 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.357 1.063 . . . . 0.0 111.195 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.5 HD12 HG12 ' A' ' 64' ' ' VAL . 1.8 mp -58.76 -44.95 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.343 1.057 . . . . 0.0 110.357 172.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -60.94 -51.09 70.76 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.351 0.661 . . . . 0.0 111.348 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -56.47 -55.52 32.63 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.316 0.385 . . . . 0.0 110.983 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.71 -38.78 75.86 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.3 mt -68.99 -31.1 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 120.661 0.267 . . . . 0.0 111.178 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -74.05 -43.63 57.15 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 122.098 -0.376 . . . . 0.0 110.675 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 79.4 mt -68.55 -65.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.83 0.852 . . . . 0.0 111.825 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.412 HG21 HG23 ' A' ' 34' ' ' VAL . 7.7 pt -105.91 6.06 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.15 176.13 47.4 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 119.094 0.861 . . . . 0.0 114.025 -166.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.33 140.31 42.99 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.613 0.765 . . . . 0.0 111.803 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -145.64 143.22 29.71 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.44 141.3 58.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.297 0.953 . . . . 0.0 111.41 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.07 -119.41 4.45 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' A' ' 12' ' ' ARG . 12.6 m120 -82.83 110.29 17.71 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.252 0.526 . . . . 0.0 109.913 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.79 174.06 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.627 0.727 . . . . 0.0 111.519 173.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.1 t -130.94 121.81 25.81 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.709 -173.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.454 HD21 ' HB ' ' A' ' 99' ' ' ILE . 8.3 tp -102.1 122.22 43.7 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.774 0.797 . . . . 0.0 109.503 -172.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.453 HG23 ' HZ3' ' A' ' 59' ' ' TRP . 32.0 mt -111.03 122.19 65.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 113.35 -1.75 . . . . 0.0 107.692 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.584 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 40.1 t -154.56 168.0 28.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.953 0.342 . . . . 0.0 111.028 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -95.96 -48.13 5.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.356 0.663 . . . . 0.0 110.827 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -111.66 138.15 48.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.428 0.691 . . . . 0.0 109.26 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 41.4 tt0 -63.49 -24.14 67.7 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.278 0.631 . . . . 0.0 111.902 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.15 -45.82 72.49 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.584 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 28.3 m -70.88 -34.45 71.6 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.929 0.892 . . . . 0.0 111.001 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.463 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 5.5 t80 -61.54 -52.31 64.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.553 0.741 . . . . 0.0 109.667 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 30.7 mtp180 -68.58 -33.62 74.37 Favored 'General case' 0 C--O 1.213 -0.855 0 O-C-N 123.685 0.616 . . . . 0.0 110.343 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' O ' HD12 ' A' ' 102' ' ' LEU . 50.4 tptt -56.46 -40.49 74.94 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.024 0.529 . . . . 0.0 110.663 175.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.454 ' HB ' HD21 ' A' ' 88' ' ' LEU . 43.2 mm -73.67 -48.64 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.6 174.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -54.54 -43.37 71.9 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 124.826 1.251 . . . . 0.0 113.702 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 56.6 mm-40 -60.88 -40.33 92.61 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.624 0.37 . . . . 0.0 110.776 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 98' ' ' LYS . 6.8 mp -72.97 -42.08 63.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.533 0.733 . . . . 0.0 112.082 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.602 HG23 HG22 ' A' ' 20' ' ' ILE . 8.2 pt -74.66 -32.59 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 118.229 0.468 . . . . 0.0 110.019 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.38 27.14 73.92 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 163.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.38 -170.58 43.72 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 172.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -111.62 146.38 37.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.35 124.54 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 121.003 0.43 . . . . 0.0 110.087 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -118.93 101.0 7.73 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.37 -41.82 76.01 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 50.4 m -56.82 -24.93 54.5 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -175.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.516 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 13.5 m -70.36 -17.75 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 118.583 0.629 . . . . 0.0 111.605 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 38' ' ' LYS . 21.2 mt -107.05 17.6 22.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.791 0.836 . . . . 0.0 111.136 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 110' ' ' SER . 8.0 pt-20 -114.46 -10.64 12.57 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.044 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 78.63 127.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 C-N-CA 124.527 1.131 . . . . 0.0 110.451 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -158.88 -172.39 3.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.554 1.142 . . . . 0.0 109.408 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.38 -47.58 83.53 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.284 0.634 . . . . 0.0 111.362 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.08 -44.04 95.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.187 0.595 . . . . 0.0 110.967 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.509 ' HE2' ' HA ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -59.97 -43.92 94.78 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.128 0.893 . . . . 0.0 110.389 177.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.01 -50.05 31.91 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.353 -167.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -64.96 -54.5 29.51 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -172.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.44 -33.09 75.06 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.14 0.275 . . . . 0.0 111.17 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.581 ' HA ' HD13 ' A' ' 125' ' ' ILE . 1.9 mt -53.84 -32.66 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 124.052 0.941 . . . . 0.0 112.048 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -64.51 -36.5 84.38 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.498 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.62 -56.69 18.73 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.581 HD13 ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -70.0 -52.92 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.414 ' HD2' HG21 ' A' ' 122' ' ' ILE . 23.6 m-85 -83.58 -33.07 25.48 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -170.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.546 ' HZ3' ' HB3' ' A' ' 127' ' ' LYS . 3.2 mmmp? 61.53 69.55 0.64 Allowed 'General case' 0 C--N 1.35 0.592 0 O-C-N 124.403 1.064 . . . . 0.0 110.586 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.9 mm . . . . . 0 CA--C 1.541 0.602 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.573 -174.212 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.466 HD21 ' HG2' ' A' ' 136' ' ' GLU . 37.0 t30 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.06 -32.12 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.892 0.877 . . . . 0.0 111.861 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.67 -53.48 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.178 0.514 . . . . 0.0 109.971 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.466 ' HG2' HD21 ' A' ' 133' ' ' ASN . 28.5 mm-40 -70.04 -37.14 75.49 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.83 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -76.91 -29.44 55.7 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 123.561 0.538 . . . . 0.0 111.817 -172.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.56 -36.15 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 172.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 40' ' ' HIS . 5.9 mp -60.49 -38.11 83.25 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.423 0.689 . . . . 0.0 110.646 172.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 31.4 mm-40 -59.65 -51.41 69.93 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.136 0.574 . . . . 0.0 110.955 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -49.19 78.2 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.557 0.743 . . . . 0.0 112.249 -175.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.9 pt -70.18 -27.59 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 122.972 0.509 . . . . 0.0 110.683 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.233 0 C-N-CA 122.848 0.459 . . . . 0.0 110.531 175.203 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.505 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 63.0 mt -101.77 106.15 19.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -171.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.51 HG12 ' HB ' ' A' ' 41' ' ' VAL . 3.7 mp -103.29 122.63 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 170.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.423 HH11 HG22 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -124.19 149.61 46.14 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -174.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' N ' HD12 ' A' ' 112' ' ' LEU . . . -104.8 137.32 13.58 Favored Glycine 0 CA--C 1.501 -0.792 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.0 tt -146.83 142.94 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.291 0.567 . . . . 0.0 111.093 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -122.56 132.28 54.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.352 1.461 . . . . 0.0 108.906 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.07 1.33 70.05 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.624 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.87 106.42 1.54 Allowed 'General case' 0 C--N 1.351 0.66 0 C-N-CA 124.287 1.035 . . . . 0.0 111.352 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -74.78 104.08 5.28 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.198 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.444 HD13 HG22 ' A' ' 86' ' ' VAL . 49.9 mm -71.25 98.2 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.687 0.756 . . . . 0.0 109.253 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.41 ' ND2' HG21 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -112.26 153.05 27.74 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.453 -178.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -67.15 -12.12 59.13 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.561 0.744 . . . . 0.0 112.349 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -67.03 -33.26 75.16 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.014 0.926 . . . . 0.0 111.83 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 HG21 ' ND2' ' A' ' 17' ' ' ASN . 12.6 pt -55.23 -22.57 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -87.36 -21.82 25.44 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.448 0.567 . . . . 0.0 111.409 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -77.35 -16.21 59.01 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.22 0.608 . . . . 0.0 112.025 -170.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.478 HD21 HD12 ' A' ' 99' ' ' ILE . 1.2 pp -80.3 -8.92 59.69 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.974 0.51 . . . . 0.0 111.814 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.7 14.92 10.53 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.854 1.501 . . . . 0.0 116.854 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.56 159.27 32.4 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.577 0.688 . . . . 0.0 110.33 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -83.3 100.68 10.79 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -145.12 166.45 25.37 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.555 1.142 . . . . 0.0 108.7 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -149.95 151.78 33.91 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 162.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.413 HG12 HD13 ' A' ' 88' ' ' LEU . 27.3 mt -128.15 127.51 67.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 89' ' ' ILE . 2.7 pt? -115.35 172.35 7.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -81.41 142.91 32.53 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.151 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB2' HG22 ' A' ' 111' ' ' VAL . . . -78.61 0.64 25.6 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.16 -28.58 57.42 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.17 0.588 . . . . 0.0 111.082 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 79' ' ' ILE . 32.4 m -107.46 -2.74 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.122 0.569 . . . . 0.0 112.484 -170.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.533 HG12 ' SG ' ' A' ' 87' ' ' CYS . 7.4 p -78.45 104.53 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.277 0.56 . . . . 0.0 109.557 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.5 -66.61 0.53 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.541 HG23 ' HA ' ' A' ' 113' ' ' GLU . 19.1 p -137.78 173.07 12.04 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.677 169.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HG3' ' HB3' ' A' ' 112' ' ' LEU . 51.3 mtpt -53.98 -25.29 20.14 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.055 0.542 . . . . 0.0 111.678 165.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 10.7 mptt -57.74 -36.74 72.47 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.317 1.047 . . . . 0.0 111.959 172.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.424 ' HA ' HD12 ' A' ' 139' ' ' LEU . 12.2 t-80 -60.18 -49.82 76.12 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.211 0.945 . . . . 0.0 110.553 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' HB ' HG12 ' A' ' 8' ' ' ILE . 59.1 t -69.53 -54.04 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.271 177.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -60.64 -36.8 79.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.001 0.521 . . . . 0.0 111.556 -172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.457 ' HD2' HD13 ' A' ' 142' ' ' ILE . 75.6 t60 -58.92 -39.82 82.71 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.781 0.832 . . . . 0.0 111.454 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.04 -33.45 70.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.266 0.626 . . . . 0.0 110.693 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.532 HG12 HD13 ' A' ' 62' ' ' ILE . 43.0 mt -65.16 -44.28 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.386 0.675 . . . . 0.0 110.426 170.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.573 ' HA ' ' HZ3' ' A' ' 49' ' ' LYS . 84.1 m-20 -55.45 -40.42 71.55 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.797 0.839 . . . . 0.0 110.538 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -60.3 -43.79 95.98 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.519 1.137 . . . . 0.0 110.601 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.61 -28.13 66.64 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.55 0.74 . . . . 0.0 112.462 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.573 ' HZ3' ' HA ' ' A' ' 46' ' ' ASN . 24.3 mtmm -76.54 -42.1 44.23 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.572 0.349 . . . . 0.0 111.038 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.55 HG22 ' HG3' ' A' ' 51' ' ' LYS . 12.8 t -88.25 -31.69 18.9 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.392 0.277 . . . . 0.0 111.479 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.655 ' HZ1' ' HD2' ' A' ' 65' ' ' ARG . 39.9 mtmt -109.53 152.95 24.79 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.911 0.863 . . . . 0.0 112.752 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.635 ' HZ3' ' HB2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -139.23 81.84 20.27 Favored Pre-proline 0 CA--C 1.553 1.087 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.627 160.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -87.73 -78.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.278 2.652 . . . . 0.0 113.017 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.3 mt -123.89 -10.82 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 124.275 1.03 . . . . 0.0 108.939 -172.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.546 ' HA ' HD13 ' A' ' 72' ' ' ILE . . . -65.06 147.34 53.64 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.954 0.902 . . . . 0.0 112.508 -172.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.646 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 75.9 mmtt -66.83 -33.44 75.61 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.566 0.747 . . . . 0.0 110.108 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.0 t -163.41 178.15 8.32 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.641 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -51.94 -60.33 3.31 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.691 1.596 . . . . 0.0 111.481 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -66.83 -20.73 65.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.294 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.646 ' HG3' ' HB2' ' A' ' 56' ' ' LYS . 22.8 mmt -76.73 -28.55 55.84 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.349 0.66 . . . . 0.0 111.534 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.452 ' HA ' HG23 ' A' ' 64' ' ' VAL . 51.6 tp10 -74.95 -32.08 61.65 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 120.641 0.257 . . . . 0.0 110.498 174.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.532 HD13 HG12 ' A' ' 45' ' ' ILE . 60.5 mt -62.01 -46.49 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.903 0.481 . . . . 0.0 110.833 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.485 HD21 ' SD ' ' A' ' 60' ' ' MET . 4.0 pp -71.91 -34.89 69.46 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.932 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.452 HG23 ' HA ' ' A' ' 61' ' ' GLU . 36.0 m -73.94 -31.55 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 118.291 0.496 . . . . 0.0 111.811 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.655 ' HD2' ' HZ1' ' A' ' 51' ' ' LYS . 12.6 mmp_? -77.28 -42.23 37.81 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.629 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.11 71.74 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.434 0.561 . . . . 0.0 111.048 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.1 p -86.57 -13.82 44.68 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 59.37 20.75 52.06 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 114.42 0.528 . . . . 0.0 114.42 -164.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -117.44 93.44 4.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.056 0.942 . . . . 0.0 108.929 -177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.416 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -59.35 -10.76 3.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -174.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -85.15 121.27 27.66 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 55' ' ' ALA . 27.6 mm -52.95 -54.88 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.696 1.198 . . . . 0.0 112.27 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -58.71 -50.96 71.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.73 0.812 . . . . 0.0 110.967 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 39.9 mm-40 -61.92 -40.0 93.96 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.053 0.846 . . . . 0.0 112.242 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.45 80.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.489 0.715 . . . . 0.0 111.788 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.1 -30.17 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 123.398 0.679 . . . . 0.0 110.808 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 58.5 mtpt -64.77 -49.12 71.98 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 122.108 -0.37 . . . . 0.0 110.781 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.84 -65.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.636 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.59 HG22 HG12 ' A' ' 34' ' ' VAL . 23.0 pt -104.36 11.21 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -169.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.13 155.15 50.33 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 118.921 0.782 . . . . 0.0 112.03 -172.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.09 54.5 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.676 0.791 . . . . 0.0 112.976 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -132.2 158.45 41.72 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -53.32 145.63 13.76 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 119.043 0.838 . . . . 0.0 112.611 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.17 -111.19 4.18 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.23 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.407 HD21 ' N ' ' A' ' 85' ' ' ASN . 0.9 OUTLIER -91.17 111.47 22.96 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.26 0.624 . . . . 0.0 109.85 -173.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.444 HG22 HD13 ' A' ' 16' ' ' ILE . 3.7 m -138.75 -179.84 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.819 1.248 . . . . 0.0 111.426 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.533 ' SG ' HG12 ' A' ' 35' ' ' VAL . 78.0 m -133.89 125.35 28.13 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.495 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.413 HD13 HG12 ' A' ' 29' ' ' ILE . 11.7 tp -104.72 126.09 51.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.232 1.013 . . . . 0.0 109.686 -170.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.604 HD11 HD22 ' A' ' 30' ' ' LEU . 7.0 mt -109.45 122.78 64.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 114.302 -1.317 . . . . 0.0 107.45 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 9.4 p -143.43 152.15 41.21 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 122.776 0.43 . . . . 0.0 109.902 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.15 -46.35 84.48 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.283 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.401 ' OD2' ' HG2' ' A' ' 94' ' ' GLU . 1.5 p-10 -148.46 171.15 16.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.411 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -69.0 -22.58 64.07 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -168.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HG2' ' OD2' ' A' ' 92' ' ' ASP . 10.1 pt-20 -74.46 -41.73 60.28 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.098 0.863 . . . . 0.0 109.281 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m -58.49 -39.69 80.74 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.605 0.762 . . . . 0.0 110.819 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.685 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 14.1 t80 -56.55 -51.23 69.34 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 123.364 0.666 . . . . 0.0 110.719 175.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -63.93 -35.21 79.92 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.75 0.656 . . . . 0.0 110.822 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 98' ' ' LYS . 10.7 mmpt? -64.59 -45.94 84.82 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.586 0.554 . . . . 0.0 111.571 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.478 HD12 HD21 ' A' ' 23' ' ' LEU . 44.4 mm -69.06 -44.57 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.395 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -53.31 -34.37 57.11 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.041 1.336 . . . . 0.0 112.182 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -60.25 -51.35 69.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.588 0.755 . . . . 0.0 111.561 174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.66 -41.43 75.53 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.8 pt -77.89 -50.2 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 118.35 0.523 . . . . 0.0 110.775 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.04 114.33 0.04 OUTLIER Glycine 0 C--N 1.35 1.353 0 N-CA-C 113.883 0.313 . . . . 0.0 113.883 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.46 -159.88 24.81 Favored Glycine 0 C--O 1.241 0.589 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.2 143.18 49.27 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.3 0.55 . . . . 0.0 109.829 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.5 mm -71.22 129.1 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 122.928 0.491 . . . . 0.0 110.18 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -116.5 101.79 8.93 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -68.12 -53.5 24.89 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.1 0.56 . . . . 0.0 111.747 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.1 p -53.06 -30.03 33.5 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 32' ' ' ALA . 10.3 p -65.3 -27.26 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 118.401 0.546 . . . . 0.0 111.44 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 10' ' ' GLY . 93.4 mt -80.46 -3.2 48.99 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.372 1.069 . . . . 0.0 112.503 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.541 ' HA ' HG23 ' A' ' 37' ' ' THR . 12.8 pt-20 -135.95 23.57 3.31 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -169.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 118' ' ' LYS . 0.4 OUTLIER 77.74 138.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 124.242 1.017 . . . . 0.0 112.46 165.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 5.2 p-10 -151.16 -179.93 7.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.527 1.131 . . . . 0.0 109.517 170.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.81 -41.61 97.85 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.315 0.646 . . . . 0.0 111.943 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.514 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 0.1 OUTLIER -62.17 -41.72 98.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.592 1.157 . . . . 0.0 109.928 176.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.613 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -62.62 -40.01 95.62 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.047 0.842 . . . . 0.0 110.691 177.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.6 -48.41 48.3 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.345 -166.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -73.55 -39.45 64.69 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.172 0.589 . . . . 0.0 110.697 -174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.8 tp -53.88 -53.15 56.65 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.278 1.431 . . . . 0.0 111.971 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.429 HG23 ' HD2' ' A' ' 126' ' ' PHE . 43.6 mt -62.44 -29.72 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.753 1.221 . . . . 0.0 111.309 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 5.4 tmm_? -72.41 -35.94 68.51 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.992 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.62 -55.99 12.75 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.63 -35.75 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 118.916 0.78 . . . . 0.0 113.075 -174.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.429 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.7 m-30 -88.39 -32.21 18.47 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 29.1 mmtp 63.84 75.86 0.37 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.176 0.99 . . . . 0.0 112.213 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.2 mt . . . . . 0 CA--C 1.537 0.447 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.524 -179.548 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.2 t30 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.24 -25.87 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 123.474 0.71 . . . . 0.0 111.516 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.432 ' O ' HD13 ' A' ' 139' ' ' LEU . 85.1 t -68.64 -58.35 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.45 0.7 . . . . 0.0 111.667 -174.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -63.05 -29.05 70.51 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 117.742 0.246 . . . . 0.0 111.042 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.449 ' HA ' ' HG2' ' A' ' 140' ' ' GLU . 77.6 mtt-85 -75.97 -32.76 59.63 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 123.736 0.648 . . . . 0.0 112.187 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.0 p -73.82 -41.05 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 CA-C-N 118.218 0.463 . . . . 0.0 110.142 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 135' ' ' VAL . 11.2 mp -57.29 -42.4 81.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.535 0.734 . . . . 0.0 112.565 175.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 137' ' ' ARG . 13.5 pt-20 -80.73 -28.57 36.54 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.054 0.141 . . . . 0.0 110.971 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -59.82 -52.55 64.99 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.694 0.797 . . . . 0.0 110.679 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.457 HD13 ' HD2' ' A' ' 43' ' ' HIS . 13.6 pt -73.59 -17.12 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.056 -171.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.809 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.327 167.743 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.739 ' SD ' ' HG2' ' A' ' 91' ' ' GLU . 5.1 mmt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.547 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 41.9 mt -96.95 102.98 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.27 122.65 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -124.65 145.87 49.41 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.039 0.935 . . . . 0.0 109.549 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.72 139.19 14.52 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.247 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.0 tt -152.48 144.07 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 122.849 0.46 . . . . 0.0 110.992 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -116.85 142.7 46.59 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.84 0.856 . . . . 0.0 109.308 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.34 11.24 85.7 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.56 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.59 95.21 1.06 Allowed 'General case' 0 C--N 1.351 0.639 0 C-N-CA 123.899 0.879 . . . . 0.0 110.604 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 51.8 mtm-85 -70.79 101.65 2.16 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.805 0.69 . . . . 0.0 109.599 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.502 HD13 HG11 ' A' ' 86' ' ' VAL . 48.2 mm -67.39 121.13 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.419 0.687 . . . . 0.0 110.377 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.29 159.34 18.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.794 0.837 . . . . 0.0 109.855 175.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -77.28 -16.55 58.93 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.539 0.735 . . . . 0.0 112.213 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.95 -30.18 63.66 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.386 0.674 . . . . 0.0 112.685 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.3 pt -60.48 -12.47 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.15 0.23 56.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.993 0.517 . . . . 0.0 112.19 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -79.4 -25.09 42.16 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.221 0.464 . . . . 0.0 111.551 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pp -85.15 -14.44 47.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.996 0.518 . . . . 0.0 111.682 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.53 16.37 7.03 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 116.616 1.406 . . . . 0.0 116.616 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.7 mt -73.82 175.17 7.51 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 117.501 0.651 . . . . 0.0 111.457 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.93 81.21 2.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.048 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -139.7 145.95 39.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.002 0.921 . . . . 0.0 108.719 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.433 ' NE2' ' HB3' ' A' ' 63' ' ' LEU . 1.6 tm0? -142.15 136.68 30.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 171.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.413 HG22 HG22 ' A' ' 86' ' ' VAL . 3.9 mt -127.21 129.74 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.34 171.05 13.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.748 0.819 . . . . 0.0 110.443 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -76.38 116.37 17.0 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.805 0.842 . . . . 0.0 109.906 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.27 3.47 51.95 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.692 ' HA ' ' HZ1' ' A' ' 118' ' ' LYS . 19.2 m-20 -78.08 -35.69 49.1 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 170.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.454 HG23 HG23 ' A' ' 79' ' ' ILE . 26.8 m -97.88 5.86 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 122.902 0.481 . . . . 0.0 111.729 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.601 HG22 ' HD1' ' A' ' 40' ' ' HIS . 3.7 p -90.48 139.14 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.81 -69.34 0.53 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.4 p -136.63 172.88 12.36 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.719 0.808 . . . . 0.0 110.065 174.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -26.34 12.33 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.506 0.722 . . . . 0.0 112.311 170.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -54.73 -32.93 60.39 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.446 1.098 . . . . 0.0 112.202 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.601 ' HD1' HG22 ' A' ' 35' ' ' VAL . 30.2 t-80 -65.44 -47.48 76.05 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.728 0.811 . . . . 0.0 110.878 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.488 HG21 ' SG ' ' A' ' 87' ' ' CYS . 38.8 t -67.3 -50.92 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.029 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -61.32 -34.6 75.52 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.039 0.535 . . . . 0.0 111.54 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -55.21 -43.95 74.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.043 0.937 . . . . 0.0 110.734 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.8 78.39 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.796 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.494 HG12 HD12 ' A' ' 62' ' ' ILE . 63.5 mt -65.02 -53.38 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.028 0.931 . . . . 0.0 112.192 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -49.28 -44.66 44.14 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.923 0.889 . . . . 0.0 110.628 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -73.44 -31.62 63.92 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.293 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.84 -21.22 60.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.244 0.618 . . . . 0.0 112.323 174.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -78.11 -48.14 16.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.869 0.468 . . . . 0.0 110.332 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.52 HG21 ' HG3' ' A' ' 51' ' ' LYS . 10.9 t -88.98 -29.12 19.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.023 0.529 . . . . 0.0 112.268 -171.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HG3' HG21 ' A' ' 50' ' ' THR . 49.1 mtmt -114.45 155.41 26.42 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.571 0.701 . . . . 0.0 112.229 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.52 ' HZ1' ' HB2' ' A' ' 52' ' ' LYS . 9.7 mtmp? -140.06 73.13 32.93 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.336 167.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.23 -78.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.206 2.604 . . . . 0.0 114.164 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.69 -26.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.066 0.546 . . . . 0.0 111.645 -166.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.21 174.09 4.21 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -169.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -73.75 -53.62 9.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.447 0.699 . . . . 0.0 112.193 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.603 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 21.4 t -157.03 -171.73 3.76 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.408 0.683 . . . . 0.0 109.453 -174.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -53.95 -60.92 2.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.497 1.119 . . . . 0.0 113.268 -174.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -64.76 -29.62 70.6 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.014 0.435 . . . . 0.0 111.144 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.3 mpt? -77.18 -27.51 53.68 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.926 0.891 . . . . 0.0 110.455 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 11.3 tp10 -74.43 -34.08 63.12 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.893 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.494 HD12 HG12 ' A' ' 45' ' ' ILE . 72.9 mt -64.38 -47.07 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.145 0.578 . . . . 0.0 111.061 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HB3' ' NE2' ' A' ' 28' ' ' GLN . 3.4 pp -68.34 -33.39 74.22 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.215 0.322 . . . . 0.0 111.607 -175.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -77.16 -40.5 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 118.094 0.406 . . . . 0.0 110.986 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -70.0 -32.63 70.9 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.035 0.534 . . . . 0.0 111.709 -170.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.64 -30.87 70.55 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.186 0.594 . . . . 0.0 112.109 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.2 p -104.37 9.32 35.82 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.85 0.46 . . . . 0.0 112.225 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.72 23.7 65.55 Favored Glycine 0 C--N 1.358 1.787 0 CA-C-O 121.328 0.404 . . . . 0.0 113.965 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -89.8 -163.23 0.98 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.509 1.124 . . . . 0.0 112.512 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.18 -34.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.628 1.571 . . . . 0.0 108.523 -165.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -101.98 121.98 43.18 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.928 0.891 . . . . 0.0 108.653 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 76' ' ' ILE . 1.8 mp -51.34 -45.78 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.587 1.179 . . . . 0.0 111.697 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -66.13 -40.58 90.77 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.265 0.626 . . . . 0.0 110.928 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.03 -47.39 81.01 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.311 0.644 . . . . 0.0 111.478 173.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.85 -35.47 74.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.209 0.604 . . . . 0.0 112.619 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 72' ' ' ILE . 71.4 mt -71.49 -29.89 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 122.991 0.516 . . . . 0.0 110.981 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -63.88 -54.88 27.9 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.012 0.434 . . . . 0.0 109.918 173.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.9 mt -73.29 -65.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.262 -173.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 34' ' ' VAL . 23.2 pt -111.0 32.64 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.47 159.47 53.09 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 113.504 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.58 98.99 2.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.41 0.684 . . . . 0.0 110.961 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -109.97 153.15 24.96 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.94 0.896 . . . . 0.0 108.835 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.24 150.69 38.34 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.56 0.744 . . . . 0.0 112.492 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.34 -120.02 6.02 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.75 104.69 14.06 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.502 HG11 HD13 ' A' ' 16' ' ' ILE . 1.3 p -134.11 151.42 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.355 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 41' ' ' VAL . 41.4 t -109.81 118.88 37.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.426 1.091 . . . . 0.0 108.99 -172.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.84 120.95 43.7 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.46 0.704 . . . . 0.0 110.153 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -107.12 137.21 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 21.8 p -152.42 151.78 31.21 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.985 0.514 . . . . 0.0 109.919 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.739 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 51.3 mt-10 -86.45 -32.23 20.95 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.31 128.89 56.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.003 0.921 . . . . 0.0 108.761 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -67.37 -21.38 65.62 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.315 0.646 . . . . 0.0 111.332 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 8.3 pt-20 -69.66 -40.02 76.7 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.667 0.387 . . . . 0.0 110.031 173.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' ILE . 99.0 m -63.55 -38.44 91.15 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.876 0.87 . . . . 0.0 109.878 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.676 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 11.6 t80 -56.96 -47.85 79.74 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.84 0.856 . . . . 0.0 110.973 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -61.54 -42.99 99.65 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.73 0.644 . . . . 0.0 110.34 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 45.6 mmtm -56.13 -45.9 79.4 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.171 0.92 . . . . 0.0 111.04 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 95' ' ' THR . 32.9 mm -69.84 -45.66 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.322 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -52.62 -43.41 65.37 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.88 1.272 . . . . 0.0 113.171 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.15 -48.27 80.78 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.777 0.673 . . . . 0.0 111.511 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.05 -36.18 56.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 pt -74.83 -39.83 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 118.311 0.505 . . . . 0.0 109.897 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.16 96.79 0.04 OUTLIER Glycine 0 C--N 1.351 1.368 0 O-C-N 123.635 0.585 . . . . 0.0 113.14 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.37 -171.36 25.09 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.16 131.03 55.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.6 mm -62.99 112.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -129.69 92.47 3.34 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 4.6 p-10 -60.27 -34.08 73.22 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.531 0.732 . . . . 0.0 111.81 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.496 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 23.8 m -52.86 -24.62 9.46 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -176.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.5 m -66.75 -32.19 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-N 118.204 0.457 . . . . 0.0 110.131 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.0 mt -95.72 -1.92 48.95 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.768 1.227 . . . . 0.0 112.253 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 110' ' ' SER . 76.0 mm-40 -103.78 -9.29 19.16 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 118.148 -0.93 . . . . 0.0 112.459 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.257 0.4 OUTLIER 84.82 135.64 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.983 1.313 . . . . 0.0 111.105 177.438 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.502 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 4.3 p-10 -159.77 170.77 20.8 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.832 1.253 . . . . 0.0 108.799 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.79 -37.62 85.02 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.59 0.756 . . . . 0.0 112.372 -168.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.502 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 16.1 t70 -54.87 -54.1 46.79 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.444 1.098 . . . . 0.0 112.219 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.692 ' HZ1' ' HA ' ' A' ' 33' ' ' ASP . 3.0 mptp? -63.1 -34.13 76.94 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.716 0.635 . . . . 0.0 110.881 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.85 -49.0 32.83 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.416 0.686 . . . . 0.0 112.159 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 67.6 mtp180 -75.22 -30.8 60.67 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.519 0.676 . . . . 0.0 110.942 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.5 tp -55.7 -48.03 75.81 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.219 165.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.405 HG21 ' HD2' ' A' ' 126' ' ' PHE . 25.2 mt -55.7 -35.11 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.229 1.012 . . . . 0.0 112.556 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -74.56 -26.53 60.01 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.951 -178.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -69.45 -58.47 3.95 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 171.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -29.49 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 119.192 0.906 . . . . 0.0 112.968 -174.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.405 ' HD2' HG21 ' A' ' 122' ' ' ILE . 23.2 m-85 -99.51 -26.24 14.17 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 68.3 mmtt 62.03 66.6 0.8 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.138 0.975 . . . . 0.0 112.506 171.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.512 HG22 ' HB3' ' A' ' 137' ' ' ARG . 16.9 mt . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.447 ' O ' ' HD3' ' A' ' 137' ' ' ARG . 31.3 t30 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.98 -31.41 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 119.124 0.875 . . . . 0.0 112.21 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.448 ' O ' HD13 ' A' ' 139' ' ' LEU . 60.9 t -69.16 -53.94 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.798 0.839 . . . . 0.0 110.415 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.438 ' HG3' HD21 ' A' ' 133' ' ' ASN . 40.8 mt-10 -59.23 -42.6 91.4 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.333 0.396 . . . . 0.0 111.074 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.512 ' HB3' HG22 ' A' ' 128' ' ' ILE . 8.7 mpt_? -73.0 -31.67 64.65 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.949 0.781 . . . . 0.0 112.074 -167.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 139' ' ' LEU . 11.1 p -70.56 -42.56 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 117.706 0.23 . . . . 0.0 110.501 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 40' ' ' HIS . 10.9 mp -60.75 -39.67 89.61 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.567 0.542 . . . . 0.0 111.625 172.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.73 -44.43 93.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.618 0.767 . . . . 0.0 111.117 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -63.87 -45.99 86.97 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.018 0.527 . . . . 0.0 111.286 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 11.5 pt -75.6 -22.23 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.019 0.2 . . . . 0.0 110.62 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.884 0 C-N-CA 123.569 0.748 . . . . 0.0 111.089 172.467 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.6 mt -101.2 111.03 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.918 1.287 . . . . 0.0 109.271 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -107.08 127.26 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 9' ' ' ARG . 2.9 mmp_? -128.15 149.89 50.23 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.718 0.807 . . . . 0.0 110.553 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.66 129.94 10.0 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.622 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 tt -141.18 147.04 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.148 0.579 . . . . 0.0 110.597 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -122.97 136.9 55.03 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.349 1.059 . . . . 0.0 109.419 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.36 7.91 87.01 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.36 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' A' ' 103' ' ' ILE . . . -76.03 104.03 6.37 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.547 0.739 . . . . 0.0 110.218 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -70.81 123.86 22.95 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.365 0.415 . . . . 0.0 110.148 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.8 mm -73.53 91.03 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.887 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.551 ' ND2' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -91.11 151.23 21.07 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.021 -177.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -63.92 -21.64 66.56 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -64.84 -29.85 70.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.405 0.682 . . . . 0.0 112.103 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.551 HG22 ' ND2' ' A' ' 17' ' ' ASN . 19.1 pt -54.37 -23.82 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -90.07 -19.45 24.33 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.284 0.493 . . . . 0.0 111.32 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.19 -22.23 63.91 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.976 0.91 . . . . 0.0 111.609 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 99' ' ' ILE . 1.5 pp -81.95 -10.17 59.35 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.282 0.633 . . . . 0.0 111.965 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.16 16.96 9.65 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.407 ' HB2' HD12 ' A' ' 23' ' ' LEU . 86.1 mt -82.39 176.57 9.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.283 0.633 . . . . 0.0 112.197 -174.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -87.56 93.44 9.42 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.102 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -145.66 160.32 41.87 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.111 0.964 . . . . 0.0 108.678 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 59' ' ' TRP . 6.6 tp-100 -148.64 153.23 38.01 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 166.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.85 137.98 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.406 HD21 HD13 ' A' ' 89' ' ' ILE . 2.2 pt? -128.16 -175.06 3.38 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.65 0.78 . . . . 0.0 109.389 170.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -89.22 120.1 30.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.784 0.834 . . . . 0.0 109.78 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.72 -5.27 56.84 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.886 0.874 . . . . 0.0 113.168 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -76.19 -33.63 59.31 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 m -105.19 9.5 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.321 0.649 . . . . 0.0 112.264 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.566 HG23 ' HD1' ' A' ' 40' ' ' HIS . 4.4 p -85.13 140.71 15.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.16 -62.16 1.57 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.564 HG21 ' HA ' ' A' ' 113' ' ' GLU . 21.5 p -145.59 169.92 17.46 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.931 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB3' HD11 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -53.71 -31.98 50.17 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.131 0.572 . . . . 0.0 110.649 162.364 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.55 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 85.5 tttt -66.99 -30.57 70.73 Favored 'General case' 0 C--N 1.36 1.059 0 C-N-CA 123.909 0.883 . . . . 0.0 111.52 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.566 ' HD1' HG23 ' A' ' 35' ' ' VAL . 16.8 t-80 -60.88 -46.75 89.38 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.091 0.556 . . . . 0.0 110.305 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 45' ' ' ILE . 38.8 t -67.64 -51.2 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 O-C-N 123.77 0.669 . . . . 0.0 111.671 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 3.2 pp -64.83 -30.13 71.12 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.617 ' HE2' ' HB3' ' A' ' 143' ' ' ALA . 35.7 t60 -65.39 -35.38 80.76 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.789 0.836 . . . . 0.0 111.119 172.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' HB1' ' HB3' ' A' ' 65' ' ' ARG . . . -67.44 -34.79 77.93 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.592 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.44 HG12 HD12 ' A' ' 62' ' ' ILE . 19.8 mt -69.79 -35.94 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.931 0.892 . . . . 0.0 110.967 175.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.33 -53.98 51.93 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.246 0.618 . . . . 0.0 109.594 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.408 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 29.1 mm-40 -60.46 -30.47 69.68 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.672 1.189 . . . . 0.0 112.079 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.5 -27.32 66.03 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -89.24 -16.81 30.38 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.443 0.64 . . . . 0.0 109.831 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.0 m -91.49 -43.92 9.41 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.393 1.477 . . . . 0.0 111.041 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . 10.3 mmpt? -114.23 141.94 46.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.133 0.973 . . . . 0.0 112.533 -174.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -123.64 88.65 51.81 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 124.834 1.254 . . . . 0.0 107.988 165.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.469 ' HG3' ' NE2' ' A' ' 69' ' ' GLN . 67.0 Cg_endo -79.15 -107.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.643 2.229 . . . . 0.0 111.941 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.1 mt -126.21 13.18 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.33 146.45 53.46 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.595 0.758 . . . . 0.0 111.688 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.67 -47.39 86.49 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.594 0.757 . . . . 0.0 111.291 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.1 m -147.63 172.18 14.45 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.856 0.863 . . . . 0.0 110.201 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.72 -52.73 64.25 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.453 1.101 . . . . 0.0 110.944 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 28' ' ' GLN . 83.8 m95 -67.43 -29.09 68.48 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.118 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.458 ' SD ' HD22 ' A' ' 63' ' ' LEU . 23.3 mmt -71.72 -28.45 63.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.153 0.581 . . . . 0.0 111.665 174.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.441 ' HA ' HG22 ' A' ' 64' ' ' VAL . 44.8 tp10 -71.05 -27.93 64.01 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.757 0.423 . . . . 0.0 110.398 174.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.44 HD12 HG12 ' A' ' 45' ' ' ILE . 67.5 mt -66.25 -45.64 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.657 0.383 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.458 HD22 ' SD ' ' A' ' 60' ' ' MET . 4.4 pp -69.77 -32.76 71.44 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.156 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.576 ' HB ' ' H ' ' A' ' 70' ' ' ARG . 10.0 m -78.33 -40.78 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 122.498 -0.126 . . . . 0.0 111.294 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.489 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 6.6 tpt180 -67.9 -39.99 83.53 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 122.494 0.318 . . . . 0.0 111.025 -169.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.03 -14.28 60.03 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 124.036 0.835 . . . . 0.0 112.308 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 p -108.85 26.78 10.18 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.464 0.706 . . . . 0.0 111.546 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 26.13 53.29 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-O 119.619 -0.545 . . . . 0.0 114.297 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.469 ' NE2' ' HG3' ' A' ' 53' ' ' PRO . 34.9 tt0 55.99 113.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.269 1.427 . . . . 0.0 113.104 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.576 ' H ' ' HB ' ' A' ' 64' ' ' VAL . 2.8 mpt_? -140.04 172.54 12.62 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.973 1.709 . . . . 0.0 109.256 -173.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -57.13 135.99 56.38 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.97 159.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.405 HD13 HG12 ' A' ' 64' ' ' VAL . 1.7 mp -51.14 -49.94 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.404 1.082 . . . . 0.0 111.957 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.77 -37.36 86.11 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.482 0.489 . . . . 0.0 110.52 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -63.28 -46.91 84.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.771 0.428 . . . . 0.0 112.084 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.53 71.54 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.883 0.473 . . . . 0.0 112.114 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.483 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 84.9 mt -64.51 -32.31 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.464 0.706 . . . . 0.0 110.554 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -72.49 -50.87 22.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.697 0.399 . . . . 0.0 110.066 174.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.517 HG21 HG23 ' A' ' 79' ' ' ILE . 43.9 mt -66.69 -65.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.8 0.84 . . . . 0.0 111.791 -173.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.517 HG23 HG21 ' A' ' 78' ' ' ILE . 38.6 pt -124.0 21.15 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 76' ' ' ILE . . . -76.36 156.78 47.22 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.09 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.26 113.97 1.46 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.82 0.848 . . . . 0.0 112.602 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -135.55 153.16 51.79 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.92 124.59 15.88 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.589 1.156 . . . . 0.0 112.755 -170.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.32 -118.26 1.58 Allowed Glycine 0 C--N 1.352 1.432 0 O-C-N 123.434 0.459 . . . . 0.0 112.379 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -84.25 108.14 16.95 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.26 159.98 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.959 0.885 . . . . 0.0 112.674 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.8 m -112.51 118.44 35.14 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.811 -1.54 . . . . 0.0 108.265 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD22 ' HB ' ' A' ' 99' ' ' ILE . 10.4 tp -102.63 121.19 41.91 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.32 0.648 . . . . 0.0 109.328 -174.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 28' ' ' GLN . 4.8 mt -111.48 125.6 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.902 1.281 . . . . 0.0 108.242 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 74.3 m -148.79 145.95 27.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.158 0.583 . . . . 0.0 109.746 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 -27.36 59.32 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.407 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 28.7 m-20 -131.27 148.92 52.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.287 0.635 . . . . 0.0 111.683 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.09 -25.17 65.21 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.944 1.298 . . . . 0.0 112.764 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 11.2 pt-20 -69.2 -43.27 74.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.788 0.435 . . . . 0.0 110.089 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 m -70.21 -33.08 71.25 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.708 0.803 . . . . 0.0 110.598 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -60.99 -50.96 71.28 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 45.0 ttp180 -59.86 -45.08 93.58 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.886 0.741 . . . . 0.0 109.862 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -59.44 -42.21 91.4 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.097 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.48 ' HB ' HD22 ' A' ' 88' ' ' LEU . 35.6 mm -71.9 -43.66 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -55.18 -37.83 67.55 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 124.596 1.158 . . . . 0.0 112.509 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 46.5 mt-10 -61.26 -39.25 89.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.684 0.794 . . . . 0.0 111.204 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.13 -47.46 35.96 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.691 0.797 . . . . 0.0 112.272 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 14' ' ' ALA . 18.2 pt -79.91 -28.95 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 122.068 0.147 . . . . 0.0 110.992 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.32 25.73 70.08 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.044 1.177 . . . . 0.0 116.044 160.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.32 -170.16 46.3 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 117.047 0.423 . . . . 0.0 112.513 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -104.71 140.45 38.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.604 0.762 . . . . 0.0 108.996 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mm -73.04 119.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.162 0.506 . . . . 0.0 109.79 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.447 ' O ' HG21 ' A' ' 111' ' ' VAL . 14.7 t70 -131.54 91.49 3.01 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.87 -32.61 73.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.958 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.534 ' HA ' ' HG3' ' A' ' 113' ' ' GLU . 12.1 p -58.34 -15.4 10.32 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 108' ' ' ASP . 35.4 m -66.42 -24.69 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 118.709 0.686 . . . . 0.0 110.888 171.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 38' ' ' LYS . 67.1 mt -99.65 18.23 18.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.827 1.251 . . . . 0.0 112.593 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.564 ' HA ' HG21 ' A' ' 37' ' ' THR . 0.0 OUTLIER -138.48 12.67 2.76 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 76.02 124.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.825 0.85 . . . . 0.0 112.375 168.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.523 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 3.3 p-10 -142.87 177.16 8.53 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.197 173.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -61.88 -42.1 98.66 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.071 0.948 . . . . 0.0 111.52 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.523 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 24.8 t70 -59.08 -47.37 85.5 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.048 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -67.01 -31.75 72.52 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.33 0.652 . . . . 0.0 111.142 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.76 -51.28 28.15 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.068 0.547 . . . . 0.0 111.364 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.33 -39.08 71.58 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.494 0.664 . . . . 0.0 110.131 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.1 tp -54.22 -52.87 59.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.315 1.446 . . . . 0.0 112.415 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 15.6 mt -57.96 -30.14 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.566 1.146 . . . . 0.0 111.282 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.4 ttm180 -72.05 -33.68 68.16 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.39 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 127' ' ' LYS . 12.4 mm-40 -73.67 -56.51 4.92 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 173.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 pp -78.38 -30.52 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -95.85 -30.5 13.63 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 119.358 -0.354 . . . . 0.0 111.539 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 26.2 mmmt 61.97 74.66 0.43 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.746 0.818 . . . . 0.0 111.848 176.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.5 mt . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 123.637 0.775 . . . . 0.0 109.463 -175.499 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.476 ' O ' ' HG2' ' A' ' 137' ' ' ARG . 39.3 t30 . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.02 -29.14 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.389 1.076 . . . . 0.0 112.476 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.12 -51.51 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.219 0.608 . . . . 0.0 110.592 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -63.55 -30.46 71.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.633 0.373 . . . . 0.0 111.441 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 133' ' ' ASN . 4.2 mmp_? -69.61 -47.7 62.55 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.107 0.563 . . . . 0.0 110.975 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.8 p -72.66 -36.59 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.82 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.0 mp -58.59 -37.21 75.33 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.149 0.98 . . . . 0.0 111.88 173.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -67.31 -41.59 85.09 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.3 0.375 . . . . 0.0 111.341 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -72.84 -42.52 63.69 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 120.876 0.37 . . . . 0.0 111.834 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 29.9 pt -74.77 -24.04 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.617 ' HB3' ' HE2' ' A' ' 43' ' ' HIS . . . . . . . . 0 C--O 1.212 -0.894 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.168 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.522 ' HG2' HG23 ' A' ' 45' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.473 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 74.3 mt -109.1 101.4 12.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 9.3 mm -110.21 124.11 66.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -121.58 145.12 48.3 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.79 137.62 13.49 Favored Glycine 0 CA--C 1.5 -0.875 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.4 tt -148.85 138.64 16.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.336 0.588 . . . . 0.0 110.357 -173.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -125.34 126.82 45.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.813 1.245 . . . . 0.0 108.714 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.96 -0.11 57.5 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 123.377 0.423 . . . . 0.0 112.565 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.8 94.37 0.45 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.22 1.008 . . . . 0.0 110.823 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -68.89 104.18 2.0 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.503 HD13 HG23 ' A' ' 86' ' ' VAL . 44.6 mm -72.61 120.78 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -176.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.445 ' ND2' HG23 ' A' ' 20' ' ' ILE . 3.4 p-10 -104.08 156.1 18.15 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -81.8 -14.58 56.18 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.099 0.559 . . . . 0.0 111.63 -174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -76.5 -17.21 59.39 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.161 0.984 . . . . 0.0 111.45 -172.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.465 ' HB ' HD12 ' A' ' 99' ' ' ILE . 30.3 pt -53.91 -19.81 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 172.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -83.32 -17.93 40.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.082 0.553 . . . . 0.0 111.94 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -91.35 47.05 1.34 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.074 0.94 . . . . 0.0 109.716 -169.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -139.29 -11.99 1.21 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.311 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.67 33.32 55.0 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 114.513 0.565 . . . . 0.0 114.513 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.502 ' HB2' HD11 ' A' ' 23' ' ' LEU . 67.2 mt -102.97 167.38 9.88 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.423 0.689 . . . . 0.0 110.715 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HB3' ' HZ2' ' A' ' 59' ' ' TRP . 60.2 mttp -81.87 91.49 6.55 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.935 0.894 . . . . 0.0 111.31 -176.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.53 158.36 43.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.068 0.547 . . . . 0.0 109.92 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.514 ' NE2' ' HB3' ' A' ' 63' ' ' LEU . 1.6 tm0? -149.26 149.81 31.55 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 165.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.3 mt -132.18 131.8 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.35 -176.12 3.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.825 0.85 . . . . 0.0 109.447 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -80.68 141.78 34.57 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.844 0.858 . . . . 0.0 109.732 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.404 ' HA ' ' SG ' ' A' ' 87' ' ' CYS . . . -96.23 7.8 45.52 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.3 0.64 . . . . 0.0 112.706 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -88.83 -19.89 25.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.316 0.647 . . . . 0.0 110.855 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' A' ' 79' ' ' ILE . 18.4 m -111.91 7.31 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.061 0.945 . . . . 0.0 111.641 -176.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.2 102.55 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 121.91 0.862 . . . . 0.0 109.971 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.537 ' HB3' HG13 ' A' ' 138' ' ' VAL . . . -79.17 74.83 5.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.539 ' HG1' HG12 ' A' ' 135' ' ' VAL . 22.1 p 62.69 162.25 0.09 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.63 1.972 . . . . 0.0 111.677 -166.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . 25.3 pttm -53.17 -22.49 6.59 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.506 0.723 . . . . 0.0 111.542 169.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.595 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 56.8 tttp -64.45 -28.42 69.66 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 123.187 0.595 . . . . 0.0 111.541 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.488 ' HA ' HD12 ' A' ' 139' ' ' LEU . 11.7 t-160 -62.73 -45.53 92.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.021 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 45' ' ' ILE . 42.3 t -67.68 -55.17 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 123.735 0.647 . . . . 0.0 111.195 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.595 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 4.1 pp -60.02 -32.69 71.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.095 0.558 . . . . 0.0 112.395 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 36.9 t60 -65.75 -40.77 92.45 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.372 0.669 . . . . 0.0 110.479 173.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.91 87.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.954 0.502 . . . . 0.0 110.789 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.538 ' HA ' HG12 ' A' ' 62' ' ' ILE . 33.8 mt -64.9 -46.59 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.232 1.013 . . . . 0.0 110.76 175.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -49.0 -48.39 43.58 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.44 1.496 . . . . 0.0 111.084 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 25.8 mm-40 -63.67 -47.24 82.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.089 176.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . . . -64.79 -28.71 69.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.462 0.705 . . . . 0.0 112.556 -175.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HE2' HG22 ' A' ' 45' ' ' ILE . 68.2 mttm -66.11 -43.69 86.49 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.279 0.632 . . . . 0.0 110.925 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.1 t -80.17 -16.82 54.01 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.799 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 51.3 mtpt -99.28 146.95 25.68 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.999 0.92 . . . . 0.0 112.27 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -142.96 72.86 18.67 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.577 161.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 51' ' ' LYS . 56.2 Cg_endo -84.25 -177.04 2.82 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.657 2.238 . . . . 0.0 111.852 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.5 mt -37.04 -22.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.21 125.42 17.51 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.446 0.698 . . . . 0.0 110.787 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -57.02 -22.26 37.34 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -167.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.618 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 41.9 t -157.36 167.29 30.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.214 0.606 . . . . 0.0 110.114 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -58.73 -50.16 74.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.589 1.156 . . . . 0.0 110.467 170.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.461 ' HA ' HD13 ' A' ' 62' ' ' ILE . 81.7 m95 -64.54 -30.99 72.02 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.651 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.644 ' HB3' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -78.81 -21.03 48.35 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.907 0.883 . . . . 0.0 111.316 176.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -74.07 -35.52 64.25 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 173.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 45' ' ' ILE . 77.5 mt -65.58 -42.36 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.722 0.809 . . . . 0.0 112.344 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.514 ' HB3' ' NE2' ' A' ' 28' ' ' GLN . 3.2 pp -71.53 -34.03 69.69 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 122.998 0.186 . . . . 0.0 110.879 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.97 -38.11 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.414 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.54 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 0.3 OUTLIER -66.48 -50.22 64.02 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 122.816 0.447 . . . . 0.0 110.659 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.29 68.51 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.225 0.61 . . . . 0.0 112.06 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 t -88.68 -0.2 57.05 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.712 0.805 . . . . 0.0 112.506 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.89 17.76 65.65 Favored Glycine 0 C--N 1.354 1.564 0 N-CA-C 114.485 0.554 . . . . 0.0 114.485 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.693 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 46.5 tp60 -107.91 164.96 11.82 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.609 1.164 . . . . 0.0 109.63 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -114.36 -6.2 12.92 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 123.038 0.535 . . . . 0.0 111.508 167.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.693 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 17.0 mm-40 -103.94 119.03 38.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.427 1.091 . . . . 0.0 110.684 -173.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.644 HD13 ' HB3' ' A' ' 60' ' ' MET . 34.7 mm -52.92 -53.02 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 124.736 1.273 . . . . 0.0 112.386 -173.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -61.09 -50.17 74.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.59 -173.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.27 -44.56 84.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.227 0.611 . . . . 0.0 112.091 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.03 94.19 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.68 -31.84 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 122.918 0.487 . . . . 0.0 110.612 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -67.13 -50.24 62.07 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.814 0.446 . . . . 0.0 110.46 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 56.6 mt -70.66 -67.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.762 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.402 ' HB ' HG23 ' A' ' 34' ' ' VAL . 16.2 pt -108.83 20.63 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.25 172.15 45.04 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 119.018 0.826 . . . . 0.0 112.92 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.97 144.18 26.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.18 0.592 . . . . 0.0 111.314 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -154.45 167.56 29.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.748 1.219 . . . . 0.0 108.25 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.02 127.27 23.37 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.074 0.95 . . . . 0.0 111.853 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.4 -116.3 2.5 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.371 0.419 . . . . 0.0 112.533 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.93 107.39 18.99 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.661 0.785 . . . . 0.0 109.373 -176.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.503 HG23 HD13 ' A' ' 16' ' ' ILE . 15.8 m -135.7 167.98 23.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-O 121.912 0.863 . . . . 0.0 111.976 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.404 ' SG ' ' HA ' ' A' ' 32' ' ' ALA . 69.9 m -119.02 117.58 29.17 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.375 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 10.2 tp -100.04 123.48 44.34 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.272 0.629 . . . . 0.0 109.326 -175.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.505 HD13 ' HB3' ' A' ' 28' ' ' GLN . 30.3 mt -109.34 137.21 42.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.195 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 26.5 p -156.84 157.69 35.41 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.578 0.751 . . . . 0.0 109.288 171.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -88.77 -28.2 20.64 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.872 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.475 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 23.8 m-20 -124.83 139.74 53.56 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.218 1.007 . . . . 0.0 110.962 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.14 -24.38 64.66 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.94 0.896 . . . . 0.0 112.435 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 11.2 pt-20 -68.31 -44.1 76.15 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.3 m -68.01 -35.87 79.02 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.599 0.76 . . . . 0.0 111.345 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.724 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 11.0 t80 -58.25 -48.05 81.66 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 122.889 0.476 . . . . 0.0 109.826 173.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -57.85 -47.58 82.29 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.298 0.999 . . . . 0.0 110.514 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 42.1 mmtm -53.83 -48.36 70.0 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 124.191 0.932 . . . . 0.0 111.469 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.465 HD12 ' HB ' ' A' ' 20' ' ' ILE . 44.1 mm -71.68 -44.72 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.065 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -55.05 -44.52 74.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.499 1.119 . . . . 0.0 112.851 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -60.07 -42.5 94.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.584 0.754 . . . . 0.0 110.248 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 98' ' ' LYS . 4.5 mm? -65.89 -51.67 56.74 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.0 pt -73.61 -42.56 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 117.915 0.325 . . . . 0.0 111.671 -167.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.13 103.32 0.03 OUTLIER Glycine 0 C--N 1.347 1.162 0 O-C-N 123.262 0.352 . . . . 0.0 113.584 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.31 -174.54 39.11 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.35 126.31 45.2 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.727 0.811 . . . . 0.0 109.334 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.6 mm -68.51 122.48 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -135.24 98.68 4.04 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.718 1.207 . . . . 0.0 108.216 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -68.24 -31.15 70.43 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.975 0.51 . . . . 0.0 111.887 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.664 ' HA ' ' HG2' ' A' ' 113' ' ' GLU . 46.9 t -52.73 -31.45 37.89 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.68 HG23 ' HE3' ' A' ' 118' ' ' LYS . 2.6 p -69.31 -29.62 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 122.7 0.4 . . . . 0.0 110.28 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 28.5 mt -95.15 9.89 37.96 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.8 0.84 . . . . 0.0 112.153 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.664 ' HG2' ' HA ' ' A' ' 110' ' ' SER . 8.4 pt-20 -120.76 4.11 10.57 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.96 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.267 0.5 OUTLIER 76.15 138.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.092 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 172.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 26.6 p-10 -136.89 171.5 14.4 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 113.154 -1.839 . . . . 0.0 108.036 170.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.97 -31.36 70.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.173 0.589 . . . . 0.0 112.223 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.41 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 19.3 t70 -60.27 -53.14 61.22 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.113 0.965 . . . . 0.0 112.31 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HE3' HG23 ' A' ' 111' ' ' VAL . 63.7 mttm -74.88 -20.69 59.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.324 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.489 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 42.8 tt0 -72.82 -43.73 62.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.332 0.653 . . . . 0.0 111.522 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -72.07 -33.97 68.34 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.095 0.558 . . . . 0.0 110.588 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.1 -49.58 76.44 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.461 1.104 . . . . 0.0 111.143 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.439 HD11 ' HB1' ' A' ' 36' ' ' ALA . 24.4 mt -57.35 -40.67 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.353 1.061 . . . . 0.0 112.051 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -74.66 -23.34 58.64 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 119.156 -0.45 . . . . 0.0 111.167 -176.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 127' ' ' LYS . 48.5 mt-10 -73.42 -55.14 6.76 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 169.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.42 -31.76 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 CA-C-N 120.573 1.533 . . . . 0.0 112.777 -176.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -88.72 -30.29 19.21 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 124' ' ' GLU . 38.9 mmtm 63.42 75.51 0.39 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.386 1.075 . . . . 0.0 112.484 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.499 HG21 ' HG3' ' A' ' 137' ' ' ARG . 14.2 mt . . . . . 0 CA--C 1.55 0.951 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.538 HD22 ' HB2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HB ' ' HG3' ' A' ' 119' ' ' GLU . 13.6 p -76.4 -33.85 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.539 HG12 ' HG1' ' A' ' 37' ' ' THR . 60.4 t -65.37 -59.8 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.565 0.746 . . . . 0.0 112.153 -164.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.538 ' HB2' HD22 ' A' ' 133' ' ' ASN . 37.7 mt-10 -73.2 -28.73 62.35 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.81 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.499 ' HG3' HG21 ' A' ' 128' ' ' ILE . 20.2 tpt180 -77.35 -32.48 55.11 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.502 -170.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 36' ' ' ALA . 14.2 p -72.24 -33.87 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 40' ' ' HIS . 2.5 mp -54.76 -38.89 67.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.254 1.021 . . . . 0.0 111.044 170.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -67.61 -37.86 83.12 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.643 0.777 . . . . 0.0 111.171 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -68.58 -48.7 63.51 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 111.503 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 26.6 pt -78.53 -10.53 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.816 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.813 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.743 171.019 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.395 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.64 42.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.558 0.743 . . . . 0.0 110.791 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.3 mtt -130.47 30.45 4.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.291 1.037 . . . . 0.0 109.575 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' HA ' HD21 ' A' ' 42' ' ' LEU . 5.3 m-20 57.24 74.36 0.67 Allowed Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 124.694 1.197 . . . . 0.0 110.555 -171.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.21 -53.42 2.48 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 122.974 2.449 . . . . 0.0 112.658 -175.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.405 ' SD ' ' HG2' ' A' ' 91' ' ' GLU . 24.3 mmt -95.12 177.48 5.86 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.595 0.758 . . . . 0.0 109.553 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.9 mt -101.39 103.56 15.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.1 mp -109.72 121.39 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -131.81 145.46 51.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.78 0.832 . . . . 0.0 109.084 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.38 124.63 8.18 Favored Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.2 tt -130.68 138.89 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 122.801 0.44 . . . . 0.0 109.869 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -129.3 124.14 33.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.839 0.855 . . . . 0.0 108.798 -172.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.41 2.36 56.64 Favored Glycine 0 N--CA 1.467 0.762 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.997 -170.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -74.44 98.17 3.25 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 123.792 0.837 . . . . 0.0 111.188 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.531 ' HA ' ' HB2' ' A' ' 83' ' ' ASP . 70.7 mtp180 -73.81 107.36 6.0 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.956 0.502 . . . . 0.0 110.616 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.468 HD12 HG12 ' A' ' 86' ' ' VAL . 49.6 mm -69.49 122.96 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.891 0.877 . . . . 0.0 110.79 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.27 165.64 18.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.519 0.728 . . . . 0.0 109.352 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -73.2 -17.0 61.41 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.39 -31.62 68.93 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.503 0.721 . . . . 0.0 111.795 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.482 HD11 HD12 ' A' ' 29' ' ' ILE . 16.0 pt -52.13 -28.35 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -90.11 -20.07 23.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.55 0.34 . . . . 0.0 111.303 -176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -76.81 -12.46 59.98 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.503 0.721 . . . . 0.0 111.83 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.469 HD22 HD12 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -81.0 -8.59 59.81 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.679 0.391 . . . . 0.0 111.776 176.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.48 19.08 17.16 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.403 ' HB2' HD13 ' A' ' 23' ' ' LEU . 98.5 mt -81.66 174.74 11.09 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.493 0.646 . . . . 0.0 110.394 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -90.18 96.49 10.69 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.228 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -147.68 157.59 43.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.702 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.557 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -138.26 147.1 43.3 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 167.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.482 HD12 HD11 ' A' ' 20' ' ' ILE . 35.6 mt -132.29 121.6 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.519 ' HB3' HE22 ' A' ' 28' ' ' GLN . 4.2 pp -121.57 177.8 5.08 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.437 ' HB3' HG22 ' A' ' 34' ' ' VAL . 38.6 t-20 -75.71 119.46 19.76 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.654 0.782 . . . . 0.0 110.038 -173.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.42 -1.52 41.81 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.558 ' HA ' ' NZ ' ' A' ' 118' ' ' LYS . 37.8 t70 -79.67 -32.41 41.52 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.495 0.188 . . . . 0.0 110.522 176.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 31' ' ' ASN . 27.7 m -98.75 -2.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.873 0.869 . . . . 0.0 112.538 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.439 HG12 HD21 ' A' ' 112' ' ' LEU . 10.5 p -78.69 139.96 17.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.1 -72.25 0.33 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 40.3 p -147.15 -177.35 5.63 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.823 0.849 . . . . 0.0 110.401 176.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -52.03 -39.77 60.06 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.168 167.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.42 ' HD2' HD12 ' A' ' 42' ' ' LEU . 22.9 tptm -56.07 -29.94 61.25 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.676 0.79 . . . . 0.0 111.504 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.533 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.6 t-80 -68.44 -50.85 49.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.425 0.69 . . . . 0.0 111.015 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.407 HG13 HG12 ' A' ' 89' ' ' ILE . 93.0 t -68.37 -54.75 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.49 ' HA ' HD13 ' A' ' 45' ' ' ILE . 4.2 pp -56.16 -33.16 64.96 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.664 0.786 . . . . 0.0 111.835 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.534 ' HE2' ' HB2' ' A' ' 143' ' ' ALA . 79.5 t60 -62.45 -45.28 93.78 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.061 173.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.17 87.51 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.383 0.673 . . . . 0.0 111.367 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.558 HG12 HD11 ' A' ' 62' ' ' ILE . 48.2 mt -56.96 -48.53 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.965 0.906 . . . . 0.0 109.815 170.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.548 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 62.1 t30 -64.95 -30.36 71.34 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.388 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 10.2 mm-40 -68.66 -39.96 80.39 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.952 0.501 . . . . 0.0 109.824 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -66.99 -26.33 66.75 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.464 0.706 . . . . 0.0 112.352 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 46' ' ' ASN . 10.1 mtmp? -78.92 -31.94 45.44 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.631 0.372 . . . . 0.0 111.847 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.498 HG23 ' HG2' ' A' ' 51' ' ' LYS . 8.6 t -95.26 -45.17 7.28 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.68 0.392 . . . . 0.0 111.954 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.629 ' HB2' HH22 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -121.13 120.04 34.12 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.002 0.921 . . . . 0.0 109.183 -175.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -103.84 99.66 17.08 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 123.016 0.526 . . . . 0.0 110.229 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.61 -81.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.858 2.372 . . . . 0.0 113.935 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.4 pt -150.67 11.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.813 0.845 . . . . 0.0 111.83 -168.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.58 160.54 27.54 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -169.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -68.59 -50.14 53.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.783 0.833 . . . . 0.0 111.125 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -146.08 171.44 14.89 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.56 0.744 . . . . 0.0 110.197 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.93 -58.7 6.92 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.855 0.862 . . . . 0.0 111.897 -174.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.557 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 91.4 m95 -63.85 -33.81 76.53 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.756 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.8 mmm -73.53 -18.98 61.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.827 0.451 . . . . 0.0 110.674 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.595 ' HG2' HH11 ' A' ' 65' ' ' ARG . 22.3 tt0 -77.68 -38.84 46.65 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.072 0.949 . . . . 0.0 110.984 173.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.558 HD11 HG12 ' A' ' 45' ' ' ILE . 82.8 mt -55.0 -53.51 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.673 0.789 . . . . 0.0 111.27 -177.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.45 ' O ' HD13 ' A' ' 79' ' ' ILE . 4.3 pp -52.74 -31.29 37.23 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.189 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 61' ' ' GLU . 1.9 m -78.78 -32.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 112.005 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.629 HH22 ' HB2' ' A' ' 51' ' ' LYS . 11.8 mmm-85 -68.12 -45.14 74.5 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 122.954 0.502 . . . . 0.0 110.866 -175.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.41 -20.15 64.19 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.892 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -97.14 12.65 32.0 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.28 41.9 7.24 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 118.349 0.522 . . . . 0.0 113.481 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 57.37 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.193 1.797 . . . . 0.0 111.152 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -121.18 -160.97 0.88 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.328 1.051 . . . . 0.0 109.354 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -120.7 162.01 20.44 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.64 -49.97 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.264 1.026 . . . . 0.0 112.137 -170.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.444 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 33.6 m170 -61.45 -55.21 33.81 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.751 0.657 . . . . 0.0 110.623 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.41 -56.61 16.92 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.055 0.847 . . . . 0.0 111.789 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 -30.4 69.35 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.5 mt -68.22 -38.38 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.49 0.316 . . . . 0.0 111.012 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 73' ' ' HIS . 60.4 mttm -68.9 -45.66 70.35 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.529 HG23 HG23 ' A' ' 79' ' ' ILE . 59.4 mt -71.22 -66.11 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.206 1.003 . . . . 0.0 111.373 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.529 HG23 HG23 ' A' ' 78' ' ' ILE . 29.8 pt -122.7 26.83 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.64 179.75 48.69 Favored Glycine 0 N--CA 1.48 1.596 0 CA-C-N 118.821 0.737 . . . . 0.0 113.402 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.1 144.37 47.03 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.779 0.432 . . . . 0.0 111.323 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -151.28 149.24 29.15 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 15' ' ' ARG . 6.2 p-10 -65.79 151.33 46.87 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.459 0.572 . . . . 0.0 111.559 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.61 -118.36 6.08 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.481 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.443 HD21 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -85.27 103.78 14.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.468 HG12 HD12 ' A' ' 16' ' ' ILE . 1.1 p -137.72 156.07 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.116 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.2 t -106.85 122.87 47.27 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.504 1.122 . . . . 0.0 109.388 -170.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -95.68 128.6 42.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 28' ' ' GLN . 7.7 mt -120.27 117.92 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.671 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 42.3 t -145.91 161.94 38.89 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.874 0.369 . . . . 0.0 111.712 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.405 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 43.6 mt-10 -91.89 -47.91 7.06 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.591 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -111.7 136.3 51.12 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.171 0.588 . . . . 0.0 110.362 -171.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -57.63 -27.39 62.75 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.517 0.727 . . . . 0.0 112.403 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.79 -42.71 69.99 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.671 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 60.5 m -65.75 -37.58 86.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.749 0.82 . . . . 0.0 111.466 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -61.85 -43.1 99.53 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -62.37 -40.96 98.16 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 123.893 0.745 . . . . 0.0 110.055 177.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 34.5 mmtp -57.35 -51.82 67.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.454 0.702 . . . . 0.0 110.58 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.469 HD12 HD22 ' A' ' 23' ' ' LEU . 43.8 mm -66.15 -44.31 91.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.372 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.97 -40.31 29.93 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.499 1.119 . . . . 0.0 112.955 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 22.6 mm-40 -59.58 -46.86 87.68 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.509 0.506 . . . . 0.0 111.66 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.403 ' HB2' HG21 ' A' ' 20' ' ' ILE . 3.1 mm? -73.82 -36.43 64.95 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.465 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 20.3 pt -80.35 -47.71 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 118.639 0.654 . . . . 0.0 110.995 -173.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.07 95.17 0.02 OUTLIER Glycine 0 C--N 1.349 1.276 0 O-C-N 123.602 0.564 . . . . 0.0 113.517 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -158.11 -169.4 21.65 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -109.66 135.14 51.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.434 0.617 . . . . 0.0 109.728 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.7 mm -78.43 122.39 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -144.14 96.5 2.89 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -67.42 -17.12 64.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.578 0.751 . . . . 0.0 111.758 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.0 t -60.04 -26.66 66.31 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.12 -22.12 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.21 0.529 . . . . 0.0 110.252 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.439 HD21 HG12 ' A' ' 35' ' ' VAL . 56.2 mt -103.02 17.43 24.09 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.455 1.102 . . . . 0.0 111.953 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -113.44 -1.97 14.04 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 120.176 1.353 . . . . 0.0 112.942 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.25 0.3 OUTLIER 76.97 139.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 124.812 1.245 . . . . 0.0 113.313 177.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -154.24 -173.38 4.55 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.851 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.12 -34.12 70.75 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -64.05 -47.09 81.52 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.624 0.37 . . . . 0.0 111.733 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.558 ' NZ ' ' HA ' ' A' ' 33' ' ' ASP . 4.8 mptp? -62.16 -34.18 75.91 Favored 'General case' 0 C--O 1.209 -1.049 0 O-C-N 123.46 0.475 . . . . 0.0 109.826 173.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.24 -51.9 65.89 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.66 0.6 . . . . 0.0 111.148 -172.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -70.45 -39.12 74.52 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -72.78 -33.06 66.05 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 122.108 -0.37 . . . . 0.0 110.833 177.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.456 HG21 ' HD2' ' A' ' 126' ' ' PHE . 6.3 mt -61.09 -38.65 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.656 0.782 . . . . 0.0 110.805 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 7.8 ptp180 -73.9 -23.86 59.62 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.025 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.545 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 13.0 tp10 -64.11 -58.53 6.37 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 170.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -35.9 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 118.68 0.673 . . . . 0.0 112.777 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.456 ' HD2' HG21 ' A' ' 122' ' ' ILE . 22.9 m-85 -87.99 -30.89 19.67 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 119.126 -0.464 . . . . 0.0 111.77 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.545 ' HE3' ' HA ' ' A' ' 124' ' ' GLU . 21.4 mmtp 59.05 76.09 0.37 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.046 0.938 . . . . 0.0 111.744 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.506 HG12 ' HD3' ' A' ' 141' ' ' LYS . 25.6 mt -120.99 127.69 75.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.77 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -86.43 105.82 17.02 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 167.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 179.57 138.69 3.4 Favored Glycine 0 C--N 1.343 0.931 0 O-C-N 123.239 0.337 . . . . 0.0 112.29 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -107.62 -169.72 1.58 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.765 1.226 . . . . 0.0 109.561 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.49 -123.74 6.25 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.79 -0.45 . . . . 0.0 111.993 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -96.8 119.49 35.38 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.403 0.681 . . . . 0.0 110.468 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.07 -26.25 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.527 1.131 . . . . 0.0 112.288 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.04 -46.67 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.484 0.659 . . . . 0.0 109.745 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.72 -40.61 88.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.855 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -67.95 -38.27 82.62 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.595 0.559 . . . . 0.0 112.344 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.432 ' HA ' HD11 ' A' ' 128' ' ' ILE . 14.4 p -70.15 -42.79 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.533 HD11 ' HA ' ' A' ' 40' ' ' HIS . 9.6 mp -62.09 -42.99 99.78 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 122.77 0.428 . . . . 0.0 111.692 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 144' ' ' LEU . 46.4 mt-10 -57.1 -44.5 83.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.528 0.331 . . . . 0.0 111.626 177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.506 ' HD3' HG12 ' A' ' 128' ' ' ILE . 8.4 ttpt -71.97 -46.87 55.8 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.185 0.303 . . . . 0.0 111.202 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.0 pt -75.84 -33.72 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.401 -171.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.534 ' HB2' ' HE2' ' A' ' 43' ' ' HIS . . . -95.58 -4.52 44.47 Favored 'General case' 0 C--O 1.246 0.876 0 C-N-CA 123.585 0.754 . . . . 0.0 112.823 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 18.7 tp -60.97 -48.94 79.52 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.9 mt -70.07 -35.73 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.495 0.718 . . . . 0.0 111.61 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.15 -7.49 12.75 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.786 0.834 . . . . 0.0 112.718 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.6 mt 81.59 18.79 0.41 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.094 1.357 . . . . 0.0 111.774 167.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.0 pttp 171.91 128.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.801 0.84 . . . . 0.0 110.482 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -77.46 35.83 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.099 0.959 . . . . 0.0 112.254 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 C--O 1.253 1.279 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -168.097 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.16 167.53 21.74 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.794 0.837 . . . . 0.0 111.291 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.66 -46.12 77.57 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.08 0.952 . . . . 0.0 109.661 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -109.13 96.69 22.03 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 165.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.679 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 56.5 Cg_endo -68.86 -36.85 12.58 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.562 2.175 . . . . 0.0 111.988 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.679 ' SD ' ' HG2' ' A' ' 5' ' ' PRO . 1.5 mpt? -105.58 174.2 5.98 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.3 mt -106.08 103.43 15.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.4 mm -107.71 122.99 62.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.69 144.86 51.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.751 0.705 . . . . 0.0 110.627 -173.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' N ' HD12 ' A' ' 112' ' ' LEU . . . -104.85 127.47 9.07 Favored Glycine 0 CA--C 1.502 -0.78 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 tt -141.64 145.71 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.072 0.549 . . . . 0.0 110.679 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -123.22 130.78 53.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.581 1.152 . . . . 0.0 109.616 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.15 7.73 69.7 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.839 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.12 94.76 1.16 Allowed 'General case' 0 C--N 1.349 0.547 0 C-N-CA 123.938 0.895 . . . . 0.0 111.131 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HA ' ' HB2' ' A' ' 83' ' ' ASP . 51.0 mtt180 -73.07 103.44 3.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.123 0.569 . . . . 0.0 109.803 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.99 108.93 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.701 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.417 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -114.08 165.56 12.51 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.597 0.759 . . . . 0.0 110.604 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -71.49 -16.4 62.35 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.89 -36.74 84.24 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 118.251 0.478 . . . . 0.0 111.671 -173.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.454 ' HA ' HD13 ' A' ' 102' ' ' LEU . 18.1 pt -50.47 -20.83 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -93.14 -26.55 17.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.422 0.689 . . . . 0.0 111.233 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -72.72 -16.92 61.66 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.641 0.776 . . . . 0.0 112.149 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.486 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -80.89 -10.21 59.74 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.883 0.473 . . . . 0.0 111.817 179.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.46 21.31 26.91 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 116.37 1.308 . . . . 0.0 116.37 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.486 ' HB2' HD13 ' A' ' 23' ' ' LEU . 92.4 mt -87.34 176.52 7.49 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.244 0.618 . . . . 0.0 111.468 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB3' ' HZ2' ' A' ' 59' ' ' TRP . 2.9 mptp? -85.69 98.33 10.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.859 0.864 . . . . 0.0 109.758 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -146.97 160.58 42.18 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.114 0.566 . . . . 0.0 110.331 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -144.39 149.71 36.55 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 161.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.1 mt -131.29 127.22 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 pp -125.64 173.22 9.14 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.197 0.599 . . . . 0.0 109.979 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 33' ' ' ASP . 61.3 t30 -77.03 138.8 39.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.353 0.661 . . . . 0.0 110.738 -171.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.579 ' HA ' ' SG ' ' A' ' 87' ' ' CYS . . . -80.37 0.1 34.57 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.533 ' HB3' HD21 ' A' ' 121' ' ' LEU . 21.4 m-20 -82.75 -23.1 34.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.257 0.623 . . . . 0.0 111.128 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.608 HG23 ' HB ' ' A' ' 79' ' ' ILE . 32.5 m -113.97 -3.73 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.692 0.797 . . . . 0.0 111.718 -171.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -59.41 -32.71 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.734 0.814 . . . . 0.0 112.38 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 59.79 -84.61 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.447 1.099 . . . . 0.0 109.372 -170.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 40.9 p -139.14 174.41 10.54 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.92 0.888 . . . . 0.0 109.353 171.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.91 -45.23 50.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.05 165.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -51.5 -34.41 35.84 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.335 1.054 . . . . 0.0 112.592 -178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.547 ' HA ' HD11 ' A' ' 139' ' ' LEU . 11.2 t-80 -66.55 -54.53 22.73 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.696 0.623 . . . . 0.0 111.028 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -70.69 -47.78 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 122.696 0.399 . . . . 0.0 112.074 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.517 HD22 ' HD2' ' A' ' 5' ' ' PRO . 3.9 pp -60.45 -30.39 69.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.191 0.596 . . . . 0.0 111.556 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.447 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 71.2 t60 -61.6 -46.74 88.57 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 169.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.462 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . . . -61.86 -44.99 95.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.959 0.504 . . . . 0.0 111.407 -176.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.505 HG23 ' HE3' ' A' ' 49' ' ' LYS . 36.0 mt -65.98 -49.77 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.322 1.049 . . . . 0.0 111.081 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -51.6 -47.42 63.61 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.291 1.036 . . . . 0.0 110.991 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 17.9 mm100 -66.77 -35.48 80.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.327 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.09 63.25 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 122.672 0.389 . . . . 0.0 111.545 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.505 ' HE3' HG23 ' A' ' 45' ' ' ILE . 98.4 mttt -86.31 -36.92 19.01 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.439 0.696 . . . . 0.0 112.06 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 47' ' ' GLN . 10.3 t -88.14 -37.28 16.31 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.909 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 47' ' ' GLN . 39.6 mtmt -85.53 157.54 20.39 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.683 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -102.64 103.31 31.57 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.18 177.43 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 124.154 3.236 . . . . 0.0 115.466 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.31 5.02 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.266 165.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.59 179.29 2.17 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.524 1.13 . . . . 0.0 111.749 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -62.33 -47.66 83.27 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.029 0.532 . . . . 0.0 110.326 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.4 m -157.85 -172.81 4.08 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.239 1.015 . . . . 0.0 110.185 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -62.01 -59.3 5.29 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.635 1.174 . . . . 0.0 112.919 -176.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.453 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 87.8 m95 -63.42 -28.71 70.16 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 120.753 0.311 . . . . 0.0 110.848 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.6 mmt -74.81 -21.22 59.42 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.687 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -75.84 -43.05 47.76 Favored 'General case' 0 C--O 1.209 -1.039 0 C-N-CA 122.398 0.279 . . . . 0.0 110.373 170.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.44 HD11 HG12 ' A' ' 45' ' ' ILE . 86.8 mt -56.47 -39.28 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.676 0.79 . . . . 0.0 112.173 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.06 -30.91 67.19 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.333 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -83.17 -29.05 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.337 -0.852 . . . . 0.0 110.922 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.481 HH22 ' HB ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -71.2 -45.75 62.71 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.548 1.139 . . . . 0.0 109.937 -172.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.22 -24.65 67.4 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.488 0.715 . . . . 0.0 112.031 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.2 p -100.18 23.67 9.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.241 0.616 . . . . 0.0 110.568 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.07 -88.54 1.54 Allowed Glycine 0 C--N 1.36 1.913 0 O-C-N 122.182 -0.324 . . . . 0.0 113.442 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.663 ' HB2' HG12 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -167.15 121.35 1.02 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -173.25 163.59 4.62 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 124.691 1.244 . . . . 0.0 109.053 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -57.39 149.69 20.06 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.136 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.32 -41.04 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.708 1.203 . . . . 0.0 111.845 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -57.21 -49.77 74.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.395 0.678 . . . . 0.0 111.096 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.501 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 49.9 mm-40 -57.0 -48.73 77.75 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.621 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.42 -36.81 83.53 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.666 0.786 . . . . 0.0 112.824 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.51 -37.55 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.041 0.536 . . . . 0.0 110.891 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 74' ' ' GLU . 53.2 mtmt -67.72 -48.65 65.91 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.798 0.333 . . . . 0.0 110.205 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.485 HG22 ' HB ' ' A' ' 125' ' ' ILE . 78.0 mt -74.21 -65.18 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.649 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.608 ' HB ' HG23 ' A' ' 34' ' ' VAL . 7.7 pt -109.41 14.3 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.61 168.55 46.07 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 119.433 1.015 . . . . 0.0 112.423 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.98 121.74 26.41 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.832 0.453 . . . . 0.0 111.323 -175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -116.95 162.36 17.89 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 165.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 15' ' ' ARG . 7.5 p-10 -65.35 153.91 39.83 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.293 0.637 . . . . 0.0 112.158 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.57 -119.46 5.81 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.358 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.454 HD21 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -87.45 104.6 16.61 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.8 p -136.92 168.74 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.562 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 32' ' ' ALA . 88.3 m -122.45 123.64 41.77 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.389 1.075 . . . . 0.0 110.238 -175.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.428 HD21 ' HB ' ' A' ' 99' ' ' ILE . 11.4 tp -102.91 125.5 49.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.281 0.632 . . . . 0.0 109.625 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mt -108.3 132.74 55.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.632 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.7 t -155.37 154.72 32.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.157 0.503 . . . . 0.0 111.225 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -87.17 -40.44 14.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.923 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.55 137.94 51.99 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.11 0.964 . . . . 0.0 110.482 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -66.64 -35.93 81.34 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -170.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.74 -26.64 57.64 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.779 0.718 . . . . 0.0 110.348 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 96.9 m -67.88 -42.58 81.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.228 0.611 . . . . 0.0 111.167 165.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -56.97 -49.65 75.08 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.998 0.919 . . . . 0.0 110.817 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 76.7 ttt180 -65.27 -36.95 85.69 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 123.569 0.543 . . . . 0.0 110.441 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -56.2 -40.32 73.83 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.771 0.428 . . . . 0.0 111.674 176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.466 HD11 HD21 ' A' ' 23' ' ' LEU . 29.1 mm -69.47 -45.83 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -53.69 -40.3 65.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.561 1.145 . . . . 0.0 112.564 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 70.7 mm-40 -59.47 -47.23 86.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.27 0.628 . . . . 0.0 110.847 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 20' ' ' ILE . 57.5 mt -72.75 -38.39 67.38 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.3 pt -74.63 -37.74 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 118.366 0.53 . . . . 0.0 110.768 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.98 93.41 0.03 OUTLIER Glycine 0 C--N 1.351 1.402 0 O-C-N 123.623 0.577 . . . . 0.0 114.312 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.27 -167.65 22.02 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -113.33 140.65 47.85 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.79 123.24 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.18 95.35 4.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.15 -42.03 85.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.898 0.479 . . . . 0.0 111.463 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.0 p -54.21 -29.91 48.01 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.6 p -67.32 -24.03 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 CA-C-N 118.565 0.621 . . . . 0.0 110.941 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 37' ' ' THR . 81.2 mt -86.28 -19.41 29.93 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.748 0.819 . . . . 0.0 112.009 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -93.37 -1.83 55.42 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 118.462 -0.78 . . . . 0.0 113.038 -165.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.26 0.5 OUTLIER 78.83 133.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 124.557 1.143 . . . . 0.0 112.89 -178.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 117' ' ' ASP . 4.4 p-10 -146.79 168.33 21.66 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.506 167.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.5 -34.13 76.26 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.906 0.482 . . . . 0.0 111.829 -169.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.42 ' HB2' ' ND2' ' A' ' 115' ' ' ASN . 14.2 m-20 -59.7 -48.95 79.65 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.928 0.491 . . . . 0.0 111.469 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -67.29 -27.25 67.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.448 0.468 . . . . 0.0 110.741 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.457 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 30.3 tt0 -72.62 -44.98 61.24 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.017 0.527 . . . . 0.0 110.998 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -73.69 -40.53 63.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.655 0.782 . . . . 0.0 109.993 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 33' ' ' ASP . 62.5 tp -53.78 -53.77 47.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.262 1.425 . . . . 0.0 112.317 170.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.1 mt -53.25 -30.64 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.621 1.169 . . . . 0.0 111.755 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.0 ttp85 -72.24 -33.62 67.67 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.045 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.72 -56.09 13.89 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 173.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.485 ' HB ' HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -74.24 -36.24 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -90.38 -33.39 16.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 119.447 -0.311 . . . . 0.0 111.706 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.621 ' HB3' ' HZ2' ' A' ' 127' ' ' LYS . 3.0 mmmp? 63.78 72.38 0.47 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.043 0.937 . . . . 0.0 111.765 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.548 HG22 ' HB3' ' A' ' 137' ' ' ARG . 9.2 mt -100.49 130.61 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -174.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.95 156.16 20.81 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.203 0.601 . . . . 0.0 110.349 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 125.06 -147.91 16.62 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.872 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -136.29 163.69 29.83 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.391 1.076 . . . . 0.0 109.264 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.0 -152.11 17.08 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 171.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -94.22 137.86 32.91 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.339 1.056 . . . . 0.0 109.851 -173.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.457 ' HB ' ' HG3' ' A' ' 119' ' ' GLU . 7.2 p -54.59 -34.19 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.369 1.068 . . . . 0.0 113.652 -176.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.4 t -71.41 -45.74 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.349 0.595 . . . . 0.0 109.759 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 40.3 mt-10 -68.52 -34.33 75.68 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.182 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.548 ' HB3' HG22 ' A' ' 128' ' ' ILE . 52.7 mtm180 -72.22 -39.05 68.8 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.863 0.865 . . . . 0.0 112.073 -176.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.04 -33.94 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.547 HD11 ' HA ' ' A' ' 40' ' ' HIS . 4.6 mp -62.98 -39.57 95.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.218 0.607 . . . . 0.0 111.148 173.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 35.0 mm-40 -59.66 -47.29 86.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 117.775 0.261 . . . . 0.0 111.009 173.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -63.87 -48.4 76.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.112 0.565 . . . . 0.0 111.973 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.6 pt -76.68 -25.33 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.95 -16.12 55.9 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 122.235 0.214 . . . . 0.0 110.54 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.95 10.26 0.75 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.681 0.793 . . . . 0.0 111.971 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.663 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.9 mp -107.22 -44.17 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.349 1.06 . . . . 0.0 108.437 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -94.8 -21.71 18.53 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.061 -170.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tt -90.74 -33.11 15.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.079 0.951 . . . . 0.0 108.753 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -76.58 134.12 39.48 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.873 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -79.71 -23.44 42.36 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.757 0.823 . . . . 0.0 110.644 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 . . . . . 0 N--CA 1.487 1.393 0 C-N-CA 126.197 1.799 . . . . 0.0 108.624 174.157 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.74 142.82 19.14 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.915 0.886 . . . . 0.0 109.865 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.8 ttt -113.66 -56.51 2.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.858 0.863 . . . . 0.0 110.57 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 1.2 m-20 64.28 94.52 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.464 0 C-N-CA 124.656 1.183 . . . . 0.0 109.979 -173.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.685 ' HD2' ' HB2' ' A' ' 42' ' ' LEU . 19.2 Cg_endo -56.09 -45.06 41.08 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.892 3.061 . . . . 0.0 113.031 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.0 mmt -109.69 163.66 13.28 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.302 0.641 . . . . 0.0 109.405 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.539 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 76.2 mt -85.96 104.78 13.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.5 mm -101.19 120.82 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -127.27 146.92 50.26 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.19 140.42 14.86 Favored Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.478 HG21 HG13 ' A' ' 86' ' ' VAL . 10.1 tt -143.01 124.9 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.777 0.799 . . . . 0.0 111.081 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -90.11 133.2 35.01 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.196 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.45 8.76 80.32 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.832 174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.04 100.76 0.23 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.033 0.933 . . . . 0.0 111.085 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -74.0 103.23 4.41 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.491 HD13 HG11 ' A' ' 86' ' ' VAL . 50.3 mm -74.05 114.91 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.354 0.597 . . . . 0.0 110.207 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.448 ' ND2' HG21 ' A' ' 20' ' ' ILE . 2.5 p-10 -103.92 134.63 46.89 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -74.08 -1.7 21.28 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.793 0.437 . . . . 0.0 111.779 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -75.68 -20.32 58.51 Favored 'General case' 0 C--O 1.217 -0.606 0 C-N-CA 124.414 1.086 . . . . 0.0 111.027 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.448 HG21 ' ND2' ' A' ' 17' ' ' ASN . 9.4 pt -49.77 -22.36 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -83.52 -0.1 48.81 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -71.4 -28.04 63.74 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.123 0.569 . . . . 0.0 112.005 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.65 -6.69 57.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.679 0.791 . . . . 0.0 111.512 -176.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.46 14.89 9.86 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.556 ' HB2' HD13 ' A' ' 23' ' ' LEU . 95.8 mt -74.73 157.77 34.69 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.159 0.584 . . . . 0.0 110.461 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -82.67 102.51 11.54 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.273 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -149.49 160.31 43.57 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.77 1.228 . . . . 0.0 108.823 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.485 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -142.22 150.43 40.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 173.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.7 mt -134.4 125.1 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.48 HD23 HG22 ' A' ' 41' ' ' VAL . 4.2 pp -118.97 172.47 7.53 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 47.6 t30 -87.93 131.34 34.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.52 1.128 . . . . 0.0 111.133 -167.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' A' ' 111' ' ' VAL . . . -83.6 -3.84 58.04 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.671 ' HB3' HD21 ' A' ' 121' ' ' LEU . 76.9 m-20 -63.74 -44.82 92.38 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.358 0.599 . . . . 0.0 109.817 171.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.06 -1.95 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.871 -166.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.412 HG11 ' HA ' ' A' ' 32' ' ' ALA . 9.9 p -85.71 129.87 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.78 -68.13 0.57 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 113' ' ' GLU . 30.8 p -128.85 166.59 18.77 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.465 1.106 . . . . 0.0 108.431 169.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -22.26 34.17 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.59 0.356 . . . . 0.0 111.493 169.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.13 -30.31 66.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.266 1.026 . . . . 0.0 112.081 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.535 ' HA ' HD12 ' A' ' 139' ' ' LEU . 12.2 t-80 -61.23 -44.82 96.65 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.806 0.842 . . . . 0.0 110.377 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG22 HD23 ' A' ' 30' ' ' LEU . 40.4 t -65.76 -54.13 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.708 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.685 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 3.2 pp -63.55 -32.12 73.49 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -61.03 -37.48 82.73 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.196 0.999 . . . . 0.0 110.886 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.79 -35.36 67.38 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.079 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 42' ' ' LEU . 53.4 mt -63.56 -47.07 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.461 0.704 . . . . 0.0 110.914 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -57.83 -37.26 73.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.776 0.831 . . . . 0.0 111.01 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.455 ' HA ' HG23 ' A' ' 50' ' ' THR . 79.7 mm-40 -67.56 -40.12 84.92 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.499 174.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.31 -27.6 68.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.979 0.512 . . . . 0.0 111.629 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -79.13 -34.3 43.48 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.978 0.511 . . . . 0.0 111.591 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 47' ' ' GLN . 11.8 t -87.48 -28.23 22.18 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.436 0.294 . . . . 0.0 110.894 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -98.8 135.26 40.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.671 0.788 . . . . 0.0 111.547 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HZ3' ' HB2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -76.13 105.5 2.28 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 162.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.402 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 41.1 Cg_endo -64.73 166.2 18.68 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.795 2.33 . . . . 0.0 114.801 -161.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 mm -108.7 -5.15 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 173.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.01 -179.5 6.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.048 1.339 . . . . 0.0 111.472 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HB2' ' HG2' ' A' ' 60' ' ' MET . 75.6 mmtt -73.22 -25.02 60.58 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.513 0.725 . . . . 0.0 112.262 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.68 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 29.0 t -165.28 -178.69 5.16 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.479 0.711 . . . . 0.0 110.327 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -57.48 -54.57 45.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.687 1.195 . . . . 0.0 111.42 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.485 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 86.5 m95 -62.14 -32.48 73.09 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.828 0.851 . . . . 0.0 111.58 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.68 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.1 mpt? -72.99 -26.47 61.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.876 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.582 ' HA ' HG22 ' A' ' 64' ' ' VAL . 19.8 tp10 -74.67 -31.59 61.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.282 0.233 . . . . 0.0 110.587 175.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.488 HD11 HG12 ' A' ' 45' ' ' ILE . 66.8 mt -61.52 -47.63 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.017 0.527 . . . . 0.0 110.183 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' O ' HD13 ' A' ' 79' ' ' ILE . 4.1 pp -71.9 -34.33 69.03 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.699 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.582 HG22 ' HA ' ' A' ' 61' ' ' GLU . 23.5 m -76.98 -34.05 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 118.783 0.72 . . . . 0.0 111.558 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.424 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 5.3 tpp180 -68.95 -46.48 68.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.757 0.423 . . . . 0.0 111.11 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.7 -18.95 64.35 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 123.458 0.474 . . . . 0.0 112.157 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.8 p -90.03 18.88 5.35 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.431 0.692 . . . . 0.0 112.501 175.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 142' ' ' ILE . . . 95.29 26.22 12.66 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.385 -0.675 . . . . 0.0 113.193 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.49 ' HB3' HG13 ' A' ' 145' ' ' ILE . 17.2 tt0 57.78 97.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.837 1.255 . . . . 0.0 109.869 -174.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -137.84 -158.11 0.83 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.725 0.81 . . . . 0.0 110.862 -168.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -120.66 164.61 16.26 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.653 1.181 . . . . 0.0 108.985 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.435 HG13 ' HG2' ' A' ' 56' ' ' LYS . 51.4 mm -47.41 -47.6 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 125.659 1.583 . . . . 0.0 112.99 -171.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 m170 -56.74 -53.37 58.52 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.856 0.863 . . . . 0.0 111.572 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.38 -58.06 10.1 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 123.519 0.512 . . . . 0.0 110.75 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.61 -54.99 34.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.428 1.091 . . . . 0.0 113.844 -170.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.3 mt -63.68 -31.24 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.49 0.716 . . . . 0.0 112.117 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.69 -39.62 19.94 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.1 mt -76.73 -66.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.83 0.452 . . . . 0.0 110.626 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 63' ' ' LEU . 9.0 pt -104.8 8.76 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.519 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 31' ' ' ASN . . . -81.83 173.95 53.8 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 119.364 0.984 . . . . 0.0 111.853 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.11 137.67 58.31 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.97 156.64 37.81 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -53.66 151.3 6.22 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.84 -115.51 5.18 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.123 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -85.5 108.55 17.97 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.491 HG11 HD13 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -135.1 171.25 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.337 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.408 ' SG ' HG12 ' A' ' 35' ' ' VAL . 61.0 m -131.64 121.46 24.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.841 1.256 . . . . 0.0 108.823 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.46 HD11 ' HB ' ' A' ' 99' ' ' ILE . 4.8 tt -99.47 128.77 45.6 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -174.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 28' ' ' GLN . 22.0 mt -113.75 114.28 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.735 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 20.8 p -138.26 156.88 47.25 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.836 0.454 . . . . 0.0 110.568 -176.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.34 -51.98 15.52 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.866 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -128.75 158.39 38.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.121 0.968 . . . . 0.0 110.068 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.87 -16.15 62.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.885 0.874 . . . . 0.0 112.266 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.58 -46.59 37.73 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.0 m -61.56 -40.4 94.57 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 123.738 0.815 . . . . 0.0 110.505 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.735 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 19.4 t80 -56.74 -51.46 68.78 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 123.819 0.699 . . . . 0.0 110.84 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -61.39 -42.72 99.17 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.822 0.701 . . . . 0.0 111.005 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -57.58 -50.14 74.09 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.654 0.596 . . . . 0.0 110.899 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.46 ' HB ' HD11 ' A' ' 88' ' ' LEU . 45.8 mm -69.82 -45.45 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.835 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -54.01 -45.7 71.57 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.257 1.423 . . . . 0.0 113.2 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.95 -30.34 68.76 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 119.463 -0.303 . . . . 0.0 111.667 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.24 -46.03 71.62 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.932 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.1 pt -75.62 -41.01 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 118.103 0.41 . . . . 0.0 110.799 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.56 109.11 0.09 OUTLIER Glycine 0 C--N 1.345 1.072 0 O-C-N 123.347 0.405 . . . . 0.0 113.706 170.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.44 -171.88 44.63 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -105.25 147.46 28.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.238 0.615 . . . . 0.0 109.568 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.36 129.29 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.248 0.619 . . . . 0.0 109.561 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -132.77 100.84 5.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.289 1.036 . . . . 0.0 108.906 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -69.88 -33.18 71.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.896 0.478 . . . . 0.0 111.622 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 113' ' ' GLU . 18.4 m -50.6 -36.82 36.81 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 32' ' ' ALA . 16.2 m -66.64 -22.52 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.8 mt -100.75 17.83 20.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.808 0.843 . . . . 0.0 111.856 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.576 ' HA ' HG23 ' A' ' 37' ' ' THR . 7.4 pt-20 -134.79 8.06 3.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 78.71 131.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.202 1.001 . . . . 0.0 111.615 173.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.469 ' ND2' ' HB2' ' A' ' 117' ' ' ASP . 4.0 p-10 -156.87 174.44 15.5 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.219 1.407 . . . . 0.0 107.915 172.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -69.4 -32.23 71.09 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.469 ' HB2' ' ND2' ' A' ' 115' ' ' ASN . 2.2 m-20 -57.34 -50.68 72.19 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.541 0.736 . . . . 0.0 110.352 171.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -40.98 76.86 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.124 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HG3' HG22 ' A' ' 134' ' ' VAL . 42.5 tt0 -72.32 -49.19 36.31 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.404 0.682 . . . . 0.0 112.485 -162.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -70.16 -36.95 75.06 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.678 0.752 . . . . 0.0 110.741 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 33' ' ' ASP . 37.4 tp -59.64 -47.8 84.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.778 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.5 mt -63.5 -38.04 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.289 1.035 . . . . 0.0 110.645 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.2 ptp180 -74.36 -26.51 60.17 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 118.983 -0.532 . . . . 0.0 110.086 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -71.47 -57.49 4.38 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -31.27 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 119.014 0.825 . . . . 0.0 112.487 -172.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -92.5 -33.59 14.42 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 119.593 -0.241 . . . . 0.0 111.553 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 12.4 mmmm 66.13 82.53 0.18 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.971 0.908 . . . . 0.0 112.419 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.517 HG21 ' HB3' ' A' ' 137' ' ' ARG . 36.9 mt -124.01 156.73 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -42.06 -55.23 3.27 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.86 0.464 . . . . 0.0 111.045 165.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.93 33.9 7.55 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -114.78 152.3 32.35 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 124.293 1.037 . . . . 0.0 109.117 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.37 -132.99 21.38 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.623 0.577 . . . . 0.0 112.138 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -96.22 116.79 29.56 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.654 0.381 . . . . 0.0 110.638 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' A' ' 119' ' ' GLU . 84.2 t -64.19 -29.4 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.152 1.381 . . . . 0.0 112.324 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.8 -49.75 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.213 0.605 . . . . 0.0 110.469 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.99 -32.1 73.66 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.097 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.517 ' HB3' HG21 ' A' ' 128' ' ' ILE . 8.5 mmm180 -76.01 -35.48 59.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.115 0.566 . . . . 0.0 112.205 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.51 -41.33 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.823 -0.548 . . . . 0.0 110.973 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 40' ' ' HIS . 5.5 mp -57.12 -40.16 76.54 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.508 1.123 . . . . 0.0 112.786 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.37 -35.52 68.5 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.024 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -64.96 -46.08 83.05 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.426 0.69 . . . . 0.0 111.281 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.5 pt -72.48 -8.48 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.403 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.75 -29.22 13.13 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 124.386 1.074 . . . . 0.0 111.267 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.89 3.97 0.95 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.16 1.384 . . . . 0.0 113.724 -165.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.49 HG13 ' HB3' ' A' ' 69' ' ' GLN . 19.1 mm -82.15 -38.06 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -98.39 -33.79 10.91 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.102 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.76 31.74 0.6 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.524 1.13 . . . . 0.0 110.007 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -102.27 -40.14 6.9 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.584 ' HB3' ' HZ1' ' A' ' 149' ' ' LYS . 6.1 ttpm? 66.99 76.18 0.3 Allowed 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.449 1.499 . . . . 0.0 110.027 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 124.729 1.212 . . . . 0.0 111.145 170.04 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.524 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.95 175.52 6.68 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.607 0.763 . . . . 0.0 110.955 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 3' ' ' MET . 1.3 mpt? -56.91 -33.49 66.98 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.899 0.88 . . . . 0.0 110.638 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.97 93.0 7.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 162.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.718 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 67.5 Cg_endo -71.72 -33.34 10.47 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.357 2.038 . . . . 0.0 112.732 -177.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.718 ' SD ' ' HG2' ' A' ' 5' ' ' PRO . 2.0 mpt? -106.94 161.45 14.71 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -103.55 104.94 17.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mm -111.83 120.31 61.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.421 HH21 HG21 ' A' ' 107' ' ' ILE . 28.0 mmm180 -133.18 145.33 50.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.876 0.471 . . . . 0.0 109.869 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.586 ' H ' HD12 ' A' ' 112' ' ' LEU . . . -107.14 118.04 5.46 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.3 tt -124.28 124.97 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.566 0.746 . . . . 0.0 111.165 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -85.11 137.74 32.85 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.156 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.29 79.51 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.211 172.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.25 109.98 4.98 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.833 0.853 . . . . 0.0 111.815 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -76.76 103.15 6.57 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.442 HD11 HG13 ' A' ' 86' ' ' VAL . 50.9 mm -70.69 93.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.511 ' ND2' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -102.01 153.59 19.75 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.625 -177.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -68.53 -13.26 62.21 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.39 -36.75 79.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.656 0.782 . . . . 0.0 112.013 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.511 HG22 ' ND2' ' A' ' 17' ' ' ASN . 6.9 pt -56.72 -22.62 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -87.25 -16.78 34.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 118.231 0.469 . . . . 0.0 111.368 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -75.31 -19.52 59.61 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.381 0.673 . . . . 0.0 112.093 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -82.65 -9.76 59.23 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.944 0.498 . . . . 0.0 111.765 -177.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.73 8.39 2.85 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.5 ' HB2' HD13 ' A' ' 23' ' ' LEU . 86.2 mt -68.57 168.69 12.44 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.977 0.888 . . . . 0.0 112.131 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -77.78 92.21 4.18 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.09 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -148.81 162.3 40.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.984 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.624 ' HB3' HD11 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -146.1 159.82 42.76 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 164.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.4 HG12 HD13 ' A' ' 88' ' ' LEU . 11.8 mt -134.08 129.68 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 121.704 -0.623 . . . . 0.0 109.39 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.419 HD22 HD12 ' A' ' 89' ' ' ILE . 2.7 pt? -119.84 179.7 4.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.072 0.949 . . . . 0.0 108.456 172.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.406 ' HB3' HG22 ' A' ' 34' ' ' VAL . 51.0 t-20 -74.51 143.16 44.68 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 87' ' ' CYS . . . -68.87 -49.67 56.28 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.038 0.447 . . . . 0.0 110.585 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' HB3' HD23 ' A' ' 121' ' ' LEU . 40.9 m-20 -52.38 -16.66 0.92 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.426 HG23 ' HB ' ' A' ' 79' ' ' ILE . 24.9 m -110.82 2.09 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.585 0.754 . . . . 0.0 111.906 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.13 -30.74 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.201 0.6 . . . . 0.0 111.95 -171.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 114' ' ' ILE . . . 58.29 -84.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.34 1.056 . . . . 0.0 109.35 -166.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 16.8 p -127.07 161.69 27.83 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.939 0.896 . . . . 0.0 111.081 172.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -53.56 -40.68 65.79 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.379 163.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' HD2' HD11 ' A' ' 42' ' ' LEU . 50.8 tptt -56.19 -35.76 67.61 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 124.994 1.318 . . . . 0.0 111.554 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -63.02 -52.6 62.27 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.889 0.743 . . . . 0.0 111.28 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 45' ' ' ILE . 40.4 t -72.66 -42.49 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 119.427 -0.321 . . . . 0.0 111.85 -175.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.506 ' HB2' ' SD ' ' A' ' 6' ' ' MET . 4.1 pp -64.6 -29.52 70.53 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.015 0.371 . . . . 0.0 111.209 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -62.6 -40.22 96.23 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.019 0.928 . . . . 0.0 110.546 169.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.27 82.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.571 0.748 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.476 ' HA ' HG12 ' A' ' 62' ' ' ILE . 41.7 mt -65.49 -45.8 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.099 0.96 . . . . 0.0 110.709 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -51.69 -48.77 63.37 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.568 1.147 . . . . 0.0 110.366 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -64.6 -31.82 73.21 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.987 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.46 -21.78 48.54 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.914 0.485 . . . . 0.0 112.025 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HE3' HG21 ' A' ' 45' ' ' ILE . 96.7 mttt -82.0 -31.75 30.91 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.973 0.509 . . . . 0.0 111.622 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.463 HG22 ' HG2' ' A' ' 51' ' ' LYS . 9.7 t -100.31 -35.98 9.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HG2' HG22 ' A' ' 50' ' ' THR . 10.9 mmpt? -119.63 153.57 35.31 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.275 0.63 . . . . 0.0 111.877 -176.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.86 124.74 9.48 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.506 1.122 . . . . 0.0 109.766 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -90.57 -115.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 123.85 3.034 . . . . 0.0 110.468 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 mm -123.63 35.26 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.516 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . . . -85.83 156.54 20.52 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.878 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' HG2' HG13 ' A' ' 72' ' ' ILE . 74.3 mmtt -62.23 -53.83 49.56 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.207 0.603 . . . . 0.0 111.945 -171.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.531 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 10.6 t -156.33 -176.94 6.23 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.039 0.536 . . . . 0.0 109.678 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -58.55 -60.33 3.97 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.407 1.083 . . . . 0.0 113.244 -173.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.511 ' CE3' ' HB2' ' A' ' 28' ' ' GLN . 92.1 m95 -66.16 -23.5 66.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.747 0.419 . . . . 0.0 112.044 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.531 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.5 mpt? -77.19 -26.09 52.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.864 0.866 . . . . 0.0 110.599 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.516 ' HG2' ' HB3' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -74.92 -41.26 60.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.967 0.907 . . . . 0.0 109.389 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 45' ' ' ILE . 81.8 mt -61.54 -39.46 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.726 0.811 . . . . 0.0 112.455 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.6 pp -72.65 -33.47 66.62 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.007 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 ' NH1' ' A' ' 70' ' ' ARG . 25.0 m -77.07 -27.0 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.973 -0.454 . . . . 0.0 111.949 174.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 35.4 mmt180 -64.56 -62.76 1.39 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.205 0.602 . . . . 0.0 110.442 172.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.79 -27.72 68.23 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.608 0.763 . . . . 0.0 112.695 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 p -79.57 -59.07 2.89 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.37 6.6 29.16 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.722 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -78.83 -25.13 44.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.498 1.119 . . . . 0.0 111.763 -172.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' NH1' HG22 ' A' ' 64' ' ' VAL . 1.1 mpt_? 66.58 -10.61 0.27 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -173.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -99.45 118.5 36.2 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.94 0.896 . . . . 0.0 109.125 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.546 HG13 ' HG2' ' A' ' 56' ' ' LYS . 24.8 mm -53.45 -59.73 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.264 1.025 . . . . 0.0 112.353 -172.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -61.76 -45.14 95.17 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.152 0.907 . . . . 0.0 110.589 -172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -58.02 -47.86 81.79 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.858 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.92 80.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.52 0.728 . . . . 0.0 112.397 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.9 mt -68.08 -33.79 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.185 0.594 . . . . 0.0 111.035 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -68.71 -49.33 59.76 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.804 0.335 . . . . 0.0 110.698 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.547 HG21 ' HB ' ' A' ' 125' ' ' ILE . 74.2 mt -64.8 -64.22 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 124.004 0.922 . . . . 0.0 111.15 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.426 ' HB ' HG23 ' A' ' 34' ' ' VAL . 24.0 pt -110.4 15.36 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -172.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.58 173.29 44.16 Favored Glycine 0 N--CA 1.479 1.52 0 CA-C-N 120.389 1.449 . . . . 0.0 113.21 -174.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.44 146.59 32.68 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.189 0.595 . . . . 0.0 111.39 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -153.18 155.53 36.84 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.417 1.087 . . . . 0.0 108.104 171.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.25 151.98 44.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.927 0.491 . . . . 0.0 111.433 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.79 -120.78 7.01 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.205 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -79.61 105.89 11.24 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.442 HG13 HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -135.74 164.53 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.647 -177.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 43.7 t -125.55 121.25 33.12 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.371 1.068 . . . . 0.0 108.959 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.4 HD13 HG12 ' A' ' 29' ' ' ILE . 10.0 tp -102.35 125.75 49.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.853 0.861 . . . . 0.0 109.865 -171.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 28' ' ' GLN . 68.4 mt -99.79 128.52 51.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 113.698 -1.592 . . . . 0.0 107.521 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.515 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 35.1 t -150.32 149.19 29.78 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 111.589 177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -86.02 -41.67 14.63 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.59 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -119.78 146.69 45.44 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.195 0.598 . . . . 0.0 110.994 -174.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -54.79 -38.31 67.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.71 0.804 . . . . 0.0 112.613 172.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -69.75 -46.51 65.7 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.515 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 28.7 m -61.21 -35.21 76.57 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.005 0.922 . . . . 0.0 110.948 178.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -63.83 -46.76 83.62 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.404 0.682 . . . . 0.0 110.152 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.58 -34.71 78.41 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.759 0.662 . . . . 0.0 110.574 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.79 -45.9 80.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.464 0.706 . . . . 0.0 111.638 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.456 HD11 HD22 ' A' ' 23' ' ' LEU . 40.2 mm -71.39 -46.72 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 122.43 -0.169 . . . . 0.0 110.766 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -54.76 -33.81 61.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.161 1.384 . . . . 0.0 112.086 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.8 -50.46 70.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.864 0.866 . . . . 0.0 111.769 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.67 -25.84 49.84 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 17.7 pt -80.24 -50.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 118.584 0.629 . . . . 0.0 109.575 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.92 124.43 0.05 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 123.443 0.464 . . . . 0.0 113.796 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.43 -153.15 20.59 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 117.028 0.414 . . . . 0.0 112.159 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -123.91 143.79 50.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.938 0.895 . . . . 0.0 109.164 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.421 HG21 HH21 ' A' ' 9' ' ' ARG . 49.3 mm -86.89 136.73 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -135.66 108.97 7.8 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.15 -25.22 66.86 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.541 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.2 m -46.54 -39.68 11.36 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' A' ' 32' ' ' ALA . 12.6 p -71.29 -41.62 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-O 120.846 0.355 . . . . 0.0 110.399 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 37' ' ' THR . 86.3 mt -67.78 -31.17 70.88 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.551 1.141 . . . . 0.0 112.623 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.3 1.54 54.48 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 118.15 -0.929 . . . . 0.0 112.924 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 36' ' ' ALA 0.253 1.5 mm 73.07 127.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.29 0 CA-C-N 119.296 0.953 . . . . 0.0 113.094 177.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.411 HD22 ' HD3' ' A' ' 118' ' ' LYS . 6.3 p30 -147.89 -176.68 5.36 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.024 1.329 . . . . 0.0 108.584 173.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -57.42 -49.61 75.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.493 0.717 . . . . 0.0 112.142 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.8 -51.39 69.93 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.53 1.132 . . . . 0.0 112.466 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.411 ' HD3' HD22 ' A' ' 115' ' ' ASN . 4.3 mptp? -70.6 -37.23 73.86 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.849 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -71.38 -39.22 71.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.976 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -72.2 -42.89 65.29 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.866 0.466 . . . . 0.0 112.046 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.511 HD23 ' HB3' ' A' ' 33' ' ' ASP . 0.7 OUTLIER -66.14 -34.1 77.28 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.464 HG21 ' HD2' ' A' ' 126' ' ' PHE . 13.5 mt -58.33 -30.02 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.948 0.899 . . . . 0.0 110.782 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -69.44 -36.79 76.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 118.839 -0.6 . . . . 0.0 109.534 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.13 -55.71 30.5 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.547 ' HB ' HG21 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -75.57 -45.07 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 118.863 0.756 . . . . 0.0 112.693 -178.026 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.567 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 21.7 m-30 -81.87 -33.1 30.75 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.539 ' HB3' ' HZ2' ' A' ' 127' ' ' LYS . 3.7 mmmp? 63.6 76.32 0.36 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.151 0.98 . . . . 0.0 112.318 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.63 HG23 ' HB3' ' A' ' 137' ' ' ARG . 2.5 mt -124.49 151.13 29.58 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -61.72 -90.82 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.619 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 173.66 -120.38 0.8 Allowed Glycine 0 C--N 1.35 1.337 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.1 t80 67.0 101.21 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.017 1.327 . . . . 0.0 111.242 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.4 -125.46 8.58 Favored Glycine 0 N--CA 1.469 0.879 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.62 165.49 19.87 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.425 0.612 . . . . 0.0 110.383 167.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.45 -16.53 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.083 0.553 . . . . 0.0 112.445 -171.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.457 ' O ' HD12 ' A' ' 139' ' ' LEU . 86.6 t -68.63 -49.29 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -174.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -52.75 -45.54 67.07 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.495 174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.63 ' HB3' HG23 ' A' ' 128' ' ' ILE . 37.4 mmt180 -73.55 -38.85 65.09 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 113.693 -1.594 . . . . 0.0 112.346 -168.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.55 -41.15 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 123.181 0.301 . . . . 0.0 110.485 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 135' ' ' VAL . 9.9 mp -55.74 -44.16 77.32 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.741 0.816 . . . . 0.0 110.509 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -74.33 -37.94 63.41 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 123.887 0.742 . . . . 0.0 111.929 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.629 ' HD3' HG12 ' A' ' 128' ' ' ILE . 16.5 ttpp -66.25 -40.01 89.91 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.086 0.47 . . . . 0.0 111.537 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 22.2 pt -73.29 -18.92 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.017 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -106.82 15.24 25.75 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.3 1.04 . . . . 0.0 110.801 174.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 tt -85.33 19.15 2.38 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 123.977 0.911 . . . . 0.0 109.987 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 12.3 mm -72.33 -30.21 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.83 -17.27 64.45 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.824 1.25 . . . . 0.0 111.824 173.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.9 mt 81.36 67.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.255 1.822 . . . . 0.0 110.596 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -71.65 -178.3 2.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.494 0.718 . . . . 0.0 111.685 175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -116.83 33.17 5.74 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.242 1.017 . . . . 0.0 109.878 -175.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 . . . . . 0 N--CA 1.481 1.105 0 C-N-CA 123.103 0.561 . . . . 0.0 110.279 -170.535 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.906 -0.478 . . . . 0.0 111.906 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.49 118.23 1.9 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.936 0.894 . . . . 0.0 109.79 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.8 mtt -144.83 87.62 1.85 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.923 0.889 . . . . 0.0 110.028 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.5 t70 60.1 91.68 0.07 OUTLIER Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 125.349 1.46 . . . . 0.0 112.295 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 42' ' ' LEU . 96.1 Cg_endo -83.41 -43.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.512 2.141 . . . . 0.0 113.319 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.4 mmt -110.64 175.97 5.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.782 0.833 . . . . 0.0 110.927 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 72.5 mt -98.75 103.81 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 108.359 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.57 122.28 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.7 mmt-85 -127.84 150.9 49.64 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.79 0.836 . . . . 0.0 109.723 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.31 126.26 8.67 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 tt -132.63 132.68 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.416 0.627 . . . . 0.0 110.452 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -107.83 133.68 51.86 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.27 1.028 . . . . 0.0 109.955 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.79 -6.27 79.62 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.534 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.57 112.77 2.12 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.112 0.965 . . . . 0.0 112.826 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -73.28 108.52 6.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.469 0.708 . . . . 0.0 110.288 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 86' ' ' VAL . 49.4 mm -70.76 94.17 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.272 1.034 . . . . 0.0 109.837 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.45 150.38 20.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.002 177.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -82.26 -4.57 57.39 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.974 0.51 . . . . 0.0 111.23 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -65.94 -40.09 91.07 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.076 0.95 . . . . 0.0 111.154 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.8 pt -70.62 -7.87 9.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.767 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -93.46 -34.32 13.46 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.226 0.921 . . . . 0.0 110.998 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -86.28 0.67 53.31 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.74 -3.94 55.04 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.365 0.666 . . . . 0.0 112.213 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.96 -11.8 2.43 Favored Glycine 0 CA--C 1.54 1.595 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.484 HD13 HG22 ' A' ' 95' ' ' THR . 85.2 mt -64.42 159.8 20.54 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.273 1.037 . . . . 0.0 112.217 -176.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -86.58 100.71 12.61 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.884 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -149.03 162.55 39.71 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.496 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.43 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 24.7 tt0 -139.02 145.55 39.76 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 166.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.0 mt -130.02 126.45 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 pp -122.39 174.28 7.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.068 0.947 . . . . 0.0 108.688 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -82.07 135.41 35.33 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.93 3.41 42.06 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.412 ' HA ' ' HZ2' ' A' ' 118' ' ' LYS . 4.4 m-20 -84.28 -34.66 23.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.271 0.629 . . . . 0.0 110.195 174.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.511 HG23 HG21 ' A' ' 79' ' ' ILE . 14.8 p -93.88 -4.47 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 123.934 0.894 . . . . 0.0 111.229 -172.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.549 HG13 ' SG ' ' A' ' 87' ' ' CYS . 8.6 p -96.41 134.42 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.59 -64.09 1.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.1 p -135.24 168.89 18.34 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.465 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HB3' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -56.6 -23.96 44.39 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 168.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.655 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 39.1 ttmt -63.02 -28.68 70.26 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 122.717 0.407 . . . . 0.0 111.947 174.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.488 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.8 t-80 -59.3 -44.82 92.5 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.853 0.461 . . . . 0.0 110.021 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.04 -52.14 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.742 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.655 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 3.8 pp -65.57 -36.42 83.71 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.764 0.256 . . . . 0.0 111.648 -171.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.45 ' CG ' ' HG ' ' A' ' 139' ' ' LEU . 57.5 t60 -57.68 -41.31 81.35 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.181 0.592 . . . . 0.0 110.71 169.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.29 -34.42 77.35 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.647 0.592 . . . . 0.0 111.13 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 42' ' ' LEU . 62.9 mt -65.78 -46.08 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.925 0.89 . . . . 0.0 110.641 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -59.39 -46.93 87.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.424 0.69 . . . . 0.0 110.247 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.423 ' HB3' ' HE ' ' A' ' 65' ' ' ARG . 29.7 mm-40 -61.68 -36.14 80.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.448 1.099 . . . . 0.0 111.166 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.15 95.92 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.565 0.746 . . . . 0.0 111.859 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -76.96 -20.35 56.22 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.538 HG22 ' HG2' ' A' ' 51' ' ' LYS . 5.1 t -105.25 -38.8 6.4 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.757 0.423 . . . . 0.0 110.757 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 50' ' ' THR . 45.2 mmtm -114.52 136.2 53.29 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.591 0.756 . . . . 0.0 110.602 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.515 ' HD3' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -109.56 116.53 54.35 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.856 -178.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.19 -142.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.126 2.551 . . . . 0.0 110.593 168.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.55 41.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 72' ' ' ILE . . . -77.68 150.94 34.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.534 -174.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -84.96 -23.14 28.89 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.85 0.86 . . . . 0.0 111.15 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -161.07 173.83 14.61 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.054 0.941 . . . . 0.0 109.399 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -66.89 -44.32 81.17 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.693 0.797 . . . . 0.0 111.177 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.43 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 94.0 m95 -76.39 -18.9 58.63 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.409 0.283 . . . . 0.0 111.589 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.5 mmt -79.15 -25.45 42.88 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.002 0.521 . . . . 0.0 110.779 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 29.8 tt0 -76.03 -37.59 58.2 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.177 0.991 . . . . 0.0 111.544 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.44 HD12 HG12 ' A' ' 45' ' ' ILE . 78.6 mt -68.25 -39.9 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.129 0.572 . . . . 0.0 111.33 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.06 -34.68 68.93 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 123.214 0.321 . . . . 0.0 111.466 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 m -74.34 -35.48 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 121.971 -0.456 . . . . 0.0 110.745 175.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 47' ' ' GLN . 16.7 tpt85 -68.42 -42.56 78.75 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.161 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.01 66.57 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.451 0.7 . . . . 0.0 111.573 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -82.93 -5.32 59.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.578 0.751 . . . . 0.0 111.947 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.9 -73.46 2.12 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -44.32 136.49 4.03 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.326 1.45 . . . . 0.0 112.365 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -96.59 5.86 49.89 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.941 0.896 . . . . 0.0 111.482 -165.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.48 126.21 43.94 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.707 1.203 . . . . 0.0 110.997 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.515 HD13 ' HA ' ' A' ' 55' ' ' ALA . 1.7 mp -53.12 -59.15 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 124.957 1.303 . . . . 0.0 112.55 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.486 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 63.0 m80 -60.36 -46.79 88.68 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.781 0.676 . . . . 0.0 110.702 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -57.2 -51.83 67.77 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.415 1.072 . . . . 0.0 111.187 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.62 72.33 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.376 0.671 . . . . 0.0 112.681 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.55 -32.6 55.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 122.918 0.487 . . . . 0.0 111.217 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 73' ' ' HIS . 32.6 mmtp -70.14 -49.38 51.28 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 175.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 52.6 mt -68.82 -67.56 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.095 0.958 . . . . 0.0 111.881 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.511 HG21 HG23 ' A' ' 34' ' ' VAL . 6.9 pt -103.85 8.91 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.92 168.59 54.75 Favored Glycine 0 C--N 1.352 1.459 0 CA-C-N 119.457 1.026 . . . . 0.0 113.11 -171.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.86 144.82 48.93 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.54 0.736 . . . . 0.0 112.755 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -147.1 151.51 36.96 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -58.77 149.94 25.1 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 119.659 1.118 . . . . 0.0 112.062 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.78 -114.52 4.39 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.083 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -89.2 109.05 19.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.136 0.575 . . . . 0.0 110.223 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.454 HG23 HD11 ' A' ' 16' ' ' ILE . 4.2 m -137.44 175.11 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.749 0.82 . . . . 0.0 112.034 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.549 ' SG ' HG13 ' A' ' 35' ' ' VAL . 57.9 m -122.82 120.88 34.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.411 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.2 tp -104.1 120.19 40.56 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.765 0.793 . . . . 0.0 109.344 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 12.1 mt -119.12 129.48 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.074 -170.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.539 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 47.9 t -157.69 164.48 37.12 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -78.27 -53.11 7.67 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.357 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -119.86 149.84 41.43 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.193 0.597 . . . . 0.0 110.18 -173.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.14 -35.67 69.79 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.382 1.073 . . . . 0.0 113.143 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 12.8 pt-20 -73.67 -40.68 63.49 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.539 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 34.9 m -66.07 -36.24 82.68 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.137 0.575 . . . . 0.0 110.938 176.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.16 -47.36 83.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.308 0.643 . . . . 0.0 109.383 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -67.46 -34.97 78.26 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.927 -175.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 30.6 mmmt -63.52 -36.66 84.51 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.39 0.676 . . . . 0.0 111.698 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.1 mm -76.25 -44.68 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 N-CA-C 110.464 -0.198 . . . . 0.0 110.464 175.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.46 -45.02 76.94 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.962 1.305 . . . . 0.0 113.221 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.662 ' HG3' HD21 ' A' ' 102' ' ' LEU . 8.0 pt-20 -62.35 -35.75 80.08 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.475 0.484 . . . . 0.0 111.959 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.662 HD21 ' HG3' ' A' ' 101' ' ' GLU . 3.5 mm? -75.83 -39.15 57.28 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 119.102 -0.475 . . . . 0.0 112.012 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.3 pt -74.73 -42.94 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 118.604 0.638 . . . . 0.0 110.639 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.27 113.81 0.06 OUTLIER Glycine 0 C--N 1.35 1.308 0 O-C-N 123.545 0.528 . . . . 0.0 113.838 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.83 -162.74 29.31 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -116.92 134.98 54.08 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.56 0.744 . . . . 0.0 109.974 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.8 mm -75.43 123.67 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -143.03 95.94 2.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.099 1.36 . . . . 0.0 107.694 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.4 -18.55 63.77 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.8 0.44 . . . . 0.0 112.157 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.5 m -57.38 -25.34 59.35 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -70.71 -25.23 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 CA-C-O 120.893 0.378 . . . . 0.0 110.159 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.546 HD12 ' HB3' ' A' ' 38' ' ' LYS . 38.6 mt -107.81 16.52 23.49 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.634 1.174 . . . . 0.0 112.051 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -103.69 -4.91 23.12 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 119.743 1.156 . . . . 0.0 112.428 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.482 HD12 HG13 ' A' ' 134' ' ' VAL 0.294 0.5 OUTLIER 93.57 123.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.803 2.041 . . . . 0.0 109.401 -176.43 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.555 ' HB2' ' HD3' ' A' ' 118' ' ' LYS . 3.7 m-80 -139.58 157.59 45.55 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 124.525 1.13 . . . . 0.0 108.328 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.72 -38.56 91.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.412 0.685 . . . . 0.0 110.733 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.79 -48.56 80.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.126 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 115' ' ' ASN . 4.2 mptp? -63.02 -42.18 99.74 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.83 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.436 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 29.1 tt0 -65.61 -44.17 87.38 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.757 -166.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -69.38 -39.02 78.25 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.54 -33.05 62.65 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 119.485 -0.293 . . . . 0.0 110.718 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.1 mt -59.14 -41.89 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.88 0.872 . . . . 0.0 110.538 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -74.53 -23.41 58.8 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.611 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -65.92 -57.65 7.37 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -78.36 -24.61 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 119.262 0.937 . . . . 0.0 112.977 -175.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -97.1 -32.42 11.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.15 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 57.88 79.11 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.062 0.945 . . . . 0.0 111.2 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.23 117.01 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -81.45 105.99 13.05 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 156.47 120.77 0.67 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -79.7 -172.15 3.17 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.997 0.919 . . . . 0.0 108.928 174.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 105.39 -125.61 8.33 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 121.628 -0.67 . . . . 0.0 111.629 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.415 HD22 ' HB ' ' A' ' 135' ' ' VAL . 10.5 t30 -108.96 119.28 39.08 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.865 0.866 . . . . 0.0 109.371 176.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.482 HG13 HD12 ' A' ' 114' ' ' ILE . 3.8 p -69.73 -15.86 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.124 0.57 . . . . 0.0 112.453 -171.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.415 ' HB ' HD22 ' A' ' 133' ' ' ASN . 21.4 t -70.34 -53.13 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -56.57 -39.37 73.38 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.41 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -68.17 -42.21 80.34 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.451 -173.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.9 p -76.23 -37.83 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 122.817 0.447 . . . . 0.0 110.892 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.5 mp -60.46 -37.24 80.38 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.015 0.926 . . . . 0.0 111.388 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -73.23 -40.96 64.25 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.499 0.499 . . . . 0.0 111.618 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -72.61 -29.54 63.58 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.396 0.278 . . . . 0.0 111.438 -171.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 22.2 pt -84.75 -18.55 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.87 -15.64 41.16 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.008 0.523 . . . . 0.0 110.334 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.0 tp -71.28 -2.73 17.16 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.587 1.555 . . . . 0.0 112.076 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 80.6 mt -92.48 -53.63 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.487 1.115 . . . . 0.0 109.2 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.46 -17.53 19.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.066 -174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.0 mt -135.55 63.74 1.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -43.88 125.89 4.48 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.529 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -98.48 17.44 18.96 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.932 0.893 . . . . 0.0 110.061 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 C--O 1.25 1.126 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.096 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.37 0 N-CA-C 112.258 -0.337 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.78 97.47 2.74 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.238 0.615 . . . . 0.0 110.325 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.2 ptm 115.29 12.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.53 0 C-N-CA 129.04 2.936 . . . . 0.0 109.797 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -166.01 68.24 1.13 Allowed Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.76 -60.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.143 2.562 . . . . 0.0 113.315 -170.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.7 mmt -83.92 173.53 11.13 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.239 0.616 . . . . 0.0 109.513 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.9 mt -93.01 102.17 13.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.4 mm -112.69 118.92 59.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -135.08 149.05 50.01 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.26 151.52 17.9 Favored Glycine 0 C--O 1.239 0.42 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.91 127.65 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.61 0.719 . . . . 0.0 112.874 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.488 ' HA ' HD21 ' A' ' 85' ' ' ASN . 11.5 ptp85 -91.72 133.17 35.84 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.823 1.249 . . . . 0.0 110.31 175.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.94 24.37 72.11 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.192 -0.458 . . . . 0.0 114.101 170.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.485 ' HB2' ' HB ' ' A' ' 103' ' ' ILE . . . -80.21 111.79 16.91 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.673 0.789 . . . . 0.0 110.974 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 110.17 8.42 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.02 92.41 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.72 0.771 . . . . 0.0 109.34 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.487 ' ND2' HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -105.01 148.58 26.58 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.486 -176.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -56.53 -24.41 46.53 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.4 -34.17 76.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.394 0.678 . . . . 0.0 112.38 -172.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.602 HG22 HG23 ' A' ' 103' ' ' ILE . 7.2 pt -62.66 -15.14 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -106.82 -17.85 14.09 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 118.525 0.602 . . . . 0.0 109.845 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -69.39 -25.44 64.15 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.08 0.952 . . . . 0.0 111.16 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -76.57 -8.94 58.21 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.196 -174.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.11 17.22 9.92 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 116.737 1.455 . . . . 0.0 116.737 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.472 ' HB2' HD12 ' A' ' 23' ' ' LEU . 93.3 mt -81.93 170.5 15.55 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.426 0.69 . . . . 0.0 110.833 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -84.58 99.41 10.74 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.643 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -149.9 162.25 40.69 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.852 0.861 . . . . 0.0 109.421 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -140.09 145.89 38.21 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.6 mt -130.98 127.48 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 172.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -120.31 176.63 5.37 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.461 ' O ' HG12 ' A' ' 34' ' ' VAL . 44.4 t30 -81.17 138.07 35.87 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.516 ' HB1' ' HB ' ' A' ' 111' ' ' VAL . . . -83.74 -2.45 56.3 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.509 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 61.3 m-20 -89.87 -30.22 18.05 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 122.854 0.462 . . . . 0.0 110.387 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.484 HG21 HG13 ' A' ' 125' ' ' ILE . 9.4 p -87.52 -16.29 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 123.309 0.644 . . . . 0.0 111.234 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.523 HG22 ' HD1' ' A' ' 40' ' ' HIS . 13.4 p -93.86 136.13 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.77 -66.93 0.64 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.681 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.4 p -138.49 167.78 21.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.595 1.158 . . . . 0.0 109.362 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.452 ' HB3' HD11 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -58.26 -22.94 54.43 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 174.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.443 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 87.4 tttt -58.95 -34.68 72.04 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.021 0.528 . . . . 0.0 111.677 174.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.523 ' HD1' HG22 ' A' ' 35' ' ' VAL . 18.1 t-80 -60.58 -44.57 96.07 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.204 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.57 -52.83 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.036 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.443 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 4.1 pp -64.57 -28.37 69.59 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -172.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.431 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 79.4 t60 -68.63 -33.48 74.09 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.226 0.61 . . . . 0.0 110.985 171.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 -40.82 69.58 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.024 0.53 . . . . 0.0 110.914 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.511 HG12 HD12 ' A' ' 62' ' ' ILE . 55.9 mt -61.3 -43.79 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.163 0.985 . . . . 0.0 109.915 172.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.419 ' O ' HG22 ' A' ' 50' ' ' THR . 25.8 t-20 -53.13 -48.39 67.93 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.634 1.173 . . . . 0.0 110.69 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 26.7 mm-40 -63.82 -34.62 78.34 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.231 0.957 . . . . 0.0 110.583 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . . . -73.35 -25.66 60.69 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HZ1' ' HB3' ' A' ' 49' ' ' LYS . 8.7 mtpm? -83.71 -46.19 12.55 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.376 0.67 . . . . 0.0 111.23 -176.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.494 HG21 ' HG3' ' A' ' 51' ' ' LYS . 15.1 t -93.9 -32.35 13.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.75 0.42 . . . . 0.0 111.827 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.494 ' HG3' HG21 ' A' ' 50' ' ' THR . 42.3 mtpt -109.51 160.97 15.78 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.925 0.49 . . . . 0.0 111.239 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -142.36 98.82 5.95 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 124.066 0.947 . . . . 0.0 110.248 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 54' ' ' ILE . 14.4 Cg_exo -68.41 -119.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.549 2.832 . . . . 0.0 112.036 169.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.44 ' H ' ' HB2' ' A' ' 53' ' ' PRO . 30.3 mt -132.99 34.73 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.39 158.59 23.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.548 -175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -60.24 -60.37 3.92 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.9 0.88 . . . . 0.0 112.416 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.535 ' HB2' ' SD ' ' A' ' 60' ' ' MET . 70.0 m -148.65 179.17 8.03 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.512 0.725 . . . . 0.0 109.818 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.402 ' O ' HG13 ' A' ' 62' ' ' ILE . 58.1 t80 -53.56 -56.97 12.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.324 1.049 . . . . 0.0 111.852 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.453 ' HZ3' HG23 ' A' ' 89' ' ' ILE . 75.7 m95 -65.54 -35.18 80.09 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.491 0.716 . . . . 0.0 111.473 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 57' ' ' SER . 1.1 mpt? -76.34 -19.81 57.85 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 22.9 tt0 -78.53 -38.94 39.37 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.442 0.697 . . . . 0.0 110.627 173.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.511 HD12 HG12 ' A' ' 45' ' ' ILE . 90.2 mt -57.01 -41.28 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.491 0.716 . . . . 0.0 111.036 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.0 -32.88 67.63 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.21 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.669 HG22 ' HE ' ' A' ' 65' ' ' ARG . 12.0 m -78.38 -34.21 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 121.771 -0.581 . . . . 0.0 111.729 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.669 ' HE ' HG22 ' A' ' 64' ' ' VAL . 5.8 mmp_? -70.39 -38.98 74.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.651 0.38 . . . . 0.0 110.919 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.81 68.84 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.34 0.656 . . . . 0.0 112.199 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.0 p -92.44 -3.53 55.08 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.764 0.426 . . . . 0.0 111.933 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.48 16.04 48.52 Favored Glycine 0 C--N 1.358 1.77 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -170.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.589 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.7 tp-100 -105.76 151.57 24.29 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.5 ptt-85 -85.19 -27.2 26.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.072 0.549 . . . . 0.0 111.361 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.589 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 5.8 mm-40 -90.04 125.45 35.41 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.357 1.063 . . . . 0.0 111.195 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.5 HD12 HG12 ' A' ' 64' ' ' VAL . 1.8 mp -58.76 -44.95 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.343 1.057 . . . . 0.0 110.357 172.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -60.94 -51.09 70.76 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.351 0.661 . . . . 0.0 111.348 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -56.47 -55.52 32.63 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.316 0.385 . . . . 0.0 110.983 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.71 -38.78 75.86 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.3 mt -68.99 -31.1 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 120.661 0.267 . . . . 0.0 111.178 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -74.05 -43.63 57.15 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 122.098 -0.376 . . . . 0.0 110.675 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 79.4 mt -68.55 -65.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.83 0.852 . . . . 0.0 111.825 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.412 HG21 HG23 ' A' ' 34' ' ' VAL . 7.7 pt -105.91 6.06 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.15 176.13 47.4 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 119.094 0.861 . . . . 0.0 114.025 -166.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.33 140.31 42.99 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.613 0.765 . . . . 0.0 111.803 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -145.64 143.22 29.71 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.44 141.3 58.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.297 0.953 . . . . 0.0 111.41 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.07 -119.41 4.45 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.488 HD21 ' HA ' ' A' ' 12' ' ' ARG . 12.6 m120 -82.83 110.29 17.71 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.252 0.526 . . . . 0.0 109.913 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.79 174.06 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.627 0.727 . . . . 0.0 111.519 173.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.1 t -130.94 121.81 25.81 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.709 -173.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.454 HD21 ' HB ' ' A' ' 99' ' ' ILE . 8.3 tp -102.1 122.22 43.7 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.774 0.797 . . . . 0.0 109.503 -172.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.453 HG23 ' HZ3' ' A' ' 59' ' ' TRP . 32.0 mt -111.03 122.19 65.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 113.35 -1.75 . . . . 0.0 107.692 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.584 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 40.1 t -154.56 168.0 28.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.953 0.342 . . . . 0.0 111.028 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -95.96 -48.13 5.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.356 0.663 . . . . 0.0 110.827 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -111.66 138.15 48.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.428 0.691 . . . . 0.0 109.26 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 41.4 tt0 -63.49 -24.14 67.7 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.278 0.631 . . . . 0.0 111.902 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.15 -45.82 72.49 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.584 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 28.3 m -70.88 -34.45 71.6 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.929 0.892 . . . . 0.0 111.001 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.463 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 5.5 t80 -61.54 -52.31 64.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.553 0.741 . . . . 0.0 109.667 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.539 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 30.7 mtp180 -68.58 -33.62 74.37 Favored 'General case' 0 C--O 1.213 -0.855 0 O-C-N 123.685 0.616 . . . . 0.0 110.343 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' O ' HD12 ' A' ' 102' ' ' LEU . 50.4 tptt -56.46 -40.49 74.94 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.024 0.529 . . . . 0.0 110.663 175.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.454 ' HB ' HD21 ' A' ' 88' ' ' LEU . 43.2 mm -73.67 -48.64 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.6 174.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -54.54 -43.37 71.9 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 124.826 1.251 . . . . 0.0 113.702 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 56.6 mm-40 -60.88 -40.33 92.61 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.624 0.37 . . . . 0.0 110.776 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 98' ' ' LYS . 6.8 mp -72.97 -42.08 63.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.533 0.733 . . . . 0.0 112.082 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.602 HG23 HG22 ' A' ' 20' ' ' ILE . 8.2 pt -74.66 -32.59 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 118.229 0.468 . . . . 0.0 110.019 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.38 27.14 73.92 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 163.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.38 -170.58 43.72 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 172.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -111.62 146.38 37.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.35 124.54 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 121.003 0.43 . . . . 0.0 110.087 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -118.93 101.0 7.73 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.37 -41.82 76.01 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 50.4 m -56.82 -24.93 54.5 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -175.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.516 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 13.5 m -70.36 -17.75 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 118.583 0.629 . . . . 0.0 111.605 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 38' ' ' LYS . 21.2 mt -107.05 17.6 22.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.791 0.836 . . . . 0.0 111.136 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 110' ' ' SER . 8.0 pt-20 -114.46 -10.64 12.57 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.044 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 78.63 127.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 C-N-CA 124.527 1.131 . . . . 0.0 110.451 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -158.88 -172.39 3.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.554 1.142 . . . . 0.0 109.408 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.38 -47.58 83.53 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.284 0.634 . . . . 0.0 111.362 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.08 -44.04 95.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.187 0.595 . . . . 0.0 110.967 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.509 ' HE2' ' HA ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -59.97 -43.92 94.78 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.128 0.893 . . . . 0.0 110.389 177.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.01 -50.05 31.91 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.353 -167.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -64.96 -54.5 29.51 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -172.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 pp -64.44 -33.09 75.06 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.14 0.275 . . . . 0.0 111.17 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.581 ' HA ' HD13 ' A' ' 125' ' ' ILE . 1.9 mt -53.84 -32.66 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 124.052 0.941 . . . . 0.0 112.048 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -64.51 -36.5 84.38 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.498 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.62 -56.69 18.73 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.581 HD13 ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -70.0 -52.92 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.414 ' HD2' HG21 ' A' ' 122' ' ' ILE . 23.6 m-85 -83.58 -33.07 25.48 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -170.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.546 ' HZ3' ' HB3' ' A' ' 127' ' ' LYS . 3.2 mmmp? 61.53 69.55 0.64 Allowed 'General case' 0 C--N 1.35 0.592 0 O-C-N 124.403 1.064 . . . . 0.0 110.586 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.42 115.07 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.573 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 53.8 mmm-85 -86.35 39.0 0.8 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.603 0.761 . . . . 0.0 111.74 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -167.38 139.73 5.88 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -94.83 -175.0 3.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.46 0.704 . . . . 0.0 110.582 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.13 -138.54 14.33 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -173.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.466 HD21 ' HG2' ' A' ' 136' ' ' GLU . 37.0 t30 -91.33 125.09 35.98 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.06 -32.12 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.892 0.877 . . . . 0.0 111.861 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.67 -53.48 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.178 0.514 . . . . 0.0 109.971 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.466 ' HG2' HD21 ' A' ' 133' ' ' ASN . 28.5 mm-40 -70.04 -37.14 75.49 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.83 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -76.91 -29.44 55.7 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 123.561 0.538 . . . . 0.0 111.817 -172.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.56 -36.15 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 172.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 40' ' ' HIS . 5.9 mp -60.49 -38.11 83.25 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.423 0.689 . . . . 0.0 110.646 172.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 31.4 mm-40 -59.65 -51.41 69.93 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.136 0.574 . . . . 0.0 110.955 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -49.19 78.2 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.557 0.743 . . . . 0.0 112.249 -175.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.9 pt -70.18 -27.59 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 122.972 0.509 . . . . 0.0 110.683 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.92 -31.94 34.86 Favored 'General case' 0 C--O 1.206 -1.233 0 C-N-CA 122.848 0.459 . . . . 0.0 110.531 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.8 tp -72.37 3.06 5.13 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.092 0.957 . . . . 0.0 112.177 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.4 mt -103.14 -50.65 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.154 0.982 . . . . 0.0 109.188 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -93.23 -3.35 53.91 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.656 0.741 . . . . 0.0 111.169 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 49.2 tp -144.08 60.66 1.36 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -57.74 163.75 2.42 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.784 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -109.53 -2.81 17.37 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.514 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.249 1.067 0 C-N-CA 123.801 0.84 . . . . 0.0 109.71 177.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.44 174.14 14.24 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.298 1.039 . . . . 0.0 109.053 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -57.91 -39.84 78.93 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.305 0.378 . . . . 0.0 110.141 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.588 ' HA ' HD22 ' A' ' 42' ' ' LEU . 14.4 m-20 -132.18 93.99 24.83 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 167.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.647 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 35.9 Cg_endo -59.81 -53.46 3.22 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.912 2.408 . . . . 0.0 112.859 -173.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.647 ' SD ' ' HG2' ' A' ' 5' ' ' PRO . 1.4 mpt? -89.63 168.53 12.06 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.505 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 63.0 mt -101.77 106.15 19.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -171.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.51 HG12 ' HB ' ' A' ' 41' ' ' VAL . 3.7 mp -103.29 122.63 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 170.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.423 HH11 HG22 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -124.19 149.61 46.14 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -174.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' N ' HD12 ' A' ' 112' ' ' LEU . . . -104.8 137.32 13.58 Favored Glycine 0 CA--C 1.501 -0.792 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.0 tt -146.83 142.94 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.291 0.567 . . . . 0.0 111.093 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -122.56 132.28 54.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.352 1.461 . . . . 0.0 108.906 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.07 1.33 70.05 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.624 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.87 106.42 1.54 Allowed 'General case' 0 C--N 1.351 0.66 0 C-N-CA 124.287 1.035 . . . . 0.0 111.352 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -74.78 104.08 5.28 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.198 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.444 HD13 HG22 ' A' ' 86' ' ' VAL . 49.9 mm -71.25 98.2 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.687 0.756 . . . . 0.0 109.253 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.41 ' ND2' HG21 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -112.26 153.05 27.74 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.453 -178.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -67.15 -12.12 59.13 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.561 0.744 . . . . 0.0 112.349 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -67.03 -33.26 75.16 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.014 0.926 . . . . 0.0 111.83 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 HG21 ' ND2' ' A' ' 17' ' ' ASN . 12.6 pt -55.23 -22.57 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -87.36 -21.82 25.44 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.448 0.567 . . . . 0.0 111.409 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -77.35 -16.21 59.01 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.22 0.608 . . . . 0.0 112.025 -170.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.478 HD21 HD12 ' A' ' 99' ' ' ILE . 1.2 pp -80.3 -8.92 59.69 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.974 0.51 . . . . 0.0 111.814 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.7 14.92 10.53 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.854 1.501 . . . . 0.0 116.854 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.56 159.27 32.4 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.577 0.688 . . . . 0.0 110.33 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -83.3 100.68 10.79 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -145.12 166.45 25.37 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.555 1.142 . . . . 0.0 108.7 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -149.95 151.78 33.91 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 162.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.413 HG12 HD13 ' A' ' 88' ' ' LEU . 27.3 mt -128.15 127.51 67.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 89' ' ' ILE . 2.7 pt? -115.35 172.35 7.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -81.41 142.91 32.53 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.151 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB2' HG22 ' A' ' 111' ' ' VAL . . . -78.61 0.64 25.6 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.16 -28.58 57.42 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.17 0.588 . . . . 0.0 111.082 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.59 HG12 HG22 ' A' ' 79' ' ' ILE . 32.4 m -107.46 -2.74 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.122 0.569 . . . . 0.0 112.484 -170.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.533 HG12 ' SG ' ' A' ' 87' ' ' CYS . 7.4 p -78.45 104.53 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.277 0.56 . . . . 0.0 109.557 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.5 -66.61 0.53 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.541 HG23 ' HA ' ' A' ' 113' ' ' GLU . 19.1 p -137.78 173.07 12.04 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.677 169.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HG3' ' HB3' ' A' ' 112' ' ' LEU . 51.3 mtpt -53.98 -25.29 20.14 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.055 0.542 . . . . 0.0 111.678 165.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 10.7 mptt -57.74 -36.74 72.47 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.317 1.047 . . . . 0.0 111.959 172.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.424 ' HA ' HD12 ' A' ' 139' ' ' LEU . 12.2 t-80 -60.18 -49.82 76.12 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.211 0.945 . . . . 0.0 110.553 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' HB ' HG12 ' A' ' 8' ' ' ILE . 59.1 t -69.53 -54.04 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.271 177.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 4' ' ' ASP . 1.8 pp -60.64 -36.8 79.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.001 0.521 . . . . 0.0 111.556 -172.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.457 ' HD2' HD13 ' A' ' 142' ' ' ILE . 75.6 t60 -58.92 -39.82 82.71 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.781 0.832 . . . . 0.0 111.454 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.04 -33.45 70.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.266 0.626 . . . . 0.0 110.693 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.532 HG12 HD13 ' A' ' 62' ' ' ILE . 43.0 mt -65.16 -44.28 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.386 0.675 . . . . 0.0 110.426 170.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.573 ' HA ' ' HZ3' ' A' ' 49' ' ' LYS . 84.1 m-20 -55.45 -40.42 71.55 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.797 0.839 . . . . 0.0 110.538 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -60.3 -43.79 95.98 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.519 1.137 . . . . 0.0 110.601 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.61 -28.13 66.64 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.55 0.74 . . . . 0.0 112.462 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.573 ' HZ3' ' HA ' ' A' ' 46' ' ' ASN . 24.3 mtmm -76.54 -42.1 44.23 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.572 0.349 . . . . 0.0 111.038 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.55 HG22 ' HG3' ' A' ' 51' ' ' LYS . 12.8 t -88.25 -31.69 18.9 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.392 0.277 . . . . 0.0 111.479 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.655 ' HZ1' ' HD2' ' A' ' 65' ' ' ARG . 39.9 mtmt -109.53 152.95 24.79 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.911 0.863 . . . . 0.0 112.752 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.635 ' HZ3' ' HB2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -139.23 81.84 20.27 Favored Pre-proline 0 CA--C 1.553 1.087 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.627 160.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -87.73 -78.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.278 2.652 . . . . 0.0 113.017 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.3 mt -123.89 -10.82 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 124.275 1.03 . . . . 0.0 108.939 -172.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.546 ' HA ' HD13 ' A' ' 72' ' ' ILE . . . -65.06 147.34 53.64 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.954 0.902 . . . . 0.0 112.508 -172.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.646 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 75.9 mmtt -66.83 -33.44 75.61 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.566 0.747 . . . . 0.0 110.108 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.0 t -163.41 178.15 8.32 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.641 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -51.94 -60.33 3.31 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.691 1.596 . . . . 0.0 111.481 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -66.83 -20.73 65.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.294 -177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.646 ' HG3' ' HB2' ' A' ' 56' ' ' LYS . 22.8 mmt -76.73 -28.55 55.84 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.349 0.66 . . . . 0.0 111.534 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.452 ' HA ' HG23 ' A' ' 64' ' ' VAL . 51.6 tp10 -74.95 -32.08 61.65 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 120.641 0.257 . . . . 0.0 110.498 174.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.532 HD13 HG12 ' A' ' 45' ' ' ILE . 60.5 mt -62.01 -46.49 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.903 0.481 . . . . 0.0 110.833 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.485 HD21 ' SD ' ' A' ' 60' ' ' MET . 4.0 pp -71.91 -34.89 69.46 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.932 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.452 HG23 ' HA ' ' A' ' 61' ' ' GLU . 36.0 m -73.94 -31.55 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 118.291 0.496 . . . . 0.0 111.811 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.655 ' HD2' ' HZ1' ' A' ' 51' ' ' LYS . 12.6 mmp_? -77.28 -42.23 37.81 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.629 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.11 71.74 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.434 0.561 . . . . 0.0 111.048 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.1 p -86.57 -13.82 44.68 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 59.37 20.75 52.06 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 114.42 0.528 . . . . 0.0 114.42 -164.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -117.44 93.44 4.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.056 0.942 . . . . 0.0 108.929 -177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.416 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -59.35 -10.76 3.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -174.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -85.15 121.27 27.66 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.546 HD13 ' HA ' ' A' ' 55' ' ' ALA . 27.6 mm -52.95 -54.88 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.696 1.198 . . . . 0.0 112.27 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -58.71 -50.96 71.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.73 0.812 . . . . 0.0 110.967 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 39.9 mm-40 -61.92 -40.0 93.96 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.053 0.846 . . . . 0.0 112.242 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.45 80.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.489 0.715 . . . . 0.0 111.788 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.1 -30.17 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 123.398 0.679 . . . . 0.0 110.808 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 58.5 mtpt -64.77 -49.12 71.98 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 122.108 -0.37 . . . . 0.0 110.781 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.84 -65.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.636 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.59 HG22 HG12 ' A' ' 34' ' ' VAL . 23.0 pt -104.36 11.21 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -169.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.13 155.15 50.33 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 118.921 0.782 . . . . 0.0 112.03 -172.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.09 54.5 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.676 0.791 . . . . 0.0 112.976 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -132.2 158.45 41.72 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -53.32 145.63 13.76 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 119.043 0.838 . . . . 0.0 112.611 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.17 -111.19 4.18 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.23 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.407 HD21 ' N ' ' A' ' 85' ' ' ASN . 0.9 OUTLIER -91.17 111.47 22.96 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.26 0.624 . . . . 0.0 109.85 -173.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.444 HG22 HD13 ' A' ' 16' ' ' ILE . 3.7 m -138.75 -179.84 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.819 1.248 . . . . 0.0 111.426 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.533 ' SG ' HG12 ' A' ' 35' ' ' VAL . 78.0 m -133.89 125.35 28.13 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.495 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.413 HD13 HG12 ' A' ' 29' ' ' ILE . 11.7 tp -104.72 126.09 51.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.232 1.013 . . . . 0.0 109.686 -170.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.604 HD11 HD22 ' A' ' 30' ' ' LEU . 7.0 mt -109.45 122.78 64.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 114.302 -1.317 . . . . 0.0 107.45 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 9.4 p -143.43 152.15 41.21 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 122.776 0.43 . . . . 0.0 109.902 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.15 -46.35 84.48 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.283 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.401 ' OD2' ' HG2' ' A' ' 94' ' ' GLU . 1.5 p-10 -148.46 171.15 16.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.411 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -69.0 -22.58 64.07 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -168.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HG2' ' OD2' ' A' ' 92' ' ' ASP . 10.1 pt-20 -74.46 -41.73 60.28 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.098 0.863 . . . . 0.0 109.281 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m -58.49 -39.69 80.74 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.605 0.762 . . . . 0.0 110.819 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.685 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 14.1 t80 -56.55 -51.23 69.34 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 123.364 0.666 . . . . 0.0 110.719 175.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -63.93 -35.21 79.92 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.75 0.656 . . . . 0.0 110.822 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 98' ' ' LYS . 10.7 mmpt? -64.59 -45.94 84.82 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.586 0.554 . . . . 0.0 111.571 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.478 HD12 HD21 ' A' ' 23' ' ' LEU . 44.4 mm -69.06 -44.57 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.395 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -53.31 -34.37 57.11 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.041 1.336 . . . . 0.0 112.182 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -60.25 -51.35 69.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.588 0.755 . . . . 0.0 111.561 174.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.66 -41.43 75.53 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.8 pt -77.89 -50.2 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 118.35 0.523 . . . . 0.0 110.775 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.04 114.33 0.04 OUTLIER Glycine 0 C--N 1.35 1.353 0 N-CA-C 113.883 0.313 . . . . 0.0 113.883 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.46 -159.88 24.81 Favored Glycine 0 C--O 1.241 0.589 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.2 143.18 49.27 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.3 0.55 . . . . 0.0 109.829 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.5 mm -71.22 129.1 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 122.928 0.491 . . . . 0.0 110.18 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -116.5 101.79 8.93 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -68.12 -53.5 24.89 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.1 0.56 . . . . 0.0 111.747 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.1 p -53.06 -30.03 33.5 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 32' ' ' ALA . 10.3 p -65.3 -27.26 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 118.401 0.546 . . . . 0.0 111.44 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 10' ' ' GLY . 93.4 mt -80.46 -3.2 48.99 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.372 1.069 . . . . 0.0 112.503 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.541 ' HA ' HG23 ' A' ' 37' ' ' THR . 12.8 pt-20 -135.95 23.57 3.31 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -169.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 118' ' ' LYS . 0.4 OUTLIER 77.74 138.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 124.242 1.017 . . . . 0.0 112.46 165.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 5.2 p-10 -151.16 -179.93 7.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.527 1.131 . . . . 0.0 109.517 170.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.81 -41.61 97.85 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.315 0.646 . . . . 0.0 111.943 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.514 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 0.1 OUTLIER -62.17 -41.72 98.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.592 1.157 . . . . 0.0 109.928 176.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.613 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -62.62 -40.01 95.62 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.047 0.842 . . . . 0.0 110.691 177.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.6 -48.41 48.3 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.345 -166.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -73.55 -39.45 64.69 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.172 0.589 . . . . 0.0 110.697 -174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.8 tp -53.88 -53.15 56.65 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.278 1.431 . . . . 0.0 111.971 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.429 HG23 ' HD2' ' A' ' 126' ' ' PHE . 43.6 mt -62.44 -29.72 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.753 1.221 . . . . 0.0 111.309 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 5.4 tmm_? -72.41 -35.94 68.51 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.992 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.62 -55.99 12.75 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.63 -35.75 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 118.916 0.78 . . . . 0.0 113.075 -174.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.429 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.7 m-30 -88.39 -32.21 18.47 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 29.1 mmtp 63.84 75.86 0.37 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.176 0.99 . . . . 0.0 112.213 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.2 mt -98.26 121.19 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.524 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -91.86 99.13 12.04 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 141.59 120.14 1.6 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -86.65 -160.83 0.6 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.156 0.982 . . . . 0.0 109.533 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.66 -68.1 2.91 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -138.6 114.31 9.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.24 -25.87 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 123.474 0.71 . . . . 0.0 111.516 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.432 ' O ' HD13 ' A' ' 139' ' ' LEU . 85.1 t -68.64 -58.35 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.45 0.7 . . . . 0.0 111.667 -174.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -63.05 -29.05 70.51 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 117.742 0.246 . . . . 0.0 111.042 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.449 ' HA ' ' HG2' ' A' ' 140' ' ' GLU . 77.6 mtt-85 -75.97 -32.76 59.63 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 123.736 0.648 . . . . 0.0 112.187 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.0 p -73.82 -41.05 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 CA-C-N 118.218 0.463 . . . . 0.0 110.142 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 135' ' ' VAL . 11.2 mp -57.29 -42.4 81.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.535 0.734 . . . . 0.0 112.565 175.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 137' ' ' ARG . 13.5 pt-20 -80.73 -28.57 36.54 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.054 0.141 . . . . 0.0 110.971 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -59.82 -52.55 64.99 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.694 0.797 . . . . 0.0 110.679 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.457 HD13 ' HD2' ' A' ' 43' ' ' HIS . 13.6 pt -73.59 -17.12 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.056 -171.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.8 57.26 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.327 167.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.2 tp -75.5 -6.04 48.19 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.802 0.841 . . . . 0.0 111.822 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.444 HG22 ' HB2' ' A' ' 146' ' ' GLU . 1.7 mp -92.29 -55.81 5.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.444 ' HB2' HG22 ' A' ' 145' ' ' ILE . 1.6 tm-20 -146.72 78.95 1.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -173.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.481 HD13 ' HD3' ' A' ' 51' ' ' LYS . 57.2 tp -170.73 -60.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.009 164.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt 14.48 -145.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 126.012 1.725 . . . . 0.0 113.584 -158.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.592 ' HB3' ' HZ1' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -135.98 74.0 1.49 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 149.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.25 1.095 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.271 -174.555 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 N-CA-C 112.131 -0.388 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.17 94.85 7.36 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.533 0.733 . . . . 0.0 109.826 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -69.47 -69.08 0.36 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.733 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.44 64.82 6.37 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.386 1.074 . . . . 0.0 109.68 -169.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 42' ' ' LEU . 45.8 Cg_endo -64.01 -50.58 2.86 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 123.19 2.593 . . . . 0.0 113.335 -168.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.739 ' SD ' ' HG2' ' A' ' 91' ' ' GLU . 5.1 mmt -97.52 -175.48 3.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.547 0.739 . . . . 0.0 109.201 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.547 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 41.9 mt -96.95 102.98 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.27 122.65 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -124.65 145.87 49.41 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.039 0.935 . . . . 0.0 109.549 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.72 139.19 14.52 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.247 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.0 tt -152.48 144.07 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 122.849 0.46 . . . . 0.0 110.992 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -116.85 142.7 46.59 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.84 0.856 . . . . 0.0 109.308 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.34 11.24 85.7 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.56 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.59 95.21 1.06 Allowed 'General case' 0 C--N 1.351 0.639 0 C-N-CA 123.899 0.879 . . . . 0.0 110.604 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 51.8 mtm-85 -70.79 101.65 2.16 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.805 0.69 . . . . 0.0 109.599 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.502 HD13 HG11 ' A' ' 86' ' ' VAL . 48.2 mm -67.39 121.13 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.419 0.687 . . . . 0.0 110.377 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.29 159.34 18.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.794 0.837 . . . . 0.0 109.855 175.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -77.28 -16.55 58.93 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.539 0.735 . . . . 0.0 112.213 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.95 -30.18 63.66 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.386 0.674 . . . . 0.0 112.685 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.3 pt -60.48 -12.47 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.15 0.23 56.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.993 0.517 . . . . 0.0 112.19 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -79.4 -25.09 42.16 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.221 0.464 . . . . 0.0 111.551 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pp -85.15 -14.44 47.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.996 0.518 . . . . 0.0 111.682 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.53 16.37 7.03 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 116.616 1.406 . . . . 0.0 116.616 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.7 mt -73.82 175.17 7.51 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 117.501 0.651 . . . . 0.0 111.457 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.93 81.21 2.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.048 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -139.7 145.95 39.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.002 0.921 . . . . 0.0 108.719 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.433 ' NE2' ' HB3' ' A' ' 63' ' ' LEU . 1.6 tm0? -142.15 136.68 30.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 171.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.413 HG22 HG22 ' A' ' 86' ' ' VAL . 3.9 mt -127.21 129.74 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.34 171.05 13.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.748 0.819 . . . . 0.0 110.443 176.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -76.38 116.37 17.0 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.805 0.842 . . . . 0.0 109.906 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.27 3.47 51.95 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.692 ' HA ' ' HZ1' ' A' ' 118' ' ' LYS . 19.2 m-20 -78.08 -35.69 49.1 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 170.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.454 HG23 HG23 ' A' ' 79' ' ' ILE . 26.8 m -97.88 5.86 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 122.902 0.481 . . . . 0.0 111.729 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.601 HG22 ' HD1' ' A' ' 40' ' ' HIS . 3.7 p -90.48 139.14 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.81 -69.34 0.53 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.4 p -136.63 172.88 12.36 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.719 0.808 . . . . 0.0 110.065 174.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -26.34 12.33 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.506 0.722 . . . . 0.0 112.311 170.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -54.73 -32.93 60.39 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.446 1.098 . . . . 0.0 112.202 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.601 ' HD1' HG22 ' A' ' 35' ' ' VAL . 30.2 t-80 -65.44 -47.48 76.05 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.728 0.811 . . . . 0.0 110.878 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.488 HG21 ' SG ' ' A' ' 87' ' ' CYS . 38.8 t -67.3 -50.92 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.029 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.559 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 3.1 pp -61.32 -34.6 75.52 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.039 0.535 . . . . 0.0 111.54 -175.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -55.21 -43.95 74.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.043 0.937 . . . . 0.0 110.734 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.8 78.39 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.796 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.494 HG12 HD12 ' A' ' 62' ' ' ILE . 63.5 mt -65.02 -53.38 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.028 0.931 . . . . 0.0 112.192 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -49.28 -44.66 44.14 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.923 0.889 . . . . 0.0 110.628 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -73.44 -31.62 63.92 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.293 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.84 -21.22 60.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.244 0.618 . . . . 0.0 112.323 174.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -78.11 -48.14 16.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.869 0.468 . . . . 0.0 110.332 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.52 HG21 ' HG3' ' A' ' 51' ' ' LYS . 10.9 t -88.98 -29.12 19.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.023 0.529 . . . . 0.0 112.268 -171.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.52 ' HG3' HG21 ' A' ' 50' ' ' THR . 49.1 mtmt -114.45 155.41 26.42 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.571 0.701 . . . . 0.0 112.229 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.52 ' HZ1' ' HB2' ' A' ' 52' ' ' LYS . 9.7 mtmp? -140.06 73.13 32.93 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.336 167.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.23 -78.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.206 2.604 . . . . 0.0 114.164 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.69 -26.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.066 0.546 . . . . 0.0 111.645 -166.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.21 174.09 4.21 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -169.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -73.75 -53.62 9.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.447 0.699 . . . . 0.0 112.193 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.603 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 21.4 t -157.03 -171.73 3.76 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.408 0.683 . . . . 0.0 109.453 -174.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -53.95 -60.92 2.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.497 1.119 . . . . 0.0 113.268 -174.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -64.76 -29.62 70.6 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.014 0.435 . . . . 0.0 111.144 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.603 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.3 mpt? -77.18 -27.51 53.68 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.926 0.891 . . . . 0.0 110.455 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 11.3 tp10 -74.43 -34.08 63.12 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.893 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.494 HD12 HG12 ' A' ' 45' ' ' ILE . 72.9 mt -64.38 -47.07 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.145 0.578 . . . . 0.0 111.061 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HB3' ' NE2' ' A' ' 28' ' ' GLN . 3.4 pp -68.34 -33.39 74.22 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.215 0.322 . . . . 0.0 111.607 -175.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -77.16 -40.5 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 118.094 0.406 . . . . 0.0 110.986 174.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -70.0 -32.63 70.9 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.035 0.534 . . . . 0.0 111.709 -170.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.64 -30.87 70.55 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.186 0.594 . . . . 0.0 112.109 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.2 p -104.37 9.32 35.82 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.85 0.46 . . . . 0.0 112.225 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.72 23.7 65.55 Favored Glycine 0 C--N 1.358 1.787 0 CA-C-O 121.328 0.404 . . . . 0.0 113.965 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -89.8 -163.23 0.98 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.509 1.124 . . . . 0.0 112.512 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.18 -34.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.628 1.571 . . . . 0.0 108.523 -165.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -101.98 121.98 43.18 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.928 0.891 . . . . 0.0 108.653 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 76' ' ' ILE . 1.8 mp -51.34 -45.78 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.587 1.179 . . . . 0.0 111.697 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -66.13 -40.58 90.77 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.265 0.626 . . . . 0.0 110.928 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.03 -47.39 81.01 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.311 0.644 . . . . 0.0 111.478 173.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.85 -35.47 74.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.209 0.604 . . . . 0.0 112.619 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 72' ' ' ILE . 71.4 mt -71.49 -29.89 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 122.991 0.516 . . . . 0.0 110.981 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -63.88 -54.88 27.9 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.012 0.434 . . . . 0.0 109.918 173.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.9 mt -73.29 -65.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.262 -173.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 34' ' ' VAL . 23.2 pt -111.0 32.64 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.47 159.47 53.09 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 113.504 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.58 98.99 2.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.41 0.684 . . . . 0.0 110.961 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -109.97 153.15 24.96 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.94 0.896 . . . . 0.0 108.835 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.24 150.69 38.34 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.56 0.744 . . . . 0.0 112.492 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.34 -120.02 6.02 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.75 104.69 14.06 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.502 HG11 HD13 ' A' ' 16' ' ' ILE . 1.3 p -134.11 151.42 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.355 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' A' ' 41' ' ' VAL . 41.4 t -109.81 118.88 37.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.426 1.091 . . . . 0.0 108.99 -172.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.84 120.95 43.7 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.46 0.704 . . . . 0.0 110.153 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -107.12 137.21 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.676 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 21.8 p -152.42 151.78 31.21 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.985 0.514 . . . . 0.0 109.919 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.739 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 51.3 mt-10 -86.45 -32.23 20.95 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.31 128.89 56.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.003 0.921 . . . . 0.0 108.761 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -67.37 -21.38 65.62 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.315 0.646 . . . . 0.0 111.332 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 8.3 pt-20 -69.66 -40.02 76.7 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.667 0.387 . . . . 0.0 110.031 173.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.422 ' O ' HG12 ' A' ' 99' ' ' ILE . 99.0 m -63.55 -38.44 91.15 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.876 0.87 . . . . 0.0 109.878 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.676 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 11.6 t80 -56.96 -47.85 79.74 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.84 0.856 . . . . 0.0 110.973 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -61.54 -42.99 99.65 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.73 0.644 . . . . 0.0 110.34 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 45.6 mmtm -56.13 -45.9 79.4 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.171 0.92 . . . . 0.0 111.04 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 95' ' ' THR . 32.9 mm -69.84 -45.66 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.322 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -52.62 -43.41 65.37 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.88 1.272 . . . . 0.0 113.171 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.15 -48.27 80.78 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.777 0.673 . . . . 0.0 111.511 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.05 -36.18 56.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 pt -74.83 -39.83 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 118.311 0.505 . . . . 0.0 109.897 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.16 96.79 0.04 OUTLIER Glycine 0 C--N 1.351 1.368 0 O-C-N 123.635 0.585 . . . . 0.0 113.14 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.37 -171.36 25.09 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.16 131.03 55.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.6 mm -62.99 112.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -129.69 92.47 3.34 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 4.6 p-10 -60.27 -34.08 73.22 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.531 0.732 . . . . 0.0 111.81 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.496 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 23.8 m -52.86 -24.62 9.46 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -176.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.5 m -66.75 -32.19 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-N 118.204 0.457 . . . . 0.0 110.131 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.0 mt -95.72 -1.92 48.95 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.768 1.227 . . . . 0.0 112.253 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 110' ' ' SER . 76.0 mm-40 -103.78 -9.29 19.16 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 118.148 -0.93 . . . . 0.0 112.459 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.257 0.4 OUTLIER 84.82 135.64 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.983 1.313 . . . . 0.0 111.105 177.438 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.502 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 4.3 p-10 -159.77 170.77 20.8 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.832 1.253 . . . . 0.0 108.799 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.79 -37.62 85.02 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.59 0.756 . . . . 0.0 112.372 -168.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.502 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 16.1 t70 -54.87 -54.1 46.79 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.444 1.098 . . . . 0.0 112.219 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.692 ' HZ1' ' HA ' ' A' ' 33' ' ' ASP . 3.0 mptp? -63.1 -34.13 76.94 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.716 0.635 . . . . 0.0 110.881 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.85 -49.0 32.83 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.416 0.686 . . . . 0.0 112.159 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 67.6 mtp180 -75.22 -30.8 60.67 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.519 0.676 . . . . 0.0 110.942 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.5 tp -55.7 -48.03 75.81 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.219 165.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.405 HG21 ' HD2' ' A' ' 126' ' ' PHE . 25.2 mt -55.7 -35.11 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.229 1.012 . . . . 0.0 112.556 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -74.56 -26.53 60.01 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.951 -178.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -69.45 -58.47 3.95 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 171.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -29.49 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 119.192 0.906 . . . . 0.0 112.968 -174.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.405 ' HD2' HG21 ' A' ' 122' ' ' ILE . 23.2 m-85 -99.51 -26.24 14.17 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 68.3 mmtt 62.03 66.6 0.8 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.138 0.975 . . . . 0.0 112.506 171.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.512 HG22 ' HB3' ' A' ' 137' ' ' ARG . 16.9 mt -116.56 143.52 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 -176.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -34.75 -51.94 0.51 Allowed 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 125.285 1.434 . . . . 0.0 114.319 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.29 32.46 4.28 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -121.77 145.39 48.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.171 0.988 . . . . 0.0 110.03 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.97 -98.73 2.43 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.474 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.447 ' O ' ' HD3' ' A' ' 137' ' ' ARG . 31.3 t30 -140.18 117.3 11.19 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.98 -31.41 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 119.124 0.875 . . . . 0.0 112.21 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.448 ' O ' HD13 ' A' ' 139' ' ' LEU . 60.9 t -69.16 -53.94 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.798 0.839 . . . . 0.0 110.415 -178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.438 ' HG3' HD21 ' A' ' 133' ' ' ASN . 40.8 mt-10 -59.23 -42.6 91.4 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.333 0.396 . . . . 0.0 111.074 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.512 ' HB3' HG22 ' A' ' 128' ' ' ILE . 8.7 mpt_? -73.0 -31.67 64.65 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.949 0.781 . . . . 0.0 112.074 -167.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 139' ' ' LEU . 11.1 p -70.56 -42.56 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 117.706 0.23 . . . . 0.0 110.501 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 40' ' ' HIS . 10.9 mp -60.75 -39.67 89.61 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.567 0.542 . . . . 0.0 111.625 172.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.73 -44.43 93.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.618 0.767 . . . . 0.0 111.117 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -63.87 -45.99 86.97 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.018 0.527 . . . . 0.0 111.286 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 11.5 pt -75.6 -22.23 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.019 0.2 . . . . 0.0 110.62 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.56 ' HB1' ' HB3' ' A' ' 148' ' ' LYS . . . -74.78 -20.09 59.94 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.569 0.748 . . . . 0.0 111.089 172.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.86 5.47 9.54 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 123.499 0.72 . . . . 0.0 110.228 174.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.6 -37.65 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 165.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.56 -13.11 61.69 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.356 1.063 . . . . 0.0 113.212 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.1 mt 71.27 49.79 0.31 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.451 1.101 . . . . 0.0 108.077 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.56 ' HB3' ' HB1' ' A' ' 143' ' ' ALA . 22.6 ttmm -137.62 159.83 40.88 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.646 -169.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -149.82 110.34 4.24 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 166.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 . . . . . 0 CA--C 1.558 1.282 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.219 -177.764 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.305 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.19 153.44 33.83 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.182 0.993 . . . . 0.0 109.377 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.7 mtm -78.09 -48.16 16.65 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -145.8 86.11 7.4 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.04 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 42' ' ' LEU . 49.3 Cg_endo -67.04 -39.32 14.0 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.496 2.131 . . . . 0.0 111.3 172.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.8 mmt -138.88 176.03 9.04 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.937 0.895 . . . . 0.0 109.568 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.6 mt -101.2 111.03 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.918 1.287 . . . . 0.0 109.271 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -107.08 127.26 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 9' ' ' ARG . 2.9 mmp_? -128.15 149.89 50.23 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.718 0.807 . . . . 0.0 110.553 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.66 129.94 10.0 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.622 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 tt -141.18 147.04 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.148 0.579 . . . . 0.0 110.597 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -122.97 136.9 55.03 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.349 1.059 . . . . 0.0 109.419 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.36 7.91 87.01 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.36 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' A' ' 103' ' ' ILE . . . -76.03 104.03 6.37 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.547 0.739 . . . . 0.0 110.218 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -70.81 123.86 22.95 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.365 0.415 . . . . 0.0 110.148 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.8 mm -73.53 91.03 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.887 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.551 ' ND2' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -91.11 151.23 21.07 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.021 -177.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -63.92 -21.64 66.56 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -64.84 -29.85 70.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.405 0.682 . . . . 0.0 112.103 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.551 HG22 ' ND2' ' A' ' 17' ' ' ASN . 19.1 pt -54.37 -23.82 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -90.07 -19.45 24.33 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.284 0.493 . . . . 0.0 111.32 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.19 -22.23 63.91 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.976 0.91 . . . . 0.0 111.609 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 99' ' ' ILE . 1.5 pp -81.95 -10.17 59.35 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.282 0.633 . . . . 0.0 111.965 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.16 16.96 9.65 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.407 ' HB2' HD12 ' A' ' 23' ' ' LEU . 86.1 mt -82.39 176.57 9.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.283 0.633 . . . . 0.0 112.197 -174.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -87.56 93.44 9.42 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.102 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -145.66 160.32 41.87 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.111 0.964 . . . . 0.0 108.678 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' A' ' 59' ' ' TRP . 6.6 tp-100 -148.64 153.23 38.01 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 166.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.85 137.98 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.406 HD21 HD13 ' A' ' 89' ' ' ILE . 2.2 pt? -128.16 -175.06 3.38 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.65 0.78 . . . . 0.0 109.389 170.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -89.22 120.1 30.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.784 0.834 . . . . 0.0 109.78 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.72 -5.27 56.84 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.886 0.874 . . . . 0.0 113.168 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -76.19 -33.63 59.31 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.3 m -105.19 9.5 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.321 0.649 . . . . 0.0 112.264 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.566 HG23 ' HD1' ' A' ' 40' ' ' HIS . 4.4 p -85.13 140.71 15.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.16 -62.16 1.57 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.564 HG21 ' HA ' ' A' ' 113' ' ' GLU . 21.5 p -145.59 169.92 17.46 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.931 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB3' HD11 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -53.71 -31.98 50.17 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.131 0.572 . . . . 0.0 110.649 162.364 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.55 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 85.5 tttt -66.99 -30.57 70.73 Favored 'General case' 0 C--N 1.36 1.059 0 C-N-CA 123.909 0.883 . . . . 0.0 111.52 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.566 ' HD1' HG23 ' A' ' 35' ' ' VAL . 16.8 t-80 -60.88 -46.75 89.38 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.091 0.556 . . . . 0.0 110.305 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 45' ' ' ILE . 38.8 t -67.64 -51.2 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 O-C-N 123.77 0.669 . . . . 0.0 111.671 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 3.2 pp -64.83 -30.13 71.12 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.617 ' HE2' ' HB3' ' A' ' 143' ' ' ALA . 35.7 t60 -65.39 -35.38 80.76 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.789 0.836 . . . . 0.0 111.119 172.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' HB1' ' HB3' ' A' ' 65' ' ' ARG . . . -67.44 -34.79 77.93 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.592 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.44 HG12 HD12 ' A' ' 62' ' ' ILE . 19.8 mt -69.79 -35.94 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.931 0.892 . . . . 0.0 110.967 175.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.33 -53.98 51.93 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.246 0.618 . . . . 0.0 109.594 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.408 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 29.1 mm-40 -60.46 -30.47 69.68 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.672 1.189 . . . . 0.0 112.079 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.5 -27.32 66.03 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -89.24 -16.81 30.38 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.443 0.64 . . . . 0.0 109.831 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.0 m -91.49 -43.92 9.41 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.393 1.477 . . . . 0.0 111.041 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.535 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . 10.3 mmpt? -114.23 141.94 46.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.133 0.973 . . . . 0.0 112.533 -174.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -123.64 88.65 51.81 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 124.834 1.254 . . . . 0.0 107.988 165.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.469 ' HG3' ' NE2' ' A' ' 69' ' ' GLN . 67.0 Cg_endo -79.15 -107.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.643 2.229 . . . . 0.0 111.941 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.1 mt -126.21 13.18 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.33 146.45 53.46 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.595 0.758 . . . . 0.0 111.688 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.67 -47.39 86.49 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.594 0.757 . . . . 0.0 111.291 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.1 m -147.63 172.18 14.45 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.856 0.863 . . . . 0.0 110.201 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.72 -52.73 64.25 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.453 1.101 . . . . 0.0 110.944 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 28' ' ' GLN . 83.8 m95 -67.43 -29.09 68.48 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.118 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.458 ' SD ' HD22 ' A' ' 63' ' ' LEU . 23.3 mmt -71.72 -28.45 63.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.153 0.581 . . . . 0.0 111.665 174.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.441 ' HA ' HG22 ' A' ' 64' ' ' VAL . 44.8 tp10 -71.05 -27.93 64.01 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.757 0.423 . . . . 0.0 110.398 174.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.44 HD12 HG12 ' A' ' 45' ' ' ILE . 67.5 mt -66.25 -45.64 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.657 0.383 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.458 HD22 ' SD ' ' A' ' 60' ' ' MET . 4.4 pp -69.77 -32.76 71.44 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.156 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.576 ' HB ' ' H ' ' A' ' 70' ' ' ARG . 10.0 m -78.33 -40.78 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 122.498 -0.126 . . . . 0.0 111.294 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.489 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 6.6 tpt180 -67.9 -39.99 83.53 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 122.494 0.318 . . . . 0.0 111.025 -169.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.03 -14.28 60.03 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 124.036 0.835 . . . . 0.0 112.308 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 p -108.85 26.78 10.18 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.464 0.706 . . . . 0.0 111.546 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 26.13 53.29 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-O 119.619 -0.545 . . . . 0.0 114.297 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.469 ' NE2' ' HG3' ' A' ' 53' ' ' PRO . 34.9 tt0 55.99 113.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.269 1.427 . . . . 0.0 113.104 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.576 ' H ' ' HB ' ' A' ' 64' ' ' VAL . 2.8 mpt_? -140.04 172.54 12.62 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.973 1.709 . . . . 0.0 109.256 -173.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -57.13 135.99 56.38 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.97 159.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.405 HD13 HG12 ' A' ' 64' ' ' VAL . 1.7 mp -51.14 -49.94 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.404 1.082 . . . . 0.0 111.957 -174.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.77 -37.36 86.11 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.482 0.489 . . . . 0.0 110.52 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -63.28 -46.91 84.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.771 0.428 . . . . 0.0 112.084 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.53 71.54 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.883 0.473 . . . . 0.0 112.114 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.483 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 84.9 mt -64.51 -32.31 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.464 0.706 . . . . 0.0 110.554 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -72.49 -50.87 22.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.697 0.399 . . . . 0.0 110.066 174.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.517 HG21 HG23 ' A' ' 79' ' ' ILE . 43.9 mt -66.69 -65.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.8 0.84 . . . . 0.0 111.791 -173.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.517 HG23 HG21 ' A' ' 78' ' ' ILE . 38.6 pt -124.0 21.15 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 76' ' ' ILE . . . -76.36 156.78 47.22 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.09 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.26 113.97 1.46 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.82 0.848 . . . . 0.0 112.602 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -135.55 153.16 51.79 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.92 124.59 15.88 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.589 1.156 . . . . 0.0 112.755 -170.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.32 -118.26 1.58 Allowed Glycine 0 C--N 1.352 1.432 0 O-C-N 123.434 0.459 . . . . 0.0 112.379 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -84.25 108.14 16.95 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.26 159.98 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.959 0.885 . . . . 0.0 112.674 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.8 m -112.51 118.44 35.14 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.811 -1.54 . . . . 0.0 108.265 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD22 ' HB ' ' A' ' 99' ' ' ILE . 10.4 tp -102.63 121.19 41.91 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.32 0.648 . . . . 0.0 109.328 -174.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 28' ' ' GLN . 4.8 mt -111.48 125.6 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.902 1.281 . . . . 0.0 108.242 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 74.3 m -148.79 145.95 27.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.158 0.583 . . . . 0.0 109.746 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 -27.36 59.32 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.407 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 28.7 m-20 -131.27 148.92 52.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.287 0.635 . . . . 0.0 111.683 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.09 -25.17 65.21 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.944 1.298 . . . . 0.0 112.764 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 11.2 pt-20 -69.2 -43.27 74.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.788 0.435 . . . . 0.0 110.089 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 m -70.21 -33.08 71.25 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.708 0.803 . . . . 0.0 110.598 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -60.99 -50.96 71.28 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 45.0 ttp180 -59.86 -45.08 93.58 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.886 0.741 . . . . 0.0 109.862 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -59.44 -42.21 91.4 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.097 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.48 ' HB ' HD22 ' A' ' 88' ' ' LEU . 35.6 mm -71.9 -43.66 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -55.18 -37.83 67.55 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 124.596 1.158 . . . . 0.0 112.509 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 46.5 mt-10 -61.26 -39.25 89.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.684 0.794 . . . . 0.0 111.204 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.13 -47.46 35.96 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.691 0.797 . . . . 0.0 112.272 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 14' ' ' ALA . 18.2 pt -79.91 -28.95 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 122.068 0.147 . . . . 0.0 110.992 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.32 25.73 70.08 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.044 1.177 . . . . 0.0 116.044 160.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.32 -170.16 46.3 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 117.047 0.423 . . . . 0.0 112.513 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -104.71 140.45 38.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.604 0.762 . . . . 0.0 108.996 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mm -73.04 119.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.162 0.506 . . . . 0.0 109.79 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.447 ' O ' HG21 ' A' ' 111' ' ' VAL . 14.7 t70 -131.54 91.49 3.01 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.87 -32.61 73.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.958 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.534 ' HA ' ' HG3' ' A' ' 113' ' ' GLU . 12.1 p -58.34 -15.4 10.32 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 108' ' ' ASP . 35.4 m -66.42 -24.69 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 118.709 0.686 . . . . 0.0 110.888 171.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 38' ' ' LYS . 67.1 mt -99.65 18.23 18.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.827 1.251 . . . . 0.0 112.593 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.564 ' HA ' HG21 ' A' ' 37' ' ' THR . 0.0 OUTLIER -138.48 12.67 2.76 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 76.02 124.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.825 0.85 . . . . 0.0 112.375 168.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.523 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 3.3 p-10 -142.87 177.16 8.53 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.197 173.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -61.88 -42.1 98.66 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.071 0.948 . . . . 0.0 111.52 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.523 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 24.8 t70 -59.08 -47.37 85.5 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.048 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -67.01 -31.75 72.52 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.33 0.652 . . . . 0.0 111.142 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.76 -51.28 28.15 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.068 0.547 . . . . 0.0 111.364 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.33 -39.08 71.58 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.494 0.664 . . . . 0.0 110.131 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.1 tp -54.22 -52.87 59.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.315 1.446 . . . . 0.0 112.415 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 15.6 mt -57.96 -30.14 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.566 1.146 . . . . 0.0 111.282 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.4 ttm180 -72.05 -33.68 68.16 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.39 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 127' ' ' LYS . 12.4 mm-40 -73.67 -56.51 4.92 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 173.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 pp -78.38 -30.52 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -95.85 -30.5 13.63 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 119.358 -0.354 . . . . 0.0 111.539 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 26.2 mmmt 61.97 74.66 0.43 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.746 0.818 . . . . 0.0 111.848 176.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.5 mt -124.92 127.75 72.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.637 0.775 . . . . 0.0 109.463 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -77.83 101.93 6.98 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 167.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -88.59 -173.84 47.06 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.651 -0.25 . . . . 0.0 112.969 -173.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -136.72 -61.58 0.67 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.442 0.697 . . . . 0.0 109.774 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.93 -68.1 0.03 OUTLIER Glycine 0 N--CA 1.471 1.01 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.081 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.476 ' O ' ' HG2' ' A' ' 137' ' ' ARG . 39.3 t30 -94.42 115.28 27.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.109 0.564 . . . . 0.0 109.971 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.02 -29.14 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.389 1.076 . . . . 0.0 112.476 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.12 -51.51 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.219 0.608 . . . . 0.0 110.592 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -63.55 -30.46 71.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.633 0.373 . . . . 0.0 111.441 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 133' ' ' ASN . 4.2 mmp_? -69.61 -47.7 62.55 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.107 0.563 . . . . 0.0 110.975 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.8 p -72.66 -36.59 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.82 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.495 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.0 mp -58.59 -37.21 75.33 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.149 0.98 . . . . 0.0 111.88 173.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -67.31 -41.59 85.09 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.3 0.375 . . . . 0.0 111.341 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -72.84 -42.52 63.69 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 120.876 0.37 . . . . 0.0 111.834 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.489 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 29.9 pt -74.77 -24.04 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.617 ' HB3' ' HE2' ' A' ' 43' ' ' HIS . . . -93.29 -15.48 25.75 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.168 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -47.28 -45.7 24.26 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.584 1.154 . . . . 0.0 112.256 -165.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 64.8 mt -49.02 -41.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.581 1.153 . . . . 0.0 113.162 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -93.91 -61.74 1.48 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.577 0.751 . . . . 0.0 109.574 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 31.4 tp -91.31 36.08 0.93 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.082 1.353 . . . . 0.0 111.847 -167.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -67.04 160.28 26.91 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.405 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -92.67 31.94 1.3 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.19 0.519 . . . . 0.0 110.593 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 C--O 1.252 1.237 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 -179.41 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.674 -0.17 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.93 104.27 5.46 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.362 0.665 . . . . 0.0 109.329 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mpp? 95.97 21.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 126.58 1.952 . . . . 0.0 108.276 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -153.61 81.59 4.84 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.588 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 60.2 Cg_endo -69.27 -63.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.616 2.211 . . . . 0.0 113.187 -169.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.588 ' SD ' ' HG2' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -95.9 175.14 6.61 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.188 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.473 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 74.3 mt -109.1 101.4 12.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 9.3 mm -110.21 124.11 66.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -121.58 145.12 48.3 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.79 137.62 13.49 Favored Glycine 0 CA--C 1.5 -0.875 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.4 tt -148.85 138.64 16.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.336 0.588 . . . . 0.0 110.357 -173.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -125.34 126.82 45.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.813 1.245 . . . . 0.0 108.714 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.96 -0.11 57.5 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 123.377 0.423 . . . . 0.0 112.565 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.8 94.37 0.45 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.22 1.008 . . . . 0.0 110.823 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -68.89 104.18 2.0 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.503 HD13 HG23 ' A' ' 86' ' ' VAL . 44.6 mm -72.61 120.78 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -176.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.445 ' ND2' HG23 ' A' ' 20' ' ' ILE . 3.4 p-10 -104.08 156.1 18.15 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -81.8 -14.58 56.18 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.099 0.559 . . . . 0.0 111.63 -174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -76.5 -17.21 59.39 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.161 0.984 . . . . 0.0 111.45 -172.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.465 ' HB ' HD12 ' A' ' 99' ' ' ILE . 30.3 pt -53.91 -19.81 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 172.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -83.32 -17.93 40.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.082 0.553 . . . . 0.0 111.94 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -91.35 47.05 1.34 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.074 0.94 . . . . 0.0 109.716 -169.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -139.29 -11.99 1.21 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.311 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.67 33.32 55.0 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 114.513 0.565 . . . . 0.0 114.513 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.502 ' HB2' HD11 ' A' ' 23' ' ' LEU . 67.2 mt -102.97 167.38 9.88 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.423 0.689 . . . . 0.0 110.715 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HB3' ' HZ2' ' A' ' 59' ' ' TRP . 60.2 mttp -81.87 91.49 6.55 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.935 0.894 . . . . 0.0 111.31 -176.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.53 158.36 43.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.068 0.547 . . . . 0.0 109.92 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.514 ' NE2' ' HB3' ' A' ' 63' ' ' LEU . 1.6 tm0? -149.26 149.81 31.55 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 165.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.3 mt -132.18 131.8 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.35 -176.12 3.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.825 0.85 . . . . 0.0 109.447 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -80.68 141.78 34.57 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.844 0.858 . . . . 0.0 109.732 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.404 ' HA ' ' SG ' ' A' ' 87' ' ' CYS . . . -96.23 7.8 45.52 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.3 0.64 . . . . 0.0 112.706 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -88.83 -19.89 25.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.316 0.647 . . . . 0.0 110.855 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' A' ' 79' ' ' ILE . 18.4 m -111.91 7.31 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.061 0.945 . . . . 0.0 111.641 -176.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.2 102.55 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 121.91 0.862 . . . . 0.0 109.971 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.537 ' HB3' HG13 ' A' ' 138' ' ' VAL . . . -79.17 74.83 5.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.539 ' HG1' HG12 ' A' ' 135' ' ' VAL . 22.1 p 62.69 162.25 0.09 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.63 1.972 . . . . 0.0 111.677 -166.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . 25.3 pttm -53.17 -22.49 6.59 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.506 0.723 . . . . 0.0 111.542 169.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.595 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 56.8 tttp -64.45 -28.42 69.66 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 123.187 0.595 . . . . 0.0 111.541 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.488 ' HA ' HD12 ' A' ' 139' ' ' LEU . 11.7 t-160 -62.73 -45.53 92.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.021 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 45' ' ' ILE . 42.3 t -67.68 -55.17 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 123.735 0.647 . . . . 0.0 111.195 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.595 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 4.1 pp -60.02 -32.69 71.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.095 0.558 . . . . 0.0 112.395 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 36.9 t60 -65.75 -40.77 92.45 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.372 0.669 . . . . 0.0 110.479 173.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.91 87.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.954 0.502 . . . . 0.0 110.789 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.538 ' HA ' HG12 ' A' ' 62' ' ' ILE . 33.8 mt -64.9 -46.59 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.232 1.013 . . . . 0.0 110.76 175.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -49.0 -48.39 43.58 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.44 1.496 . . . . 0.0 111.084 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 25.8 mm-40 -63.67 -47.24 82.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.089 176.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . . . -64.79 -28.71 69.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.462 0.705 . . . . 0.0 112.556 -175.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HE2' HG22 ' A' ' 45' ' ' ILE . 68.2 mttm -66.11 -43.69 86.49 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.279 0.632 . . . . 0.0 110.925 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.1 t -80.17 -16.82 54.01 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.799 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 51.3 mtpt -99.28 146.95 25.68 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.999 0.92 . . . . 0.0 112.27 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -142.96 72.86 18.67 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.577 161.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.475 ' HD3' ' HB3' ' A' ' 51' ' ' LYS . 56.2 Cg_endo -84.25 -177.04 2.82 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.657 2.238 . . . . 0.0 111.852 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.5 mt -37.04 -22.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.21 125.42 17.51 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.446 0.698 . . . . 0.0 110.787 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -57.02 -22.26 37.34 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -167.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.618 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 41.9 t -157.36 167.29 30.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.214 0.606 . . . . 0.0 110.114 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -58.73 -50.16 74.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.589 1.156 . . . . 0.0 110.467 170.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.461 ' HA ' HD13 ' A' ' 62' ' ' ILE . 81.7 m95 -64.54 -30.99 72.02 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.651 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.644 ' HB3' HD13 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -78.81 -21.03 48.35 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.907 0.883 . . . . 0.0 111.316 176.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -74.07 -35.52 64.25 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 173.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 45' ' ' ILE . 77.5 mt -65.58 -42.36 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.722 0.809 . . . . 0.0 112.344 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.514 ' HB3' ' NE2' ' A' ' 28' ' ' GLN . 3.2 pp -71.53 -34.03 69.69 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 122.998 0.186 . . . . 0.0 110.879 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.97 -38.11 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.414 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.54 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 0.3 OUTLIER -66.48 -50.22 64.02 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 122.816 0.447 . . . . 0.0 110.659 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.29 68.51 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.225 0.61 . . . . 0.0 112.06 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 t -88.68 -0.2 57.05 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.712 0.805 . . . . 0.0 112.506 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.89 17.76 65.65 Favored Glycine 0 C--N 1.354 1.564 0 N-CA-C 114.485 0.554 . . . . 0.0 114.485 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.693 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 46.5 tp60 -107.91 164.96 11.82 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.609 1.164 . . . . 0.0 109.63 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -114.36 -6.2 12.92 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 123.038 0.535 . . . . 0.0 111.508 167.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.693 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 17.0 mm-40 -103.94 119.03 38.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.427 1.091 . . . . 0.0 110.684 -173.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.644 HD13 ' HB3' ' A' ' 60' ' ' MET . 34.7 mm -52.92 -53.02 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 124.736 1.273 . . . . 0.0 112.386 -173.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -61.09 -50.17 74.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.59 -173.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.27 -44.56 84.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.227 0.611 . . . . 0.0 112.091 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.03 94.19 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.68 -31.84 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 122.918 0.487 . . . . 0.0 110.612 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -67.13 -50.24 62.07 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.814 0.446 . . . . 0.0 110.46 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 56.6 mt -70.66 -67.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.762 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.402 ' HB ' HG23 ' A' ' 34' ' ' VAL . 16.2 pt -108.83 20.63 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.25 172.15 45.04 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 119.018 0.826 . . . . 0.0 112.92 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.97 144.18 26.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.18 0.592 . . . . 0.0 111.314 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -154.45 167.56 29.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.748 1.219 . . . . 0.0 108.25 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.02 127.27 23.37 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.074 0.95 . . . . 0.0 111.853 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.4 -116.3 2.5 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.371 0.419 . . . . 0.0 112.533 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.93 107.39 18.99 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.661 0.785 . . . . 0.0 109.373 -176.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.503 HG23 HD13 ' A' ' 16' ' ' ILE . 15.8 m -135.7 167.98 23.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-O 121.912 0.863 . . . . 0.0 111.976 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.404 ' SG ' ' HA ' ' A' ' 32' ' ' ALA . 69.9 m -119.02 117.58 29.17 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.375 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 10.2 tp -100.04 123.48 44.34 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.272 0.629 . . . . 0.0 109.326 -175.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.505 HD13 ' HB3' ' A' ' 28' ' ' GLN . 30.3 mt -109.34 137.21 42.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.195 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 26.5 p -156.84 157.69 35.41 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.578 0.751 . . . . 0.0 109.288 171.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -88.77 -28.2 20.64 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.872 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.475 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 23.8 m-20 -124.83 139.74 53.56 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.218 1.007 . . . . 0.0 110.962 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.14 -24.38 64.66 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.94 0.896 . . . . 0.0 112.435 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.475 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 11.2 pt-20 -68.31 -44.1 76.15 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.3 m -68.01 -35.87 79.02 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.599 0.76 . . . . 0.0 111.345 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.724 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 11.0 t80 -58.25 -48.05 81.66 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 122.889 0.476 . . . . 0.0 109.826 173.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -57.85 -47.58 82.29 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.298 0.999 . . . . 0.0 110.514 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 42.1 mmtm -53.83 -48.36 70.0 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 124.191 0.932 . . . . 0.0 111.469 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.465 HD12 ' HB ' ' A' ' 20' ' ' ILE . 44.1 mm -71.68 -44.72 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.065 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -55.05 -44.52 74.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.499 1.119 . . . . 0.0 112.851 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -60.07 -42.5 94.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.584 0.754 . . . . 0.0 110.248 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 98' ' ' LYS . 4.5 mm? -65.89 -51.67 56.74 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.0 pt -73.61 -42.56 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 117.915 0.325 . . . . 0.0 111.671 -167.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.13 103.32 0.03 OUTLIER Glycine 0 C--N 1.347 1.162 0 O-C-N 123.262 0.352 . . . . 0.0 113.584 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.31 -174.54 39.11 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.35 126.31 45.2 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.727 0.811 . . . . 0.0 109.334 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.6 mm -68.51 122.48 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -135.24 98.68 4.04 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.718 1.207 . . . . 0.0 108.216 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -68.24 -31.15 70.43 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.975 0.51 . . . . 0.0 111.887 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.664 ' HA ' ' HG2' ' A' ' 113' ' ' GLU . 46.9 t -52.73 -31.45 37.89 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.68 HG23 ' HE3' ' A' ' 118' ' ' LYS . 2.6 p -69.31 -29.62 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 122.7 0.4 . . . . 0.0 110.28 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 28.5 mt -95.15 9.89 37.96 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.8 0.84 . . . . 0.0 112.153 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.664 ' HG2' ' HA ' ' A' ' 110' ' ' SER . 8.4 pt-20 -120.76 4.11 10.57 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.96 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.267 0.5 OUTLIER 76.15 138.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.092 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 172.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.41 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 26.6 p-10 -136.89 171.5 14.4 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 113.154 -1.839 . . . . 0.0 108.036 170.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.97 -31.36 70.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.173 0.589 . . . . 0.0 112.223 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.41 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 19.3 t70 -60.27 -53.14 61.22 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.113 0.965 . . . . 0.0 112.31 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.68 ' HE3' HG23 ' A' ' 111' ' ' VAL . 63.7 mttm -74.88 -20.69 59.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.324 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.489 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 42.8 tt0 -72.82 -43.73 62.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.332 0.653 . . . . 0.0 111.522 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -72.07 -33.97 68.34 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.095 0.558 . . . . 0.0 110.588 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.1 -49.58 76.44 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.461 1.104 . . . . 0.0 111.143 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.439 HD11 ' HB1' ' A' ' 36' ' ' ALA . 24.4 mt -57.35 -40.67 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.353 1.061 . . . . 0.0 112.051 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -74.66 -23.34 58.64 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 119.156 -0.45 . . . . 0.0 111.167 -176.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.472 ' O ' ' HG2' ' A' ' 127' ' ' LYS . 48.5 mt-10 -73.42 -55.14 6.76 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 169.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.42 -31.76 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 CA-C-N 120.573 1.533 . . . . 0.0 112.777 -176.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -88.72 -30.29 19.21 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 124' ' ' GLU . 38.9 mmtm 63.42 75.51 0.39 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.386 1.075 . . . . 0.0 112.484 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.499 HG21 ' HG3' ' A' ' 137' ' ' ARG . 14.2 mt -109.68 109.33 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -76.61 -37.62 56.13 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.83 0.852 . . . . 0.0 110.81 -173.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -91.36 124.42 7.59 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -149.54 113.82 5.21 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.686 1.243 . . . . 0.0 112.182 -170.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -103.03 -83.61 1.73 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 161.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.538 HD22 ' HB2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -96.58 158.93 15.2 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 166.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.489 ' HB ' ' HG3' ' A' ' 119' ' ' GLU . 13.6 p -76.4 -33.85 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.539 HG12 ' HG1' ' A' ' 37' ' ' THR . 60.4 t -65.37 -59.8 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.565 0.746 . . . . 0.0 112.153 -164.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.538 ' HB2' HD22 ' A' ' 133' ' ' ASN . 37.7 mt-10 -73.2 -28.73 62.35 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.81 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.499 ' HG3' HG21 ' A' ' 128' ' ' ILE . 20.2 tpt180 -77.35 -32.48 55.11 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.502 -170.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 36' ' ' ALA . 14.2 p -72.24 -33.87 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 40' ' ' HIS . 2.5 mp -54.76 -38.89 67.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.254 1.021 . . . . 0.0 111.044 170.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -67.61 -37.86 83.12 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.643 0.777 . . . . 0.0 111.171 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -68.58 -48.7 63.51 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 111.503 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 26.6 pt -78.53 -10.53 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.816 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.74 -20.63 29.01 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.743 171.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.79 10.33 1.17 Allowed 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.849 0.859 . . . . 0.0 112.416 -170.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.8 mp -91.96 -46.37 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -122.73 -14.23 7.75 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.11 0.964 . . . . 0.0 111.822 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.18 42.75 2.15 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.496 ' HZ1' ' HB3' ' A' ' 148' ' ' LYS . 7.1 mtpm? -40.31 122.27 1.53 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.433 1.493 . . . . 0.0 113.295 -178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -93.76 -3.46 52.12 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.902 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.249 1.033 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.536 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.415 ' SD ' ' HG2' ' A' ' 91' ' ' GLU . 24.3 mmt . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.9 mt -101.39 103.56 15.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.1 mp -109.72 121.39 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -131.81 145.46 51.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.78 0.832 . . . . 0.0 109.084 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.38 124.63 8.18 Favored Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.2 tt -130.68 138.89 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 122.801 0.44 . . . . 0.0 109.869 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -129.3 124.14 33.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.839 0.855 . . . . 0.0 108.798 -172.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.41 2.36 56.64 Favored Glycine 0 N--CA 1.467 0.762 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.997 -170.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -74.44 98.17 3.25 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 123.792 0.837 . . . . 0.0 111.188 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.542 ' HA ' ' HB2' ' A' ' 83' ' ' ASP . 70.7 mtp180 -73.81 107.36 6.0 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.956 0.502 . . . . 0.0 110.616 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.548 HD11 HG11 ' A' ' 86' ' ' VAL . 49.6 mm -69.49 122.96 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.891 0.877 . . . . 0.0 110.79 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -126.27 165.64 18.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.519 0.728 . . . . 0.0 109.352 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -73.2 -17.0 61.41 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.39 -31.62 68.93 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.503 0.721 . . . . 0.0 111.795 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.567 HD12 HD12 ' A' ' 29' ' ' ILE . 16.0 pt -52.13 -28.35 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -90.11 -20.07 23.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.55 0.34 . . . . 0.0 111.303 -176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -76.81 -12.46 59.98 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.503 0.721 . . . . 0.0 111.83 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -81.0 -8.59 59.81 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.679 0.391 . . . . 0.0 111.776 176.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.48 19.08 17.16 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 23' ' ' LEU . 98.5 mt -81.66 174.74 11.09 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.493 0.646 . . . . 0.0 110.394 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -90.18 96.49 10.69 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.228 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -147.68 157.59 43.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.702 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.576 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -138.26 147.1 43.3 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 167.134 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.567 HD12 HD12 ' A' ' 20' ' ' ILE . 35.6 mt -132.29 121.6 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -121.57 177.8 5.08 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' HB3' HG22 ' A' ' 34' ' ' VAL . 38.6 t-20 -75.71 119.46 19.76 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.654 0.782 . . . . 0.0 110.038 -173.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.42 -1.52 41.81 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.571 ' HA ' ' NZ ' ' A' ' 118' ' ' LYS . 37.8 t70 -79.67 -32.41 41.52 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.495 0.188 . . . . 0.0 110.522 176.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.522 HG21 HG22 ' A' ' 79' ' ' ILE . 27.7 m -98.75 -2.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.873 0.869 . . . . 0.0 112.538 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG11 HD23 ' A' ' 112' ' ' LEU . 10.5 p -78.69 139.96 17.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.401 ' HA ' HG12 ' A' ' 114' ' ' ILE . . . -76.1 -72.25 0.33 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 40.3 p -147.15 -177.35 5.63 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.823 0.849 . . . . 0.0 110.401 176.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.528 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -52.03 -39.77 60.06 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.168 167.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HD2' HD11 ' A' ' 42' ' ' LEU . 22.9 tptm -56.07 -29.94 61.25 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.676 0.79 . . . . 0.0 111.504 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.527 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.6 t-80 -68.44 -50.85 49.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.425 0.69 . . . . 0.0 111.015 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.408 HG11 HG12 ' A' ' 89' ' ' ILE . 93.0 t -68.37 -54.75 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HA ' HD12 ' A' ' 45' ' ' ILE . 4.2 pp -56.16 -33.16 64.96 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.664 0.786 . . . . 0.0 111.835 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.559 ' NE2' ' HB2' ' A' ' 143' ' ' ALA . 79.5 t60 -62.45 -45.28 93.78 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.061 173.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.17 87.51 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.383 0.673 . . . . 0.0 111.367 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.6 HG12 HD13 ' A' ' 62' ' ' ILE . 48.2 mt -56.96 -48.53 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.965 0.906 . . . . 0.0 109.815 170.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.523 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 62.1 t30 -64.95 -30.36 71.34 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.388 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 10.2 mm-40 -68.66 -39.96 80.39 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.952 0.501 . . . . 0.0 109.824 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -66.99 -26.33 66.75 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.464 0.706 . . . . 0.0 112.352 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' HE3' ' HA ' ' A' ' 46' ' ' ASN . 10.1 mtmp? -78.92 -31.94 45.44 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.631 0.372 . . . . 0.0 111.847 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.501 HG23 ' HG2' ' A' ' 51' ' ' LYS . 8.6 t -95.26 -45.17 7.28 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.68 0.392 . . . . 0.0 111.954 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.662 ' HB2' HH22 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -121.13 120.04 34.12 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.002 0.921 . . . . 0.0 109.183 -175.43 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -103.84 99.66 17.08 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 123.016 0.526 . . . . 0.0 110.229 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.61 -81.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.858 2.372 . . . . 0.0 113.935 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.4 pt -150.67 11.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.813 0.845 . . . . 0.0 111.83 -168.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.58 160.54 27.54 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -169.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -68.59 -50.14 53.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.783 0.833 . . . . 0.0 111.125 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -146.08 171.44 14.89 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.56 0.744 . . . . 0.0 110.197 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.93 -58.7 6.92 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.855 0.862 . . . . 0.0 111.897 -174.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.576 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 91.4 m95 -63.85 -33.81 76.53 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.756 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.8 mmm -73.53 -18.98 61.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.827 0.451 . . . . 0.0 110.674 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.612 ' HG2' HH11 ' A' ' 65' ' ' ARG . 22.3 tt0 -77.68 -38.84 46.65 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.072 0.949 . . . . 0.0 110.984 173.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.6 HD13 HG12 ' A' ' 45' ' ' ILE . 82.8 mt -55.0 -53.51 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.673 0.789 . . . . 0.0 111.27 -177.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.46 ' O ' HD11 ' A' ' 79' ' ' ILE . 4.3 pp -52.74 -31.29 37.23 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.189 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 61' ' ' GLU . 1.9 m -78.78 -32.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 112.005 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.662 HH22 ' HB2' ' A' ' 51' ' ' LYS . 11.8 mmm-85 -68.12 -45.14 74.5 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 122.954 0.502 . . . . 0.0 110.866 -175.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.41 -20.15 64.19 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.892 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -97.14 12.65 32.0 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.28 41.9 7.24 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 118.349 0.522 . . . . 0.0 113.481 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 57.37 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.193 1.797 . . . . 0.0 111.152 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -121.18 -160.97 0.88 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.328 1.051 . . . . 0.0 109.354 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -120.7 162.01 20.44 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.64 -49.97 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.264 1.026 . . . . 0.0 112.137 -170.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.443 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 33.6 m170 -61.45 -55.21 33.81 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.751 0.657 . . . . 0.0 110.623 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.41 -56.61 16.92 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.055 0.847 . . . . 0.0 111.789 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 -30.4 69.35 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.5 mt -68.22 -38.38 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.49 0.316 . . . . 0.0 111.012 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 73' ' ' HIS . 60.4 mttm -68.9 -45.66 70.35 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.685 HG22 HG23 ' A' ' 79' ' ' ILE . 59.4 mt -71.22 -66.11 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.206 1.003 . . . . 0.0 111.373 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.685 HG23 HG22 ' A' ' 78' ' ' ILE . 29.8 pt -122.7 26.83 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.64 179.75 48.69 Favored Glycine 0 N--CA 1.48 1.596 0 CA-C-N 118.821 0.737 . . . . 0.0 113.402 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.1 144.37 47.03 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.779 0.432 . . . . 0.0 111.323 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -151.28 149.24 29.15 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 15' ' ' ARG . 6.2 p-10 -65.79 151.33 46.87 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.459 0.572 . . . . 0.0 111.559 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.61 -118.36 6.08 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.481 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -85.27 103.78 14.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.222 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.548 HG11 HD11 ' A' ' 16' ' ' ILE . 1.1 p -137.72 156.07 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.116 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.2 t -106.85 122.87 47.27 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.504 1.122 . . . . 0.0 109.388 -170.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -95.68 128.6 42.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 28' ' ' GLN . 7.7 mt -120.27 117.92 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.701 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 42.3 t -145.91 161.94 38.89 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.874 0.369 . . . . 0.0 111.712 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.415 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 43.6 mt-10 -91.89 -47.91 7.06 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.591 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -111.7 136.3 51.12 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.171 0.588 . . . . 0.0 110.362 -171.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -57.63 -27.39 62.75 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.517 0.727 . . . . 0.0 112.403 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.79 -42.71 69.99 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.701 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 60.5 m -65.75 -37.58 86.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.749 0.82 . . . . 0.0 111.466 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -61.85 -43.1 99.53 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.538 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -62.37 -40.96 98.16 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 123.893 0.745 . . . . 0.0 110.055 177.701 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 34.5 mmtp -57.35 -51.82 67.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.454 0.702 . . . . 0.0 110.58 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.48 HD13 HD21 ' A' ' 23' ' ' LEU . 43.8 mm -66.15 -44.31 91.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.372 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.97 -40.31 29.93 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.499 1.119 . . . . 0.0 112.955 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 22.6 mm-40 -59.58 -46.86 87.68 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.509 0.506 . . . . 0.0 111.66 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.82 -36.43 64.95 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.469 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 20.3 pt -80.35 -47.71 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 118.639 0.654 . . . . 0.0 110.995 -173.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.07 95.17 0.02 OUTLIER Glycine 0 C--N 1.349 1.276 0 O-C-N 123.602 0.564 . . . . 0.0 113.517 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -158.11 -169.4 21.65 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -109.66 135.14 51.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.434 0.617 . . . . 0.0 109.728 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.7 mm -78.43 122.39 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -144.14 96.5 2.89 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -67.42 -17.12 64.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.578 0.751 . . . . 0.0 111.758 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.0 t -60.04 -26.66 66.31 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.12 -22.12 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.21 0.529 . . . . 0.0 110.252 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.486 HD23 HG11 ' A' ' 35' ' ' VAL . 56.2 mt -103.02 17.43 24.09 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.455 1.102 . . . . 0.0 111.953 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -113.44 -1.97 14.04 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 120.176 1.353 . . . . 0.0 112.942 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.401 HG12 ' HA ' ' A' ' 36' ' ' ALA 0.25 0.3 OUTLIER 76.97 139.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 124.812 1.245 . . . . 0.0 113.313 177.903 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.4 HD21 ' HB2' ' A' ' 117' ' ' ASP . 26.7 p-10 -154.24 -173.38 4.55 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.851 172.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.12 -34.12 70.75 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.4 ' HB2' HD21 ' A' ' 115' ' ' ASN . 44.6 m-20 -64.05 -47.09 81.52 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.624 0.37 . . . . 0.0 111.733 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.571 ' NZ ' ' HA ' ' A' ' 33' ' ' ASP . 4.8 mptp? -62.16 -34.18 75.91 Favored 'General case' 0 C--O 1.209 -1.049 0 O-C-N 123.46 0.475 . . . . 0.0 109.826 173.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.24 -51.9 65.89 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.66 0.6 . . . . 0.0 111.148 -172.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -70.45 -39.12 74.52 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.78 -33.06 66.05 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 122.108 -0.37 . . . . 0.0 110.833 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' A' ' 126' ' ' PHE . 6.3 mt -61.09 -38.65 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.656 0.782 . . . . 0.0 110.805 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 7.8 ptp180 -73.9 -23.86 59.62 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.025 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.604 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 13.0 tp10 -64.11 -58.53 6.37 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 170.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -35.9 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 118.68 0.673 . . . . 0.0 112.777 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.472 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.9 m-85 -87.99 -30.89 19.67 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 119.126 -0.464 . . . . 0.0 111.77 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 124' ' ' GLU . 21.4 mmtp 59.05 76.09 0.37 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.046 0.938 . . . . 0.0 111.744 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.526 HG12 ' HD3' ' A' ' 141' ' ' LYS . 25.6 mt . . . . . 0 C--O 1.242 0.673 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.77 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 120.685 0.279 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.07 -26.25 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.527 1.131 . . . . 0.0 112.288 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.04 -46.67 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.484 0.659 . . . . 0.0 109.745 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.72 -40.61 88.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.855 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -67.95 -38.27 82.62 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.595 0.559 . . . . 0.0 112.344 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.42 ' HA ' HD13 ' A' ' 128' ' ' ILE . 14.4 p -70.15 -42.79 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 40' ' ' HIS . 9.6 mp -62.09 -42.99 99.78 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 122.77 0.428 . . . . 0.0 111.692 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -57.1 -44.5 83.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.528 0.331 . . . . 0.0 111.626 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.526 ' HD3' HG12 ' A' ' 128' ' ' ILE . 8.4 ttpt -71.97 -46.87 55.8 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.185 0.303 . . . . 0.0 111.202 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.0 pt -75.84 -33.72 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.401 -171.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.559 ' HB2' ' NE2' ' A' ' 43' ' ' HIS . . . . . . . . 0 C--O 1.246 0.876 0 C-N-CA 123.585 0.754 . . . . 0.0 112.823 -173.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.504 ' HG2' HG21 ' A' ' 45' ' ' ILE . 1.5 mpt? . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.3 mt -106.08 103.43 15.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.4 mm -107.71 122.99 62.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.69 144.86 51.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.751 0.705 . . . . 0.0 110.627 -173.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.452 ' N ' HD11 ' A' ' 112' ' ' LEU . . . -104.85 127.47 9.07 Favored Glycine 0 CA--C 1.502 -0.78 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 tt -141.64 145.71 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.072 0.549 . . . . 0.0 110.679 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -123.22 130.78 53.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.581 1.152 . . . . 0.0 109.616 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.15 7.73 69.7 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.839 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.12 94.76 1.16 Allowed 'General case' 0 C--N 1.349 0.547 0 C-N-CA 123.938 0.895 . . . . 0.0 111.131 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.478 ' HA ' ' HB2' ' A' ' 83' ' ' ASP . 51.0 mtt180 -73.07 103.44 3.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.123 0.569 . . . . 0.0 109.803 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.99 108.93 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.701 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.407 ' O ' HG12 ' A' ' 20' ' ' ILE . 26.4 p30 -114.08 165.56 12.51 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.597 0.759 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -71.49 -16.4 62.35 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.89 -36.74 84.24 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 118.251 0.478 . . . . 0.0 111.671 -173.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.459 ' HA ' HD12 ' A' ' 102' ' ' LEU . 18.1 pt -50.47 -20.83 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -93.14 -26.55 17.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.422 0.689 . . . . 0.0 111.233 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -72.72 -16.92 61.66 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.641 0.776 . . . . 0.0 112.149 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.498 HD21 HD13 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -80.89 -10.21 59.74 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.883 0.473 . . . . 0.0 111.817 179.18 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.46 21.31 26.91 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 116.37 1.308 . . . . 0.0 116.37 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB2' HD13 ' A' ' 23' ' ' LEU . 92.4 mt -87.34 176.52 7.49 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.244 0.618 . . . . 0.0 111.468 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.468 ' HB3' ' HZ2' ' A' ' 59' ' ' TRP . 2.9 mptp? -85.69 98.33 10.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.859 0.864 . . . . 0.0 109.758 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -146.97 160.58 42.18 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.114 0.566 . . . . 0.0 110.331 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.415 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 19.1 tm0? -144.39 149.71 36.55 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 161.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.1 mt -131.29 127.22 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 pp -125.64 173.22 9.14 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.197 0.599 . . . . 0.0 109.979 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 33' ' ' ASP . 61.3 t30 -77.03 138.8 39.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.353 0.661 . . . . 0.0 110.738 -171.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.549 ' HA ' ' SG ' ' A' ' 87' ' ' CYS . . . -80.37 0.1 34.57 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.528 ' HB3' HD21 ' A' ' 121' ' ' LEU . 21.4 m-20 -82.75 -23.1 34.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.257 0.623 . . . . 0.0 111.128 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 79' ' ' ILE . 32.5 m -113.97 -3.73 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.692 0.797 . . . . 0.0 111.718 -171.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -59.41 -32.71 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.734 0.814 . . . . 0.0 112.38 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 59.79 -84.61 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.447 1.099 . . . . 0.0 109.372 -170.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 40.9 p -139.14 174.41 10.54 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.92 0.888 . . . . 0.0 109.353 171.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.91 -45.23 50.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.05 165.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -51.5 -34.41 35.84 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.335 1.054 . . . . 0.0 112.592 -178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.558 ' HA ' HD11 ' A' ' 139' ' ' LEU . 11.2 t-80 -66.55 -54.53 22.73 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.696 0.623 . . . . 0.0 111.028 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -70.69 -47.78 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 122.696 0.399 . . . . 0.0 112.074 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.45 -30.39 69.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.191 0.596 . . . . 0.0 111.556 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.46 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 71.2 t60 -61.6 -46.74 88.57 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 169.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . . . -61.86 -44.99 95.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.959 0.504 . . . . 0.0 111.407 -176.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.514 HG22 ' HE3' ' A' ' 49' ' ' LYS . 36.0 mt -65.98 -49.77 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.322 1.049 . . . . 0.0 111.081 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -51.6 -47.42 63.61 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.291 1.036 . . . . 0.0 110.991 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 17.9 mm100 -66.77 -35.48 80.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.327 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.09 63.25 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 122.672 0.389 . . . . 0.0 111.545 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HE3' HG22 ' A' ' 45' ' ' ILE . 98.4 mttt -86.31 -36.92 19.01 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.439 0.696 . . . . 0.0 112.06 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 47' ' ' GLN . 10.3 t -88.14 -37.28 16.31 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.909 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 47' ' ' GLN . 39.6 mtmt -85.53 157.54 20.39 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.683 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -102.64 103.31 31.57 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.18 177.43 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 124.154 3.236 . . . . 0.0 115.466 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.31 5.02 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.266 165.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.59 179.29 2.17 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.524 1.13 . . . . 0.0 111.749 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -62.33 -47.66 83.27 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.029 0.532 . . . . 0.0 110.326 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.4 m -157.85 -172.81 4.08 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.239 1.015 . . . . 0.0 110.185 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -62.01 -59.3 5.29 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.635 1.174 . . . . 0.0 112.919 -176.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.468 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 87.8 m95 -63.42 -28.71 70.16 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 120.753 0.311 . . . . 0.0 110.848 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.6 mmt -74.81 -21.22 59.42 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.687 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -75.84 -43.05 47.76 Favored 'General case' 0 C--O 1.209 -1.039 0 C-N-CA 122.398 0.279 . . . . 0.0 110.373 170.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.469 HD13 HG12 ' A' ' 45' ' ' ILE . 86.8 mt -56.47 -39.28 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.676 0.79 . . . . 0.0 112.173 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.407 ' O ' HD11 ' A' ' 79' ' ' ILE . 3.6 pp -71.06 -30.91 67.19 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.333 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -83.17 -29.05 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.337 -0.852 . . . . 0.0 110.922 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.5 ' HD2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.2 -45.75 62.71 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.548 1.139 . . . . 0.0 109.937 -172.245 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.22 -24.65 67.4 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.488 0.715 . . . . 0.0 112.031 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.2 p -100.18 23.67 9.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.241 0.616 . . . . 0.0 110.568 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.07 -88.54 1.54 Allowed Glycine 0 C--N 1.36 1.913 0 O-C-N 122.182 -0.324 . . . . 0.0 113.442 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.15 121.35 1.02 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -173.25 163.59 4.62 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 124.691 1.244 . . . . 0.0 109.053 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -57.39 149.69 20.06 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.136 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.32 -41.04 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.708 1.203 . . . . 0.0 111.845 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -57.21 -49.77 74.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.395 0.678 . . . . 0.0 111.096 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.524 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 49.9 mm-40 -57.0 -48.73 77.75 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.621 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.42 -36.81 83.53 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.666 0.786 . . . . 0.0 112.824 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.51 -37.55 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.041 0.536 . . . . 0.0 110.891 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 74' ' ' GLU . 53.2 mtmt -67.72 -48.65 65.91 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.798 0.333 . . . . 0.0 110.205 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.453 HG23 ' HB ' ' A' ' 125' ' ' ILE . 78.0 mt -74.21 -65.18 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.649 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.608 ' HB ' HG21 ' A' ' 34' ' ' VAL . 7.7 pt -109.41 14.3 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.61 168.55 46.07 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 119.433 1.015 . . . . 0.0 112.423 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.98 121.74 26.41 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.832 0.453 . . . . 0.0 111.323 -175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -116.95 162.36 17.89 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 165.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 15' ' ' ARG . 7.5 p-10 -65.35 153.91 39.83 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.293 0.637 . . . . 0.0 112.158 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.57 -119.46 5.81 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.358 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -87.45 104.6 16.61 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.8 p -136.92 168.74 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.562 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 32' ' ' ALA . 88.3 m -122.45 123.64 41.77 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.389 1.075 . . . . 0.0 110.238 -175.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.477 HD21 ' HB ' ' A' ' 99' ' ' ILE . 11.4 tp -102.91 125.5 49.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.281 0.632 . . . . 0.0 109.625 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mt -108.3 132.74 55.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.632 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.7 t -155.37 154.72 32.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.157 0.503 . . . . 0.0 111.225 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -87.17 -40.44 14.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.923 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.55 137.94 51.99 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.11 0.964 . . . . 0.0 110.482 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 39.6 tt0 -66.64 -35.93 81.34 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -170.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.74 -26.64 57.64 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.779 0.718 . . . . 0.0 110.348 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 96.9 m -67.88 -42.58 81.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.228 0.611 . . . . 0.0 111.167 165.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.418 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 2.3 t80 -56.97 -49.65 75.08 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.998 0.919 . . . . 0.0 110.817 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 76.7 ttt180 -65.27 -36.95 85.69 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 123.569 0.543 . . . . 0.0 110.441 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -56.2 -40.32 73.83 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.771 0.428 . . . . 0.0 111.674 176.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.498 HD13 HD21 ' A' ' 23' ' ' LEU . 29.1 mm -69.47 -45.83 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -53.69 -40.3 65.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.561 1.145 . . . . 0.0 112.564 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 70.7 mm-40 -59.47 -47.23 86.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.27 0.628 . . . . 0.0 110.847 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 20' ' ' ILE . 57.5 mt -72.75 -38.39 67.38 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.3 pt -74.63 -37.74 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 118.366 0.53 . . . . 0.0 110.768 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.98 93.41 0.03 OUTLIER Glycine 0 C--N 1.351 1.402 0 O-C-N 123.623 0.577 . . . . 0.0 114.312 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.27 -167.65 22.02 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -113.33 140.65 47.85 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.79 123.24 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.18 95.35 4.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.15 -42.03 85.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.898 0.479 . . . . 0.0 111.463 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.0 p -54.21 -29.91 48.01 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.6 p -67.32 -24.03 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 CA-C-N 118.565 0.621 . . . . 0.0 110.941 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 37' ' ' THR . 81.2 mt -86.28 -19.41 29.93 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.748 0.819 . . . . 0.0 112.009 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -93.37 -1.83 55.42 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 118.462 -0.78 . . . . 0.0 113.038 -165.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 114' ' ' ILE 0.26 0.5 OUTLIER 78.83 133.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 124.557 1.143 . . . . 0.0 112.89 -178.446 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 117' ' ' ASP . 4.4 p-10 -146.79 168.33 21.66 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.506 167.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.5 -34.13 76.26 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.906 0.482 . . . . 0.0 111.829 -169.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.422 ' HB2' ' ND2' ' A' ' 115' ' ' ASN . 14.2 m-20 -59.7 -48.95 79.65 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.928 0.491 . . . . 0.0 111.469 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -67.29 -27.25 67.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.448 0.468 . . . . 0.0 110.741 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.466 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 30.3 tt0 -72.62 -44.98 61.24 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.017 0.527 . . . . 0.0 110.998 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -73.69 -40.53 63.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.655 0.782 . . . . 0.0 109.993 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 33' ' ' ASP . 62.5 tp -53.78 -53.77 47.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.262 1.425 . . . . 0.0 112.317 170.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.1 mt -53.25 -30.64 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.621 1.169 . . . . 0.0 111.755 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.0 ttp85 -72.24 -33.62 67.67 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.045 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.72 -56.09 13.89 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 173.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.453 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -74.24 -36.24 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -90.38 -33.39 16.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 119.447 -0.311 . . . . 0.0 111.706 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 3.0 mmmp? 63.78 72.38 0.47 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.043 0.937 . . . . 0.0 111.765 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.566 HG21 ' HB3' ' A' ' 137' ' ' ARG . 9.2 mt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.2 t30 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HB ' ' HG3' ' A' ' 119' ' ' GLU . 7.2 p -54.59 -34.19 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.369 1.068 . . . . 0.0 113.652 -176.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.4 t -71.41 -45.74 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.349 0.595 . . . . 0.0 109.759 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 40.3 mt-10 -68.52 -34.33 75.68 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.182 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.566 ' HB3' HG21 ' A' ' 128' ' ' ILE . 52.7 mtm180 -72.22 -39.05 68.8 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.863 0.865 . . . . 0.0 112.073 -176.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.04 -33.94 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.558 HD11 ' HA ' ' A' ' 40' ' ' HIS . 4.6 mp -62.98 -39.57 95.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.218 0.607 . . . . 0.0 111.148 173.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 35.0 mm-40 -59.66 -47.29 86.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 117.775 0.261 . . . . 0.0 111.009 173.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -63.87 -48.4 76.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.112 0.565 . . . . 0.0 111.973 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.6 pt -76.68 -25.33 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.746 0 C-N-CA 122.235 0.214 . . . . 0.0 110.54 173.293 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.544 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 76.2 mt -85.96 104.78 13.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.5 mm -101.19 120.82 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -127.27 146.92 50.26 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.19 140.42 14.86 Favored Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.473 HG23 HG12 ' A' ' 86' ' ' VAL . 10.1 tt -143.01 124.9 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.777 0.799 . . . . 0.0 111.081 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -90.11 133.2 35.01 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.196 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.45 8.76 80.32 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.832 174.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.04 100.76 0.23 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.033 0.933 . . . . 0.0 111.085 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -74.0 103.23 4.41 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.524 HD11 HG11 ' A' ' 86' ' ' VAL . 50.3 mm -74.05 114.91 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.354 0.597 . . . . 0.0 110.207 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' A' ' 20' ' ' ILE . 2.5 p-10 -103.92 134.63 46.89 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -74.08 -1.7 21.28 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.793 0.437 . . . . 0.0 111.779 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -75.68 -20.32 58.51 Favored 'General case' 0 C--O 1.217 -0.606 0 C-N-CA 124.414 1.086 . . . . 0.0 111.027 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.479 HG23 ' ND2' ' A' ' 17' ' ' ASN . 9.4 pt -49.77 -22.36 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -83.52 -0.1 48.81 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -71.4 -28.04 63.74 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.123 0.569 . . . . 0.0 112.005 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.65 -6.69 57.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.679 0.791 . . . . 0.0 111.512 -176.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.46 14.89 9.86 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB2' HD13 ' A' ' 23' ' ' LEU . 95.8 mt -74.73 157.77 34.69 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.159 0.584 . . . . 0.0 110.461 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -82.67 102.51 11.54 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.273 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -149.49 160.31 43.57 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.77 1.228 . . . . 0.0 108.823 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.511 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -142.22 150.43 40.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 173.677 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.7 mt -134.4 125.1 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.497 HD21 HG22 ' A' ' 41' ' ' VAL . 4.2 pp -118.97 172.47 7.53 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 47.6 t30 -87.93 131.34 34.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.52 1.128 . . . . 0.0 111.133 -167.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 111' ' ' VAL . . . -83.6 -3.84 58.04 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.682 ' HB3' HD21 ' A' ' 121' ' ' LEU . 76.9 m-20 -63.74 -44.82 92.38 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.358 0.599 . . . . 0.0 109.817 171.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.06 -1.95 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.871 -166.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 32' ' ' ALA . 9.9 p -85.71 129.87 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.78 -68.13 0.57 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 113' ' ' GLU . 30.8 p -128.85 166.59 18.77 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.465 1.106 . . . . 0.0 108.431 169.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -22.26 34.17 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.59 0.356 . . . . 0.0 111.493 169.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.13 -30.31 66.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.266 1.026 . . . . 0.0 112.081 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.571 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.2 t-80 -61.23 -44.82 96.65 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.806 0.842 . . . . 0.0 110.377 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 30' ' ' LEU . 40.4 t -65.76 -54.13 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.708 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.492 ' HA ' HD12 ' A' ' 45' ' ' ILE . 3.2 pp -63.55 -32.12 73.49 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -61.03 -37.48 82.73 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.196 0.999 . . . . 0.0 110.886 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.79 -35.36 67.38 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.079 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.498 HG12 HD13 ' A' ' 62' ' ' ILE . 53.4 mt -63.56 -47.07 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.461 0.704 . . . . 0.0 110.914 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -57.83 -37.26 73.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.776 0.831 . . . . 0.0 111.01 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.461 ' HA ' HG22 ' A' ' 50' ' ' THR . 79.7 mm-40 -67.56 -40.12 84.92 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.499 174.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.31 -27.6 68.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.979 0.512 . . . . 0.0 111.629 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -79.13 -34.3 43.48 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.978 0.511 . . . . 0.0 111.591 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.461 HG22 ' HA ' ' A' ' 47' ' ' GLN . 11.8 t -87.48 -28.23 22.18 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.436 0.294 . . . . 0.0 110.894 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -98.8 135.26 40.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.671 0.788 . . . . 0.0 111.547 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 105.5 2.28 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 162.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 41.1 Cg_endo -64.73 166.2 18.68 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.795 2.33 . . . . 0.0 114.801 -161.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 mm -108.7 -5.15 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 173.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.01 -179.5 6.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.048 1.339 . . . . 0.0 111.472 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HB2' ' HG2' ' A' ' 60' ' ' MET . 75.6 mmtt -73.22 -25.02 60.58 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.513 0.725 . . . . 0.0 112.262 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.691 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 29.0 t -165.28 -178.69 5.16 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.479 0.711 . . . . 0.0 110.327 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -57.48 -54.57 45.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.687 1.195 . . . . 0.0 111.42 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.511 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 86.5 m95 -62.14 -32.48 73.09 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.828 0.851 . . . . 0.0 111.58 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.691 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.1 mpt? -72.99 -26.47 61.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.876 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.573 ' HA ' HG22 ' A' ' 64' ' ' VAL . 19.8 tp10 -74.67 -31.59 61.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.282 0.233 . . . . 0.0 110.587 175.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.498 HD13 HG12 ' A' ' 45' ' ' ILE . 66.8 mt -61.52 -47.63 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.017 0.527 . . . . 0.0 110.183 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' O ' HD11 ' A' ' 79' ' ' ILE . 4.1 pp -71.9 -34.33 69.03 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.699 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 61' ' ' GLU . 23.5 m -76.98 -34.05 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 118.783 0.72 . . . . 0.0 111.558 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.41 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 5.3 tpp180 -68.95 -46.48 68.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.757 0.423 . . . . 0.0 111.11 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.7 -18.95 64.35 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 123.458 0.474 . . . . 0.0 112.157 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.8 p -90.03 18.88 5.35 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.431 0.692 . . . . 0.0 112.501 175.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 142' ' ' ILE . . . 95.29 26.22 12.66 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.385 -0.675 . . . . 0.0 113.193 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 57.78 97.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.837 1.255 . . . . 0.0 109.869 -174.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -137.84 -158.11 0.83 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.725 0.81 . . . . 0.0 110.862 -168.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -120.66 164.61 16.26 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.653 1.181 . . . . 0.0 108.985 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.442 HG13 ' HG2' ' A' ' 56' ' ' LYS . 51.4 mm -47.41 -47.6 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 125.659 1.583 . . . . 0.0 112.99 -171.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 m170 -56.74 -53.37 58.52 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.856 0.863 . . . . 0.0 111.572 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.38 -58.06 10.1 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 123.519 0.512 . . . . 0.0 110.75 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . . . -54.61 -54.99 34.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.428 1.091 . . . . 0.0 113.844 -170.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.3 mt -63.68 -31.24 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.49 0.716 . . . . 0.0 112.117 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.69 -39.62 19.94 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.1 mt -76.73 -66.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.83 0.452 . . . . 0.0 110.626 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.43 HD11 ' O ' ' A' ' 63' ' ' LEU . 9.0 pt -104.8 8.76 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.519 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 31' ' ' ASN . . . -81.83 173.95 53.8 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 119.364 0.984 . . . . 0.0 111.853 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.11 137.67 58.31 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.97 156.64 37.81 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -53.66 151.3 6.22 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.84 -115.51 5.18 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.123 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -85.5 108.55 17.97 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.524 HG11 HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -135.1 171.25 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.337 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 32' ' ' ALA . 61.0 m -131.64 121.46 24.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.841 1.256 . . . . 0.0 108.823 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.464 HD11 ' HB ' ' A' ' 99' ' ' ILE . 4.8 tt -99.47 128.77 45.6 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -174.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.456 HG22 ' HZ3' ' A' ' 59' ' ' TRP . 22.0 mt -113.75 114.28 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 20.8 p -138.26 156.88 47.25 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.836 0.454 . . . . 0.0 110.568 -176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.34 -51.98 15.52 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.866 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -128.75 158.39 38.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.121 0.968 . . . . 0.0 110.068 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 43.4 mt-10 -64.87 -16.15 62.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.885 0.874 . . . . 0.0 112.266 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 13.4 pt-20 -74.58 -46.59 37.73 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.0 m -61.56 -40.4 94.57 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 123.738 0.815 . . . . 0.0 110.505 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.745 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 19.4 t80 -56.74 -51.46 68.78 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 123.819 0.699 . . . . 0.0 110.84 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -61.39 -42.72 99.17 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.822 0.701 . . . . 0.0 111.005 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 74.8 mmtt -57.58 -50.14 74.09 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.654 0.596 . . . . 0.0 110.899 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.464 ' HB ' HD11 ' A' ' 88' ' ' LEU . 45.8 mm -69.82 -45.45 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.835 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.405 ' HD1' HD12 ' A' ' 11' ' ' ILE . 14.7 t80 -54.01 -45.7 71.57 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.257 1.423 . . . . 0.0 113.2 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.95 -30.34 68.76 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 119.463 -0.303 . . . . 0.0 111.667 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.24 -46.03 71.62 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.932 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.1 pt -75.62 -41.01 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 118.103 0.41 . . . . 0.0 110.799 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.56 109.11 0.09 OUTLIER Glycine 0 C--N 1.345 1.072 0 O-C-N 123.347 0.405 . . . . 0.0 113.706 170.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.44 -171.88 44.63 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -105.25 147.46 28.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.238 0.615 . . . . 0.0 109.568 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.36 129.29 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.248 0.619 . . . . 0.0 109.561 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -132.77 100.84 5.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.289 1.036 . . . . 0.0 108.906 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -69.88 -33.18 71.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.896 0.478 . . . . 0.0 111.622 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.516 ' HA ' ' HG2' ' A' ' 113' ' ' GLU . 18.4 m -50.6 -36.82 36.81 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 16.2 m -66.64 -22.52 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.8 mt -100.75 17.83 20.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.808 0.843 . . . . 0.0 111.856 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.593 ' HA ' HG22 ' A' ' 37' ' ' THR . 7.4 pt-20 -134.79 8.06 3.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 78.71 131.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.202 1.001 . . . . 0.0 111.615 173.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 117' ' ' ASP . 4.0 p-10 -156.87 174.44 15.5 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.219 1.407 . . . . 0.0 107.915 172.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -69.4 -32.23 71.09 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.46 ' HB2' ' ND2' ' A' ' 115' ' ' ASN . 2.2 m-20 -57.34 -50.68 72.19 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.541 0.736 . . . . 0.0 110.352 171.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -40.98 76.86 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.124 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.463 ' HG3' HG21 ' A' ' 134' ' ' VAL . 42.5 tt0 -72.32 -49.19 36.31 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.404 0.682 . . . . 0.0 112.485 -162.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 12.5 ptm180 -70.16 -36.95 75.06 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.678 0.752 . . . . 0.0 110.741 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.682 HD21 ' HB3' ' A' ' 33' ' ' ASP . 37.4 tp -59.64 -47.8 84.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.778 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.4 HG23 ' HD2' ' A' ' 126' ' ' PHE . 31.5 mt -63.5 -38.04 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.289 1.035 . . . . 0.0 110.645 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.2 ptp180 -74.36 -26.51 60.17 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 118.983 -0.532 . . . . 0.0 110.086 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -71.47 -57.49 4.38 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -31.27 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 119.014 0.825 . . . . 0.0 112.487 -172.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.4 ' HD2' HG23 ' A' ' 122' ' ' ILE . 23.0 m-30 -92.5 -33.59 14.42 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 119.593 -0.241 . . . . 0.0 111.553 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 12.4 mmmm 66.13 82.53 0.18 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.971 0.908 . . . . 0.0 112.419 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 137' ' ' ARG . 36.9 mt . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' A' ' 136' ' ' GLU . 54.0 t30 . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 120.847 0.356 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.463 HG21 ' HG3' ' A' ' 119' ' ' GLU . 84.2 t -64.19 -29.4 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.152 1.381 . . . . 0.0 112.324 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.8 -49.75 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.213 0.605 . . . . 0.0 110.469 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.414 ' HG3' HD22 ' A' ' 133' ' ' ASN . 41.1 mt-10 -64.99 -32.1 73.66 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.097 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.537 ' HB3' HG21 ' A' ' 128' ' ' ILE . 8.5 mmm180 -76.01 -35.48 59.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.115 0.566 . . . . 0.0 112.205 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.51 -41.33 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.823 -0.548 . . . . 0.0 110.973 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.5 mp -57.12 -40.16 76.54 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.508 1.123 . . . . 0.0 112.786 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.37 -35.52 68.5 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.024 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -64.96 -46.08 83.05 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.426 0.69 . . . . 0.0 111.281 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.5 pt -72.48 -8.48 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.403 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.561 0 C-N-CA 124.386 1.074 . . . . 0.0 111.267 171.497 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.508 ' SD ' ' HB2' ' A' ' 42' ' ' LEU . 2.0 mpt? . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -103.55 104.94 17.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mm -111.83 120.31 61.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.434 HH21 HG21 ' A' ' 107' ' ' ILE . 28.0 mmm180 -133.18 145.33 50.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.876 0.471 . . . . 0.0 109.869 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.564 ' H ' HD11 ' A' ' 112' ' ' LEU . . . -107.14 118.04 5.46 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.3 tt -124.28 124.97 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.566 0.746 . . . . 0.0 111.165 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -85.11 137.74 32.85 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.156 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.29 79.51 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.211 172.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.25 109.98 4.98 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.833 0.853 . . . . 0.0 111.815 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -76.76 103.15 6.57 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.546 HD11 HG11 ' A' ' 86' ' ' VAL . 50.9 mm -70.69 93.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.413 ' O ' HG12 ' A' ' 20' ' ' ILE . 30.4 p-10 -102.01 153.59 19.75 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.625 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -68.53 -13.26 62.21 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.39 -36.75 79.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.656 0.782 . . . . 0.0 112.013 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 17' ' ' ASN . 6.9 pt -56.72 -22.62 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -87.25 -16.78 34.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 118.231 0.469 . . . . 0.0 111.368 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -75.31 -19.52 59.61 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.381 0.673 . . . . 0.0 112.093 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -82.65 -9.76 59.23 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.944 0.498 . . . . 0.0 111.765 -177.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.73 8.39 2.85 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB2' HD13 ' A' ' 23' ' ' LEU . 86.2 mt -68.57 168.69 12.44 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.977 0.888 . . . . 0.0 112.131 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -77.78 92.21 4.18 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.09 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -148.81 162.3 40.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.984 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.648 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -146.1 159.82 42.76 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 164.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.8 mt -134.08 129.68 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 121.704 -0.623 . . . . 0.0 109.39 173.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.7 pt? -119.84 179.7 4.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.072 0.949 . . . . 0.0 108.456 172.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.467 ' HB3' HG22 ' A' ' 34' ' ' VAL . 51.0 t-20 -74.51 143.16 44.68 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.557 ' HB1' HG21 ' A' ' 111' ' ' VAL . . . -68.87 -49.67 56.28 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.038 0.447 . . . . 0.0 110.585 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HB3' HD21 ' A' ' 121' ' ' LEU . 40.9 m-20 -52.38 -16.66 0.92 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 31' ' ' ASN . 24.9 m -110.82 2.09 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.585 0.754 . . . . 0.0 111.906 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.13 -30.74 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.201 0.6 . . . . 0.0 111.95 -171.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.427 ' O ' HG12 ' A' ' 114' ' ' ILE . . . 58.29 -84.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.34 1.056 . . . . 0.0 109.35 -166.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 16.8 p -127.07 161.69 27.83 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.939 0.896 . . . . 0.0 111.081 172.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -53.56 -40.68 65.79 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.379 163.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.507 ' HD2' HD11 ' A' ' 42' ' ' LEU . 50.8 tptt -56.19 -35.76 67.61 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 124.994 1.318 . . . . 0.0 111.554 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -63.02 -52.6 62.27 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.889 0.743 . . . . 0.0 111.28 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 45' ' ' ILE . 40.4 t -72.66 -42.49 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 119.427 -0.321 . . . . 0.0 111.85 -175.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.508 ' HB2' ' SD ' ' A' ' 6' ' ' MET . 4.1 pp -64.6 -29.52 70.53 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.015 0.371 . . . . 0.0 111.209 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -62.6 -40.22 96.23 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.019 0.928 . . . . 0.0 110.546 169.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.27 82.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.571 0.748 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.467 ' HA ' HG12 ' A' ' 62' ' ' ILE . 41.7 mt -65.49 -45.8 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.099 0.96 . . . . 0.0 110.709 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -51.69 -48.77 63.37 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.568 1.147 . . . . 0.0 110.366 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -64.6 -31.82 73.21 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.987 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.46 -21.78 48.54 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.914 0.485 . . . . 0.0 112.025 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HE3' HG22 ' A' ' 45' ' ' ILE . 96.7 mttt -82.0 -31.75 30.91 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.973 0.509 . . . . 0.0 111.622 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.478 HG23 ' HG2' ' A' ' 51' ' ' LYS . 9.7 t -100.31 -35.98 9.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.478 ' HG2' HG23 ' A' ' 50' ' ' THR . 10.9 mmpt? -119.63 153.57 35.31 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.275 0.63 . . . . 0.0 111.877 -176.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.86 124.74 9.48 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.506 1.122 . . . . 0.0 109.766 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -90.57 -115.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 123.85 3.034 . . . . 0.0 110.468 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 mm -123.63 35.26 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . . . -85.83 156.54 20.52 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.878 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.554 ' HG2' HG13 ' A' ' 72' ' ' ILE . 74.3 mmtt -62.23 -53.83 49.56 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.207 0.603 . . . . 0.0 111.945 -171.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.539 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 10.6 t -156.33 -176.94 6.23 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.039 0.536 . . . . 0.0 109.678 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -58.55 -60.33 3.97 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.407 1.083 . . . . 0.0 113.244 -173.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.518 ' CE3' ' HB2' ' A' ' 28' ' ' GLN . 92.1 m95 -66.16 -23.5 66.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.747 0.419 . . . . 0.0 112.044 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.5 mpt? -77.19 -26.09 52.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.864 0.866 . . . . 0.0 110.599 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.524 ' HG2' ' HB3' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -74.92 -41.26 60.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.967 0.907 . . . . 0.0 109.389 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 45' ' ' ILE . 81.8 mt -61.54 -39.46 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.726 0.811 . . . . 0.0 112.455 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.455 HD12 HG13 ' A' ' 64' ' ' VAL . 3.6 pp -72.65 -33.47 66.62 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.007 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.455 HG13 HD12 ' A' ' 63' ' ' LEU . 25.0 m -77.07 -27.0 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.973 -0.454 . . . . 0.0 111.949 174.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.444 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 35.4 mmt180 -64.56 -62.76 1.39 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.205 0.602 . . . . 0.0 110.442 172.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.79 -27.72 68.23 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.608 0.763 . . . . 0.0 112.695 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 p -79.57 -59.07 2.89 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.37 6.6 29.16 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.722 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -78.83 -25.13 44.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.498 1.119 . . . . 0.0 111.763 -172.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.44 ' NH1' HG23 ' A' ' 64' ' ' VAL . 1.1 mpt_? 66.58 -10.61 0.27 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -173.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -99.45 118.5 36.2 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.94 0.896 . . . . 0.0 109.125 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.554 HG13 ' HG2' ' A' ' 56' ' ' LYS . 24.8 mm -53.45 -59.73 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.264 1.025 . . . . 0.0 112.353 -172.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -61.76 -45.14 95.17 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.152 0.907 . . . . 0.0 110.589 -172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -58.02 -47.86 81.79 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.858 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.92 80.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.52 0.728 . . . . 0.0 112.397 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.9 mt -68.08 -33.79 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.185 0.594 . . . . 0.0 111.035 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -68.71 -49.33 59.76 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.804 0.335 . . . . 0.0 110.698 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.518 HG23 ' HB ' ' A' ' 125' ' ' ILE . 74.2 mt -64.8 -64.22 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 124.004 0.922 . . . . 0.0 111.15 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.45 ' HB ' HG21 ' A' ' 34' ' ' VAL . 24.0 pt -110.4 15.36 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -172.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.58 173.29 44.16 Favored Glycine 0 N--CA 1.479 1.52 0 CA-C-N 120.389 1.449 . . . . 0.0 113.21 -174.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.44 146.59 32.68 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.189 0.595 . . . . 0.0 111.39 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -153.18 155.53 36.84 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.417 1.087 . . . . 0.0 108.104 171.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.25 151.98 44.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.927 0.491 . . . . 0.0 111.433 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.79 -120.78 7.01 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.205 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -79.61 105.89 11.24 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG11 HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -135.74 164.53 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.647 -177.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 43.7 t -125.55 121.25 33.12 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.371 1.068 . . . . 0.0 108.959 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.41 HD21 ' HB ' ' A' ' 99' ' ' ILE . 10.0 tp -102.35 125.75 49.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.853 0.861 . . . . 0.0 109.865 -171.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 28' ' ' GLN . 68.4 mt -99.79 128.52 51.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 113.698 -1.592 . . . . 0.0 107.521 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.547 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 35.1 t -150.32 149.19 29.78 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 111.589 177.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -86.02 -41.67 14.63 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.59 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -119.78 146.69 45.44 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.195 0.598 . . . . 0.0 110.994 -174.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -54.79 -38.31 67.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.71 0.804 . . . . 0.0 112.613 172.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -69.75 -46.51 65.7 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.547 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 28.7 m -61.21 -35.21 76.57 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.005 0.922 . . . . 0.0 110.948 178.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -63.83 -46.76 83.62 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.404 0.682 . . . . 0.0 110.152 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.58 -34.71 78.41 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.759 0.662 . . . . 0.0 110.574 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.79 -45.9 80.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.464 0.706 . . . . 0.0 111.638 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.474 HD13 HD21 ' A' ' 23' ' ' LEU . 40.2 mm -71.39 -46.72 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 122.43 -0.169 . . . . 0.0 110.766 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -54.76 -33.81 61.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.161 1.384 . . . . 0.0 112.086 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.8 -50.46 70.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.864 0.866 . . . . 0.0 111.769 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.67 -25.84 49.84 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 20' ' ' ILE . 17.7 pt -80.24 -50.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 118.584 0.629 . . . . 0.0 109.575 174.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.92 124.43 0.05 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 123.443 0.464 . . . . 0.0 113.796 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.43 -153.15 20.59 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 117.028 0.414 . . . . 0.0 112.159 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -123.91 143.79 50.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.938 0.895 . . . . 0.0 109.164 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.434 HG21 HH21 ' A' ' 9' ' ' ARG . 49.3 mm -86.89 136.73 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -135.66 108.97 7.8 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.15 -25.22 66.86 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.541 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.2 m -46.54 -39.68 11.36 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.557 HG21 ' HB1' ' A' ' 32' ' ' ALA . 12.6 p -71.29 -41.62 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-O 120.846 0.355 . . . . 0.0 110.399 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 37' ' ' THR . 86.3 mt -67.78 -31.17 70.88 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.551 1.141 . . . . 0.0 112.623 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.3 1.54 54.48 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 118.15 -0.929 . . . . 0.0 112.924 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.433 ' HA ' HD13 ' A' ' 114' ' ' ILE 0.253 1.5 mm 73.07 127.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.29 0 CA-C-N 119.296 0.953 . . . . 0.0 113.094 177.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.438 HD21 ' HD3' ' A' ' 118' ' ' LYS . 6.3 p30 -147.89 -176.68 5.36 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.024 1.329 . . . . 0.0 108.584 173.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -57.42 -49.61 75.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.493 0.717 . . . . 0.0 112.142 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.8 -51.39 69.93 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.53 1.132 . . . . 0.0 112.466 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.438 ' HD3' HD21 ' A' ' 115' ' ' ASN . 4.3 mptp? -70.6 -37.23 73.86 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.849 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -71.38 -39.22 71.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.976 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -72.2 -42.89 65.29 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.866 0.466 . . . . 0.0 112.046 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 33' ' ' ASP . 0.7 OUTLIER -66.14 -34.1 77.28 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.487 HG23 ' HD2' ' A' ' 126' ' ' PHE . 13.5 mt -58.33 -30.02 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.948 0.899 . . . . 0.0 110.782 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -69.44 -36.79 76.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 118.839 -0.6 . . . . 0.0 109.534 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.13 -55.71 30.5 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.518 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -75.57 -45.07 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 118.863 0.756 . . . . 0.0 112.693 -178.026 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.582 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 21.7 m-30 -81.87 -33.1 30.75 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? 63.6 76.32 0.36 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.151 0.98 . . . . 0.0 112.318 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.685 HG21 ' HB3' ' A' ' 137' ' ' ARG . 2.5 mt . . . . . 0 C--O 1.245 0.822 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.657 0.265 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.45 -16.53 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.083 0.553 . . . . 0.0 112.445 -171.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.476 ' O ' HD13 ' A' ' 139' ' ' LEU . 86.6 t -68.63 -49.29 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -174.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -52.75 -45.54 67.07 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.495 174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.685 ' HB3' HG21 ' A' ' 128' ' ' ILE . 37.4 mmt180 -73.55 -38.85 65.09 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 113.693 -1.594 . . . . 0.0 112.346 -168.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.55 -41.15 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 123.181 0.301 . . . . 0.0 110.485 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 135' ' ' VAL . 9.9 mp -55.74 -44.16 77.32 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.741 0.816 . . . . 0.0 110.509 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -74.33 -37.94 63.41 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 123.887 0.742 . . . . 0.0 111.929 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.633 ' HD3' HG12 ' A' ' 128' ' ' ILE . 16.5 ttpp -66.25 -40.01 89.91 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.086 0.47 . . . . 0.0 111.537 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 22.2 pt -73.29 -18.92 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.017 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.875 0 C-N-CA 124.3 1.04 . . . . 0.0 110.801 174.045 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 121.523 0.678 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 72.5 mt -98.75 103.81 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 108.359 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.57 122.28 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.7 mmt-85 -127.84 150.9 49.64 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.79 0.836 . . . . 0.0 109.723 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.31 126.26 8.67 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 tt -132.63 132.68 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.416 0.627 . . . . 0.0 110.452 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -107.83 133.68 51.86 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.27 1.028 . . . . 0.0 109.955 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.79 -6.27 79.62 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.534 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.57 112.77 2.12 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.112 0.965 . . . . 0.0 112.826 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -73.28 108.52 6.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.469 0.708 . . . . 0.0 110.288 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 86' ' ' VAL . 49.4 mm -70.76 94.17 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.272 1.034 . . . . 0.0 109.837 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.45 150.38 20.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.002 177.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -82.26 -4.57 57.39 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.974 0.51 . . . . 0.0 111.23 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -65.94 -40.09 91.07 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.076 0.95 . . . . 0.0 111.154 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.8 pt -70.62 -7.87 9.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.767 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -93.46 -34.32 13.46 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.226 0.921 . . . . 0.0 110.998 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -86.28 0.67 53.31 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -172.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.74 -3.94 55.04 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.365 0.666 . . . . 0.0 112.213 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.96 -11.8 2.43 Favored Glycine 0 CA--C 1.54 1.595 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.501 HD13 HG23 ' A' ' 95' ' ' THR . 85.2 mt -64.42 159.8 20.54 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.273 1.037 . . . . 0.0 112.217 -176.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -86.58 100.71 12.61 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.884 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -149.03 162.55 39.71 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.496 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.451 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 24.7 tt0 -139.02 145.55 39.76 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 166.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.0 mt -130.02 126.45 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 pp -122.39 174.28 7.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.068 0.947 . . . . 0.0 108.688 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -82.07 135.41 35.33 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -85.93 3.41 42.06 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -175.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -84.28 -34.66 23.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.271 0.629 . . . . 0.0 110.195 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 79' ' ' ILE . 14.8 p -93.88 -4.47 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 123.934 0.894 . . . . 0.0 111.229 -172.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG11 ' SG ' ' A' ' 87' ' ' CYS . 8.6 p -96.41 134.42 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.59 -64.09 1.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.1 p -135.24 168.89 18.34 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.465 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.595 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -56.6 -23.96 44.39 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 168.453 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 39.1 ttmt -63.02 -28.68 70.26 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 122.717 0.407 . . . . 0.0 111.947 174.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.485 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.8 t-80 -59.3 -44.82 92.5 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.853 0.461 . . . . 0.0 110.021 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.04 -52.14 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.742 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.632 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 3.8 pp -65.57 -36.42 83.71 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.764 0.256 . . . . 0.0 111.648 -171.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.458 ' CG ' ' HG ' ' A' ' 139' ' ' LEU . 25.2 t-80 -57.68 -41.31 81.35 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.181 0.592 . . . . 0.0 110.71 169.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.29 -34.42 77.35 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.647 0.592 . . . . 0.0 111.13 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 42' ' ' LEU . 62.9 mt -65.78 -46.08 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.925 0.89 . . . . 0.0 110.641 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.411 ' O ' HG22 ' A' ' 50' ' ' THR . 67.4 m-20 -59.39 -46.93 87.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.424 0.69 . . . . 0.0 110.247 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -61.68 -36.14 80.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.448 1.099 . . . . 0.0 111.166 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.15 95.92 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.565 0.746 . . . . 0.0 111.859 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -76.96 -20.35 56.22 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 51' ' ' LYS . 5.1 t -105.25 -38.8 6.4 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.757 0.423 . . . . 0.0 110.757 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HG2' HG23 ' A' ' 50' ' ' THR . 45.2 mmtm -114.52 136.2 53.29 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.591 0.756 . . . . 0.0 110.602 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.603 ' HD3' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -109.56 116.53 54.35 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.856 -178.153 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.19 -142.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.126 2.551 . . . . 0.0 110.593 168.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.55 41.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 72' ' ' ILE . . . -77.68 150.94 34.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.534 -174.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -84.96 -23.14 28.89 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.85 0.86 . . . . 0.0 111.15 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -161.07 173.83 14.61 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.054 0.941 . . . . 0.0 109.399 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -66.89 -44.32 81.17 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.693 0.797 . . . . 0.0 111.177 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.451 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 94.0 m95 -76.39 -18.9 58.63 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.409 0.283 . . . . 0.0 111.589 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.5 mmt -79.15 -25.45 42.88 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.002 0.521 . . . . 0.0 110.779 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 29.8 tt0 -76.03 -37.59 58.2 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.177 0.991 . . . . 0.0 111.544 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.448 HD13 HG12 ' A' ' 45' ' ' ILE . 78.6 mt -68.25 -39.9 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.129 0.572 . . . . 0.0 111.33 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.413 HD12 HG13 ' A' ' 64' ' ' VAL . 3.9 pp -72.06 -34.68 68.93 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 123.214 0.321 . . . . 0.0 111.466 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.413 HG13 HD12 ' A' ' 63' ' ' LEU . 21.9 m -74.34 -35.48 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 121.971 -0.456 . . . . 0.0 110.745 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 16.7 tpt85 -68.42 -42.56 78.75 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.161 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.01 66.57 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.451 0.7 . . . . 0.0 111.573 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -82.93 -5.32 59.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.578 0.751 . . . . 0.0 111.947 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.9 -73.46 2.12 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -44.32 136.49 4.03 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.326 1.45 . . . . 0.0 112.365 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -96.59 5.86 49.89 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.941 0.896 . . . . 0.0 111.482 -165.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.48 126.21 43.94 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.707 1.203 . . . . 0.0 110.997 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 55' ' ' ALA . 1.7 mp -53.12 -59.15 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 124.957 1.303 . . . . 0.0 112.55 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.491 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 63.0 m80 -60.36 -46.79 88.68 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.781 0.676 . . . . 0.0 110.702 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -57.2 -51.83 67.77 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.415 1.072 . . . . 0.0 111.187 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.62 72.33 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.376 0.671 . . . . 0.0 112.681 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.55 -32.6 55.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 122.918 0.487 . . . . 0.0 111.217 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 73' ' ' HIS . 32.6 mmtp -70.14 -49.38 51.28 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 175.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 52.6 mt -68.82 -67.56 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.095 0.958 . . . . 0.0 111.881 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 34' ' ' VAL . 6.9 pt -103.85 8.91 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.92 168.59 54.75 Favored Glycine 0 C--N 1.352 1.459 0 CA-C-N 119.457 1.026 . . . . 0.0 113.11 -171.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.86 144.82 48.93 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.54 0.736 . . . . 0.0 112.755 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -147.1 151.51 36.96 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -58.77 149.94 25.1 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 119.659 1.118 . . . . 0.0 112.062 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.78 -114.52 4.39 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.083 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -89.2 109.05 19.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.136 0.575 . . . . 0.0 110.223 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG21 HD11 ' A' ' 16' ' ' ILE . 4.2 m -137.44 175.11 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.749 0.82 . . . . 0.0 112.034 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.507 ' SG ' HG11 ' A' ' 35' ' ' VAL . 57.9 m -122.82 120.88 34.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.411 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD21 ' HB ' ' A' ' 99' ' ' ILE . 9.2 tp -104.1 120.19 40.56 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.765 0.793 . . . . 0.0 109.344 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 12.1 mt -119.12 129.48 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.074 -170.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.565 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 47.9 t -157.69 164.48 37.12 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -78.27 -53.11 7.67 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.357 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -119.86 149.84 41.43 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.193 0.597 . . . . 0.0 110.18 -173.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.14 -35.67 69.79 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.382 1.073 . . . . 0.0 113.143 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 12.8 pt-20 -73.67 -40.68 63.49 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.565 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 34.9 m -66.07 -36.24 82.68 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.137 0.575 . . . . 0.0 110.938 176.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.16 -47.36 83.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.308 0.643 . . . . 0.0 109.383 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -67.46 -34.97 78.26 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.927 -175.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 30.6 mmmt -63.52 -36.66 84.51 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.39 0.676 . . . . 0.0 111.698 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.431 ' HB ' HD21 ' A' ' 88' ' ' LEU . 38.1 mm -76.25 -44.68 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 N-CA-C 110.464 -0.198 . . . . 0.0 110.464 175.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.46 -45.02 76.94 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.962 1.305 . . . . 0.0 113.221 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.675 ' HG3' HD22 ' A' ' 102' ' ' LEU . 8.0 pt-20 -62.35 -35.75 80.08 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.475 0.484 . . . . 0.0 111.959 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.675 HD22 ' HG3' ' A' ' 101' ' ' GLU . 3.5 mm? -75.83 -39.15 57.28 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 119.102 -0.475 . . . . 0.0 112.012 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.3 pt -74.73 -42.94 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 118.604 0.638 . . . . 0.0 110.639 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.27 113.81 0.06 OUTLIER Glycine 0 C--N 1.35 1.308 0 O-C-N 123.545 0.528 . . . . 0.0 113.838 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.83 -162.74 29.31 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -116.92 134.98 54.08 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.56 0.744 . . . . 0.0 109.974 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.8 mm -75.43 123.67 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -143.03 95.94 2.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.099 1.36 . . . . 0.0 107.694 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.4 -18.55 63.77 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.8 0.44 . . . . 0.0 112.157 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.5 m -57.38 -25.34 59.35 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -70.71 -25.23 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 CA-C-O 120.893 0.378 . . . . 0.0 110.159 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.564 HD13 ' HB3' ' A' ' 38' ' ' LYS . 38.6 mt -107.81 16.52 23.49 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.634 1.174 . . . . 0.0 112.051 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -103.69 -4.91 23.12 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 119.743 1.156 . . . . 0.0 112.428 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.528 HD11 HG12 ' A' ' 134' ' ' VAL 0.294 0.5 OUTLIER 93.57 123.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.803 2.041 . . . . 0.0 109.401 -176.43 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.552 ' HB2' ' HD3' ' A' ' 118' ' ' LYS . 4.2 m120 -139.58 157.59 45.55 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 124.525 1.13 . . . . 0.0 108.328 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.72 -38.56 91.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.412 0.685 . . . . 0.0 110.733 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.79 -48.56 80.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.126 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' A' ' 115' ' ' ASN . 4.2 mptp? -63.02 -42.18 99.74 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.83 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 29.1 tt0 -65.61 -44.17 87.38 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.757 -166.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -69.38 -39.02 78.25 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.54 -33.05 62.65 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 119.485 -0.293 . . . . 0.0 110.718 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.1 mt -59.14 -41.89 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.88 0.872 . . . . 0.0 110.538 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -74.53 -23.41 58.8 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.611 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -65.92 -57.65 7.37 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.519 HD11 HG23 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -78.36 -24.61 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 119.262 0.937 . . . . 0.0 112.977 -175.027 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -97.1 -32.42 11.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.15 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 57.88 79.11 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.062 0.945 . . . . 0.0 111.2 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.528 HG12 HD11 ' A' ' 114' ' ' ILE . 3.8 p -69.73 -15.86 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.124 0.57 . . . . 0.0 112.453 -171.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.422 ' O ' HD13 ' A' ' 139' ' ' LEU . 21.4 t -70.34 -53.13 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -56.57 -39.37 73.38 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.41 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -68.17 -42.21 80.34 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.451 -173.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.9 p -76.23 -37.83 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 122.817 0.447 . . . . 0.0 110.892 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.5 mp -60.46 -37.24 80.38 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.015 0.926 . . . . 0.0 111.388 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -73.23 -40.96 64.25 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.499 0.499 . . . . 0.0 111.618 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -72.61 -29.54 63.58 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.396 0.278 . . . . 0.0 111.438 -171.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 22.2 pt -84.75 -18.55 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.212 0 C-N-CA 123.008 0.523 . . . . 0.0 110.334 172.554 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.9 mt -93.01 102.17 13.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.4 mm -112.69 118.92 59.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -135.08 149.05 50.01 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.26 151.52 17.9 Favored Glycine 0 C--O 1.239 0.42 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.91 127.65 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.61 0.719 . . . . 0.0 112.874 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -91.72 133.17 35.84 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.823 1.249 . . . . 0.0 110.31 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.94 24.37 72.11 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.192 -0.458 . . . . 0.0 114.101 170.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.497 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -80.21 111.79 16.91 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.673 0.789 . . . . 0.0 110.974 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 110.17 8.42 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.409 HD11 HG21 ' A' ' 86' ' ' VAL . 49.6 mm -69.02 92.41 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.72 0.771 . . . . 0.0 109.34 175.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 20' ' ' ILE . 4.7 p30 -105.01 148.58 26.58 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.486 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -56.53 -24.41 46.53 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.4 -34.17 76.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.394 0.678 . . . . 0.0 112.38 -172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.621 HG21 HG23 ' A' ' 103' ' ' ILE . 7.2 pt -62.66 -15.14 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -106.82 -17.85 14.09 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 118.525 0.602 . . . . 0.0 109.845 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -69.39 -25.44 64.15 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.08 0.952 . . . . 0.0 111.16 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -76.57 -8.94 58.21 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.196 -174.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.11 17.22 9.92 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 116.737 1.455 . . . . 0.0 116.737 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.468 ' HB2' HD13 ' A' ' 23' ' ' LEU . 93.3 mt -81.93 170.5 15.55 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.426 0.69 . . . . 0.0 110.833 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -84.58 99.41 10.74 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.643 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -149.9 162.25 40.69 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.852 0.861 . . . . 0.0 109.421 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.433 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -140.09 145.89 38.21 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.6 mt -130.98 127.48 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 172.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -120.31 176.63 5.37 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 34' ' ' VAL . 2.1 t-20 -81.17 138.07 35.87 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.541 ' HB1' ' HB ' ' A' ' 111' ' ' VAL . . . -83.74 -2.45 56.3 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.507 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 61.3 m-20 -89.87 -30.22 18.05 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 122.854 0.462 . . . . 0.0 110.387 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.469 HG23 HG13 ' A' ' 125' ' ' ILE . 9.4 p -87.52 -16.29 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 123.309 0.644 . . . . 0.0 111.234 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 32' ' ' ALA . 13.4 p -93.86 136.13 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.77 -66.93 0.64 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.681 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.4 p -138.49 167.78 21.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.595 1.158 . . . . 0.0 109.362 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB3' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -58.26 -22.94 54.43 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 174.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 87.4 tttt -58.95 -34.68 72.04 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.021 0.528 . . . . 0.0 111.677 174.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.509 ' HA ' HD11 ' A' ' 139' ' ' LEU . 18.1 t-80 -60.58 -44.57 96.07 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.204 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.57 -52.83 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.036 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 4.1 pp -64.57 -28.37 69.59 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -172.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.441 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 47.6 t-80 -68.63 -33.48 74.09 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.226 0.61 . . . . 0.0 110.985 171.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 -40.82 69.58 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.024 0.53 . . . . 0.0 110.914 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.504 HG12 HD13 ' A' ' 62' ' ' ILE . 55.9 mt -61.3 -43.79 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.163 0.985 . . . . 0.0 109.915 172.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 50' ' ' THR . 25.8 t-20 -53.13 -48.39 67.93 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.634 1.173 . . . . 0.0 110.69 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 26.7 mm-40 -63.82 -34.62 78.34 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.231 0.957 . . . . 0.0 110.583 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.452 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . . . -73.35 -25.66 60.69 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -83.71 -46.19 12.55 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.376 0.67 . . . . 0.0 111.23 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.537 HG23 ' HG3' ' A' ' 51' ' ' LYS . 15.1 t -93.9 -32.35 13.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.75 0.42 . . . . 0.0 111.827 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.537 ' HG3' HG23 ' A' ' 50' ' ' THR . 42.3 mtpt -109.51 160.97 15.78 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.925 0.49 . . . . 0.0 111.239 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -142.36 98.82 5.95 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 124.066 0.947 . . . . 0.0 110.248 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.41 -119.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.549 2.832 . . . . 0.0 112.036 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.3 mt -132.99 34.73 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.39 158.59 23.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.548 -175.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -60.24 -60.37 3.92 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.9 0.88 . . . . 0.0 112.416 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.543 ' HB2' ' SD ' ' A' ' 60' ' ' MET . 70.0 m -148.65 179.17 8.03 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.512 0.725 . . . . 0.0 109.818 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.402 ' O ' HG13 ' A' ' 62' ' ' ILE . 58.1 t80 -53.56 -56.97 12.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.324 1.049 . . . . 0.0 111.852 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.515 ' HZ3' HG22 ' A' ' 89' ' ' ILE . 75.7 m95 -65.54 -35.18 80.09 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.491 0.716 . . . . 0.0 111.473 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 57' ' ' SER . 1.1 mpt? -76.34 -19.81 57.85 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 22.9 tt0 -78.53 -38.94 39.37 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.442 0.697 . . . . 0.0 110.627 173.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.504 HD13 HG12 ' A' ' 45' ' ' ILE . 90.2 mt -57.01 -41.28 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.491 0.716 . . . . 0.0 111.036 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.403 HD12 HG13 ' A' ' 64' ' ' VAL . 3.9 pp -72.0 -32.88 67.63 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.21 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.713 HG23 ' HE ' ' A' ' 65' ' ' ARG . 12.0 m -78.38 -34.21 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 121.771 -0.581 . . . . 0.0 111.729 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.713 ' HE ' HG23 ' A' ' 64' ' ' VAL . 5.8 mmp_? -70.39 -38.98 74.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.651 0.38 . . . . 0.0 110.919 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.81 68.84 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.34 0.656 . . . . 0.0 112.199 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.0 p -92.44 -3.53 55.08 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.764 0.426 . . . . 0.0 111.933 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.48 16.04 48.52 Favored Glycine 0 C--N 1.358 1.77 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -170.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.605 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.7 tp-100 -105.76 151.57 24.29 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.5 ptt-85 -85.19 -27.2 26.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.072 0.549 . . . . 0.0 111.361 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.605 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 5.8 mm-40 -90.04 125.45 35.41 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.357 1.063 . . . . 0.0 111.195 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.499 HD12 HG11 ' A' ' 64' ' ' VAL . 1.8 mp -58.76 -44.95 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.343 1.057 . . . . 0.0 110.357 172.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -60.94 -51.09 70.76 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.351 0.661 . . . . 0.0 111.348 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.408 ' HB2' ' HG2' ' A' ' 69' ' ' GLN . 16.8 mm-40 -56.47 -55.52 32.63 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.316 0.385 . . . . 0.0 110.983 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.71 -38.78 75.86 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.3 mt -68.99 -31.1 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 120.661 0.267 . . . . 0.0 111.178 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -74.05 -43.63 57.15 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 122.098 -0.376 . . . . 0.0 110.675 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 79.4 mt -68.55 -65.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.83 0.852 . . . . 0.0 111.825 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.462 HG22 HG21 ' A' ' 34' ' ' VAL . 7.7 pt -105.91 6.06 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.15 176.13 47.4 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 119.094 0.861 . . . . 0.0 114.025 -166.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.33 140.31 42.99 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.613 0.765 . . . . 0.0 111.803 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -145.64 143.22 29.71 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.44 141.3 58.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.297 0.953 . . . . 0.0 111.41 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.07 -119.41 4.45 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 94.9 m-20 -82.83 110.29 17.71 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.252 0.526 . . . . 0.0 109.913 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.409 HG21 HD11 ' A' ' 16' ' ' ILE . 3.6 m -134.79 174.06 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.627 0.727 . . . . 0.0 111.519 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.1 t -130.94 121.81 25.81 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.709 -173.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.515 HD21 ' HB ' ' A' ' 99' ' ' ILE . 8.3 tp -102.1 122.22 43.7 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.774 0.797 . . . . 0.0 109.503 -172.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.515 HG22 ' HZ3' ' A' ' 59' ' ' TRP . 32.0 mt -111.03 122.19 65.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 113.35 -1.75 . . . . 0.0 107.692 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.609 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 40.1 t -154.56 168.0 28.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.953 0.342 . . . . 0.0 111.028 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -95.96 -48.13 5.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.356 0.663 . . . . 0.0 110.827 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -111.66 138.15 48.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.428 0.691 . . . . 0.0 109.26 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 41.4 tt0 -63.49 -24.14 67.7 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.278 0.631 . . . . 0.0 111.902 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.15 -45.82 72.49 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.609 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 28.3 m -70.88 -34.45 71.6 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.929 0.892 . . . . 0.0 111.001 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 5.5 t80 -61.54 -52.31 64.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.553 0.741 . . . . 0.0 109.667 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 30.7 mtp180 -68.58 -33.62 74.37 Favored 'General case' 0 C--O 1.213 -0.855 0 O-C-N 123.685 0.616 . . . . 0.0 110.343 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.415 ' O ' HD13 ' A' ' 102' ' ' LEU . 50.4 tptt -56.46 -40.49 74.94 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.024 0.529 . . . . 0.0 110.663 175.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.515 ' HB ' HD21 ' A' ' 88' ' ' LEU . 43.2 mm -73.67 -48.64 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.6 174.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -54.54 -43.37 71.9 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 124.826 1.251 . . . . 0.0 113.702 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 56.6 mm-40 -60.88 -40.33 92.61 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.624 0.37 . . . . 0.0 110.776 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 98' ' ' LYS . 6.8 mp -72.97 -42.08 63.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.533 0.733 . . . . 0.0 112.082 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.621 HG23 HG21 ' A' ' 20' ' ' ILE . 8.2 pt -74.66 -32.59 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 118.229 0.468 . . . . 0.0 110.019 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.38 27.14 73.92 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 163.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.38 -170.58 43.72 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 172.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -111.62 146.38 37.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.35 124.54 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 121.003 0.43 . . . . 0.0 110.087 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -118.93 101.0 7.73 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.37 -41.82 76.01 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 50.4 m -56.82 -24.93 54.5 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -175.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.541 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 13.5 m -70.36 -17.75 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 118.583 0.629 . . . . 0.0 111.605 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 38' ' ' LYS . 21.2 mt -107.05 17.6 22.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.791 0.836 . . . . 0.0 111.136 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 110' ' ' SER . 8.0 pt-20 -114.46 -10.64 12.57 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.044 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 78.63 127.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 C-N-CA 124.527 1.131 . . . . 0.0 110.451 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -158.88 -172.39 3.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.554 1.142 . . . . 0.0 109.408 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.38 -47.58 83.53 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.284 0.634 . . . . 0.0 111.362 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.08 -44.04 95.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.187 0.595 . . . . 0.0 110.967 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -59.97 -43.92 94.78 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.128 0.893 . . . . 0.0 110.389 177.012 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.01 -50.05 31.91 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.353 -167.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -64.96 -54.5 29.51 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -172.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 33' ' ' ASP . 1.2 pp -64.44 -33.09 75.06 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.14 0.275 . . . . 0.0 111.17 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.526 ' HA ' HD11 ' A' ' 125' ' ' ILE . 1.9 mt -53.84 -32.66 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 124.052 0.941 . . . . 0.0 112.048 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -64.51 -36.5 84.38 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.498 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.62 -56.69 18.73 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.526 HD11 ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -70.0 -52.92 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.328 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.424 ' HD2' HG23 ' A' ' 122' ' ' ILE . 23.6 m-85 -83.58 -33.07 25.48 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -170.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? 61.53 69.55 0.64 Allowed 'General case' 0 C--N 1.35 0.592 0 O-C-N 124.403 1.064 . . . . 0.0 110.586 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.9 mm . . . . . 0 CA--C 1.541 0.602 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.573 -174.212 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.06 -32.12 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.892 0.877 . . . . 0.0 111.861 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.67 -53.48 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.178 0.514 . . . . 0.0 109.971 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 28.5 mm-40 -70.04 -37.14 75.49 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.83 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -76.91 -29.44 55.7 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 123.561 0.538 . . . . 0.0 111.817 -172.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.56 -36.15 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 172.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.9 mp -60.49 -38.11 83.25 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.423 0.689 . . . . 0.0 110.646 172.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 31.4 mm-40 -59.65 -51.41 69.93 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.136 0.574 . . . . 0.0 110.955 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -49.19 78.2 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.557 0.743 . . . . 0.0 112.249 -175.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.9 pt -70.18 -27.59 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 122.972 0.509 . . . . 0.0 110.683 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.233 0 C-N-CA 122.848 0.459 . . . . 0.0 110.531 175.203 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.517 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 63.0 mt -101.77 106.15 19.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -171.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.516 HG12 ' HB ' ' A' ' 41' ' ' VAL . 3.7 mp -103.29 122.63 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 170.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.427 HH11 HG23 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -124.19 149.61 46.14 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -174.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' N ' HD11 ' A' ' 112' ' ' LEU . . . -104.8 137.32 13.58 Favored Glycine 0 CA--C 1.501 -0.792 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.0 tt -146.83 142.94 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.291 0.567 . . . . 0.0 111.093 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -122.56 132.28 54.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.352 1.461 . . . . 0.0 108.906 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.07 1.33 70.05 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.624 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.87 106.42 1.54 Allowed 'General case' 0 C--N 1.351 0.66 0 C-N-CA 124.287 1.035 . . . . 0.0 111.352 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -74.78 104.08 5.28 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.198 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.483 HD11 HG21 ' A' ' 86' ' ' VAL . 49.9 mm -71.25 98.2 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.687 0.756 . . . . 0.0 109.253 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -112.26 153.05 27.74 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.453 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -67.15 -12.12 59.13 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.561 0.744 . . . . 0.0 112.349 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -67.03 -33.26 75.16 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.014 0.926 . . . . 0.0 111.83 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.6 pt -55.23 -22.57 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -87.36 -21.82 25.44 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.448 0.567 . . . . 0.0 111.409 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -77.35 -16.21 59.01 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.22 0.608 . . . . 0.0 112.025 -170.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 99' ' ' ILE . 1.2 pp -80.3 -8.92 59.69 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.974 0.51 . . . . 0.0 111.814 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.7 14.92 10.53 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.854 1.501 . . . . 0.0 116.854 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.56 159.27 32.4 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.577 0.688 . . . . 0.0 110.33 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -83.3 100.68 10.79 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -145.12 166.45 25.37 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.555 1.142 . . . . 0.0 108.7 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -149.95 151.78 33.91 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 162.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.415 HG12 HD13 ' A' ' 88' ' ' LEU . 27.3 mt -128.15 127.51 67.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.616 HD22 HD11 ' A' ' 89' ' ' ILE . 2.7 pt? -115.35 172.35 7.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -81.41 142.91 32.53 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.151 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 111' ' ' VAL . . . -78.61 0.64 25.6 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.16 -28.58 57.42 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.17 0.588 . . . . 0.0 111.082 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 HG11 HG22 ' A' ' 79' ' ' ILE . 32.4 m -107.46 -2.74 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.122 0.569 . . . . 0.0 112.484 -170.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.515 HG11 ' SG ' ' A' ' 87' ' ' CYS . 7.4 p -78.45 104.53 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.277 0.56 . . . . 0.0 109.557 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.5 -66.61 0.53 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.565 HG22 ' HA ' ' A' ' 113' ' ' GLU . 19.1 p -137.78 173.07 12.04 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.677 169.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' A' ' 112' ' ' LEU . 51.3 mtpt -53.98 -25.29 20.14 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.055 0.542 . . . . 0.0 111.678 165.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 10.7 mptt -57.74 -36.74 72.47 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.317 1.047 . . . . 0.0 111.959 172.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.409 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.2 t-80 -60.18 -49.82 76.12 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.211 0.945 . . . . 0.0 110.553 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.516 ' HB ' HG12 ' A' ' 8' ' ' ILE . 59.1 t -69.53 -54.04 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.271 177.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 45' ' ' ILE . 1.8 pp -60.64 -36.8 79.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.001 0.521 . . . . 0.0 111.556 -172.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -58.92 -39.82 82.71 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.781 0.832 . . . . 0.0 111.454 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.04 -33.45 70.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.266 0.626 . . . . 0.0 110.693 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.537 HG12 HD13 ' A' ' 62' ' ' ILE . 43.0 mt -65.16 -44.28 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.386 0.675 . . . . 0.0 110.426 170.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -55.45 -40.42 71.55 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.797 0.839 . . . . 0.0 110.538 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -60.3 -43.79 95.98 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.519 1.137 . . . . 0.0 110.601 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.61 -28.13 66.64 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.55 0.74 . . . . 0.0 112.462 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -76.54 -42.1 44.23 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.572 0.349 . . . . 0.0 111.038 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.572 HG23 ' HG3' ' A' ' 51' ' ' LYS . 12.8 t -88.25 -31.69 18.9 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.392 0.277 . . . . 0.0 111.479 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.572 ' HG3' HG23 ' A' ' 50' ' ' THR . 39.9 mtmt -109.53 152.95 24.79 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.911 0.863 . . . . 0.0 112.752 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -139.23 81.84 20.27 Favored Pre-proline 0 CA--C 1.553 1.087 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.627 160.39 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -87.73 -78.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.278 2.652 . . . . 0.0 113.017 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.3 mt -123.89 -10.82 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 124.275 1.03 . . . . 0.0 108.939 -172.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HA ' HD11 ' A' ' 72' ' ' ILE . . . -65.06 147.34 53.64 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.954 0.902 . . . . 0.0 112.508 -172.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.654 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 75.9 mmtt -66.83 -33.44 75.61 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.566 0.747 . . . . 0.0 110.108 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.406 ' H ' ' HB2' ' A' ' 60' ' ' MET . 28.0 t -163.41 178.15 8.32 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.641 -175.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -51.94 -60.33 3.31 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.691 1.596 . . . . 0.0 111.481 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.402 ' HA ' HD12 ' A' ' 62' ' ' ILE . 78.6 m95 -66.83 -20.73 65.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.294 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.654 ' HG3' ' HB2' ' A' ' 56' ' ' LYS . 22.8 mmt -76.73 -28.55 55.84 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.349 0.66 . . . . 0.0 111.534 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 64' ' ' VAL . 51.6 tp10 -74.95 -32.08 61.65 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 120.641 0.257 . . . . 0.0 110.498 174.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.537 HD13 HG12 ' A' ' 45' ' ' ILE . 60.5 mt -62.01 -46.49 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.903 0.481 . . . . 0.0 110.833 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.492 HD21 ' SD ' ' A' ' 60' ' ' MET . 4.0 pp -71.91 -34.89 69.46 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.932 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 61' ' ' GLU . 36.0 m -73.94 -31.55 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 118.291 0.496 . . . . 0.0 111.811 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.513 ' HA ' ' NE ' ' A' ' 65' ' ' ARG . 12.6 mmp_? -77.28 -42.23 37.81 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.629 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.11 71.74 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.434 0.561 . . . . 0.0 111.048 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.1 p -86.57 -13.82 44.68 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 59.37 20.75 52.06 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 114.42 0.528 . . . . 0.0 114.42 -164.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -117.44 93.44 4.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.056 0.942 . . . . 0.0 108.929 -177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -59.35 -10.76 3.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -174.428 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -85.15 121.27 27.66 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 55' ' ' ALA . 27.6 mm -52.95 -54.88 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.696 1.198 . . . . 0.0 112.27 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -58.71 -50.96 71.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.73 0.812 . . . . 0.0 110.967 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.525 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 39.9 mm-40 -61.92 -40.0 93.96 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.053 0.846 . . . . 0.0 112.242 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.45 80.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.489 0.715 . . . . 0.0 111.788 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.1 -30.17 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 123.398 0.679 . . . . 0.0 110.808 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 58.5 mtpt -64.77 -49.12 71.98 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 122.108 -0.37 . . . . 0.0 110.781 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.84 -65.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.636 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.617 HG22 HG11 ' A' ' 34' ' ' VAL . 23.0 pt -104.36 11.21 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -169.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.13 155.15 50.33 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 118.921 0.782 . . . . 0.0 112.03 -172.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.09 54.5 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.676 0.791 . . . . 0.0 112.976 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -132.2 158.45 41.72 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -53.32 145.63 13.76 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 119.043 0.838 . . . . 0.0 112.611 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.17 -111.19 4.18 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.23 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -91.17 111.47 22.96 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.26 0.624 . . . . 0.0 109.85 -173.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 16' ' ' ILE . 3.7 m -138.75 -179.84 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.819 1.248 . . . . 0.0 111.426 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.515 ' SG ' HG11 ' A' ' 35' ' ' VAL . 78.0 m -133.89 125.35 28.13 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.495 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.455 HD21 ' HB ' ' A' ' 99' ' ' ILE . 11.7 tp -104.72 126.09 51.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.232 1.013 . . . . 0.0 109.686 -170.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.616 HD11 HD22 ' A' ' 30' ' ' LEU . 7.0 mt -109.45 122.78 64.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 114.302 -1.317 . . . . 0.0 107.45 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 9.4 p -143.43 152.15 41.21 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 122.776 0.43 . . . . 0.0 109.902 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.15 -46.35 84.48 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.283 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.401 ' OD2' ' HG2' ' A' ' 94' ' ' GLU . 1.5 p-10 -148.46 171.15 16.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.411 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -69.0 -22.58 64.07 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -168.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HG2' ' OD2' ' A' ' 92' ' ' ASP . 10.1 pt-20 -74.46 -41.73 60.28 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.098 0.863 . . . . 0.0 109.281 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m -58.49 -39.69 80.74 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.605 0.762 . . . . 0.0 110.819 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.697 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 14.1 t80 -56.55 -51.23 69.34 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 123.364 0.666 . . . . 0.0 110.719 175.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -63.93 -35.21 79.92 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.75 0.656 . . . . 0.0 110.822 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 10.7 mmpt? -64.59 -45.94 84.82 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.586 0.554 . . . . 0.0 111.571 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.487 HD13 HD21 ' A' ' 23' ' ' LEU . 44.4 mm -69.06 -44.57 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.395 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -53.31 -34.37 57.11 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.041 1.336 . . . . 0.0 112.182 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -60.25 -51.35 69.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.588 0.755 . . . . 0.0 111.561 174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.66 -41.43 75.53 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.8 pt -77.89 -50.2 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 118.35 0.523 . . . . 0.0 110.775 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.04 114.33 0.04 OUTLIER Glycine 0 C--N 1.35 1.353 0 N-CA-C 113.883 0.313 . . . . 0.0 113.883 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.46 -159.88 24.81 Favored Glycine 0 C--O 1.241 0.589 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.2 143.18 49.27 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.3 0.55 . . . . 0.0 109.829 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.5 mm -71.22 129.1 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 122.928 0.491 . . . . 0.0 110.18 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -116.5 101.79 8.93 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -68.12 -53.5 24.89 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.1 0.56 . . . . 0.0 111.747 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.1 p -53.06 -30.03 33.5 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.546 HG21 ' HB1' ' A' ' 32' ' ' ALA . 10.3 p -65.3 -27.26 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 118.401 0.546 . . . . 0.0 111.44 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.459 HD11 ' N ' ' A' ' 10' ' ' GLY . 93.4 mt -80.46 -3.2 48.99 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.372 1.069 . . . . 0.0 112.503 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 37' ' ' THR . 12.8 pt-20 -135.95 23.57 3.31 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -169.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 118' ' ' LYS . 0.4 OUTLIER 77.74 138.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 124.242 1.017 . . . . 0.0 112.46 165.386 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 5.2 p-10 -151.16 -179.93 7.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.527 1.131 . . . . 0.0 109.517 170.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.81 -41.61 97.85 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.315 0.646 . . . . 0.0 111.943 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.514 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 0.1 OUTLIER -62.17 -41.72 98.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.592 1.157 . . . . 0.0 109.928 176.235 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -62.62 -40.01 95.62 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.047 0.842 . . . . 0.0 110.691 177.062 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.6 -48.41 48.3 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.345 -166.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -73.55 -39.45 64.69 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.172 0.589 . . . . 0.0 110.697 -174.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.8 tp -53.88 -53.15 56.65 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.278 1.431 . . . . 0.0 111.971 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.443 HG23 ' HD2' ' A' ' 126' ' ' PHE . 43.6 mt -62.44 -29.72 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.753 1.221 . . . . 0.0 111.309 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 5.4 tmm_? -72.41 -35.94 68.51 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.992 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.62 -55.99 12.75 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.63 -35.75 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 118.916 0.78 . . . . 0.0 113.075 -174.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.443 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.7 m-30 -88.39 -32.21 18.47 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 29.1 mmtp 63.84 75.86 0.37 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.176 0.99 . . . . 0.0 112.213 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.2 mt . . . . . 0 CA--C 1.537 0.447 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.524 -179.548 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.2 t30 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.24 -25.87 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 123.474 0.71 . . . . 0.0 111.516 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.436 ' O ' HD13 ' A' ' 139' ' ' LEU . 85.1 t -68.64 -58.35 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.45 0.7 . . . . 0.0 111.667 -174.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -63.05 -29.05 70.51 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 117.742 0.246 . . . . 0.0 111.042 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.46 ' HA ' ' HG2' ' A' ' 140' ' ' GLU . 77.6 mtt-85 -75.97 -32.76 59.63 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 123.736 0.648 . . . . 0.0 112.187 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.0 p -73.82 -41.05 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 CA-C-N 118.218 0.463 . . . . 0.0 110.142 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 135' ' ' VAL . 11.2 mp -57.29 -42.4 81.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.535 0.734 . . . . 0.0 112.565 175.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 137' ' ' ARG . 13.5 pt-20 -80.73 -28.57 36.54 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.054 0.141 . . . . 0.0 110.971 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -59.82 -52.55 64.99 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.694 0.797 . . . . 0.0 110.679 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.6 pt -73.59 -17.12 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.056 -171.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.809 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.327 167.743 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.759 ' SD ' ' HG2' ' A' ' 91' ' ' GLU . 5.1 mmt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.548 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 41.9 mt -96.95 102.98 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.27 122.65 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -124.65 145.87 49.41 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.039 0.935 . . . . 0.0 109.549 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.72 139.19 14.52 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.247 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.0 tt -152.48 144.07 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 122.849 0.46 . . . . 0.0 110.992 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -116.85 142.7 46.59 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.84 0.856 . . . . 0.0 109.308 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.34 11.24 85.7 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.56 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.59 95.21 1.06 Allowed 'General case' 0 C--N 1.351 0.639 0 C-N-CA 123.899 0.879 . . . . 0.0 110.604 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 51.8 mtm-85 -70.79 101.65 2.16 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.805 0.69 . . . . 0.0 109.599 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.585 HD11 HG11 ' A' ' 86' ' ' VAL . 48.2 mm -67.39 121.13 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.419 0.687 . . . . 0.0 110.377 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.43 HD21 HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -112.29 159.34 18.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.794 0.837 . . . . 0.0 109.855 175.174 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -77.28 -16.55 58.93 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.539 0.735 . . . . 0.0 112.213 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.95 -30.18 63.66 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.386 0.674 . . . . 0.0 112.685 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.43 HG23 HD21 ' A' ' 17' ' ' ASN . 8.3 pt -60.48 -12.47 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.15 0.23 56.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.993 0.517 . . . . 0.0 112.19 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -79.4 -25.09 42.16 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.221 0.464 . . . . 0.0 111.551 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pp -85.15 -14.44 47.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.996 0.518 . . . . 0.0 111.682 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.53 16.37 7.03 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 116.616 1.406 . . . . 0.0 116.616 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.7 mt -73.82 175.17 7.51 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 117.501 0.651 . . . . 0.0 111.457 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.93 81.21 2.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.048 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -139.7 145.95 39.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.002 0.921 . . . . 0.0 108.719 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.418 ' NE2' ' HB3' ' A' ' 63' ' ' LEU . 1.6 tm0? -142.15 136.68 30.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 171.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 86' ' ' VAL . 3.9 mt -127.21 129.74 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.404 ' H ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -131.34 171.05 13.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.748 0.819 . . . . 0.0 110.443 176.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -76.38 116.37 17.0 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.805 0.842 . . . . 0.0 109.906 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.27 3.47 51.95 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.08 -35.69 49.1 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 79' ' ' ILE . 26.8 m -97.88 5.86 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 122.902 0.481 . . . . 0.0 111.729 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.48 139.14 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.81 -69.34 0.53 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.4 p -136.63 172.88 12.36 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.719 0.808 . . . . 0.0 110.065 174.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -26.34 12.33 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.506 0.722 . . . . 0.0 112.311 170.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -54.73 -32.93 60.39 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.446 1.098 . . . . 0.0 112.202 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.582 ' HA ' HD11 ' A' ' 139' ' ' LEU . 30.2 t-80 -65.44 -47.48 76.05 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.728 0.811 . . . . 0.0 110.878 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.507 HG21 ' SG ' ' A' ' 87' ' ' CYS . 38.8 t -67.3 -50.92 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.029 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -61.32 -34.6 75.52 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.039 0.535 . . . . 0.0 111.54 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -55.21 -43.95 74.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.043 0.937 . . . . 0.0 110.734 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.8 78.39 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.796 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.512 HG12 HD13 ' A' ' 62' ' ' ILE . 63.5 mt -65.02 -53.38 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.028 0.931 . . . . 0.0 112.192 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -49.28 -44.66 44.14 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.923 0.889 . . . . 0.0 110.628 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -73.44 -31.62 63.92 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.293 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.84 -21.22 60.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.244 0.618 . . . . 0.0 112.323 174.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -78.11 -48.14 16.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.869 0.468 . . . . 0.0 110.332 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.53 HG23 ' HG3' ' A' ' 51' ' ' LYS . 10.9 t -88.98 -29.12 19.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.023 0.529 . . . . 0.0 112.268 -171.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.53 ' HG3' HG23 ' A' ' 50' ' ' THR . 49.1 mtmt -114.45 155.41 26.42 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.571 0.701 . . . . 0.0 112.229 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -140.06 73.13 32.93 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.336 167.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.23 -78.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.206 2.604 . . . . 0.0 114.164 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.69 -26.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.066 0.546 . . . . 0.0 111.645 -166.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.21 174.09 4.21 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -169.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -73.75 -53.62 9.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.447 0.699 . . . . 0.0 112.193 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.614 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 21.4 t -157.03 -171.73 3.76 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.408 0.683 . . . . 0.0 109.453 -174.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -53.95 -60.92 2.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.497 1.119 . . . . 0.0 113.268 -174.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.403 ' CE3' ' HB2' ' A' ' 28' ' ' GLN . 79.8 m95 -64.76 -29.62 70.6 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.014 0.435 . . . . 0.0 111.144 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.614 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.3 mpt? -77.18 -27.51 53.68 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.926 0.891 . . . . 0.0 110.455 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 11.3 tp10 -74.43 -34.08 63.12 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.893 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.512 HD13 HG12 ' A' ' 45' ' ' ILE . 72.9 mt -64.38 -47.07 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.145 0.578 . . . . 0.0 111.061 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.443 ' O ' HD11 ' A' ' 79' ' ' ILE . 3.4 pp -68.34 -33.39 74.22 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.215 0.322 . . . . 0.0 111.607 -175.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.438 HG13 HD12 ' A' ' 63' ' ' LEU . 35.0 m -77.16 -40.5 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 118.094 0.406 . . . . 0.0 110.986 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -70.0 -32.63 70.9 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.035 0.534 . . . . 0.0 111.709 -170.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.64 -30.87 70.55 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.186 0.594 . . . . 0.0 112.109 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.2 p -104.37 9.32 35.82 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.85 0.46 . . . . 0.0 112.225 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.72 23.7 65.55 Favored Glycine 0 C--N 1.358 1.787 0 CA-C-O 121.328 0.404 . . . . 0.0 113.965 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HB3' ' H ' ' A' ' 70' ' ' ARG . 88.2 mm-40 -89.8 -163.23 0.98 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.509 1.124 . . . . 0.0 112.512 -177.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -165.18 -34.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.628 1.571 . . . . 0.0 108.523 -165.189 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -101.98 121.98 43.18 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.928 0.891 . . . . 0.0 108.653 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 76' ' ' ILE . 1.8 mp -51.34 -45.78 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.587 1.179 . . . . 0.0 111.697 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -66.13 -40.58 90.77 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.265 0.626 . . . . 0.0 110.928 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.03 -47.39 81.01 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.311 0.644 . . . . 0.0 111.478 173.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.85 -35.47 74.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.209 0.604 . . . . 0.0 112.619 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 72' ' ' ILE . 71.4 mt -71.49 -29.89 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 122.991 0.516 . . . . 0.0 110.981 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -63.88 -54.88 27.9 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.012 0.434 . . . . 0.0 109.918 173.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.9 mt -73.29 -65.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.262 -173.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.455 HG22 HG21 ' A' ' 34' ' ' VAL . 23.2 pt -111.0 32.64 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.47 159.47 53.09 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 113.504 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.58 98.99 2.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.41 0.684 . . . . 0.0 110.961 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -109.97 153.15 24.96 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.94 0.896 . . . . 0.0 108.835 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.24 150.69 38.34 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.56 0.744 . . . . 0.0 112.492 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.34 -120.02 6.02 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.75 104.69 14.06 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.585 HG11 HD11 ' A' ' 16' ' ' ILE . 1.3 p -134.11 151.42 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.355 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.507 ' SG ' HG21 ' A' ' 41' ' ' VAL . 41.4 t -109.81 118.88 37.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.426 1.091 . . . . 0.0 108.99 -172.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.84 120.95 43.7 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.46 0.704 . . . . 0.0 110.153 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -107.12 137.21 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 21.8 p -152.42 151.78 31.21 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.985 0.514 . . . . 0.0 109.919 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.759 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 51.3 mt-10 -86.45 -32.23 20.95 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.31 128.89 56.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.003 0.921 . . . . 0.0 108.761 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -67.37 -21.38 65.62 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.315 0.646 . . . . 0.0 111.332 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 8.3 pt-20 -69.66 -40.02 76.7 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.667 0.387 . . . . 0.0 110.031 173.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 99' ' ' ILE . 99.0 m -63.55 -38.44 91.15 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.876 0.87 . . . . 0.0 109.878 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.688 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 11.6 t80 -56.96 -47.85 79.74 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.84 0.856 . . . . 0.0 110.973 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -61.54 -42.99 99.65 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.73 0.644 . . . . 0.0 110.34 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 45.6 mmtm -56.13 -45.9 79.4 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.171 0.92 . . . . 0.0 111.04 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 95' ' ' THR . 32.9 mm -69.84 -45.66 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.322 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -52.62 -43.41 65.37 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.88 1.272 . . . . 0.0 113.171 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.15 -48.27 80.78 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.777 0.673 . . . . 0.0 111.511 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.05 -36.18 56.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 pt -74.83 -39.83 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 118.311 0.505 . . . . 0.0 109.897 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.16 96.79 0.04 OUTLIER Glycine 0 C--N 1.351 1.368 0 O-C-N 123.635 0.585 . . . . 0.0 113.14 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.37 -171.36 25.09 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.16 131.03 55.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.6 mm -62.99 112.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -129.69 92.47 3.34 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 4.6 p-10 -60.27 -34.08 73.22 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.531 0.732 . . . . 0.0 111.81 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 23.8 m -52.86 -24.62 9.46 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -176.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.5 m -66.75 -32.19 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-N 118.204 0.457 . . . . 0.0 110.131 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.0 mt -95.72 -1.92 48.95 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.768 1.227 . . . . 0.0 112.253 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 110' ' ' SER . 76.0 mm-40 -103.78 -9.29 19.16 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 118.148 -0.93 . . . . 0.0 112.459 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.257 0.4 OUTLIER 84.82 135.64 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.983 1.313 . . . . 0.0 111.105 177.438 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 4.3 p-10 -159.77 170.77 20.8 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.832 1.253 . . . . 0.0 108.799 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.79 -37.62 85.02 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.59 0.756 . . . . 0.0 112.372 -168.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.507 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 16.1 t70 -54.87 -54.1 46.79 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.444 1.098 . . . . 0.0 112.219 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -63.1 -34.13 76.94 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.716 0.635 . . . . 0.0 110.881 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.85 -49.0 32.83 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.416 0.686 . . . . 0.0 112.159 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 67.6 mtp180 -75.22 -30.8 60.67 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.519 0.676 . . . . 0.0 110.942 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.5 tp -55.7 -48.03 75.81 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.219 165.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.422 HG23 ' HD2' ' A' ' 126' ' ' PHE . 25.2 mt -55.7 -35.11 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.229 1.012 . . . . 0.0 112.556 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -74.56 -26.53 60.01 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.951 -178.507 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -69.45 -58.47 3.95 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 171.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -29.49 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 119.192 0.906 . . . . 0.0 112.968 -174.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.422 ' HD2' HG23 ' A' ' 122' ' ' ILE . 23.2 m-85 -99.51 -26.24 14.17 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 68.3 mmtt 62.03 66.6 0.8 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.138 0.975 . . . . 0.0 112.506 171.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.507 HG21 ' HB3' ' A' ' 137' ' ' ARG . 16.9 mt . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.456 ' O ' ' HD3' ' A' ' 137' ' ' ARG . 1.7 t-20 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.98 -31.41 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 119.124 0.875 . . . . 0.0 112.21 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.16 -53.94 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.798 0.839 . . . . 0.0 110.415 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -59.23 -42.6 91.4 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.333 0.396 . . . . 0.0 111.074 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.507 ' HB3' HG21 ' A' ' 128' ' ' ILE . 8.7 mpt_? -73.0 -31.67 64.65 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.949 0.781 . . . . 0.0 112.074 -167.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 139' ' ' LEU . 11.1 p -70.56 -42.56 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 117.706 0.23 . . . . 0.0 110.501 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 40' ' ' HIS . 10.9 mp -60.75 -39.67 89.61 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.567 0.542 . . . . 0.0 111.625 172.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.73 -44.43 93.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.618 0.767 . . . . 0.0 111.117 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -63.87 -45.99 86.97 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.018 0.527 . . . . 0.0 111.286 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 11.5 pt -75.6 -22.23 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.019 0.2 . . . . 0.0 110.62 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.884 0 C-N-CA 123.569 0.748 . . . . 0.0 111.089 172.467 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.6 mt -101.2 111.03 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.918 1.287 . . . . 0.0 109.271 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -107.08 127.26 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.468 ' HA ' ' NE ' ' A' ' 9' ' ' ARG . 2.9 mmp_? -128.15 149.89 50.23 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.718 0.807 . . . . 0.0 110.553 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.66 129.94 10.0 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.622 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 tt -141.18 147.04 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.148 0.579 . . . . 0.0 110.597 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -122.97 136.9 55.03 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.349 1.059 . . . . 0.0 109.419 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.36 7.91 87.01 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.36 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.508 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -76.03 104.03 6.37 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.547 0.739 . . . . 0.0 110.218 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -70.81 123.86 22.95 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.365 0.415 . . . . 0.0 110.148 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.8 mm -73.53 91.03 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.887 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.401 ' OD1' HG23 ' A' ' 20' ' ' ILE . 23.5 p30 -91.11 151.23 21.07 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.021 -177.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -63.92 -21.64 66.56 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -64.84 -29.85 70.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.405 0.682 . . . . 0.0 112.103 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.401 HG23 ' OD1' ' A' ' 17' ' ' ASN . 19.1 pt -54.37 -23.82 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -90.07 -19.45 24.33 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.284 0.493 . . . . 0.0 111.32 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.19 -22.23 63.91 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.976 0.91 . . . . 0.0 111.609 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.481 HD21 HD13 ' A' ' 99' ' ' ILE . 1.5 pp -81.95 -10.17 59.35 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.282 0.633 . . . . 0.0 111.965 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.16 16.96 9.65 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 23' ' ' LEU . 86.1 mt -82.39 176.57 9.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.283 0.633 . . . . 0.0 112.197 -174.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -87.56 93.44 9.42 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.102 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -145.66 160.32 41.87 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.111 0.964 . . . . 0.0 108.678 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 59' ' ' TRP . 6.6 tp-100 -148.64 153.23 38.01 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 166.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.85 137.98 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.424 HD22 HD11 ' A' ' 89' ' ' ILE . 2.2 pt? -128.16 -175.06 3.38 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.65 0.78 . . . . 0.0 109.389 170.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -89.22 120.1 30.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.784 0.834 . . . . 0.0 109.78 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.72 -5.27 56.84 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.886 0.874 . . . . 0.0 113.168 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -76.19 -33.63 59.31 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.408 HG21 HG22 ' A' ' 79' ' ' ILE . 3.3 m -105.19 9.5 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.321 0.649 . . . . 0.0 112.264 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.4 p -85.13 140.71 15.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.16 -62.16 1.57 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 113' ' ' GLU . 21.5 p -145.59 169.92 17.46 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.931 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HB3' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -53.71 -31.98 50.17 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.131 0.572 . . . . 0.0 110.649 162.364 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.539 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 85.5 tttt -66.99 -30.57 70.73 Favored 'General case' 0 C--N 1.36 1.059 0 C-N-CA 123.909 0.883 . . . . 0.0 111.52 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.554 ' HA ' HD11 ' A' ' 139' ' ' LEU . 16.8 t-80 -60.88 -46.75 89.38 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.091 0.556 . . . . 0.0 110.305 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 45' ' ' ILE . 38.8 t -67.64 -51.2 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 O-C-N 123.77 0.669 . . . . 0.0 111.671 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 3.2 pp -64.83 -30.13 71.12 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.516 ' NE2' ' HB2' ' A' ' 143' ' ' ALA . 35.7 t60 -65.39 -35.38 80.76 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.789 0.836 . . . . 0.0 111.119 172.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 65' ' ' ARG . . . -67.44 -34.79 77.93 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.592 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.424 HG12 HD13 ' A' ' 62' ' ' ILE . 19.8 mt -69.79 -35.94 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.931 0.892 . . . . 0.0 110.967 175.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -57.33 -53.98 51.93 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.246 0.618 . . . . 0.0 109.594 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.445 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 29.1 mm-40 -60.46 -30.47 69.68 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.672 1.189 . . . . 0.0 112.079 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.5 -27.32 66.03 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -89.24 -16.81 30.38 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.443 0.64 . . . . 0.0 109.831 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.0 m -91.49 -43.92 9.41 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.393 1.477 . . . . 0.0 111.041 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 10.3 mmpt? -114.23 141.94 46.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.133 0.973 . . . . 0.0 112.533 -174.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -123.64 88.65 51.81 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 124.834 1.254 . . . . 0.0 107.988 165.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.15 -107.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.643 2.229 . . . . 0.0 111.941 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.1 mt -126.21 13.18 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.33 146.45 53.46 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.595 0.758 . . . . 0.0 111.688 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.67 -47.39 86.49 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.594 0.757 . . . . 0.0 111.291 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.1 m -147.63 172.18 14.45 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.856 0.863 . . . . 0.0 110.201 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.72 -52.73 64.25 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.453 1.101 . . . . 0.0 110.944 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 28' ' ' GLN . 83.8 m95 -67.43 -29.09 68.48 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.118 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.444 ' SD ' HD21 ' A' ' 63' ' ' LEU . 23.3 mmt -71.72 -28.45 63.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.153 0.581 . . . . 0.0 111.665 174.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 64' ' ' VAL . 44.8 tp10 -71.05 -27.93 64.01 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.757 0.423 . . . . 0.0 110.398 174.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 HG12 ' A' ' 45' ' ' ILE . 67.5 mt -66.25 -45.64 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.657 0.383 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.451 HD23 ' NE2' ' A' ' 28' ' ' GLN . 4.4 pp -69.77 -32.76 71.44 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.156 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.675 ' HB ' ' H ' ' A' ' 70' ' ' ARG . 10.0 m -78.33 -40.78 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 122.498 -0.126 . . . . 0.0 111.294 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.471 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 6.6 tpt180 -67.9 -39.99 83.53 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 122.494 0.318 . . . . 0.0 111.025 -169.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.03 -14.28 60.03 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 124.036 0.835 . . . . 0.0 112.308 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 p -108.85 26.78 10.18 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.464 0.706 . . . . 0.0 111.546 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 26.13 53.29 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-O 119.619 -0.545 . . . . 0.0 114.297 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 55.99 113.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.269 1.427 . . . . 0.0 113.104 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.675 ' H ' ' HB ' ' A' ' 64' ' ' VAL . 2.8 mpt_? -140.04 172.54 12.62 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.973 1.709 . . . . 0.0 109.256 -173.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -57.13 135.99 56.38 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.97 159.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.14 -49.94 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.404 1.082 . . . . 0.0 111.957 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.77 -37.36 86.11 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.482 0.489 . . . . 0.0 110.52 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -63.28 -46.91 84.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.771 0.428 . . . . 0.0 112.084 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.53 71.54 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.883 0.473 . . . . 0.0 112.114 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.51 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 84.9 mt -64.51 -32.31 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.464 0.706 . . . . 0.0 110.554 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -72.49 -50.87 22.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.697 0.399 . . . . 0.0 110.066 174.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.576 HG22 HG23 ' A' ' 79' ' ' ILE . 43.9 mt -66.69 -65.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.8 0.84 . . . . 0.0 111.791 -173.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.576 HG23 HG22 ' A' ' 78' ' ' ILE . 38.6 pt -124.0 21.15 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 76' ' ' ILE . . . -76.36 156.78 47.22 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.09 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.26 113.97 1.46 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.82 0.848 . . . . 0.0 112.602 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -135.55 153.16 51.79 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.92 124.59 15.88 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.589 1.156 . . . . 0.0 112.755 -170.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.32 -118.26 1.58 Allowed Glycine 0 C--N 1.352 1.432 0 O-C-N 123.434 0.459 . . . . 0.0 112.379 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -84.25 108.14 16.95 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.26 159.98 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.959 0.885 . . . . 0.0 112.674 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.8 m -112.51 118.44 35.14 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.811 -1.54 . . . . 0.0 108.265 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.541 HD21 ' HB ' ' A' ' 99' ' ' ILE . 10.4 tp -102.63 121.19 41.91 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.32 0.648 . . . . 0.0 109.328 -174.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 28' ' ' GLN . 4.8 mt -111.48 125.6 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.902 1.281 . . . . 0.0 108.242 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 74.3 m -148.79 145.95 27.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.158 0.583 . . . . 0.0 109.746 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 -27.36 59.32 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.43 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 28.7 m-20 -131.27 148.92 52.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.287 0.635 . . . . 0.0 111.683 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.09 -25.17 65.21 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.944 1.298 . . . . 0.0 112.764 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 11.2 pt-20 -69.2 -43.27 74.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.788 0.435 . . . . 0.0 110.089 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 m -70.21 -33.08 71.25 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.708 0.803 . . . . 0.0 110.598 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -60.99 -50.96 71.28 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 45.0 ttp180 -59.86 -45.08 93.58 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.886 0.741 . . . . 0.0 109.862 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -59.44 -42.21 91.4 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.097 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.541 ' HB ' HD21 ' A' ' 88' ' ' LEU . 35.6 mm -71.9 -43.66 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -55.18 -37.83 67.55 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 124.596 1.158 . . . . 0.0 112.509 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 46.5 mt-10 -61.26 -39.25 89.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.684 0.794 . . . . 0.0 111.204 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.13 -47.46 35.96 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.691 0.797 . . . . 0.0 112.272 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.508 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 18.2 pt -79.91 -28.95 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 122.068 0.147 . . . . 0.0 110.992 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.32 25.73 70.08 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.044 1.177 . . . . 0.0 116.044 160.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.32 -170.16 46.3 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 117.047 0.423 . . . . 0.0 112.513 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -104.71 140.45 38.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.604 0.762 . . . . 0.0 108.996 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mm -73.04 119.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.162 0.506 . . . . 0.0 109.79 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 111' ' ' VAL . 14.7 t70 -131.54 91.49 3.01 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.87 -32.61 73.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.958 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.591 ' HA ' ' HG3' ' A' ' 113' ' ' GLU . 12.1 p -58.34 -15.4 10.32 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 108' ' ' ASP . 35.4 m -66.42 -24.69 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 118.709 0.686 . . . . 0.0 110.888 171.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 38' ' ' LYS . 67.1 mt -99.65 18.23 18.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.827 1.251 . . . . 0.0 112.593 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.591 ' HG3' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -138.48 12.67 2.76 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.243 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 76.02 124.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.825 0.85 . . . . 0.0 112.375 168.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 3.3 p-10 -142.87 177.16 8.53 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.197 173.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -61.88 -42.1 98.66 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.071 0.948 . . . . 0.0 111.52 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 24.8 t70 -59.08 -47.37 85.5 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.048 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -67.01 -31.75 72.52 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.33 0.652 . . . . 0.0 111.142 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.76 -51.28 28.15 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.068 0.547 . . . . 0.0 111.364 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.33 -39.08 71.58 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.494 0.664 . . . . 0.0 110.131 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.1 tp -54.22 -52.87 59.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.315 1.446 . . . . 0.0 112.415 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.42 HG23 ' HD2' ' A' ' 126' ' ' PHE . 15.6 mt -57.96 -30.14 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.566 1.146 . . . . 0.0 111.282 177.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.4 ttm180 -72.05 -33.68 68.16 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.39 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 127' ' ' LYS . 12.4 mm-40 -73.67 -56.51 4.92 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 173.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 pp -78.38 -30.52 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.42 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.1 m-30 -95.85 -30.5 13.63 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 119.358 -0.354 . . . . 0.0 111.539 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 26.2 mmmt 61.97 74.66 0.43 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.746 0.818 . . . . 0.0 111.848 176.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.5 mt . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 123.637 0.775 . . . . 0.0 109.463 -175.499 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 137' ' ' ARG . 4.0 t-20 . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.02 -29.14 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.389 1.076 . . . . 0.0 112.476 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.12 -51.51 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.219 0.608 . . . . 0.0 110.592 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -63.55 -30.46 71.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.633 0.373 . . . . 0.0 111.441 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 133' ' ' ASN . 4.2 mmp_? -69.61 -47.7 62.55 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.107 0.563 . . . . 0.0 110.975 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.8 p -72.66 -36.59 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.82 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.554 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.0 mp -58.59 -37.21 75.33 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.149 0.98 . . . . 0.0 111.88 173.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -67.31 -41.59 85.09 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.3 0.375 . . . . 0.0 111.341 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -72.84 -42.52 63.69 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 120.876 0.37 . . . . 0.0 111.834 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 29.9 pt -74.77 -24.04 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.516 ' HB2' ' NE2' ' A' ' 43' ' ' HIS . . . . . . . . 0 C--O 1.212 -0.894 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.168 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.51 ' HG2' HG21 ' A' ' 45' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 74.3 mt -109.1 101.4 12.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.3 mm -110.21 124.11 66.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -121.58 145.12 48.3 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.79 137.62 13.49 Favored Glycine 0 CA--C 1.5 -0.875 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.4 tt -148.85 138.64 16.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.336 0.588 . . . . 0.0 110.357 -173.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -125.34 126.82 45.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.813 1.245 . . . . 0.0 108.714 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.96 -0.11 57.5 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 123.377 0.423 . . . . 0.0 112.565 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.8 94.37 0.45 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.22 1.008 . . . . 0.0 110.823 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -68.89 104.18 2.0 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.577 HD11 HG21 ' A' ' 86' ' ' VAL . 44.6 mm -72.61 120.78 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -176.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.47 ' ND2' HG23 ' A' ' 20' ' ' ILE . 3.4 p-10 -104.08 156.1 18.15 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -81.8 -14.58 56.18 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.099 0.559 . . . . 0.0 111.63 -174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -76.5 -17.21 59.39 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.161 0.984 . . . . 0.0 111.45 -172.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.47 HG23 ' ND2' ' A' ' 17' ' ' ASN . 30.3 pt -53.91 -19.81 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 172.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -83.32 -17.93 40.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.082 0.553 . . . . 0.0 111.94 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -91.35 47.05 1.34 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.074 0.94 . . . . 0.0 109.716 -169.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -139.29 -11.99 1.21 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.311 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.67 33.32 55.0 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 114.513 0.565 . . . . 0.0 114.513 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' HB2' HD13 ' A' ' 23' ' ' LEU . 67.2 mt -102.97 167.38 9.88 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.423 0.689 . . . . 0.0 110.715 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HB3' ' HZ2' ' A' ' 59' ' ' TRP . 60.2 mttp -81.87 91.49 6.55 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.935 0.894 . . . . 0.0 111.31 -176.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.53 158.36 43.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.068 0.547 . . . . 0.0 109.92 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.512 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.6 tm0? -149.26 149.81 31.55 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 165.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 99' ' ' ILE . 16.3 mt -132.18 131.8 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.35 -176.12 3.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.825 0.85 . . . . 0.0 109.447 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -80.68 141.78 34.57 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.844 0.858 . . . . 0.0 109.732 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.23 7.8 45.52 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.3 0.64 . . . . 0.0 112.706 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -88.83 -19.89 25.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.316 0.647 . . . . 0.0 110.855 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 m -111.91 7.31 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.061 0.945 . . . . 0.0 111.641 -176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.2 102.55 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 121.91 0.862 . . . . 0.0 109.971 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.597 ' HB3' HG11 ' A' ' 138' ' ' VAL . . . -79.17 74.83 5.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p 62.69 162.25 0.09 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.63 1.972 . . . . 0.0 111.677 -166.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . 25.3 pttm -53.17 -22.49 6.59 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.506 0.723 . . . . 0.0 111.542 169.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.568 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 56.8 tttp -64.45 -28.42 69.66 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 123.187 0.595 . . . . 0.0 111.541 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.506 ' HA ' HD11 ' A' ' 139' ' ' LEU . 11.7 t-160 -62.73 -45.53 92.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.021 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 45' ' ' ILE . 42.3 t -67.68 -55.17 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 123.735 0.647 . . . . 0.0 111.195 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 4.1 pp -60.02 -32.69 71.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.095 0.558 . . . . 0.0 112.395 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.467 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 33.9 t-80 -65.75 -40.77 92.45 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.372 0.669 . . . . 0.0 110.479 173.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.91 87.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.954 0.502 . . . . 0.0 110.789 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.552 HG12 HD13 ' A' ' 62' ' ' ILE . 33.8 mt -64.9 -46.59 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.232 1.013 . . . . 0.0 110.76 175.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -49.0 -48.39 43.58 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.44 1.496 . . . . 0.0 111.084 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 25.8 mm-40 -63.67 -47.24 82.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.089 176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.79 -28.71 69.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.462 0.705 . . . . 0.0 112.556 -175.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HE2' HG22 ' A' ' 45' ' ' ILE . 68.2 mttm -66.11 -43.69 86.49 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.279 0.632 . . . . 0.0 110.925 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.1 t -80.17 -16.82 54.01 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.799 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 51.3 mtpt -99.28 146.95 25.68 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.999 0.92 . . . . 0.0 112.27 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -142.96 72.86 18.67 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.577 161.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 51' ' ' LYS . 56.2 Cg_endo -84.25 -177.04 2.82 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.657 2.238 . . . . 0.0 111.852 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.5 mt -37.04 -22.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.464 ' HA ' HD11 ' A' ' 72' ' ' ILE . . . -53.21 125.42 17.51 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.446 0.698 . . . . 0.0 110.787 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -57.02 -22.26 37.34 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -167.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.623 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 41.9 t -157.36 167.29 30.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.214 0.606 . . . . 0.0 110.114 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -58.73 -50.16 74.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.589 1.156 . . . . 0.0 110.467 170.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.466 ' HA ' HD12 ' A' ' 62' ' ' ILE . 81.7 m95 -64.54 -30.99 72.02 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.651 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.753 ' HB3' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -78.81 -21.03 48.35 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.907 0.883 . . . . 0.0 111.316 176.232 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -35.52 64.25 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 173.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 HG12 ' A' ' 45' ' ' ILE . 77.5 mt -65.58 -42.36 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.722 0.809 . . . . 0.0 112.344 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.5 ' HB3' ' NE2' ' A' ' 28' ' ' GLN . 3.2 pp -71.53 -34.03 69.69 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 122.998 0.186 . . . . 0.0 110.879 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.97 -38.11 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.414 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.531 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 0.3 OUTLIER -66.48 -50.22 64.02 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 122.816 0.447 . . . . 0.0 110.659 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.29 68.51 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.225 0.61 . . . . 0.0 112.06 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 t -88.68 -0.2 57.05 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.712 0.805 . . . . 0.0 112.506 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.89 17.76 65.65 Favored Glycine 0 C--N 1.354 1.564 0 N-CA-C 114.485 0.554 . . . . 0.0 114.485 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.774 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 46.5 tp60 -107.91 164.96 11.82 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.609 1.164 . . . . 0.0 109.63 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -114.36 -6.2 12.92 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 123.038 0.535 . . . . 0.0 111.508 167.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.774 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 17.0 mm-40 -103.94 119.03 38.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.427 1.091 . . . . 0.0 110.684 -173.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.753 HD12 ' HB3' ' A' ' 60' ' ' MET . 34.7 mm -52.92 -53.02 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 124.736 1.273 . . . . 0.0 112.386 -173.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.4 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 73.7 m80 -61.09 -50.17 74.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.59 -173.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.27 -44.56 84.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.227 0.611 . . . . 0.0 112.091 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.03 94.19 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.68 -31.84 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 122.918 0.487 . . . . 0.0 110.612 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 73' ' ' HIS . 32.3 mmmt -67.13 -50.24 62.07 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.814 0.446 . . . . 0.0 110.46 175.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 56.6 mt -70.66 -67.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.762 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.2 pt -108.83 20.63 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -170.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.25 172.15 45.04 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 119.018 0.826 . . . . 0.0 112.92 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.97 144.18 26.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.18 0.592 . . . . 0.0 111.314 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -154.45 167.56 29.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.748 1.219 . . . . 0.0 108.25 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.02 127.27 23.37 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.074 0.95 . . . . 0.0 111.853 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.4 -116.3 2.5 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.371 0.419 . . . . 0.0 112.533 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -88.93 107.39 18.99 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.661 0.785 . . . . 0.0 109.373 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 16' ' ' ILE . 15.8 m -135.7 167.98 23.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-O 121.912 0.863 . . . . 0.0 111.976 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 69.9 m -119.02 117.58 29.17 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.375 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 tp -100.04 123.48 44.34 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.272 0.629 . . . . 0.0 109.326 -175.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 28' ' ' GLN . 30.3 mt -109.34 137.21 42.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.195 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.741 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 26.5 p -156.84 157.69 35.41 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.578 0.751 . . . . 0.0 109.288 171.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -88.77 -28.2 20.64 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.872 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.498 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 23.8 m-20 -124.83 139.74 53.56 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.218 1.007 . . . . 0.0 110.962 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.14 -24.38 64.66 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.94 0.896 . . . . 0.0 112.435 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.498 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 11.2 pt-20 -68.31 -44.1 76.15 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.3 m -68.01 -35.87 79.02 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.599 0.76 . . . . 0.0 111.345 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.741 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 11.0 t80 -58.25 -48.05 81.66 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 122.889 0.476 . . . . 0.0 109.826 173.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -57.85 -47.58 82.29 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.298 0.999 . . . . 0.0 110.514 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 42.1 mmtm -53.83 -48.36 70.0 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 124.191 0.932 . . . . 0.0 111.469 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' A' ' 20' ' ' ILE . 44.1 mm -71.68 -44.72 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.065 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -55.05 -44.52 74.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.499 1.119 . . . . 0.0 112.851 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -60.07 -42.5 94.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.584 0.754 . . . . 0.0 110.248 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 98' ' ' LYS . 4.5 mm? -65.89 -51.67 56.74 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.0 pt -73.61 -42.56 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 117.915 0.325 . . . . 0.0 111.671 -167.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.13 103.32 0.03 OUTLIER Glycine 0 C--N 1.347 1.162 0 O-C-N 123.262 0.352 . . . . 0.0 113.584 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.31 -174.54 39.11 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.35 126.31 45.2 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.727 0.811 . . . . 0.0 109.334 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.6 mm -68.51 122.48 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.426 ' O ' HG12 ' A' ' 111' ' ' VAL . 12.5 t70 -135.24 98.68 4.04 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.718 1.207 . . . . 0.0 108.216 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -68.24 -31.15 70.43 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.975 0.51 . . . . 0.0 111.887 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.716 ' HA ' ' HG2' ' A' ' 113' ' ' GLU . 46.9 t -52.73 -31.45 37.89 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.673 HG23 ' HE3' ' A' ' 118' ' ' LYS . 2.6 p -69.31 -29.62 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 122.7 0.4 . . . . 0.0 110.28 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 28.5 mt -95.15 9.89 37.96 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.8 0.84 . . . . 0.0 112.153 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.716 ' HG2' ' HA ' ' A' ' 110' ' ' SER . 8.4 pt-20 -120.76 4.11 10.57 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.96 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.267 0.5 OUTLIER 76.15 138.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.092 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 172.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 26.6 p-10 -136.89 171.5 14.4 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 113.154 -1.839 . . . . 0.0 108.036 170.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.97 -31.36 70.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.173 0.589 . . . . 0.0 112.223 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.416 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 19.3 t70 -60.27 -53.14 61.22 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.113 0.965 . . . . 0.0 112.31 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HE3' HG23 ' A' ' 111' ' ' VAL . 63.7 mttm -74.88 -20.69 59.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.324 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.496 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 42.8 tt0 -72.82 -43.73 62.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.332 0.653 . . . . 0.0 111.522 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -72.07 -33.97 68.34 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.095 0.558 . . . . 0.0 110.588 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.1 -49.58 76.44 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.461 1.104 . . . . 0.0 111.143 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 36' ' ' ALA . 24.4 mt -57.35 -40.67 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.353 1.061 . . . . 0.0 112.051 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -74.66 -23.34 58.64 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 119.156 -0.45 . . . . 0.0 111.167 -176.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 127' ' ' LYS . 48.5 mt-10 -73.42 -55.14 6.76 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 169.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.42 -31.76 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 CA-C-N 120.573 1.533 . . . . 0.0 112.777 -176.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -88.72 -30.29 19.21 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 124' ' ' GLU . 38.9 mmtm 63.42 75.51 0.39 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.386 1.075 . . . . 0.0 112.484 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.515 HG21 ' HG3' ' A' ' 137' ' ' ARG . 14.2 mt . . . . . 0 CA--C 1.55 0.951 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.567 HD21 ' HB2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.496 ' HB ' ' HG3' ' A' ' 119' ' ' GLU . 13.6 p -76.4 -33.85 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.425 ' O ' HD13 ' A' ' 139' ' ' LEU . 60.4 t -65.37 -59.8 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.565 0.746 . . . . 0.0 112.153 -164.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.567 ' HB2' HD21 ' A' ' 133' ' ' ASN . 37.7 mt-10 -73.2 -28.73 62.35 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.81 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.515 ' HG3' HG21 ' A' ' 128' ' ' ILE . 20.2 tpt180 -77.35 -32.48 55.11 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.502 -170.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 36' ' ' ALA . 14.2 p -72.24 -33.87 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 40' ' ' HIS . 2.5 mp -54.76 -38.89 67.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.254 1.021 . . . . 0.0 111.044 170.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -67.61 -37.86 83.12 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.643 0.777 . . . . 0.0 111.171 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -68.58 -48.7 63.51 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 111.503 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 26.6 pt -78.53 -10.53 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.816 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.813 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.743 171.019 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.395 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.64 42.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.558 0.743 . . . . 0.0 110.791 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.3 mtt -130.47 30.45 4.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.291 1.037 . . . . 0.0 109.575 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.485 ' HA ' HD22 ' A' ' 42' ' ' LEU . 5.3 m-20 57.24 74.36 0.67 Allowed Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 124.694 1.197 . . . . 0.0 110.555 -171.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.446 ' HD2' HD22 ' A' ' 42' ' ' LEU . 34.2 Cg_endo -61.21 -53.42 2.48 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 122.974 2.449 . . . . 0.0 112.658 -175.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.415 ' SD ' ' HG2' ' A' ' 91' ' ' GLU . 24.3 mmt -95.12 177.48 5.86 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.595 0.758 . . . . 0.0 109.553 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.9 mt -101.39 103.56 15.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.1 mp -109.72 121.39 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -131.81 145.46 51.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.78 0.832 . . . . 0.0 109.084 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.38 124.63 8.18 Favored Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.2 tt -130.68 138.89 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 122.801 0.44 . . . . 0.0 109.869 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -129.3 124.14 33.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.839 0.855 . . . . 0.0 108.798 -172.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.41 2.36 56.64 Favored Glycine 0 N--CA 1.467 0.762 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.997 -170.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -74.44 98.17 3.25 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 123.792 0.837 . . . . 0.0 111.188 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.542 ' HA ' ' HB2' ' A' ' 83' ' ' ASP . 70.7 mtp180 -73.81 107.36 6.0 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.956 0.502 . . . . 0.0 110.616 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.548 HD11 HG11 ' A' ' 86' ' ' VAL . 49.6 mm -69.49 122.96 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.891 0.877 . . . . 0.0 110.79 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -126.27 165.64 18.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.519 0.728 . . . . 0.0 109.352 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -73.2 -17.0 61.41 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.39 -31.62 68.93 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.503 0.721 . . . . 0.0 111.795 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.567 HD12 HD12 ' A' ' 29' ' ' ILE . 16.0 pt -52.13 -28.35 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -90.11 -20.07 23.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.55 0.34 . . . . 0.0 111.303 -176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -76.81 -12.46 59.98 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.503 0.721 . . . . 0.0 111.83 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -81.0 -8.59 59.81 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.679 0.391 . . . . 0.0 111.776 176.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.48 19.08 17.16 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 23' ' ' LEU . 98.5 mt -81.66 174.74 11.09 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.493 0.646 . . . . 0.0 110.394 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -90.18 96.49 10.69 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.228 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -147.68 157.59 43.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.702 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.576 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -138.26 147.1 43.3 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 167.134 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.567 HD12 HD12 ' A' ' 20' ' ' ILE . 35.6 mt -132.29 121.6 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -121.57 177.8 5.08 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' HB3' HG22 ' A' ' 34' ' ' VAL . 38.6 t-20 -75.71 119.46 19.76 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.654 0.782 . . . . 0.0 110.038 -173.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.42 -1.52 41.81 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.571 ' HA ' ' NZ ' ' A' ' 118' ' ' LYS . 37.8 t70 -79.67 -32.41 41.52 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.495 0.188 . . . . 0.0 110.522 176.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.522 HG21 HG22 ' A' ' 79' ' ' ILE . 27.7 m -98.75 -2.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.873 0.869 . . . . 0.0 112.538 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG11 HD23 ' A' ' 112' ' ' LEU . 10.5 p -78.69 139.96 17.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.401 ' HA ' HG12 ' A' ' 114' ' ' ILE . . . -76.1 -72.25 0.33 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 40.3 p -147.15 -177.35 5.63 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.823 0.849 . . . . 0.0 110.401 176.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.528 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -52.03 -39.77 60.06 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.168 167.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HD2' HD11 ' A' ' 42' ' ' LEU . 22.9 tptm -56.07 -29.94 61.25 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.676 0.79 . . . . 0.0 111.504 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.527 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.6 t-80 -68.44 -50.85 49.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.425 0.69 . . . . 0.0 111.015 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.408 HG11 HG12 ' A' ' 89' ' ' ILE . 93.0 t -68.37 -54.75 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HA ' HD12 ' A' ' 45' ' ' ILE . 4.2 pp -56.16 -33.16 64.96 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.664 0.786 . . . . 0.0 111.835 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.559 ' NE2' ' HB2' ' A' ' 143' ' ' ALA . 79.5 t60 -62.45 -45.28 93.78 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.061 173.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.17 87.51 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.383 0.673 . . . . 0.0 111.367 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.6 HG12 HD13 ' A' ' 62' ' ' ILE . 48.2 mt -56.96 -48.53 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.965 0.906 . . . . 0.0 109.815 170.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.523 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 62.1 t30 -64.95 -30.36 71.34 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.388 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 10.2 mm-40 -68.66 -39.96 80.39 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.952 0.501 . . . . 0.0 109.824 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -66.99 -26.33 66.75 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.464 0.706 . . . . 0.0 112.352 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' HE3' ' HA ' ' A' ' 46' ' ' ASN . 10.1 mtmp? -78.92 -31.94 45.44 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.631 0.372 . . . . 0.0 111.847 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.501 HG23 ' HG2' ' A' ' 51' ' ' LYS . 8.6 t -95.26 -45.17 7.28 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.68 0.392 . . . . 0.0 111.954 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.662 ' HB2' HH22 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -121.13 120.04 34.12 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.002 0.921 . . . . 0.0 109.183 -175.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -103.84 99.66 17.08 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 123.016 0.526 . . . . 0.0 110.229 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.61 -81.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.858 2.372 . . . . 0.0 113.935 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.4 pt -150.67 11.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.813 0.845 . . . . 0.0 111.83 -168.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.58 160.54 27.54 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -169.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -68.59 -50.14 53.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.783 0.833 . . . . 0.0 111.125 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -146.08 171.44 14.89 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.56 0.744 . . . . 0.0 110.197 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.93 -58.7 6.92 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.855 0.862 . . . . 0.0 111.897 -174.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.576 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 91.4 m95 -63.85 -33.81 76.53 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.756 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.8 mmm -73.53 -18.98 61.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.827 0.451 . . . . 0.0 110.674 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.612 ' HG2' HH11 ' A' ' 65' ' ' ARG . 22.3 tt0 -77.68 -38.84 46.65 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.072 0.949 . . . . 0.0 110.984 173.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.6 HD13 HG12 ' A' ' 45' ' ' ILE . 82.8 mt -55.0 -53.51 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.673 0.789 . . . . 0.0 111.27 -177.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.46 ' O ' HD11 ' A' ' 79' ' ' ILE . 4.3 pp -52.74 -31.29 37.23 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.189 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 61' ' ' GLU . 1.9 m -78.78 -32.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 112.005 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.662 HH22 ' HB2' ' A' ' 51' ' ' LYS . 11.8 mmm-85 -68.12 -45.14 74.5 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 122.954 0.502 . . . . 0.0 110.866 -175.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.41 -20.15 64.19 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.892 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -97.14 12.65 32.0 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.28 41.9 7.24 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 118.349 0.522 . . . . 0.0 113.481 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 57.37 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.193 1.797 . . . . 0.0 111.152 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -121.18 -160.97 0.88 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.328 1.051 . . . . 0.0 109.354 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -120.7 162.01 20.44 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.64 -49.97 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.264 1.026 . . . . 0.0 112.137 -170.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.443 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 33.6 m170 -61.45 -55.21 33.81 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.751 0.657 . . . . 0.0 110.623 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.41 -56.61 16.92 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.055 0.847 . . . . 0.0 111.789 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 -30.4 69.35 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.5 mt -68.22 -38.38 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.49 0.316 . . . . 0.0 111.012 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 73' ' ' HIS . 60.4 mttm -68.9 -45.66 70.35 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.685 HG22 HG23 ' A' ' 79' ' ' ILE . 59.4 mt -71.22 -66.11 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.206 1.003 . . . . 0.0 111.373 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.685 HG23 HG22 ' A' ' 78' ' ' ILE . 29.8 pt -122.7 26.83 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.64 179.75 48.69 Favored Glycine 0 N--CA 1.48 1.596 0 CA-C-N 118.821 0.737 . . . . 0.0 113.402 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.1 144.37 47.03 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.779 0.432 . . . . 0.0 111.323 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -151.28 149.24 29.15 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 15' ' ' ARG . 6.2 p-10 -65.79 151.33 46.87 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.459 0.572 . . . . 0.0 111.559 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.61 -118.36 6.08 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.481 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -85.27 103.78 14.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.222 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.548 HG11 HD11 ' A' ' 16' ' ' ILE . 1.1 p -137.72 156.07 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.116 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.2 t -106.85 122.87 47.27 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.504 1.122 . . . . 0.0 109.388 -170.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -95.68 128.6 42.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 28' ' ' GLN . 7.7 mt -120.27 117.92 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.701 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 42.3 t -145.91 161.94 38.89 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.874 0.369 . . . . 0.0 111.712 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.415 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 43.6 mt-10 -91.89 -47.91 7.06 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.591 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -111.7 136.3 51.12 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.171 0.588 . . . . 0.0 110.362 -171.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -57.63 -27.39 62.75 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.517 0.727 . . . . 0.0 112.403 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.79 -42.71 69.99 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.701 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 60.5 m -65.75 -37.58 86.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.749 0.82 . . . . 0.0 111.466 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -61.85 -43.1 99.53 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.538 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -62.37 -40.96 98.16 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 123.893 0.745 . . . . 0.0 110.055 177.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 34.5 mmtp -57.35 -51.82 67.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.454 0.702 . . . . 0.0 110.58 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.48 HD13 HD21 ' A' ' 23' ' ' LEU . 43.8 mm -66.15 -44.31 91.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.372 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.97 -40.31 29.93 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.499 1.119 . . . . 0.0 112.955 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 22.6 mm-40 -59.58 -46.86 87.68 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.509 0.506 . . . . 0.0 111.66 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.82 -36.43 64.95 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.469 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 20.3 pt -80.35 -47.71 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 118.639 0.654 . . . . 0.0 110.995 -173.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.07 95.17 0.02 OUTLIER Glycine 0 C--N 1.349 1.276 0 O-C-N 123.602 0.564 . . . . 0.0 113.517 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -158.11 -169.4 21.65 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -109.66 135.14 51.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.434 0.617 . . . . 0.0 109.728 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.7 mm -78.43 122.39 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -144.14 96.5 2.89 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -67.42 -17.12 64.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.578 0.751 . . . . 0.0 111.758 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.0 t -60.04 -26.66 66.31 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.12 -22.12 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.21 0.529 . . . . 0.0 110.252 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.486 HD23 HG11 ' A' ' 35' ' ' VAL . 56.2 mt -103.02 17.43 24.09 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.455 1.102 . . . . 0.0 111.953 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -113.44 -1.97 14.04 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 120.176 1.353 . . . . 0.0 112.942 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.401 HG12 ' HA ' ' A' ' 36' ' ' ALA 0.25 0.3 OUTLIER 76.97 139.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 124.812 1.245 . . . . 0.0 113.313 177.903 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.4 HD21 ' HB2' ' A' ' 117' ' ' ASP . 26.7 p-10 -154.24 -173.38 4.55 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.851 172.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.12 -34.12 70.75 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.4 ' HB2' HD21 ' A' ' 115' ' ' ASN . 44.6 m-20 -64.05 -47.09 81.52 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.624 0.37 . . . . 0.0 111.733 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.571 ' NZ ' ' HA ' ' A' ' 33' ' ' ASP . 4.8 mptp? -62.16 -34.18 75.91 Favored 'General case' 0 C--O 1.209 -1.049 0 O-C-N 123.46 0.475 . . . . 0.0 109.826 173.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.24 -51.9 65.89 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.66 0.6 . . . . 0.0 111.148 -172.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -70.45 -39.12 74.52 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.78 -33.06 66.05 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 122.108 -0.37 . . . . 0.0 110.833 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' A' ' 126' ' ' PHE . 6.3 mt -61.09 -38.65 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.656 0.782 . . . . 0.0 110.805 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 7.8 ptp180 -73.9 -23.86 59.62 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.025 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.604 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 13.0 tp10 -64.11 -58.53 6.37 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 170.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -35.9 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 118.68 0.673 . . . . 0.0 112.777 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.472 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.9 m-85 -87.99 -30.89 19.67 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 119.126 -0.464 . . . . 0.0 111.77 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 124' ' ' GLU . 21.4 mmtp 59.05 76.09 0.37 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.046 0.938 . . . . 0.0 111.744 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.526 HG12 ' HD3' ' A' ' 141' ' ' LYS . 25.6 mt -120.99 127.69 75.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.77 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -86.43 105.82 17.02 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 167.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 179.57 138.69 3.4 Favored Glycine 0 C--N 1.343 0.931 0 O-C-N 123.239 0.337 . . . . 0.0 112.29 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -107.62 -169.72 1.58 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.765 1.226 . . . . 0.0 109.561 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.49 -123.74 6.25 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.79 -0.45 . . . . 0.0 111.993 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -96.8 119.49 35.38 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.403 0.681 . . . . 0.0 110.468 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.07 -26.25 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.527 1.131 . . . . 0.0 112.288 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.04 -46.67 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.484 0.659 . . . . 0.0 109.745 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.72 -40.61 88.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.855 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -67.95 -38.27 82.62 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.595 0.559 . . . . 0.0 112.344 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.42 ' HA ' HD13 ' A' ' 128' ' ' ILE . 14.4 p -70.15 -42.79 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 40' ' ' HIS . 9.6 mp -62.09 -42.99 99.78 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 122.77 0.428 . . . . 0.0 111.692 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 144' ' ' LEU . 46.4 mt-10 -57.1 -44.5 83.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.528 0.331 . . . . 0.0 111.626 177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.526 ' HD3' HG12 ' A' ' 128' ' ' ILE . 8.4 ttpt -71.97 -46.87 55.8 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.185 0.303 . . . . 0.0 111.202 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.0 pt -75.84 -33.72 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.401 -171.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.559 ' HB2' ' NE2' ' A' ' 43' ' ' HIS . . . -95.58 -4.52 44.47 Favored 'General case' 0 C--O 1.246 0.876 0 C-N-CA 123.585 0.754 . . . . 0.0 112.823 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 18.7 tp -60.97 -48.94 79.52 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.9 mt -70.07 -35.73 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.495 0.718 . . . . 0.0 111.61 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.15 -7.49 12.75 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.786 0.834 . . . . 0.0 112.718 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.6 mt 81.59 18.79 0.41 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.094 1.357 . . . . 0.0 111.774 167.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.408 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 21.0 pttp 171.91 128.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.801 0.84 . . . . 0.0 110.482 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -77.46 35.83 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.099 0.959 . . . . 0.0 112.254 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 C--O 1.253 1.279 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -168.097 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.16 167.53 21.74 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.794 0.837 . . . . 0.0 111.291 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.66 -46.12 77.57 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.08 0.952 . . . . 0.0 109.661 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -109.13 96.69 22.03 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 165.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.673 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 56.5 Cg_endo -68.86 -36.85 12.58 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.562 2.175 . . . . 0.0 111.988 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.673 ' SD ' ' HG2' ' A' ' 5' ' ' PRO . 1.5 mpt? -105.58 174.2 5.98 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.3 mt -106.08 103.43 15.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.4 mm -107.71 122.99 62.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.69 144.86 51.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.751 0.705 . . . . 0.0 110.627 -173.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.452 ' N ' HD11 ' A' ' 112' ' ' LEU . . . -104.85 127.47 9.07 Favored Glycine 0 CA--C 1.502 -0.78 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 tt -141.64 145.71 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.072 0.549 . . . . 0.0 110.679 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -123.22 130.78 53.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.581 1.152 . . . . 0.0 109.616 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.15 7.73 69.7 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.839 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.12 94.76 1.16 Allowed 'General case' 0 C--N 1.349 0.547 0 C-N-CA 123.938 0.895 . . . . 0.0 111.131 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.478 ' HA ' ' HB2' ' A' ' 83' ' ' ASP . 51.0 mtt180 -73.07 103.44 3.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.123 0.569 . . . . 0.0 109.803 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.99 108.93 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.701 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.407 ' O ' HG12 ' A' ' 20' ' ' ILE . 26.4 p30 -114.08 165.56 12.51 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.597 0.759 . . . . 0.0 110.604 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -71.49 -16.4 62.35 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.89 -36.74 84.24 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 118.251 0.478 . . . . 0.0 111.671 -173.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.459 ' HA ' HD12 ' A' ' 102' ' ' LEU . 18.1 pt -50.47 -20.83 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -93.14 -26.55 17.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.422 0.689 . . . . 0.0 111.233 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -72.72 -16.92 61.66 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.641 0.776 . . . . 0.0 112.149 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.498 HD21 HD13 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -80.89 -10.21 59.74 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.883 0.473 . . . . 0.0 111.817 179.18 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.46 21.31 26.91 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 116.37 1.308 . . . . 0.0 116.37 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB2' HD13 ' A' ' 23' ' ' LEU . 92.4 mt -87.34 176.52 7.49 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.244 0.618 . . . . 0.0 111.468 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.468 ' HB3' ' HZ2' ' A' ' 59' ' ' TRP . 2.9 mptp? -85.69 98.33 10.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.859 0.864 . . . . 0.0 109.758 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -146.97 160.58 42.18 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.114 0.566 . . . . 0.0 110.331 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.415 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 19.1 tm0? -144.39 149.71 36.55 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 161.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.1 mt -131.29 127.22 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 pp -125.64 173.22 9.14 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.197 0.599 . . . . 0.0 109.979 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 33' ' ' ASP . 61.3 t30 -77.03 138.8 39.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.353 0.661 . . . . 0.0 110.738 -171.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.549 ' HA ' ' SG ' ' A' ' 87' ' ' CYS . . . -80.37 0.1 34.57 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.528 ' HB3' HD21 ' A' ' 121' ' ' LEU . 21.4 m-20 -82.75 -23.1 34.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.257 0.623 . . . . 0.0 111.128 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 79' ' ' ILE . 32.5 m -113.97 -3.73 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.692 0.797 . . . . 0.0 111.718 -171.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -59.41 -32.71 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.734 0.814 . . . . 0.0 112.38 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 59.79 -84.61 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.447 1.099 . . . . 0.0 109.372 -170.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 40.9 p -139.14 174.41 10.54 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.92 0.888 . . . . 0.0 109.353 171.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.91 -45.23 50.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.05 165.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -51.5 -34.41 35.84 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.335 1.054 . . . . 0.0 112.592 -178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.558 ' HA ' HD11 ' A' ' 139' ' ' LEU . 11.2 t-80 -66.55 -54.53 22.73 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.696 0.623 . . . . 0.0 111.028 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -70.69 -47.78 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 122.696 0.399 . . . . 0.0 112.074 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.567 HD22 ' HD2' ' A' ' 5' ' ' PRO . 3.9 pp -60.45 -30.39 69.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.191 0.596 . . . . 0.0 111.556 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.46 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 71.2 t60 -61.6 -46.74 88.57 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 169.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . . . -61.86 -44.99 95.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.959 0.504 . . . . 0.0 111.407 -176.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.514 HG22 ' HE3' ' A' ' 49' ' ' LYS . 36.0 mt -65.98 -49.77 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.322 1.049 . . . . 0.0 111.081 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -51.6 -47.42 63.61 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.291 1.036 . . . . 0.0 110.991 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 17.9 mm100 -66.77 -35.48 80.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.327 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.09 63.25 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 122.672 0.389 . . . . 0.0 111.545 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HE3' HG22 ' A' ' 45' ' ' ILE . 98.4 mttt -86.31 -36.92 19.01 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.439 0.696 . . . . 0.0 112.06 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 47' ' ' GLN . 10.3 t -88.14 -37.28 16.31 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.909 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 47' ' ' GLN . 39.6 mtmt -85.53 157.54 20.39 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.683 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -102.64 103.31 31.57 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.18 177.43 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 124.154 3.236 . . . . 0.0 115.466 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.31 5.02 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.266 165.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.59 179.29 2.17 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.524 1.13 . . . . 0.0 111.749 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -62.33 -47.66 83.27 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.029 0.532 . . . . 0.0 110.326 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.4 m -157.85 -172.81 4.08 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.239 1.015 . . . . 0.0 110.185 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -62.01 -59.3 5.29 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.635 1.174 . . . . 0.0 112.919 -176.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.468 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 87.8 m95 -63.42 -28.71 70.16 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 120.753 0.311 . . . . 0.0 110.848 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.6 mmt -74.81 -21.22 59.42 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.687 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -75.84 -43.05 47.76 Favored 'General case' 0 C--O 1.209 -1.039 0 C-N-CA 122.398 0.279 . . . . 0.0 110.373 170.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.469 HD13 HG12 ' A' ' 45' ' ' ILE . 86.8 mt -56.47 -39.28 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.676 0.79 . . . . 0.0 112.173 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.407 ' O ' HD11 ' A' ' 79' ' ' ILE . 3.6 pp -71.06 -30.91 67.19 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.333 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -83.17 -29.05 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.337 -0.852 . . . . 0.0 110.922 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.5 ' HD2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.2 -45.75 62.71 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.548 1.139 . . . . 0.0 109.937 -172.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.22 -24.65 67.4 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.488 0.715 . . . . 0.0 112.031 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.2 p -100.18 23.67 9.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.241 0.616 . . . . 0.0 110.568 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.07 -88.54 1.54 Allowed Glycine 0 C--N 1.36 1.913 0 O-C-N 122.182 -0.324 . . . . 0.0 113.442 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.706 ' HB2' HG12 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -167.15 121.35 1.02 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -173.25 163.59 4.62 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 124.691 1.244 . . . . 0.0 109.053 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -57.39 149.69 20.06 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.136 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.32 -41.04 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.708 1.203 . . . . 0.0 111.845 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -57.21 -49.77 74.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.395 0.678 . . . . 0.0 111.096 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.524 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 49.9 mm-40 -57.0 -48.73 77.75 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.621 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.42 -36.81 83.53 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.666 0.786 . . . . 0.0 112.824 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.51 -37.55 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.041 0.536 . . . . 0.0 110.891 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 74' ' ' GLU . 53.2 mtmt -67.72 -48.65 65.91 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.798 0.333 . . . . 0.0 110.205 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.453 HG23 ' HB ' ' A' ' 125' ' ' ILE . 78.0 mt -74.21 -65.18 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.649 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.608 ' HB ' HG21 ' A' ' 34' ' ' VAL . 7.7 pt -109.41 14.3 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.61 168.55 46.07 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 119.433 1.015 . . . . 0.0 112.423 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.98 121.74 26.41 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.832 0.453 . . . . 0.0 111.323 -175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -116.95 162.36 17.89 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 165.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 15' ' ' ARG . 7.5 p-10 -65.35 153.91 39.83 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.293 0.637 . . . . 0.0 112.158 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.57 -119.46 5.81 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.358 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -87.45 104.6 16.61 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.8 p -136.92 168.74 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.562 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 32' ' ' ALA . 88.3 m -122.45 123.64 41.77 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.389 1.075 . . . . 0.0 110.238 -175.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.477 HD21 ' HB ' ' A' ' 99' ' ' ILE . 11.4 tp -102.91 125.5 49.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.281 0.632 . . . . 0.0 109.625 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mt -108.3 132.74 55.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.632 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.7 t -155.37 154.72 32.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.157 0.503 . . . . 0.0 111.225 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -87.17 -40.44 14.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.923 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.55 137.94 51.99 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.11 0.964 . . . . 0.0 110.482 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 39.6 tt0 -66.64 -35.93 81.34 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -170.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.74 -26.64 57.64 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.779 0.718 . . . . 0.0 110.348 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 96.9 m -67.88 -42.58 81.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.228 0.611 . . . . 0.0 111.167 165.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.418 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 2.3 t80 -56.97 -49.65 75.08 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.998 0.919 . . . . 0.0 110.817 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 76.7 ttt180 -65.27 -36.95 85.69 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 123.569 0.543 . . . . 0.0 110.441 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -56.2 -40.32 73.83 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.771 0.428 . . . . 0.0 111.674 176.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.498 HD13 HD21 ' A' ' 23' ' ' LEU . 29.1 mm -69.47 -45.83 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -53.69 -40.3 65.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.561 1.145 . . . . 0.0 112.564 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 70.7 mm-40 -59.47 -47.23 86.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.27 0.628 . . . . 0.0 110.847 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 20' ' ' ILE . 57.5 mt -72.75 -38.39 67.38 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.3 pt -74.63 -37.74 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 118.366 0.53 . . . . 0.0 110.768 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.98 93.41 0.03 OUTLIER Glycine 0 C--N 1.351 1.402 0 O-C-N 123.623 0.577 . . . . 0.0 114.312 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.27 -167.65 22.02 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -113.33 140.65 47.85 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.79 123.24 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.18 95.35 4.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.15 -42.03 85.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.898 0.479 . . . . 0.0 111.463 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.0 p -54.21 -29.91 48.01 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.6 p -67.32 -24.03 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 CA-C-N 118.565 0.621 . . . . 0.0 110.941 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 37' ' ' THR . 81.2 mt -86.28 -19.41 29.93 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.748 0.819 . . . . 0.0 112.009 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -93.37 -1.83 55.42 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 118.462 -0.78 . . . . 0.0 113.038 -165.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 114' ' ' ILE 0.26 0.5 OUTLIER 78.83 133.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 124.557 1.143 . . . . 0.0 112.89 -178.446 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 117' ' ' ASP . 4.4 p-10 -146.79 168.33 21.66 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.506 167.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.5 -34.13 76.26 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.906 0.482 . . . . 0.0 111.829 -169.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.422 ' HB2' ' ND2' ' A' ' 115' ' ' ASN . 14.2 m-20 -59.7 -48.95 79.65 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.928 0.491 . . . . 0.0 111.469 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -67.29 -27.25 67.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.448 0.468 . . . . 0.0 110.741 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.466 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 30.3 tt0 -72.62 -44.98 61.24 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.017 0.527 . . . . 0.0 110.998 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -73.69 -40.53 63.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.655 0.782 . . . . 0.0 109.993 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 33' ' ' ASP . 62.5 tp -53.78 -53.77 47.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.262 1.425 . . . . 0.0 112.317 170.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.1 mt -53.25 -30.64 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.621 1.169 . . . . 0.0 111.755 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.0 ttp85 -72.24 -33.62 67.67 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.045 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.72 -56.09 13.89 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 173.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.453 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -74.24 -36.24 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -90.38 -33.39 16.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 119.447 -0.311 . . . . 0.0 111.706 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 3.0 mmmp? 63.78 72.38 0.47 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.043 0.937 . . . . 0.0 111.765 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.566 HG21 ' HB3' ' A' ' 137' ' ' ARG . 9.2 mt -100.49 130.61 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -174.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.95 156.16 20.81 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.203 0.601 . . . . 0.0 110.349 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 125.06 -147.91 16.62 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.872 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -136.29 163.69 29.83 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.391 1.076 . . . . 0.0 109.264 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.0 -152.11 17.08 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 171.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -94.22 137.86 32.91 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.339 1.056 . . . . 0.0 109.851 -173.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HB ' ' HG3' ' A' ' 119' ' ' GLU . 7.2 p -54.59 -34.19 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.369 1.068 . . . . 0.0 113.652 -176.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.4 t -71.41 -45.74 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.349 0.595 . . . . 0.0 109.759 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 40.3 mt-10 -68.52 -34.33 75.68 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.182 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.566 ' HB3' HG21 ' A' ' 128' ' ' ILE . 52.7 mtm180 -72.22 -39.05 68.8 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.863 0.865 . . . . 0.0 112.073 -176.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.04 -33.94 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.558 HD11 ' HA ' ' A' ' 40' ' ' HIS . 4.6 mp -62.98 -39.57 95.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.218 0.607 . . . . 0.0 111.148 173.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 35.0 mm-40 -59.66 -47.29 86.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 117.775 0.261 . . . . 0.0 111.009 173.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -63.87 -48.4 76.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.112 0.565 . . . . 0.0 111.973 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.6 pt -76.68 -25.33 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.95 -16.12 55.9 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 122.235 0.214 . . . . 0.0 110.54 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.95 10.26 0.75 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.681 0.793 . . . . 0.0 111.971 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.706 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.9 mp -107.22 -44.17 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.349 1.06 . . . . 0.0 108.437 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -94.8 -21.71 18.53 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.061 -170.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tt -90.74 -33.11 15.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.079 0.951 . . . . 0.0 108.753 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -76.58 134.12 39.48 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.873 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -79.71 -23.44 42.36 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.757 0.823 . . . . 0.0 110.644 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 . . . . . 0 N--CA 1.487 1.393 0 C-N-CA 126.197 1.799 . . . . 0.0 108.624 174.157 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.74 142.82 19.14 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.915 0.886 . . . . 0.0 109.865 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.8 ttt -113.66 -56.51 2.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.858 0.863 . . . . 0.0 110.57 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.28 94.52 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.464 0 C-N-CA 124.656 1.183 . . . . 0.0 109.979 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 42' ' ' LEU . 19.2 Cg_endo -56.09 -45.06 41.08 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.892 3.061 . . . . 0.0 113.031 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.0 mmt -109.69 163.66 13.28 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.302 0.641 . . . . 0.0 109.405 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.544 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 76.2 mt -85.96 104.78 13.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.5 mm -101.19 120.82 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -127.27 146.92 50.26 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.19 140.42 14.86 Favored Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.473 HG23 HG12 ' A' ' 86' ' ' VAL . 10.1 tt -143.01 124.9 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.777 0.799 . . . . 0.0 111.081 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -90.11 133.2 35.01 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.196 175.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.45 8.76 80.32 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.832 174.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.04 100.76 0.23 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.033 0.933 . . . . 0.0 111.085 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -74.0 103.23 4.41 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.524 HD11 HG11 ' A' ' 86' ' ' VAL . 50.3 mm -74.05 114.91 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.354 0.597 . . . . 0.0 110.207 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' A' ' 20' ' ' ILE . 2.5 p-10 -103.92 134.63 46.89 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -74.08 -1.7 21.28 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.793 0.437 . . . . 0.0 111.779 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -75.68 -20.32 58.51 Favored 'General case' 0 C--O 1.217 -0.606 0 C-N-CA 124.414 1.086 . . . . 0.0 111.027 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.479 HG23 ' ND2' ' A' ' 17' ' ' ASN . 9.4 pt -49.77 -22.36 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -83.52 -0.1 48.81 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -71.4 -28.04 63.74 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.123 0.569 . . . . 0.0 112.005 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.65 -6.69 57.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.679 0.791 . . . . 0.0 111.512 -176.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.46 14.89 9.86 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB2' HD13 ' A' ' 23' ' ' LEU . 95.8 mt -74.73 157.77 34.69 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.159 0.584 . . . . 0.0 110.461 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -82.67 102.51 11.54 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.273 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -149.49 160.31 43.57 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.77 1.228 . . . . 0.0 108.823 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.511 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -142.22 150.43 40.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 173.677 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.7 mt -134.4 125.1 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.497 HD21 HG22 ' A' ' 41' ' ' VAL . 4.2 pp -118.97 172.47 7.53 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 47.6 t30 -87.93 131.34 34.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.52 1.128 . . . . 0.0 111.133 -167.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 111' ' ' VAL . . . -83.6 -3.84 58.04 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.682 ' HB3' HD21 ' A' ' 121' ' ' LEU . 76.9 m-20 -63.74 -44.82 92.38 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.358 0.599 . . . . 0.0 109.817 171.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.06 -1.95 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.871 -166.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 32' ' ' ALA . 9.9 p -85.71 129.87 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.78 -68.13 0.57 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 113' ' ' GLU . 30.8 p -128.85 166.59 18.77 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.465 1.106 . . . . 0.0 108.431 169.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -22.26 34.17 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.59 0.356 . . . . 0.0 111.493 169.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.13 -30.31 66.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.266 1.026 . . . . 0.0 112.081 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.571 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.2 t-80 -61.23 -44.82 96.65 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.806 0.842 . . . . 0.0 110.377 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 30' ' ' LEU . 40.4 t -65.76 -54.13 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.708 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.684 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 3.2 pp -63.55 -32.12 73.49 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -61.03 -37.48 82.73 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.196 0.999 . . . . 0.0 110.886 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.79 -35.36 67.38 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.079 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.498 HG12 HD13 ' A' ' 62' ' ' ILE . 53.4 mt -63.56 -47.07 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.461 0.704 . . . . 0.0 110.914 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -57.83 -37.26 73.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.776 0.831 . . . . 0.0 111.01 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.461 ' HA ' HG22 ' A' ' 50' ' ' THR . 79.7 mm-40 -67.56 -40.12 84.92 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.499 174.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.31 -27.6 68.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.979 0.512 . . . . 0.0 111.629 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -79.13 -34.3 43.48 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.978 0.511 . . . . 0.0 111.591 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.461 HG22 ' HA ' ' A' ' 47' ' ' GLN . 11.8 t -87.48 -28.23 22.18 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.436 0.294 . . . . 0.0 110.894 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -98.8 135.26 40.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.671 0.788 . . . . 0.0 111.547 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 105.5 2.28 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 162.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 41.1 Cg_endo -64.73 166.2 18.68 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.795 2.33 . . . . 0.0 114.801 -161.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 mm -108.7 -5.15 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 173.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.01 -179.5 6.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.048 1.339 . . . . 0.0 111.472 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HB2' ' HG2' ' A' ' 60' ' ' MET . 75.6 mmtt -73.22 -25.02 60.58 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.513 0.725 . . . . 0.0 112.262 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.691 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 29.0 t -165.28 -178.69 5.16 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.479 0.711 . . . . 0.0 110.327 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -57.48 -54.57 45.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.687 1.195 . . . . 0.0 111.42 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.511 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 86.5 m95 -62.14 -32.48 73.09 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.828 0.851 . . . . 0.0 111.58 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.691 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.1 mpt? -72.99 -26.47 61.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.876 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.573 ' HA ' HG22 ' A' ' 64' ' ' VAL . 19.8 tp10 -74.67 -31.59 61.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.282 0.233 . . . . 0.0 110.587 175.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.498 HD13 HG12 ' A' ' 45' ' ' ILE . 66.8 mt -61.52 -47.63 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.017 0.527 . . . . 0.0 110.183 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' O ' HD11 ' A' ' 79' ' ' ILE . 4.1 pp -71.9 -34.33 69.03 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.699 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 61' ' ' GLU . 23.5 m -76.98 -34.05 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 118.783 0.72 . . . . 0.0 111.558 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.41 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 5.3 tpp180 -68.95 -46.48 68.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.757 0.423 . . . . 0.0 111.11 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.7 -18.95 64.35 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 123.458 0.474 . . . . 0.0 112.157 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.8 p -90.03 18.88 5.35 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.431 0.692 . . . . 0.0 112.501 175.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 142' ' ' ILE . . . 95.29 26.22 12.66 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.385 -0.675 . . . . 0.0 113.193 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.513 ' HB3' HG13 ' A' ' 145' ' ' ILE . 17.2 tt0 57.78 97.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.837 1.255 . . . . 0.0 109.869 -174.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -137.84 -158.11 0.83 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.725 0.81 . . . . 0.0 110.862 -168.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -120.66 164.61 16.26 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.653 1.181 . . . . 0.0 108.985 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.442 HG13 ' HG2' ' A' ' 56' ' ' LYS . 51.4 mm -47.41 -47.6 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 125.659 1.583 . . . . 0.0 112.99 -171.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 m170 -56.74 -53.37 58.52 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.856 0.863 . . . . 0.0 111.572 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.38 -58.06 10.1 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 123.519 0.512 . . . . 0.0 110.75 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . . . -54.61 -54.99 34.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.428 1.091 . . . . 0.0 113.844 -170.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.3 mt -63.68 -31.24 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.49 0.716 . . . . 0.0 112.117 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.69 -39.62 19.94 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.1 mt -76.73 -66.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.83 0.452 . . . . 0.0 110.626 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.43 HD11 ' O ' ' A' ' 63' ' ' LEU . 9.0 pt -104.8 8.76 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.519 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 31' ' ' ASN . . . -81.83 173.95 53.8 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 119.364 0.984 . . . . 0.0 111.853 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.11 137.67 58.31 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.97 156.64 37.81 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -53.66 151.3 6.22 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.84 -115.51 5.18 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.123 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -85.5 108.55 17.97 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.524 HG11 HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -135.1 171.25 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.337 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 32' ' ' ALA . 61.0 m -131.64 121.46 24.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.841 1.256 . . . . 0.0 108.823 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.464 HD11 ' HB ' ' A' ' 99' ' ' ILE . 4.8 tt -99.47 128.77 45.6 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -174.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.456 HG22 ' HZ3' ' A' ' 59' ' ' TRP . 22.0 mt -113.75 114.28 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 20.8 p -138.26 156.88 47.25 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.836 0.454 . . . . 0.0 110.568 -176.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.34 -51.98 15.52 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.866 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -128.75 158.39 38.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.121 0.968 . . . . 0.0 110.068 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 43.4 mt-10 -64.87 -16.15 62.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.885 0.874 . . . . 0.0 112.266 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 13.4 pt-20 -74.58 -46.59 37.73 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.0 m -61.56 -40.4 94.57 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 123.738 0.815 . . . . 0.0 110.505 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.745 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 19.4 t80 -56.74 -51.46 68.78 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 123.819 0.699 . . . . 0.0 110.84 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -61.39 -42.72 99.17 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.822 0.701 . . . . 0.0 111.005 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 74.8 mmtt -57.58 -50.14 74.09 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.654 0.596 . . . . 0.0 110.899 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.464 ' HB ' HD11 ' A' ' 88' ' ' LEU . 45.8 mm -69.82 -45.45 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.835 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.405 ' HD1' HD12 ' A' ' 11' ' ' ILE . 14.7 t80 -54.01 -45.7 71.57 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.257 1.423 . . . . 0.0 113.2 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.95 -30.34 68.76 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 119.463 -0.303 . . . . 0.0 111.667 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.24 -46.03 71.62 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.932 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.1 pt -75.62 -41.01 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 118.103 0.41 . . . . 0.0 110.799 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.56 109.11 0.09 OUTLIER Glycine 0 C--N 1.345 1.072 0 O-C-N 123.347 0.405 . . . . 0.0 113.706 170.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.44 -171.88 44.63 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -105.25 147.46 28.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.238 0.615 . . . . 0.0 109.568 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.36 129.29 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.248 0.619 . . . . 0.0 109.561 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -132.77 100.84 5.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.289 1.036 . . . . 0.0 108.906 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -69.88 -33.18 71.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.896 0.478 . . . . 0.0 111.622 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.516 ' HA ' ' HG2' ' A' ' 113' ' ' GLU . 18.4 m -50.6 -36.82 36.81 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 16.2 m -66.64 -22.52 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.8 mt -100.75 17.83 20.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.808 0.843 . . . . 0.0 111.856 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.593 ' HA ' HG22 ' A' ' 37' ' ' THR . 7.4 pt-20 -134.79 8.06 3.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 78.71 131.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.202 1.001 . . . . 0.0 111.615 173.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 117' ' ' ASP . 4.0 p-10 -156.87 174.44 15.5 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.219 1.407 . . . . 0.0 107.915 172.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -69.4 -32.23 71.09 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.46 ' HB2' ' ND2' ' A' ' 115' ' ' ASN . 2.2 m-20 -57.34 -50.68 72.19 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.541 0.736 . . . . 0.0 110.352 171.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -40.98 76.86 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.124 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.463 ' HG3' HG21 ' A' ' 134' ' ' VAL . 42.5 tt0 -72.32 -49.19 36.31 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.404 0.682 . . . . 0.0 112.485 -162.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 12.5 ptm180 -70.16 -36.95 75.06 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.678 0.752 . . . . 0.0 110.741 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.682 HD21 ' HB3' ' A' ' 33' ' ' ASP . 37.4 tp -59.64 -47.8 84.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.778 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.4 HG23 ' HD2' ' A' ' 126' ' ' PHE . 31.5 mt -63.5 -38.04 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.289 1.035 . . . . 0.0 110.645 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.2 ptp180 -74.36 -26.51 60.17 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 118.983 -0.532 . . . . 0.0 110.086 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -71.47 -57.49 4.38 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -31.27 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 119.014 0.825 . . . . 0.0 112.487 -172.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.4 ' HD2' HG23 ' A' ' 122' ' ' ILE . 23.0 m-30 -92.5 -33.59 14.42 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 119.593 -0.241 . . . . 0.0 111.553 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 12.4 mmmm 66.13 82.53 0.18 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.971 0.908 . . . . 0.0 112.419 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 137' ' ' ARG . 36.9 mt -124.01 156.73 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -42.06 -55.23 3.27 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.86 0.464 . . . . 0.0 111.045 165.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.93 33.9 7.55 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -114.78 152.3 32.35 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 124.293 1.037 . . . . 0.0 109.117 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.37 -132.99 21.38 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.623 0.577 . . . . 0.0 112.138 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' A' ' 136' ' ' GLU . 54.0 t30 -96.22 116.79 29.56 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.654 0.381 . . . . 0.0 110.638 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.463 HG21 ' HG3' ' A' ' 119' ' ' GLU . 84.2 t -64.19 -29.4 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.152 1.381 . . . . 0.0 112.324 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.8 -49.75 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.213 0.605 . . . . 0.0 110.469 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.414 ' HG3' HD22 ' A' ' 133' ' ' ASN . 41.1 mt-10 -64.99 -32.1 73.66 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.097 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.537 ' HB3' HG21 ' A' ' 128' ' ' ILE . 8.5 mmm180 -76.01 -35.48 59.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.115 0.566 . . . . 0.0 112.205 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.51 -41.33 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.823 -0.548 . . . . 0.0 110.973 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.5 mp -57.12 -40.16 76.54 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.508 1.123 . . . . 0.0 112.786 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.37 -35.52 68.5 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.024 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -64.96 -46.08 83.05 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.426 0.69 . . . . 0.0 111.281 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 19.5 pt -72.48 -8.48 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.403 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.75 -29.22 13.13 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 124.386 1.074 . . . . 0.0 111.267 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.89 3.97 0.95 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.16 1.384 . . . . 0.0 113.724 -165.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.513 HG13 ' HB3' ' A' ' 69' ' ' GLN . 19.1 mm -82.15 -38.06 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -98.39 -33.79 10.91 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.102 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.76 31.74 0.6 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.524 1.13 . . . . 0.0 110.007 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -102.27 -40.14 6.9 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? 66.99 76.18 0.3 Allowed 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.449 1.499 . . . . 0.0 110.027 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 124.729 1.212 . . . . 0.0 111.145 170.04 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.524 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.95 175.52 6.68 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.607 0.763 . . . . 0.0 110.955 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 3' ' ' MET . 1.3 mpt? -56.91 -33.49 66.98 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.899 0.88 . . . . 0.0 110.638 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.97 93.0 7.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 162.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.719 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 67.5 Cg_endo -71.72 -33.34 10.47 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.357 2.038 . . . . 0.0 112.732 -177.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.719 ' SD ' ' HG2' ' A' ' 5' ' ' PRO . 2.0 mpt? -106.94 161.45 14.71 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -103.55 104.94 17.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mm -111.83 120.31 61.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.434 HH21 HG21 ' A' ' 107' ' ' ILE . 28.0 mmm180 -133.18 145.33 50.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.876 0.471 . . . . 0.0 109.869 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.564 ' H ' HD11 ' A' ' 112' ' ' LEU . . . -107.14 118.04 5.46 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.3 tt -124.28 124.97 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.566 0.746 . . . . 0.0 111.165 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -85.11 137.74 32.85 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.156 170.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.29 79.51 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.211 172.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.25 109.98 4.98 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.833 0.853 . . . . 0.0 111.815 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -76.76 103.15 6.57 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.546 HD11 HG11 ' A' ' 86' ' ' VAL . 50.9 mm -70.69 93.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.413 ' O ' HG12 ' A' ' 20' ' ' ILE . 30.4 p-10 -102.01 153.59 19.75 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.625 -177.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -68.53 -13.26 62.21 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.39 -36.75 79.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.656 0.782 . . . . 0.0 112.013 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 17' ' ' ASN . 6.9 pt -56.72 -22.62 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -87.25 -16.78 34.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 118.231 0.469 . . . . 0.0 111.368 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -75.31 -19.52 59.61 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.381 0.673 . . . . 0.0 112.093 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -82.65 -9.76 59.23 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.944 0.498 . . . . 0.0 111.765 -177.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.73 8.39 2.85 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB2' HD13 ' A' ' 23' ' ' LEU . 86.2 mt -68.57 168.69 12.44 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.977 0.888 . . . . 0.0 112.131 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -77.78 92.21 4.18 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.09 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -148.81 162.3 40.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.984 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.648 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -146.1 159.82 42.76 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 164.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.8 mt -134.08 129.68 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 121.704 -0.623 . . . . 0.0 109.39 173.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.7 pt? -119.84 179.7 4.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.072 0.949 . . . . 0.0 108.456 172.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.467 ' HB3' HG22 ' A' ' 34' ' ' VAL . 51.0 t-20 -74.51 143.16 44.68 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.557 ' HB1' HG21 ' A' ' 111' ' ' VAL . . . -68.87 -49.67 56.28 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.038 0.447 . . . . 0.0 110.585 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HB3' HD21 ' A' ' 121' ' ' LEU . 40.9 m-20 -52.38 -16.66 0.92 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 31' ' ' ASN . 24.9 m -110.82 2.09 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.585 0.754 . . . . 0.0 111.906 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.13 -30.74 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.201 0.6 . . . . 0.0 111.95 -171.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.427 ' O ' HG12 ' A' ' 114' ' ' ILE . . . 58.29 -84.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.34 1.056 . . . . 0.0 109.35 -166.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 16.8 p -127.07 161.69 27.83 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.939 0.896 . . . . 0.0 111.081 172.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -53.56 -40.68 65.79 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.379 163.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.507 ' HD2' HD11 ' A' ' 42' ' ' LEU . 50.8 tptt -56.19 -35.76 67.61 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 124.994 1.318 . . . . 0.0 111.554 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -63.02 -52.6 62.27 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.889 0.743 . . . . 0.0 111.28 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 45' ' ' ILE . 40.4 t -72.66 -42.49 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 119.427 -0.321 . . . . 0.0 111.85 -175.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.508 ' HB2' ' SD ' ' A' ' 6' ' ' MET . 4.1 pp -64.6 -29.52 70.53 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.015 0.371 . . . . 0.0 111.209 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -62.6 -40.22 96.23 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.019 0.928 . . . . 0.0 110.546 169.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.27 82.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.571 0.748 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.467 ' HA ' HG12 ' A' ' 62' ' ' ILE . 41.7 mt -65.49 -45.8 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.099 0.96 . . . . 0.0 110.709 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -51.69 -48.77 63.37 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.568 1.147 . . . . 0.0 110.366 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -64.6 -31.82 73.21 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.987 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.46 -21.78 48.54 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.914 0.485 . . . . 0.0 112.025 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HE3' HG22 ' A' ' 45' ' ' ILE . 96.7 mttt -82.0 -31.75 30.91 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.973 0.509 . . . . 0.0 111.622 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.478 HG23 ' HG2' ' A' ' 51' ' ' LYS . 9.7 t -100.31 -35.98 9.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.478 ' HG2' HG23 ' A' ' 50' ' ' THR . 10.9 mmpt? -119.63 153.57 35.31 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.275 0.63 . . . . 0.0 111.877 -176.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.86 124.74 9.48 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.506 1.122 . . . . 0.0 109.766 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -90.57 -115.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 123.85 3.034 . . . . 0.0 110.468 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 mm -123.63 35.26 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . . . -85.83 156.54 20.52 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.878 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.554 ' HG2' HG13 ' A' ' 72' ' ' ILE . 74.3 mmtt -62.23 -53.83 49.56 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.207 0.603 . . . . 0.0 111.945 -171.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.539 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 10.6 t -156.33 -176.94 6.23 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.039 0.536 . . . . 0.0 109.678 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -58.55 -60.33 3.97 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.407 1.083 . . . . 0.0 113.244 -173.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.518 ' CE3' ' HB2' ' A' ' 28' ' ' GLN . 92.1 m95 -66.16 -23.5 66.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.747 0.419 . . . . 0.0 112.044 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.5 mpt? -77.19 -26.09 52.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.864 0.866 . . . . 0.0 110.599 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.524 ' HG2' ' HB3' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -74.92 -41.26 60.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.967 0.907 . . . . 0.0 109.389 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 45' ' ' ILE . 81.8 mt -61.54 -39.46 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.726 0.811 . . . . 0.0 112.455 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.455 HD12 HG13 ' A' ' 64' ' ' VAL . 3.6 pp -72.65 -33.47 66.62 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.007 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.455 HG13 HD12 ' A' ' 63' ' ' LEU . 25.0 m -77.07 -27.0 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.973 -0.454 . . . . 0.0 111.949 174.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.444 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 35.4 mmt180 -64.56 -62.76 1.39 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.205 0.602 . . . . 0.0 110.442 172.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.79 -27.72 68.23 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.608 0.763 . . . . 0.0 112.695 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 p -79.57 -59.07 2.89 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.37 6.6 29.16 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.722 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -78.83 -25.13 44.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.498 1.119 . . . . 0.0 111.763 -172.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' NH1' HG23 ' A' ' 64' ' ' VAL . 1.1 mpt_? 66.58 -10.61 0.27 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -173.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -99.45 118.5 36.2 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.94 0.896 . . . . 0.0 109.125 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.554 HG13 ' HG2' ' A' ' 56' ' ' LYS . 24.8 mm -53.45 -59.73 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.264 1.025 . . . . 0.0 112.353 -172.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -61.76 -45.14 95.17 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.152 0.907 . . . . 0.0 110.589 -172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -58.02 -47.86 81.79 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.858 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.92 80.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.52 0.728 . . . . 0.0 112.397 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.9 mt -68.08 -33.79 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.185 0.594 . . . . 0.0 111.035 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -68.71 -49.33 59.76 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.804 0.335 . . . . 0.0 110.698 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.518 HG23 ' HB ' ' A' ' 125' ' ' ILE . 74.2 mt -64.8 -64.22 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 124.004 0.922 . . . . 0.0 111.15 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.45 ' HB ' HG21 ' A' ' 34' ' ' VAL . 24.0 pt -110.4 15.36 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -172.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.58 173.29 44.16 Favored Glycine 0 N--CA 1.479 1.52 0 CA-C-N 120.389 1.449 . . . . 0.0 113.21 -174.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.44 146.59 32.68 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.189 0.595 . . . . 0.0 111.39 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -153.18 155.53 36.84 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.417 1.087 . . . . 0.0 108.104 171.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.25 151.98 44.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.927 0.491 . . . . 0.0 111.433 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.79 -120.78 7.01 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.205 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -79.61 105.89 11.24 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG11 HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -135.74 164.53 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.647 -177.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 43.7 t -125.55 121.25 33.12 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.371 1.068 . . . . 0.0 108.959 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.41 HD21 ' HB ' ' A' ' 99' ' ' ILE . 10.0 tp -102.35 125.75 49.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.853 0.861 . . . . 0.0 109.865 -171.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 28' ' ' GLN . 68.4 mt -99.79 128.52 51.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 113.698 -1.592 . . . . 0.0 107.521 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.547 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 35.1 t -150.32 149.19 29.78 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 111.589 177.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -86.02 -41.67 14.63 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.59 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -119.78 146.69 45.44 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.195 0.598 . . . . 0.0 110.994 -174.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -54.79 -38.31 67.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.71 0.804 . . . . 0.0 112.613 172.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -69.75 -46.51 65.7 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.547 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 28.7 m -61.21 -35.21 76.57 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.005 0.922 . . . . 0.0 110.948 178.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -63.83 -46.76 83.62 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.404 0.682 . . . . 0.0 110.152 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.58 -34.71 78.41 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.759 0.662 . . . . 0.0 110.574 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.79 -45.9 80.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.464 0.706 . . . . 0.0 111.638 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.474 HD13 HD21 ' A' ' 23' ' ' LEU . 40.2 mm -71.39 -46.72 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 122.43 -0.169 . . . . 0.0 110.766 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -54.76 -33.81 61.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.161 1.384 . . . . 0.0 112.086 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.8 -50.46 70.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.864 0.866 . . . . 0.0 111.769 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.67 -25.84 49.84 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 20' ' ' ILE . 17.7 pt -80.24 -50.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 118.584 0.629 . . . . 0.0 109.575 174.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.92 124.43 0.05 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 123.443 0.464 . . . . 0.0 113.796 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.43 -153.15 20.59 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 117.028 0.414 . . . . 0.0 112.159 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -123.91 143.79 50.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.938 0.895 . . . . 0.0 109.164 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.434 HG21 HH21 ' A' ' 9' ' ' ARG . 49.3 mm -86.89 136.73 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -135.66 108.97 7.8 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.15 -25.22 66.86 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.541 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.2 m -46.54 -39.68 11.36 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.557 HG21 ' HB1' ' A' ' 32' ' ' ALA . 12.6 p -71.29 -41.62 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-O 120.846 0.355 . . . . 0.0 110.399 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 37' ' ' THR . 86.3 mt -67.78 -31.17 70.88 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.551 1.141 . . . . 0.0 112.623 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.3 1.54 54.48 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 118.15 -0.929 . . . . 0.0 112.924 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.433 ' HA ' HD13 ' A' ' 114' ' ' ILE 0.253 1.5 mm 73.07 127.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.29 0 CA-C-N 119.296 0.953 . . . . 0.0 113.094 177.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.438 HD21 ' HD3' ' A' ' 118' ' ' LYS . 6.3 p30 -147.89 -176.68 5.36 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.024 1.329 . . . . 0.0 108.584 173.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -57.42 -49.61 75.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.493 0.717 . . . . 0.0 112.142 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.8 -51.39 69.93 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.53 1.132 . . . . 0.0 112.466 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.438 ' HD3' HD21 ' A' ' 115' ' ' ASN . 4.3 mptp? -70.6 -37.23 73.86 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.849 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -71.38 -39.22 71.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.976 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -72.2 -42.89 65.29 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.866 0.466 . . . . 0.0 112.046 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 33' ' ' ASP . 0.7 OUTLIER -66.14 -34.1 77.28 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.487 HG23 ' HD2' ' A' ' 126' ' ' PHE . 13.5 mt -58.33 -30.02 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.948 0.899 . . . . 0.0 110.782 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -69.44 -36.79 76.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 118.839 -0.6 . . . . 0.0 109.534 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.13 -55.71 30.5 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.518 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -75.57 -45.07 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 118.863 0.756 . . . . 0.0 112.693 -178.026 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.582 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 21.7 m-30 -81.87 -33.1 30.75 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? 63.6 76.32 0.36 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.151 0.98 . . . . 0.0 112.318 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.685 HG21 ' HB3' ' A' ' 137' ' ' ARG . 2.5 mt -124.49 151.13 29.58 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -61.72 -90.82 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.619 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 173.66 -120.38 0.8 Allowed Glycine 0 C--N 1.35 1.337 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.1 t80 67.0 101.21 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.017 1.327 . . . . 0.0 111.242 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.4 -125.46 8.58 Favored Glycine 0 N--CA 1.469 0.879 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -127.62 165.49 19.87 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.425 0.612 . . . . 0.0 110.383 167.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.45 -16.53 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.083 0.553 . . . . 0.0 112.445 -171.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.476 ' O ' HD13 ' A' ' 139' ' ' LEU . 86.6 t -68.63 -49.29 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -174.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -52.75 -45.54 67.07 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.495 174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.685 ' HB3' HG21 ' A' ' 128' ' ' ILE . 37.4 mmt180 -73.55 -38.85 65.09 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 113.693 -1.594 . . . . 0.0 112.346 -168.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.55 -41.15 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 123.181 0.301 . . . . 0.0 110.485 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 135' ' ' VAL . 9.9 mp -55.74 -44.16 77.32 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.741 0.816 . . . . 0.0 110.509 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -74.33 -37.94 63.41 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 123.887 0.742 . . . . 0.0 111.929 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.633 ' HD3' HG12 ' A' ' 128' ' ' ILE . 16.5 ttpp -66.25 -40.01 89.91 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.086 0.47 . . . . 0.0 111.537 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 22.2 pt -73.29 -18.92 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.017 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -106.82 15.24 25.75 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.3 1.04 . . . . 0.0 110.801 174.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 tt -85.33 19.15 2.38 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 123.977 0.911 . . . . 0.0 109.987 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 12.3 mm -72.33 -30.21 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.83 -17.27 64.45 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.824 1.25 . . . . 0.0 111.824 173.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.9 mt 81.36 67.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.255 1.822 . . . . 0.0 110.596 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -71.65 -178.3 2.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.494 0.718 . . . . 0.0 111.685 175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -116.83 33.17 5.74 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.242 1.017 . . . . 0.0 109.878 -175.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 . . . . . 0 N--CA 1.481 1.105 0 C-N-CA 123.103 0.561 . . . . 0.0 110.279 -170.535 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.906 -0.478 . . . . 0.0 111.906 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.49 118.23 1.9 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.936 0.894 . . . . 0.0 109.79 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.8 mtt -144.83 87.62 1.85 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.923 0.889 . . . . 0.0 110.028 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.5 t70 60.1 91.68 0.07 OUTLIER Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 125.349 1.46 . . . . 0.0 112.295 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 42' ' ' LEU . 96.1 Cg_endo -83.41 -43.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.512 2.141 . . . . 0.0 113.319 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.4 mmt -110.64 175.97 5.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.782 0.833 . . . . 0.0 110.927 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 72.5 mt -98.75 103.81 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 108.359 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.57 122.28 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.7 mmt-85 -127.84 150.9 49.64 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.79 0.836 . . . . 0.0 109.723 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.31 126.26 8.67 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 tt -132.63 132.68 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.416 0.627 . . . . 0.0 110.452 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -107.83 133.68 51.86 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.27 1.028 . . . . 0.0 109.955 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.79 -6.27 79.62 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.534 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.57 112.77 2.12 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.112 0.965 . . . . 0.0 112.826 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -73.28 108.52 6.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.469 0.708 . . . . 0.0 110.288 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 86' ' ' VAL . 49.4 mm -70.76 94.17 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.272 1.034 . . . . 0.0 109.837 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.45 150.38 20.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.002 177.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -82.26 -4.57 57.39 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.974 0.51 . . . . 0.0 111.23 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -65.94 -40.09 91.07 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.076 0.95 . . . . 0.0 111.154 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.8 pt -70.62 -7.87 9.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.767 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -93.46 -34.32 13.46 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.226 0.921 . . . . 0.0 110.998 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -86.28 0.67 53.31 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -172.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.74 -3.94 55.04 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.365 0.666 . . . . 0.0 112.213 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.96 -11.8 2.43 Favored Glycine 0 CA--C 1.54 1.595 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.501 HD13 HG23 ' A' ' 95' ' ' THR . 85.2 mt -64.42 159.8 20.54 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.273 1.037 . . . . 0.0 112.217 -176.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -86.58 100.71 12.61 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.884 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -149.03 162.55 39.71 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.496 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.451 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 24.7 tt0 -139.02 145.55 39.76 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 166.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.0 mt -130.02 126.45 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 pp -122.39 174.28 7.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.068 0.947 . . . . 0.0 108.688 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -82.07 135.41 35.33 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -85.93 3.41 42.06 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -175.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -84.28 -34.66 23.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.271 0.629 . . . . 0.0 110.195 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 79' ' ' ILE . 14.8 p -93.88 -4.47 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 123.934 0.894 . . . . 0.0 111.229 -172.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG11 ' SG ' ' A' ' 87' ' ' CYS . 8.6 p -96.41 134.42 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.59 -64.09 1.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.1 p -135.24 168.89 18.34 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.465 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.595 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -56.6 -23.96 44.39 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 168.453 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 39.1 ttmt -63.02 -28.68 70.26 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 122.717 0.407 . . . . 0.0 111.947 174.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.485 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.8 t-80 -59.3 -44.82 92.5 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.853 0.461 . . . . 0.0 110.021 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.04 -52.14 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.742 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.632 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 3.8 pp -65.57 -36.42 83.71 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.764 0.256 . . . . 0.0 111.648 -171.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.458 ' CG ' ' HG ' ' A' ' 139' ' ' LEU . 25.2 t-80 -57.68 -41.31 81.35 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.181 0.592 . . . . 0.0 110.71 169.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.29 -34.42 77.35 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.647 0.592 . . . . 0.0 111.13 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 42' ' ' LEU . 62.9 mt -65.78 -46.08 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.925 0.89 . . . . 0.0 110.641 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' O ' HG22 ' A' ' 50' ' ' THR . 67.4 m-20 -59.39 -46.93 87.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.424 0.69 . . . . 0.0 110.247 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -61.68 -36.14 80.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.448 1.099 . . . . 0.0 111.166 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.15 95.92 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.565 0.746 . . . . 0.0 111.859 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -76.96 -20.35 56.22 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 51' ' ' LYS . 5.1 t -105.25 -38.8 6.4 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.757 0.423 . . . . 0.0 110.757 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HG2' HG23 ' A' ' 50' ' ' THR . 45.2 mmtm -114.52 136.2 53.29 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.591 0.756 . . . . 0.0 110.602 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.603 ' HD3' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -109.56 116.53 54.35 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.856 -178.153 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.19 -142.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.126 2.551 . . . . 0.0 110.593 168.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.55 41.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 72' ' ' ILE . . . -77.68 150.94 34.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.534 -174.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -84.96 -23.14 28.89 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.85 0.86 . . . . 0.0 111.15 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -161.07 173.83 14.61 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.054 0.941 . . . . 0.0 109.399 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -66.89 -44.32 81.17 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.693 0.797 . . . . 0.0 111.177 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.451 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 94.0 m95 -76.39 -18.9 58.63 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.409 0.283 . . . . 0.0 111.589 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.5 mmt -79.15 -25.45 42.88 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.002 0.521 . . . . 0.0 110.779 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 29.8 tt0 -76.03 -37.59 58.2 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.177 0.991 . . . . 0.0 111.544 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.448 HD13 HG12 ' A' ' 45' ' ' ILE . 78.6 mt -68.25 -39.9 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.129 0.572 . . . . 0.0 111.33 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.413 HD12 HG13 ' A' ' 64' ' ' VAL . 3.9 pp -72.06 -34.68 68.93 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 123.214 0.321 . . . . 0.0 111.466 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.413 HG13 HD12 ' A' ' 63' ' ' LEU . 21.9 m -74.34 -35.48 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 121.971 -0.456 . . . . 0.0 110.745 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 16.7 tpt85 -68.42 -42.56 78.75 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.161 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.01 66.57 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.451 0.7 . . . . 0.0 111.573 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -82.93 -5.32 59.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.578 0.751 . . . . 0.0 111.947 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.9 -73.46 2.12 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -44.32 136.49 4.03 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.326 1.45 . . . . 0.0 112.365 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -96.59 5.86 49.89 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.941 0.896 . . . . 0.0 111.482 -165.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.48 126.21 43.94 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.707 1.203 . . . . 0.0 110.997 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 55' ' ' ALA . 1.7 mp -53.12 -59.15 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 124.957 1.303 . . . . 0.0 112.55 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.491 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 63.0 m80 -60.36 -46.79 88.68 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.781 0.676 . . . . 0.0 110.702 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -57.2 -51.83 67.77 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.415 1.072 . . . . 0.0 111.187 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.62 72.33 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.376 0.671 . . . . 0.0 112.681 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.55 -32.6 55.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 122.918 0.487 . . . . 0.0 111.217 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 73' ' ' HIS . 32.6 mmtp -70.14 -49.38 51.28 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 175.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 52.6 mt -68.82 -67.56 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.095 0.958 . . . . 0.0 111.881 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 34' ' ' VAL . 6.9 pt -103.85 8.91 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.92 168.59 54.75 Favored Glycine 0 C--N 1.352 1.459 0 CA-C-N 119.457 1.026 . . . . 0.0 113.11 -171.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.86 144.82 48.93 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.54 0.736 . . . . 0.0 112.755 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -147.1 151.51 36.96 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -58.77 149.94 25.1 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 119.659 1.118 . . . . 0.0 112.062 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.78 -114.52 4.39 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.083 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -89.2 109.05 19.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.136 0.575 . . . . 0.0 110.223 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG21 HD11 ' A' ' 16' ' ' ILE . 4.2 m -137.44 175.11 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.749 0.82 . . . . 0.0 112.034 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.507 ' SG ' HG11 ' A' ' 35' ' ' VAL . 57.9 m -122.82 120.88 34.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.411 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD21 ' HB ' ' A' ' 99' ' ' ILE . 9.2 tp -104.1 120.19 40.56 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.765 0.793 . . . . 0.0 109.344 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 12.1 mt -119.12 129.48 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.074 -170.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.565 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 47.9 t -157.69 164.48 37.12 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -78.27 -53.11 7.67 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.357 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -119.86 149.84 41.43 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.193 0.597 . . . . 0.0 110.18 -173.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.14 -35.67 69.79 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.382 1.073 . . . . 0.0 113.143 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 12.8 pt-20 -73.67 -40.68 63.49 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.565 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 34.9 m -66.07 -36.24 82.68 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.137 0.575 . . . . 0.0 110.938 176.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.16 -47.36 83.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.308 0.643 . . . . 0.0 109.383 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -67.46 -34.97 78.26 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.927 -175.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 30.6 mmmt -63.52 -36.66 84.51 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.39 0.676 . . . . 0.0 111.698 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.431 ' HB ' HD21 ' A' ' 88' ' ' LEU . 38.1 mm -76.25 -44.68 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 N-CA-C 110.464 -0.198 . . . . 0.0 110.464 175.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.46 -45.02 76.94 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.962 1.305 . . . . 0.0 113.221 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.675 ' HG3' HD22 ' A' ' 102' ' ' LEU . 8.0 pt-20 -62.35 -35.75 80.08 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.475 0.484 . . . . 0.0 111.959 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.675 HD22 ' HG3' ' A' ' 101' ' ' GLU . 3.5 mm? -75.83 -39.15 57.28 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 119.102 -0.475 . . . . 0.0 112.012 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.3 pt -74.73 -42.94 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 118.604 0.638 . . . . 0.0 110.639 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.27 113.81 0.06 OUTLIER Glycine 0 C--N 1.35 1.308 0 O-C-N 123.545 0.528 . . . . 0.0 113.838 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.83 -162.74 29.31 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -116.92 134.98 54.08 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.56 0.744 . . . . 0.0 109.974 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.8 mm -75.43 123.67 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -143.03 95.94 2.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.099 1.36 . . . . 0.0 107.694 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.4 -18.55 63.77 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.8 0.44 . . . . 0.0 112.157 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.5 m -57.38 -25.34 59.35 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -70.71 -25.23 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 CA-C-O 120.893 0.378 . . . . 0.0 110.159 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.564 HD13 ' HB3' ' A' ' 38' ' ' LYS . 38.6 mt -107.81 16.52 23.49 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.634 1.174 . . . . 0.0 112.051 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -103.69 -4.91 23.12 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 119.743 1.156 . . . . 0.0 112.428 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.528 HD11 HG12 ' A' ' 134' ' ' VAL 0.294 0.5 OUTLIER 93.57 123.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.803 2.041 . . . . 0.0 109.401 -176.43 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.552 ' HB2' ' HD3' ' A' ' 118' ' ' LYS . 4.2 m120 -139.58 157.59 45.55 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 124.525 1.13 . . . . 0.0 108.328 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.72 -38.56 91.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.412 0.685 . . . . 0.0 110.733 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.79 -48.56 80.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.126 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' A' ' 115' ' ' ASN . 4.2 mptp? -63.02 -42.18 99.74 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.83 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 29.1 tt0 -65.61 -44.17 87.38 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.757 -166.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -69.38 -39.02 78.25 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.54 -33.05 62.65 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 119.485 -0.293 . . . . 0.0 110.718 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.1 mt -59.14 -41.89 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.88 0.872 . . . . 0.0 110.538 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -74.53 -23.41 58.8 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.611 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -65.92 -57.65 7.37 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.519 HD11 HG23 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -78.36 -24.61 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 119.262 0.937 . . . . 0.0 112.977 -175.027 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -97.1 -32.42 11.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.15 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 57.88 79.11 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.062 0.945 . . . . 0.0 111.2 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.23 117.01 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -81.45 105.99 13.05 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 156.47 120.77 0.67 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -79.7 -172.15 3.17 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.997 0.919 . . . . 0.0 108.928 174.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 105.39 -125.61 8.33 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 121.628 -0.67 . . . . 0.0 111.629 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -108.96 119.28 39.08 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.865 0.866 . . . . 0.0 109.371 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.528 HG12 HD11 ' A' ' 114' ' ' ILE . 3.8 p -69.73 -15.86 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.124 0.57 . . . . 0.0 112.453 -171.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.422 ' O ' HD13 ' A' ' 139' ' ' LEU . 21.4 t -70.34 -53.13 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -56.57 -39.37 73.38 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.41 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -68.17 -42.21 80.34 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.451 -173.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.9 p -76.23 -37.83 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 122.817 0.447 . . . . 0.0 110.892 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.5 mp -60.46 -37.24 80.38 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.015 0.926 . . . . 0.0 111.388 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -73.23 -40.96 64.25 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.499 0.499 . . . . 0.0 111.618 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -72.61 -29.54 63.58 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.396 0.278 . . . . 0.0 111.438 -171.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 22.2 pt -84.75 -18.55 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.87 -15.64 41.16 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.008 0.523 . . . . 0.0 110.334 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 149' ' ' LYS . 32.0 tp -71.28 -2.73 17.16 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.587 1.555 . . . . 0.0 112.076 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 80.6 mt -92.48 -53.63 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.487 1.115 . . . . 0.0 109.2 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.46 -17.53 19.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.066 -174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.0 mt -135.55 63.74 1.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -43.88 125.89 4.48 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.529 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.452 ' H ' HD12 ' A' ' 144' ' ' LEU . 1.5 tppp? -98.48 17.44 18.96 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.932 0.893 . . . . 0.0 110.061 -174.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 C--O 1.25 1.126 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.096 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.37 0 N-CA-C 112.258 -0.337 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.78 97.47 2.74 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.238 0.615 . . . . 0.0 110.325 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.2 ptm 115.29 12.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.53 0 C-N-CA 129.04 2.936 . . . . 0.0 109.797 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -166.01 68.24 1.13 Allowed Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.76 -60.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.143 2.562 . . . . 0.0 113.315 -170.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.7 mmt -83.92 173.53 11.13 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.239 0.616 . . . . 0.0 109.513 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.9 mt -93.01 102.17 13.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.4 mm -112.69 118.92 59.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -135.08 149.05 50.01 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.26 151.52 17.9 Favored Glycine 0 C--O 1.239 0.42 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.91 127.65 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.61 0.719 . . . . 0.0 112.874 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -91.72 133.17 35.84 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.823 1.249 . . . . 0.0 110.31 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.94 24.37 72.11 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.192 -0.458 . . . . 0.0 114.101 170.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.497 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -80.21 111.79 16.91 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.673 0.789 . . . . 0.0 110.974 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 110.17 8.42 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.409 HD11 HG21 ' A' ' 86' ' ' VAL . 49.6 mm -69.02 92.41 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.72 0.771 . . . . 0.0 109.34 175.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 20' ' ' ILE . 4.7 p30 -105.01 148.58 26.58 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.486 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -56.53 -24.41 46.53 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.4 -34.17 76.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.394 0.678 . . . . 0.0 112.38 -172.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.621 HG21 HG23 ' A' ' 103' ' ' ILE . 7.2 pt -62.66 -15.14 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -106.82 -17.85 14.09 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 118.525 0.602 . . . . 0.0 109.845 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -69.39 -25.44 64.15 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.08 0.952 . . . . 0.0 111.16 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -76.57 -8.94 58.21 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.196 -174.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.11 17.22 9.92 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 116.737 1.455 . . . . 0.0 116.737 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.468 ' HB2' HD13 ' A' ' 23' ' ' LEU . 93.3 mt -81.93 170.5 15.55 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.426 0.69 . . . . 0.0 110.833 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -84.58 99.41 10.74 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.643 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -149.9 162.25 40.69 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.852 0.861 . . . . 0.0 109.421 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.433 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -140.09 145.89 38.21 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.6 mt -130.98 127.48 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 172.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -120.31 176.63 5.37 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 34' ' ' VAL . 2.1 t-20 -81.17 138.07 35.87 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.541 ' HB1' ' HB ' ' A' ' 111' ' ' VAL . . . -83.74 -2.45 56.3 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.507 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 61.3 m-20 -89.87 -30.22 18.05 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 122.854 0.462 . . . . 0.0 110.387 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.469 HG23 HG13 ' A' ' 125' ' ' ILE . 9.4 p -87.52 -16.29 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 123.309 0.644 . . . . 0.0 111.234 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 32' ' ' ALA . 13.4 p -93.86 136.13 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.77 -66.93 0.64 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.681 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.4 p -138.49 167.78 21.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.595 1.158 . . . . 0.0 109.362 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB3' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -58.26 -22.94 54.43 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 174.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 87.4 tttt -58.95 -34.68 72.04 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.021 0.528 . . . . 0.0 111.677 174.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.509 ' HA ' HD11 ' A' ' 139' ' ' LEU . 18.1 t-80 -60.58 -44.57 96.07 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.204 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.57 -52.83 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.036 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 4.1 pp -64.57 -28.37 69.59 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -172.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.441 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 47.6 t-80 -68.63 -33.48 74.09 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.226 0.61 . . . . 0.0 110.985 171.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 -40.82 69.58 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.024 0.53 . . . . 0.0 110.914 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.504 HG12 HD13 ' A' ' 62' ' ' ILE . 55.9 mt -61.3 -43.79 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.163 0.985 . . . . 0.0 109.915 172.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 50' ' ' THR . 25.8 t-20 -53.13 -48.39 67.93 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.634 1.173 . . . . 0.0 110.69 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 26.7 mm-40 -63.82 -34.62 78.34 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.231 0.957 . . . . 0.0 110.583 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.452 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . . . -73.35 -25.66 60.69 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -83.71 -46.19 12.55 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.376 0.67 . . . . 0.0 111.23 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.537 HG23 ' HG3' ' A' ' 51' ' ' LYS . 15.1 t -93.9 -32.35 13.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.75 0.42 . . . . 0.0 111.827 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.537 ' HG3' HG23 ' A' ' 50' ' ' THR . 42.3 mtpt -109.51 160.97 15.78 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.925 0.49 . . . . 0.0 111.239 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -142.36 98.82 5.95 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 124.066 0.947 . . . . 0.0 110.248 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.41 -119.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.549 2.832 . . . . 0.0 112.036 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.3 mt -132.99 34.73 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.39 158.59 23.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.548 -175.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -60.24 -60.37 3.92 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.9 0.88 . . . . 0.0 112.416 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.543 ' HB2' ' SD ' ' A' ' 60' ' ' MET . 70.0 m -148.65 179.17 8.03 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.512 0.725 . . . . 0.0 109.818 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.402 ' O ' HG13 ' A' ' 62' ' ' ILE . 58.1 t80 -53.56 -56.97 12.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.324 1.049 . . . . 0.0 111.852 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.515 ' HZ3' HG22 ' A' ' 89' ' ' ILE . 75.7 m95 -65.54 -35.18 80.09 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.491 0.716 . . . . 0.0 111.473 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 57' ' ' SER . 1.1 mpt? -76.34 -19.81 57.85 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 22.9 tt0 -78.53 -38.94 39.37 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.442 0.697 . . . . 0.0 110.627 173.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.504 HD13 HG12 ' A' ' 45' ' ' ILE . 90.2 mt -57.01 -41.28 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.491 0.716 . . . . 0.0 111.036 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.403 HD12 HG13 ' A' ' 64' ' ' VAL . 3.9 pp -72.0 -32.88 67.63 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.21 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.713 HG23 ' HE ' ' A' ' 65' ' ' ARG . 12.0 m -78.38 -34.21 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 121.771 -0.581 . . . . 0.0 111.729 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.713 ' HE ' HG23 ' A' ' 64' ' ' VAL . 5.8 mmp_? -70.39 -38.98 74.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.651 0.38 . . . . 0.0 110.919 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.81 68.84 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.34 0.656 . . . . 0.0 112.199 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.0 p -92.44 -3.53 55.08 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.764 0.426 . . . . 0.0 111.933 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.48 16.04 48.52 Favored Glycine 0 C--N 1.358 1.77 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -170.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.605 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.7 tp-100 -105.76 151.57 24.29 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.5 ptt-85 -85.19 -27.2 26.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.072 0.549 . . . . 0.0 111.361 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.605 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 5.8 mm-40 -90.04 125.45 35.41 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.357 1.063 . . . . 0.0 111.195 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.499 HD12 HG11 ' A' ' 64' ' ' VAL . 1.8 mp -58.76 -44.95 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.343 1.057 . . . . 0.0 110.357 172.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -60.94 -51.09 70.76 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.351 0.661 . . . . 0.0 111.348 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.408 ' HB2' ' HG2' ' A' ' 69' ' ' GLN . 16.8 mm-40 -56.47 -55.52 32.63 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.316 0.385 . . . . 0.0 110.983 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.71 -38.78 75.86 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.3 mt -68.99 -31.1 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 120.661 0.267 . . . . 0.0 111.178 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -74.05 -43.63 57.15 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 122.098 -0.376 . . . . 0.0 110.675 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 79.4 mt -68.55 -65.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.83 0.852 . . . . 0.0 111.825 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.462 HG22 HG21 ' A' ' 34' ' ' VAL . 7.7 pt -105.91 6.06 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.15 176.13 47.4 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 119.094 0.861 . . . . 0.0 114.025 -166.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.33 140.31 42.99 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.613 0.765 . . . . 0.0 111.803 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -145.64 143.22 29.71 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.44 141.3 58.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.297 0.953 . . . . 0.0 111.41 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.07 -119.41 4.45 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 94.9 m-20 -82.83 110.29 17.71 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.252 0.526 . . . . 0.0 109.913 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.409 HG21 HD11 ' A' ' 16' ' ' ILE . 3.6 m -134.79 174.06 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.627 0.727 . . . . 0.0 111.519 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.1 t -130.94 121.81 25.81 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.709 -173.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.515 HD21 ' HB ' ' A' ' 99' ' ' ILE . 8.3 tp -102.1 122.22 43.7 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.774 0.797 . . . . 0.0 109.503 -172.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.515 HG22 ' HZ3' ' A' ' 59' ' ' TRP . 32.0 mt -111.03 122.19 65.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 113.35 -1.75 . . . . 0.0 107.692 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.609 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 40.1 t -154.56 168.0 28.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.953 0.342 . . . . 0.0 111.028 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -95.96 -48.13 5.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.356 0.663 . . . . 0.0 110.827 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -111.66 138.15 48.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.428 0.691 . . . . 0.0 109.26 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 41.4 tt0 -63.49 -24.14 67.7 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.278 0.631 . . . . 0.0 111.902 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.15 -45.82 72.49 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.609 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 28.3 m -70.88 -34.45 71.6 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.929 0.892 . . . . 0.0 111.001 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 5.5 t80 -61.54 -52.31 64.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.553 0.741 . . . . 0.0 109.667 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 30.7 mtp180 -68.58 -33.62 74.37 Favored 'General case' 0 C--O 1.213 -0.855 0 O-C-N 123.685 0.616 . . . . 0.0 110.343 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.415 ' O ' HD13 ' A' ' 102' ' ' LEU . 50.4 tptt -56.46 -40.49 74.94 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.024 0.529 . . . . 0.0 110.663 175.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.515 ' HB ' HD21 ' A' ' 88' ' ' LEU . 43.2 mm -73.67 -48.64 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.6 174.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -54.54 -43.37 71.9 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 124.826 1.251 . . . . 0.0 113.702 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 56.6 mm-40 -60.88 -40.33 92.61 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.624 0.37 . . . . 0.0 110.776 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 98' ' ' LYS . 6.8 mp -72.97 -42.08 63.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.533 0.733 . . . . 0.0 112.082 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.621 HG23 HG21 ' A' ' 20' ' ' ILE . 8.2 pt -74.66 -32.59 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 118.229 0.468 . . . . 0.0 110.019 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.38 27.14 73.92 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 163.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.38 -170.58 43.72 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 172.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -111.62 146.38 37.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.35 124.54 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 121.003 0.43 . . . . 0.0 110.087 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -118.93 101.0 7.73 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.37 -41.82 76.01 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 50.4 m -56.82 -24.93 54.5 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -175.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.541 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 13.5 m -70.36 -17.75 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 118.583 0.629 . . . . 0.0 111.605 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 38' ' ' LYS . 21.2 mt -107.05 17.6 22.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.791 0.836 . . . . 0.0 111.136 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 110' ' ' SER . 8.0 pt-20 -114.46 -10.64 12.57 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.044 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 78.63 127.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 C-N-CA 124.527 1.131 . . . . 0.0 110.451 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -158.88 -172.39 3.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.554 1.142 . . . . 0.0 109.408 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.38 -47.58 83.53 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.284 0.634 . . . . 0.0 111.362 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.08 -44.04 95.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.187 0.595 . . . . 0.0 110.967 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -59.97 -43.92 94.78 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.128 0.893 . . . . 0.0 110.389 177.012 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.01 -50.05 31.91 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.353 -167.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -64.96 -54.5 29.51 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -172.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 33' ' ' ASP . 1.2 pp -64.44 -33.09 75.06 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.14 0.275 . . . . 0.0 111.17 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.526 ' HA ' HD11 ' A' ' 125' ' ' ILE . 1.9 mt -53.84 -32.66 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 124.052 0.941 . . . . 0.0 112.048 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -64.51 -36.5 84.38 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.498 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.62 -56.69 18.73 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.526 HD11 ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -70.0 -52.92 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.328 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.424 ' HD2' HG23 ' A' ' 122' ' ' ILE . 23.6 m-85 -83.58 -33.07 25.48 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -170.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? 61.53 69.55 0.64 Allowed 'General case' 0 C--N 1.35 0.592 0 O-C-N 124.403 1.064 . . . . 0.0 110.586 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.42 115.07 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.573 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 53.8 mmm-85 -86.35 39.0 0.8 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.603 0.761 . . . . 0.0 111.74 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -167.38 139.73 5.88 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -94.83 -175.0 3.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.46 0.704 . . . . 0.0 110.582 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.13 -138.54 14.33 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -173.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -91.33 125.09 35.98 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.06 -32.12 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.892 0.877 . . . . 0.0 111.861 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.67 -53.48 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.178 0.514 . . . . 0.0 109.971 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 28.5 mm-40 -70.04 -37.14 75.49 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.83 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -76.91 -29.44 55.7 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 123.561 0.538 . . . . 0.0 111.817 -172.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.56 -36.15 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 172.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.9 mp -60.49 -38.11 83.25 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.423 0.689 . . . . 0.0 110.646 172.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 31.4 mm-40 -59.65 -51.41 69.93 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.136 0.574 . . . . 0.0 110.955 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -49.19 78.2 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.557 0.743 . . . . 0.0 112.249 -175.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.9 pt -70.18 -27.59 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 122.972 0.509 . . . . 0.0 110.683 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.92 -31.94 34.86 Favored 'General case' 0 C--O 1.206 -1.233 0 C-N-CA 122.848 0.459 . . . . 0.0 110.531 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.8 tp -72.37 3.06 5.13 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.092 0.957 . . . . 0.0 112.177 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.4 mt -103.14 -50.65 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.154 0.982 . . . . 0.0 109.188 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -93.23 -3.35 53.91 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.656 0.741 . . . . 0.0 111.169 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 49.2 tp -144.08 60.66 1.36 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -57.74 163.75 2.42 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.784 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -109.53 -2.81 17.37 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.514 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.249 1.067 0 C-N-CA 123.801 0.84 . . . . 0.0 109.71 177.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.44 174.14 14.24 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.298 1.039 . . . . 0.0 109.053 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -57.91 -39.84 78.93 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.305 0.378 . . . . 0.0 110.141 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.593 ' HA ' HD22 ' A' ' 42' ' ' LEU . 14.4 m-20 -132.18 93.99 24.83 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 167.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.643 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 35.9 Cg_endo -59.81 -53.46 3.22 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.912 2.408 . . . . 0.0 112.859 -173.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.643 ' SD ' ' HG2' ' A' ' 5' ' ' PRO . 1.4 mpt? -89.63 168.53 12.06 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.517 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 63.0 mt -101.77 106.15 19.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -171.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.516 HG12 ' HB ' ' A' ' 41' ' ' VAL . 3.7 mp -103.29 122.63 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 170.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.427 HH11 HG23 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -124.19 149.61 46.14 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -174.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' N ' HD11 ' A' ' 112' ' ' LEU . . . -104.8 137.32 13.58 Favored Glycine 0 CA--C 1.501 -0.792 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.0 tt -146.83 142.94 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.291 0.567 . . . . 0.0 111.093 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -122.56 132.28 54.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.352 1.461 . . . . 0.0 108.906 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.07 1.33 70.05 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.624 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.87 106.42 1.54 Allowed 'General case' 0 C--N 1.351 0.66 0 C-N-CA 124.287 1.035 . . . . 0.0 111.352 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -74.78 104.08 5.28 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.198 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.483 HD11 HG21 ' A' ' 86' ' ' VAL . 49.9 mm -71.25 98.2 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.687 0.756 . . . . 0.0 109.253 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -112.26 153.05 27.74 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.453 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -67.15 -12.12 59.13 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.561 0.744 . . . . 0.0 112.349 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -67.03 -33.26 75.16 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.014 0.926 . . . . 0.0 111.83 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.6 pt -55.23 -22.57 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -87.36 -21.82 25.44 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.448 0.567 . . . . 0.0 111.409 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -77.35 -16.21 59.01 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.22 0.608 . . . . 0.0 112.025 -170.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 99' ' ' ILE . 1.2 pp -80.3 -8.92 59.69 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.974 0.51 . . . . 0.0 111.814 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.7 14.92 10.53 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.854 1.501 . . . . 0.0 116.854 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.56 159.27 32.4 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.577 0.688 . . . . 0.0 110.33 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -83.3 100.68 10.79 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -145.12 166.45 25.37 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.555 1.142 . . . . 0.0 108.7 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -149.95 151.78 33.91 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 162.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.415 HG12 HD13 ' A' ' 88' ' ' LEU . 27.3 mt -128.15 127.51 67.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.616 HD22 HD11 ' A' ' 89' ' ' ILE . 2.7 pt? -115.35 172.35 7.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -81.41 142.91 32.53 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.151 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 111' ' ' VAL . . . -78.61 0.64 25.6 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.16 -28.58 57.42 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.17 0.588 . . . . 0.0 111.082 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 HG11 HG22 ' A' ' 79' ' ' ILE . 32.4 m -107.46 -2.74 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.122 0.569 . . . . 0.0 112.484 -170.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.515 HG11 ' SG ' ' A' ' 87' ' ' CYS . 7.4 p -78.45 104.53 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.277 0.56 . . . . 0.0 109.557 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.5 -66.61 0.53 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.565 HG22 ' HA ' ' A' ' 113' ' ' GLU . 19.1 p -137.78 173.07 12.04 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.677 169.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' A' ' 112' ' ' LEU . 51.3 mtpt -53.98 -25.29 20.14 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.055 0.542 . . . . 0.0 111.678 165.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 10.7 mptt -57.74 -36.74 72.47 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.317 1.047 . . . . 0.0 111.959 172.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.409 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.2 t-80 -60.18 -49.82 76.12 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.211 0.945 . . . . 0.0 110.553 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.516 ' HB ' HG12 ' A' ' 8' ' ' ILE . 59.1 t -69.53 -54.04 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.271 177.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.593 HD22 ' HA ' ' A' ' 4' ' ' ASP . 1.8 pp -60.64 -36.8 79.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.001 0.521 . . . . 0.0 111.556 -172.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -58.92 -39.82 82.71 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.781 0.832 . . . . 0.0 111.454 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.04 -33.45 70.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.266 0.626 . . . . 0.0 110.693 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.537 HG12 HD13 ' A' ' 62' ' ' ILE . 43.0 mt -65.16 -44.28 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.386 0.675 . . . . 0.0 110.426 170.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -55.45 -40.42 71.55 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.797 0.839 . . . . 0.0 110.538 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -60.3 -43.79 95.98 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.519 1.137 . . . . 0.0 110.601 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.61 -28.13 66.64 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.55 0.74 . . . . 0.0 112.462 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -76.54 -42.1 44.23 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.572 0.349 . . . . 0.0 111.038 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.572 HG23 ' HG3' ' A' ' 51' ' ' LYS . 12.8 t -88.25 -31.69 18.9 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.392 0.277 . . . . 0.0 111.479 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.572 ' HG3' HG23 ' A' ' 50' ' ' THR . 39.9 mtmt -109.53 152.95 24.79 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.911 0.863 . . . . 0.0 112.752 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -139.23 81.84 20.27 Favored Pre-proline 0 CA--C 1.553 1.087 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.627 160.39 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -87.73 -78.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.278 2.652 . . . . 0.0 113.017 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.3 mt -123.89 -10.82 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 124.275 1.03 . . . . 0.0 108.939 -172.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HA ' HD11 ' A' ' 72' ' ' ILE . . . -65.06 147.34 53.64 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.954 0.902 . . . . 0.0 112.508 -172.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.654 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 75.9 mmtt -66.83 -33.44 75.61 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.566 0.747 . . . . 0.0 110.108 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.406 ' H ' ' HB2' ' A' ' 60' ' ' MET . 28.0 t -163.41 178.15 8.32 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.641 -175.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -51.94 -60.33 3.31 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.691 1.596 . . . . 0.0 111.481 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.402 ' HA ' HD12 ' A' ' 62' ' ' ILE . 78.6 m95 -66.83 -20.73 65.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.294 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.654 ' HG3' ' HB2' ' A' ' 56' ' ' LYS . 22.8 mmt -76.73 -28.55 55.84 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.349 0.66 . . . . 0.0 111.534 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 64' ' ' VAL . 51.6 tp10 -74.95 -32.08 61.65 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 120.641 0.257 . . . . 0.0 110.498 174.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.537 HD13 HG12 ' A' ' 45' ' ' ILE . 60.5 mt -62.01 -46.49 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.903 0.481 . . . . 0.0 110.833 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.492 HD21 ' SD ' ' A' ' 60' ' ' MET . 4.0 pp -71.91 -34.89 69.46 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.932 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 61' ' ' GLU . 36.0 m -73.94 -31.55 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 118.291 0.496 . . . . 0.0 111.811 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.513 ' HA ' ' NE ' ' A' ' 65' ' ' ARG . 12.6 mmp_? -77.28 -42.23 37.81 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.629 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.11 71.74 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.434 0.561 . . . . 0.0 111.048 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.1 p -86.57 -13.82 44.68 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 59.37 20.75 52.06 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 114.42 0.528 . . . . 0.0 114.42 -164.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -117.44 93.44 4.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.056 0.942 . . . . 0.0 108.929 -177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -59.35 -10.76 3.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -174.428 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -85.15 121.27 27.66 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 55' ' ' ALA . 27.6 mm -52.95 -54.88 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.696 1.198 . . . . 0.0 112.27 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -58.71 -50.96 71.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.73 0.812 . . . . 0.0 110.967 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.525 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 39.9 mm-40 -61.92 -40.0 93.96 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.053 0.846 . . . . 0.0 112.242 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.45 80.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.489 0.715 . . . . 0.0 111.788 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.1 -30.17 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 123.398 0.679 . . . . 0.0 110.808 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 58.5 mtpt -64.77 -49.12 71.98 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 122.108 -0.37 . . . . 0.0 110.781 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.84 -65.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.636 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.617 HG22 HG11 ' A' ' 34' ' ' VAL . 23.0 pt -104.36 11.21 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -169.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.13 155.15 50.33 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 118.921 0.782 . . . . 0.0 112.03 -172.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.09 54.5 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.676 0.791 . . . . 0.0 112.976 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -132.2 158.45 41.72 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -53.32 145.63 13.76 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 119.043 0.838 . . . . 0.0 112.611 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.17 -111.19 4.18 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.23 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -91.17 111.47 22.96 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.26 0.624 . . . . 0.0 109.85 -173.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 16' ' ' ILE . 3.7 m -138.75 -179.84 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.819 1.248 . . . . 0.0 111.426 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.515 ' SG ' HG11 ' A' ' 35' ' ' VAL . 78.0 m -133.89 125.35 28.13 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.495 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.455 HD21 ' HB ' ' A' ' 99' ' ' ILE . 11.7 tp -104.72 126.09 51.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.232 1.013 . . . . 0.0 109.686 -170.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.616 HD11 HD22 ' A' ' 30' ' ' LEU . 7.0 mt -109.45 122.78 64.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 114.302 -1.317 . . . . 0.0 107.45 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 9.4 p -143.43 152.15 41.21 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 122.776 0.43 . . . . 0.0 109.902 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.15 -46.35 84.48 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.283 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.401 ' OD2' ' HG2' ' A' ' 94' ' ' GLU . 1.5 p-10 -148.46 171.15 16.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.411 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -69.0 -22.58 64.07 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -168.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HG2' ' OD2' ' A' ' 92' ' ' ASP . 10.1 pt-20 -74.46 -41.73 60.28 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.098 0.863 . . . . 0.0 109.281 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m -58.49 -39.69 80.74 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.605 0.762 . . . . 0.0 110.819 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.697 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 14.1 t80 -56.55 -51.23 69.34 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 123.364 0.666 . . . . 0.0 110.719 175.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -63.93 -35.21 79.92 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.75 0.656 . . . . 0.0 110.822 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 10.7 mmpt? -64.59 -45.94 84.82 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.586 0.554 . . . . 0.0 111.571 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.487 HD13 HD21 ' A' ' 23' ' ' LEU . 44.4 mm -69.06 -44.57 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.395 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -53.31 -34.37 57.11 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.041 1.336 . . . . 0.0 112.182 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -60.25 -51.35 69.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.588 0.755 . . . . 0.0 111.561 174.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.66 -41.43 75.53 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.8 pt -77.89 -50.2 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 118.35 0.523 . . . . 0.0 110.775 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.04 114.33 0.04 OUTLIER Glycine 0 C--N 1.35 1.353 0 N-CA-C 113.883 0.313 . . . . 0.0 113.883 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.46 -159.88 24.81 Favored Glycine 0 C--O 1.241 0.589 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.2 143.18 49.27 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.3 0.55 . . . . 0.0 109.829 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.5 mm -71.22 129.1 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 122.928 0.491 . . . . 0.0 110.18 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -116.5 101.79 8.93 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -68.12 -53.5 24.89 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.1 0.56 . . . . 0.0 111.747 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.1 p -53.06 -30.03 33.5 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.546 HG21 ' HB1' ' A' ' 32' ' ' ALA . 10.3 p -65.3 -27.26 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 118.401 0.546 . . . . 0.0 111.44 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.459 HD11 ' N ' ' A' ' 10' ' ' GLY . 93.4 mt -80.46 -3.2 48.99 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.372 1.069 . . . . 0.0 112.503 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 37' ' ' THR . 12.8 pt-20 -135.95 23.57 3.31 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -169.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 118' ' ' LYS . 0.4 OUTLIER 77.74 138.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 124.242 1.017 . . . . 0.0 112.46 165.386 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 5.2 p-10 -151.16 -179.93 7.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.527 1.131 . . . . 0.0 109.517 170.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.81 -41.61 97.85 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.315 0.646 . . . . 0.0 111.943 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.514 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 0.1 OUTLIER -62.17 -41.72 98.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.592 1.157 . . . . 0.0 109.928 176.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -62.62 -40.01 95.62 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.047 0.842 . . . . 0.0 110.691 177.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.6 -48.41 48.3 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.345 -166.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -73.55 -39.45 64.69 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.172 0.589 . . . . 0.0 110.697 -174.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.8 tp -53.88 -53.15 56.65 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.278 1.431 . . . . 0.0 111.971 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.443 HG23 ' HD2' ' A' ' 126' ' ' PHE . 43.6 mt -62.44 -29.72 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.753 1.221 . . . . 0.0 111.309 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 5.4 tmm_? -72.41 -35.94 68.51 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.992 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.62 -55.99 12.75 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.63 -35.75 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 118.916 0.78 . . . . 0.0 113.075 -174.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.443 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.7 m-30 -88.39 -32.21 18.47 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 29.1 mmtp 63.84 75.86 0.37 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.176 0.99 . . . . 0.0 112.213 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.2 mt -98.26 121.19 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.524 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -91.86 99.13 12.04 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 141.59 120.14 1.6 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -86.65 -160.83 0.6 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.156 0.982 . . . . 0.0 109.533 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.66 -68.1 2.91 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -138.6 114.31 9.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.24 -25.87 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 123.474 0.71 . . . . 0.0 111.516 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.436 ' O ' HD13 ' A' ' 139' ' ' LEU . 85.1 t -68.64 -58.35 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.45 0.7 . . . . 0.0 111.667 -174.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -63.05 -29.05 70.51 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 117.742 0.246 . . . . 0.0 111.042 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.46 ' HA ' ' HG2' ' A' ' 140' ' ' GLU . 77.6 mtt-85 -75.97 -32.76 59.63 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 123.736 0.648 . . . . 0.0 112.187 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.0 p -73.82 -41.05 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 CA-C-N 118.218 0.463 . . . . 0.0 110.142 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 135' ' ' VAL . 11.2 mp -57.29 -42.4 81.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.535 0.734 . . . . 0.0 112.565 175.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 137' ' ' ARG . 13.5 pt-20 -80.73 -28.57 36.54 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.054 0.141 . . . . 0.0 110.971 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -59.82 -52.55 64.99 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.694 0.797 . . . . 0.0 110.679 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 13.6 pt -73.59 -17.12 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.056 -171.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.8 57.26 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.327 167.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.2 tp -75.5 -6.04 48.19 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.802 0.841 . . . . 0.0 111.822 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.464 HG22 ' HB2' ' A' ' 146' ' ' GLU . 1.7 mp -92.29 -55.81 5.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.464 ' HB2' HG22 ' A' ' 145' ' ' ILE . 1.6 tm-20 -146.72 78.95 1.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -173.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.5 HD13 ' HD3' ' A' ' 51' ' ' LYS . 57.2 tp -170.73 -60.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.009 164.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt 14.48 -145.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 126.012 1.725 . . . . 0.0 113.584 -158.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -135.98 74.0 1.49 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 149.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.25 1.095 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.271 -174.555 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 N-CA-C 112.131 -0.388 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.17 94.85 7.36 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.533 0.733 . . . . 0.0 109.826 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -69.47 -69.08 0.36 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.733 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.44 64.82 6.37 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.386 1.074 . . . . 0.0 109.68 -169.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.576 ' HD2' ' HB2' ' A' ' 42' ' ' LEU . 45.8 Cg_endo -64.01 -50.58 2.86 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 123.19 2.593 . . . . 0.0 113.335 -168.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.759 ' SD ' ' HG2' ' A' ' 91' ' ' GLU . 5.1 mmt -97.52 -175.48 3.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.547 0.739 . . . . 0.0 109.201 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.548 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 41.9 mt -96.95 102.98 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.27 122.65 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -124.65 145.87 49.41 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.039 0.935 . . . . 0.0 109.549 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.72 139.19 14.52 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.247 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.0 tt -152.48 144.07 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 122.849 0.46 . . . . 0.0 110.992 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -116.85 142.7 46.59 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.84 0.856 . . . . 0.0 109.308 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.34 11.24 85.7 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.56 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.59 95.21 1.06 Allowed 'General case' 0 C--N 1.351 0.639 0 C-N-CA 123.899 0.879 . . . . 0.0 110.604 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 51.8 mtm-85 -70.79 101.65 2.16 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.805 0.69 . . . . 0.0 109.599 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.585 HD11 HG11 ' A' ' 86' ' ' VAL . 48.2 mm -67.39 121.13 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.419 0.687 . . . . 0.0 110.377 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.43 HD21 HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -112.29 159.34 18.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.794 0.837 . . . . 0.0 109.855 175.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -77.28 -16.55 58.93 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.539 0.735 . . . . 0.0 112.213 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.95 -30.18 63.66 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.386 0.674 . . . . 0.0 112.685 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.43 HG23 HD21 ' A' ' 17' ' ' ASN . 8.3 pt -60.48 -12.47 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.15 0.23 56.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.993 0.517 . . . . 0.0 112.19 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -79.4 -25.09 42.16 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.221 0.464 . . . . 0.0 111.551 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pp -85.15 -14.44 47.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.996 0.518 . . . . 0.0 111.682 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.53 16.37 7.03 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 116.616 1.406 . . . . 0.0 116.616 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.7 mt -73.82 175.17 7.51 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 117.501 0.651 . . . . 0.0 111.457 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.93 81.21 2.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.048 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -139.7 145.95 39.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.002 0.921 . . . . 0.0 108.719 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.418 ' NE2' ' HB3' ' A' ' 63' ' ' LEU . 1.6 tm0? -142.15 136.68 30.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 171.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 86' ' ' VAL . 3.9 mt -127.21 129.74 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' H ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -131.34 171.05 13.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.748 0.819 . . . . 0.0 110.443 176.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -76.38 116.37 17.0 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.805 0.842 . . . . 0.0 109.906 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.27 3.47 51.95 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.08 -35.69 49.1 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 79' ' ' ILE . 26.8 m -97.88 5.86 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 122.902 0.481 . . . . 0.0 111.729 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.48 139.14 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.81 -69.34 0.53 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.4 p -136.63 172.88 12.36 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.719 0.808 . . . . 0.0 110.065 174.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -26.34 12.33 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.506 0.722 . . . . 0.0 112.311 170.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -54.73 -32.93 60.39 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.446 1.098 . . . . 0.0 112.202 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.582 ' HA ' HD11 ' A' ' 139' ' ' LEU . 30.2 t-80 -65.44 -47.48 76.05 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.728 0.811 . . . . 0.0 110.878 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.507 HG21 ' SG ' ' A' ' 87' ' ' CYS . 38.8 t -67.3 -50.92 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.029 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.576 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 3.1 pp -61.32 -34.6 75.52 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.039 0.535 . . . . 0.0 111.54 -175.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -55.21 -43.95 74.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.043 0.937 . . . . 0.0 110.734 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.8 78.39 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.796 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.512 HG12 HD13 ' A' ' 62' ' ' ILE . 63.5 mt -65.02 -53.38 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.028 0.931 . . . . 0.0 112.192 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -49.28 -44.66 44.14 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.923 0.889 . . . . 0.0 110.628 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -73.44 -31.62 63.92 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.293 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.84 -21.22 60.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.244 0.618 . . . . 0.0 112.323 174.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -78.11 -48.14 16.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.869 0.468 . . . . 0.0 110.332 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.53 HG23 ' HG3' ' A' ' 51' ' ' LYS . 10.9 t -88.98 -29.12 19.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.023 0.529 . . . . 0.0 112.268 -171.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.53 ' HG3' HG23 ' A' ' 50' ' ' THR . 49.1 mtmt -114.45 155.41 26.42 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.571 0.701 . . . . 0.0 112.229 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -140.06 73.13 32.93 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.336 167.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.23 -78.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.206 2.604 . . . . 0.0 114.164 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.69 -26.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.066 0.546 . . . . 0.0 111.645 -166.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.21 174.09 4.21 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -169.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -73.75 -53.62 9.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.447 0.699 . . . . 0.0 112.193 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.614 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 21.4 t -157.03 -171.73 3.76 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.408 0.683 . . . . 0.0 109.453 -174.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -53.95 -60.92 2.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.497 1.119 . . . . 0.0 113.268 -174.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.403 ' CE3' ' HB2' ' A' ' 28' ' ' GLN . 79.8 m95 -64.76 -29.62 70.6 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.014 0.435 . . . . 0.0 111.144 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.614 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.3 mpt? -77.18 -27.51 53.68 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.926 0.891 . . . . 0.0 110.455 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 11.3 tp10 -74.43 -34.08 63.12 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.893 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.512 HD13 HG12 ' A' ' 45' ' ' ILE . 72.9 mt -64.38 -47.07 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.145 0.578 . . . . 0.0 111.061 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.443 ' O ' HD11 ' A' ' 79' ' ' ILE . 3.4 pp -68.34 -33.39 74.22 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.215 0.322 . . . . 0.0 111.607 -175.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.438 HG13 HD12 ' A' ' 63' ' ' LEU . 35.0 m -77.16 -40.5 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 118.094 0.406 . . . . 0.0 110.986 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -70.0 -32.63 70.9 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.035 0.534 . . . . 0.0 111.709 -170.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.64 -30.87 70.55 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.186 0.594 . . . . 0.0 112.109 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.2 p -104.37 9.32 35.82 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.85 0.46 . . . . 0.0 112.225 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.72 23.7 65.55 Favored Glycine 0 C--N 1.358 1.787 0 CA-C-O 121.328 0.404 . . . . 0.0 113.965 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HB3' ' H ' ' A' ' 70' ' ' ARG . 88.2 mm-40 -89.8 -163.23 0.98 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.509 1.124 . . . . 0.0 112.512 -177.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -165.18 -34.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.628 1.571 . . . . 0.0 108.523 -165.189 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -101.98 121.98 43.18 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.928 0.891 . . . . 0.0 108.653 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 76' ' ' ILE . 1.8 mp -51.34 -45.78 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.587 1.179 . . . . 0.0 111.697 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -66.13 -40.58 90.77 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.265 0.626 . . . . 0.0 110.928 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.03 -47.39 81.01 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.311 0.644 . . . . 0.0 111.478 173.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.85 -35.47 74.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.209 0.604 . . . . 0.0 112.619 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 72' ' ' ILE . 71.4 mt -71.49 -29.89 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 122.991 0.516 . . . . 0.0 110.981 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -63.88 -54.88 27.9 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.012 0.434 . . . . 0.0 109.918 173.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.9 mt -73.29 -65.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.262 -173.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.455 HG22 HG21 ' A' ' 34' ' ' VAL . 23.2 pt -111.0 32.64 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.47 159.47 53.09 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 113.504 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.58 98.99 2.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.41 0.684 . . . . 0.0 110.961 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -109.97 153.15 24.96 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.94 0.896 . . . . 0.0 108.835 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.24 150.69 38.34 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.56 0.744 . . . . 0.0 112.492 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.34 -120.02 6.02 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.75 104.69 14.06 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.585 HG11 HD11 ' A' ' 16' ' ' ILE . 1.3 p -134.11 151.42 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.355 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.507 ' SG ' HG21 ' A' ' 41' ' ' VAL . 41.4 t -109.81 118.88 37.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.426 1.091 . . . . 0.0 108.99 -172.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.84 120.95 43.7 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.46 0.704 . . . . 0.0 110.153 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -107.12 137.21 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 21.8 p -152.42 151.78 31.21 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.985 0.514 . . . . 0.0 109.919 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.759 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 51.3 mt-10 -86.45 -32.23 20.95 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.31 128.89 56.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.003 0.921 . . . . 0.0 108.761 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -67.37 -21.38 65.62 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.315 0.646 . . . . 0.0 111.332 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 8.3 pt-20 -69.66 -40.02 76.7 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.667 0.387 . . . . 0.0 110.031 173.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 99' ' ' ILE . 99.0 m -63.55 -38.44 91.15 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.876 0.87 . . . . 0.0 109.878 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.688 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 11.6 t80 -56.96 -47.85 79.74 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.84 0.856 . . . . 0.0 110.973 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -61.54 -42.99 99.65 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.73 0.644 . . . . 0.0 110.34 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 45.6 mmtm -56.13 -45.9 79.4 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.171 0.92 . . . . 0.0 111.04 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 95' ' ' THR . 32.9 mm -69.84 -45.66 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.322 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -52.62 -43.41 65.37 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.88 1.272 . . . . 0.0 113.171 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.15 -48.27 80.78 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.777 0.673 . . . . 0.0 111.511 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.05 -36.18 56.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 pt -74.83 -39.83 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 118.311 0.505 . . . . 0.0 109.897 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.16 96.79 0.04 OUTLIER Glycine 0 C--N 1.351 1.368 0 O-C-N 123.635 0.585 . . . . 0.0 113.14 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.37 -171.36 25.09 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.16 131.03 55.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.6 mm -62.99 112.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -129.69 92.47 3.34 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 4.6 p-10 -60.27 -34.08 73.22 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.531 0.732 . . . . 0.0 111.81 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 23.8 m -52.86 -24.62 9.46 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -176.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.5 m -66.75 -32.19 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-N 118.204 0.457 . . . . 0.0 110.131 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.0 mt -95.72 -1.92 48.95 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.768 1.227 . . . . 0.0 112.253 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 110' ' ' SER . 76.0 mm-40 -103.78 -9.29 19.16 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 118.148 -0.93 . . . . 0.0 112.459 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.257 0.4 OUTLIER 84.82 135.64 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.983 1.313 . . . . 0.0 111.105 177.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 4.3 p-10 -159.77 170.77 20.8 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.832 1.253 . . . . 0.0 108.799 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.79 -37.62 85.02 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.59 0.756 . . . . 0.0 112.372 -168.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.507 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 16.1 t70 -54.87 -54.1 46.79 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.444 1.098 . . . . 0.0 112.219 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -63.1 -34.13 76.94 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.716 0.635 . . . . 0.0 110.881 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.85 -49.0 32.83 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.416 0.686 . . . . 0.0 112.159 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 67.6 mtp180 -75.22 -30.8 60.67 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.519 0.676 . . . . 0.0 110.942 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.5 tp -55.7 -48.03 75.81 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.219 165.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.422 HG23 ' HD2' ' A' ' 126' ' ' PHE . 25.2 mt -55.7 -35.11 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.229 1.012 . . . . 0.0 112.556 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -74.56 -26.53 60.01 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.951 -178.507 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -69.45 -58.47 3.95 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 171.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -29.49 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 119.192 0.906 . . . . 0.0 112.968 -174.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.422 ' HD2' HG23 ' A' ' 122' ' ' ILE . 23.2 m-85 -99.51 -26.24 14.17 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 68.3 mmtt 62.03 66.6 0.8 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.138 0.975 . . . . 0.0 112.506 171.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.507 HG21 ' HB3' ' A' ' 137' ' ' ARG . 16.9 mt -116.56 143.52 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 -176.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -34.75 -51.94 0.51 Allowed 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 125.285 1.434 . . . . 0.0 114.319 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.29 32.46 4.28 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -121.77 145.39 48.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.171 0.988 . . . . 0.0 110.03 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.97 -98.73 2.43 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.474 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.456 ' O ' ' HD3' ' A' ' 137' ' ' ARG . 1.7 t-20 -140.18 117.3 11.19 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.98 -31.41 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 119.124 0.875 . . . . 0.0 112.21 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.16 -53.94 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.798 0.839 . . . . 0.0 110.415 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -59.23 -42.6 91.4 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.333 0.396 . . . . 0.0 111.074 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.507 ' HB3' HG21 ' A' ' 128' ' ' ILE . 8.7 mpt_? -73.0 -31.67 64.65 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.949 0.781 . . . . 0.0 112.074 -167.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 139' ' ' LEU . 11.1 p -70.56 -42.56 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 117.706 0.23 . . . . 0.0 110.501 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 40' ' ' HIS . 10.9 mp -60.75 -39.67 89.61 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.567 0.542 . . . . 0.0 111.625 172.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.73 -44.43 93.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.618 0.767 . . . . 0.0 111.117 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -63.87 -45.99 86.97 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.018 0.527 . . . . 0.0 111.286 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 11.5 pt -75.6 -22.23 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.019 0.2 . . . . 0.0 110.62 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 148' ' ' LYS . . . -74.78 -20.09 59.94 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.569 0.748 . . . . 0.0 111.089 172.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.86 5.47 9.54 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 123.499 0.72 . . . . 0.0 110.228 174.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.6 -37.65 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 165.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.56 -13.11 61.69 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.356 1.063 . . . . 0.0 113.212 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.1 mt 71.27 49.79 0.31 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.451 1.101 . . . . 0.0 108.077 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.558 ' HB3' ' HB1' ' A' ' 143' ' ' ALA . 22.6 ttmm -137.62 159.83 40.88 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.646 -169.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -149.82 110.34 4.24 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 166.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 . . . . . 0 CA--C 1.558 1.282 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.219 -177.764 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.305 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.19 153.44 33.83 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.182 0.993 . . . . 0.0 109.377 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.7 mtm -78.09 -48.16 16.65 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -145.8 86.11 7.4 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.04 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 42' ' ' LEU . 49.3 Cg_endo -67.04 -39.32 14.0 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.496 2.131 . . . . 0.0 111.3 172.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.8 mmt -138.88 176.03 9.04 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.937 0.895 . . . . 0.0 109.568 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.6 mt -101.2 111.03 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.918 1.287 . . . . 0.0 109.271 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -107.08 127.26 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.468 ' HA ' ' NE ' ' A' ' 9' ' ' ARG . 2.9 mmp_? -128.15 149.89 50.23 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.718 0.807 . . . . 0.0 110.553 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.66 129.94 10.0 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.622 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 tt -141.18 147.04 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.148 0.579 . . . . 0.0 110.597 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -122.97 136.9 55.03 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.349 1.059 . . . . 0.0 109.419 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.36 7.91 87.01 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.36 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.508 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -76.03 104.03 6.37 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.547 0.739 . . . . 0.0 110.218 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -70.81 123.86 22.95 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.365 0.415 . . . . 0.0 110.148 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.8 mm -73.53 91.03 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.887 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.401 ' OD1' HG23 ' A' ' 20' ' ' ILE . 23.5 p30 -91.11 151.23 21.07 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.021 -177.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -63.92 -21.64 66.56 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -64.84 -29.85 70.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.405 0.682 . . . . 0.0 112.103 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.401 HG23 ' OD1' ' A' ' 17' ' ' ASN . 19.1 pt -54.37 -23.82 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -90.07 -19.45 24.33 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.284 0.493 . . . . 0.0 111.32 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.19 -22.23 63.91 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.976 0.91 . . . . 0.0 111.609 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.481 HD21 HD13 ' A' ' 99' ' ' ILE . 1.5 pp -81.95 -10.17 59.35 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.282 0.633 . . . . 0.0 111.965 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.16 16.96 9.65 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 23' ' ' LEU . 86.1 mt -82.39 176.57 9.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.283 0.633 . . . . 0.0 112.197 -174.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -87.56 93.44 9.42 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.102 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -145.66 160.32 41.87 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.111 0.964 . . . . 0.0 108.678 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 59' ' ' TRP . 6.6 tp-100 -148.64 153.23 38.01 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 166.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.85 137.98 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.424 HD22 HD11 ' A' ' 89' ' ' ILE . 2.2 pt? -128.16 -175.06 3.38 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.65 0.78 . . . . 0.0 109.389 170.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -89.22 120.1 30.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.784 0.834 . . . . 0.0 109.78 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.72 -5.27 56.84 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.886 0.874 . . . . 0.0 113.168 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -76.19 -33.63 59.31 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.408 HG21 HG22 ' A' ' 79' ' ' ILE . 3.3 m -105.19 9.5 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.321 0.649 . . . . 0.0 112.264 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.4 p -85.13 140.71 15.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.16 -62.16 1.57 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 113' ' ' GLU . 21.5 p -145.59 169.92 17.46 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.931 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HB3' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -53.71 -31.98 50.17 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.131 0.572 . . . . 0.0 110.649 162.364 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.539 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 85.5 tttt -66.99 -30.57 70.73 Favored 'General case' 0 C--N 1.36 1.059 0 C-N-CA 123.909 0.883 . . . . 0.0 111.52 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.554 ' HA ' HD11 ' A' ' 139' ' ' LEU . 16.8 t-80 -60.88 -46.75 89.38 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.091 0.556 . . . . 0.0 110.305 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 45' ' ' ILE . 38.8 t -67.64 -51.2 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 O-C-N 123.77 0.669 . . . . 0.0 111.671 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 3.2 pp -64.83 -30.13 71.12 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.516 ' NE2' ' HB2' ' A' ' 143' ' ' ALA . 35.7 t60 -65.39 -35.38 80.76 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.789 0.836 . . . . 0.0 111.119 172.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 65' ' ' ARG . . . -67.44 -34.79 77.93 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.592 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.424 HG12 HD13 ' A' ' 62' ' ' ILE . 19.8 mt -69.79 -35.94 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.931 0.892 . . . . 0.0 110.967 175.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.33 -53.98 51.93 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.246 0.618 . . . . 0.0 109.594 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.445 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 29.1 mm-40 -60.46 -30.47 69.68 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.672 1.189 . . . . 0.0 112.079 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.5 -27.32 66.03 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -89.24 -16.81 30.38 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.443 0.64 . . . . 0.0 109.831 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.0 m -91.49 -43.92 9.41 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.393 1.477 . . . . 0.0 111.041 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 10.3 mmpt? -114.23 141.94 46.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.133 0.973 . . . . 0.0 112.533 -174.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -123.64 88.65 51.81 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 124.834 1.254 . . . . 0.0 107.988 165.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.15 -107.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.643 2.229 . . . . 0.0 111.941 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.1 mt -126.21 13.18 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.33 146.45 53.46 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.595 0.758 . . . . 0.0 111.688 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.67 -47.39 86.49 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.594 0.757 . . . . 0.0 111.291 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.1 m -147.63 172.18 14.45 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.856 0.863 . . . . 0.0 110.201 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.72 -52.73 64.25 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.453 1.101 . . . . 0.0 110.944 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 28' ' ' GLN . 83.8 m95 -67.43 -29.09 68.48 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.118 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.444 ' SD ' HD21 ' A' ' 63' ' ' LEU . 23.3 mmt -71.72 -28.45 63.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.153 0.581 . . . . 0.0 111.665 174.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 64' ' ' VAL . 44.8 tp10 -71.05 -27.93 64.01 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.757 0.423 . . . . 0.0 110.398 174.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 HG12 ' A' ' 45' ' ' ILE . 67.5 mt -66.25 -45.64 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.657 0.383 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.451 HD23 ' NE2' ' A' ' 28' ' ' GLN . 4.4 pp -69.77 -32.76 71.44 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.156 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.675 ' HB ' ' H ' ' A' ' 70' ' ' ARG . 10.0 m -78.33 -40.78 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 122.498 -0.126 . . . . 0.0 111.294 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.471 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 6.6 tpt180 -67.9 -39.99 83.53 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 122.494 0.318 . . . . 0.0 111.025 -169.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.03 -14.28 60.03 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 124.036 0.835 . . . . 0.0 112.308 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 p -108.85 26.78 10.18 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.464 0.706 . . . . 0.0 111.546 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 26.13 53.29 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-O 119.619 -0.545 . . . . 0.0 114.297 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 55.99 113.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.269 1.427 . . . . 0.0 113.104 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.675 ' H ' ' HB ' ' A' ' 64' ' ' VAL . 2.8 mpt_? -140.04 172.54 12.62 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.973 1.709 . . . . 0.0 109.256 -173.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -57.13 135.99 56.38 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.97 159.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.14 -49.94 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.404 1.082 . . . . 0.0 111.957 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.77 -37.36 86.11 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.482 0.489 . . . . 0.0 110.52 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -63.28 -46.91 84.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.771 0.428 . . . . 0.0 112.084 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.53 71.54 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.883 0.473 . . . . 0.0 112.114 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.51 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 84.9 mt -64.51 -32.31 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.464 0.706 . . . . 0.0 110.554 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -72.49 -50.87 22.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.697 0.399 . . . . 0.0 110.066 174.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.576 HG22 HG23 ' A' ' 79' ' ' ILE . 43.9 mt -66.69 -65.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.8 0.84 . . . . 0.0 111.791 -173.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.576 HG23 HG22 ' A' ' 78' ' ' ILE . 38.6 pt -124.0 21.15 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 76' ' ' ILE . . . -76.36 156.78 47.22 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.09 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.26 113.97 1.46 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.82 0.848 . . . . 0.0 112.602 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -135.55 153.16 51.79 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.92 124.59 15.88 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.589 1.156 . . . . 0.0 112.755 -170.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.32 -118.26 1.58 Allowed Glycine 0 C--N 1.352 1.432 0 O-C-N 123.434 0.459 . . . . 0.0 112.379 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -84.25 108.14 16.95 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.26 159.98 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.959 0.885 . . . . 0.0 112.674 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.8 m -112.51 118.44 35.14 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.811 -1.54 . . . . 0.0 108.265 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.541 HD21 ' HB ' ' A' ' 99' ' ' ILE . 10.4 tp -102.63 121.19 41.91 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.32 0.648 . . . . 0.0 109.328 -174.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 28' ' ' GLN . 4.8 mt -111.48 125.6 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.902 1.281 . . . . 0.0 108.242 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 74.3 m -148.79 145.95 27.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.158 0.583 . . . . 0.0 109.746 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 -27.36 59.32 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.43 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 28.7 m-20 -131.27 148.92 52.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.287 0.635 . . . . 0.0 111.683 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.09 -25.17 65.21 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.944 1.298 . . . . 0.0 112.764 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 11.2 pt-20 -69.2 -43.27 74.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.788 0.435 . . . . 0.0 110.089 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 m -70.21 -33.08 71.25 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.708 0.803 . . . . 0.0 110.598 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -60.99 -50.96 71.28 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 45.0 ttp180 -59.86 -45.08 93.58 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.886 0.741 . . . . 0.0 109.862 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -59.44 -42.21 91.4 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.097 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.541 ' HB ' HD21 ' A' ' 88' ' ' LEU . 35.6 mm -71.9 -43.66 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -55.18 -37.83 67.55 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 124.596 1.158 . . . . 0.0 112.509 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 46.5 mt-10 -61.26 -39.25 89.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.684 0.794 . . . . 0.0 111.204 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.13 -47.46 35.96 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.691 0.797 . . . . 0.0 112.272 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.508 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 18.2 pt -79.91 -28.95 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 122.068 0.147 . . . . 0.0 110.992 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.32 25.73 70.08 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.044 1.177 . . . . 0.0 116.044 160.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.32 -170.16 46.3 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 117.047 0.423 . . . . 0.0 112.513 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -104.71 140.45 38.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.604 0.762 . . . . 0.0 108.996 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mm -73.04 119.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.162 0.506 . . . . 0.0 109.79 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 111' ' ' VAL . 14.7 t70 -131.54 91.49 3.01 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.87 -32.61 73.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.958 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.591 ' HA ' ' HG3' ' A' ' 113' ' ' GLU . 12.1 p -58.34 -15.4 10.32 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 108' ' ' ASP . 35.4 m -66.42 -24.69 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 118.709 0.686 . . . . 0.0 110.888 171.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 38' ' ' LYS . 67.1 mt -99.65 18.23 18.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.827 1.251 . . . . 0.0 112.593 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.591 ' HG3' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -138.48 12.67 2.76 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 76.02 124.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.825 0.85 . . . . 0.0 112.375 168.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 3.3 p-10 -142.87 177.16 8.53 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.197 173.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -61.88 -42.1 98.66 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.071 0.948 . . . . 0.0 111.52 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 24.8 t70 -59.08 -47.37 85.5 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.048 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -67.01 -31.75 72.52 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.33 0.652 . . . . 0.0 111.142 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.76 -51.28 28.15 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.068 0.547 . . . . 0.0 111.364 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.33 -39.08 71.58 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.494 0.664 . . . . 0.0 110.131 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.1 tp -54.22 -52.87 59.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.315 1.446 . . . . 0.0 112.415 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.42 HG23 ' HD2' ' A' ' 126' ' ' PHE . 15.6 mt -57.96 -30.14 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.566 1.146 . . . . 0.0 111.282 177.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.4 ttm180 -72.05 -33.68 68.16 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.39 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 127' ' ' LYS . 12.4 mm-40 -73.67 -56.51 4.92 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 173.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 pp -78.38 -30.52 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.42 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.1 m-30 -95.85 -30.5 13.63 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 119.358 -0.354 . . . . 0.0 111.539 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 26.2 mmmt 61.97 74.66 0.43 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.746 0.818 . . . . 0.0 111.848 176.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.5 mt -124.92 127.75 72.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.637 0.775 . . . . 0.0 109.463 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -77.83 101.93 6.98 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 167.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -88.59 -173.84 47.06 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.651 -0.25 . . . . 0.0 112.969 -173.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -136.72 -61.58 0.67 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.442 0.697 . . . . 0.0 109.774 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.93 -68.1 0.03 OUTLIER Glycine 0 N--CA 1.471 1.01 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.081 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 137' ' ' ARG . 4.0 t-20 -94.42 115.28 27.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.109 0.564 . . . . 0.0 109.971 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.02 -29.14 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.389 1.076 . . . . 0.0 112.476 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.12 -51.51 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.219 0.608 . . . . 0.0 110.592 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -63.55 -30.46 71.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.633 0.373 . . . . 0.0 111.441 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 133' ' ' ASN . 4.2 mmp_? -69.61 -47.7 62.55 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.107 0.563 . . . . 0.0 110.975 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.8 p -72.66 -36.59 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.82 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.554 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.0 mp -58.59 -37.21 75.33 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.149 0.98 . . . . 0.0 111.88 173.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -67.31 -41.59 85.09 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.3 0.375 . . . . 0.0 111.341 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -72.84 -42.52 63.69 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 120.876 0.37 . . . . 0.0 111.834 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 29.9 pt -74.77 -24.04 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.516 ' HB2' ' NE2' ' A' ' 43' ' ' HIS . . . -93.29 -15.48 25.75 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.168 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -47.28 -45.7 24.26 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.584 1.154 . . . . 0.0 112.256 -165.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 64.8 mt -49.02 -41.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.581 1.153 . . . . 0.0 113.162 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.404 ' HB2' HH22 ' A' ' 65' ' ' ARG . 5.5 tm-20 -93.91 -61.74 1.48 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.577 0.751 . . . . 0.0 109.574 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 31.4 tp -91.31 36.08 0.93 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.082 1.353 . . . . 0.0 111.847 -167.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -67.04 160.28 26.91 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.405 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -92.67 31.94 1.3 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.19 0.519 . . . . 0.0 110.593 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 C--O 1.252 1.237 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 -179.41 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.674 -0.17 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.93 104.27 5.46 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.362 0.665 . . . . 0.0 109.329 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mpp? 95.97 21.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 126.58 1.952 . . . . 0.0 108.276 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -153.61 81.59 4.84 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.583 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 60.2 Cg_endo -69.27 -63.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.616 2.211 . . . . 0.0 113.187 -169.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.583 ' SD ' ' HG2' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -95.9 175.14 6.61 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.188 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 74.3 mt -109.1 101.4 12.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.3 mm -110.21 124.11 66.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -121.58 145.12 48.3 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.79 137.62 13.49 Favored Glycine 0 CA--C 1.5 -0.875 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.4 tt -148.85 138.64 16.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.336 0.588 . . . . 0.0 110.357 -173.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -125.34 126.82 45.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.813 1.245 . . . . 0.0 108.714 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.96 -0.11 57.5 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 123.377 0.423 . . . . 0.0 112.565 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.8 94.37 0.45 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.22 1.008 . . . . 0.0 110.823 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -68.89 104.18 2.0 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.577 HD11 HG21 ' A' ' 86' ' ' VAL . 44.6 mm -72.61 120.78 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -176.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.47 ' ND2' HG23 ' A' ' 20' ' ' ILE . 3.4 p-10 -104.08 156.1 18.15 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -81.8 -14.58 56.18 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.099 0.559 . . . . 0.0 111.63 -174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -76.5 -17.21 59.39 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.161 0.984 . . . . 0.0 111.45 -172.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.47 HG23 ' ND2' ' A' ' 17' ' ' ASN . 30.3 pt -53.91 -19.81 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 172.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -83.32 -17.93 40.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.082 0.553 . . . . 0.0 111.94 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -91.35 47.05 1.34 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.074 0.94 . . . . 0.0 109.716 -169.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -139.29 -11.99 1.21 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.311 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.67 33.32 55.0 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 114.513 0.565 . . . . 0.0 114.513 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' HB2' HD13 ' A' ' 23' ' ' LEU . 67.2 mt -102.97 167.38 9.88 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.423 0.689 . . . . 0.0 110.715 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HB3' ' HZ2' ' A' ' 59' ' ' TRP . 60.2 mttp -81.87 91.49 6.55 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.935 0.894 . . . . 0.0 111.31 -176.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.53 158.36 43.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.068 0.547 . . . . 0.0 109.92 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.512 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.6 tm0? -149.26 149.81 31.55 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 165.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 99' ' ' ILE . 16.3 mt -132.18 131.8 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.35 -176.12 3.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.825 0.85 . . . . 0.0 109.447 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -80.68 141.78 34.57 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.844 0.858 . . . . 0.0 109.732 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.23 7.8 45.52 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.3 0.64 . . . . 0.0 112.706 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -88.83 -19.89 25.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.316 0.647 . . . . 0.0 110.855 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 m -111.91 7.31 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.061 0.945 . . . . 0.0 111.641 -176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.2 102.55 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 121.91 0.862 . . . . 0.0 109.971 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.597 ' HB3' HG11 ' A' ' 138' ' ' VAL . . . -79.17 74.83 5.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p 62.69 162.25 0.09 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.63 1.972 . . . . 0.0 111.677 -166.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . 25.3 pttm -53.17 -22.49 6.59 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.506 0.723 . . . . 0.0 111.542 169.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.568 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 56.8 tttp -64.45 -28.42 69.66 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 123.187 0.595 . . . . 0.0 111.541 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.506 ' HA ' HD11 ' A' ' 139' ' ' LEU . 11.7 t-160 -62.73 -45.53 92.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.021 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 45' ' ' ILE . 42.3 t -67.68 -55.17 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 123.735 0.647 . . . . 0.0 111.195 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 4.1 pp -60.02 -32.69 71.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.095 0.558 . . . . 0.0 112.395 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.467 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 33.9 t-80 -65.75 -40.77 92.45 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.372 0.669 . . . . 0.0 110.479 173.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.91 87.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.954 0.502 . . . . 0.0 110.789 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.552 HG12 HD13 ' A' ' 62' ' ' ILE . 33.8 mt -64.9 -46.59 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.232 1.013 . . . . 0.0 110.76 175.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -49.0 -48.39 43.58 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.44 1.496 . . . . 0.0 111.084 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 25.8 mm-40 -63.67 -47.24 82.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.089 176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.79 -28.71 69.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.462 0.705 . . . . 0.0 112.556 -175.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HE2' HG22 ' A' ' 45' ' ' ILE . 68.2 mttm -66.11 -43.69 86.49 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.279 0.632 . . . . 0.0 110.925 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.1 t -80.17 -16.82 54.01 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.799 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 51.3 mtpt -99.28 146.95 25.68 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.999 0.92 . . . . 0.0 112.27 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -142.96 72.86 18.67 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.577 161.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 51' ' ' LYS . 56.2 Cg_endo -84.25 -177.04 2.82 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.657 2.238 . . . . 0.0 111.852 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.5 mt -37.04 -22.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.464 ' HA ' HD11 ' A' ' 72' ' ' ILE . . . -53.21 125.42 17.51 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.446 0.698 . . . . 0.0 110.787 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -57.02 -22.26 37.34 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -167.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.623 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 41.9 t -157.36 167.29 30.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.214 0.606 . . . . 0.0 110.114 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -58.73 -50.16 74.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.589 1.156 . . . . 0.0 110.467 170.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.466 ' HA ' HD12 ' A' ' 62' ' ' ILE . 81.7 m95 -64.54 -30.99 72.02 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.651 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.753 ' HB3' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -78.81 -21.03 48.35 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.907 0.883 . . . . 0.0 111.316 176.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -35.52 64.25 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 173.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 HG12 ' A' ' 45' ' ' ILE . 77.5 mt -65.58 -42.36 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.722 0.809 . . . . 0.0 112.344 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.5 ' HB3' ' NE2' ' A' ' 28' ' ' GLN . 3.2 pp -71.53 -34.03 69.69 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 122.998 0.186 . . . . 0.0 110.879 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.97 -38.11 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.414 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.531 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 0.3 OUTLIER -66.48 -50.22 64.02 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 122.816 0.447 . . . . 0.0 110.659 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.29 68.51 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.225 0.61 . . . . 0.0 112.06 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 t -88.68 -0.2 57.05 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.712 0.805 . . . . 0.0 112.506 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.89 17.76 65.65 Favored Glycine 0 C--N 1.354 1.564 0 N-CA-C 114.485 0.554 . . . . 0.0 114.485 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.774 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 46.5 tp60 -107.91 164.96 11.82 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.609 1.164 . . . . 0.0 109.63 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -114.36 -6.2 12.92 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 123.038 0.535 . . . . 0.0 111.508 167.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.774 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 17.0 mm-40 -103.94 119.03 38.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.427 1.091 . . . . 0.0 110.684 -173.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.753 HD12 ' HB3' ' A' ' 60' ' ' MET . 34.7 mm -52.92 -53.02 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 124.736 1.273 . . . . 0.0 112.386 -173.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 73.7 m80 -61.09 -50.17 74.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.59 -173.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.27 -44.56 84.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.227 0.611 . . . . 0.0 112.091 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.03 94.19 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.68 -31.84 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 122.918 0.487 . . . . 0.0 110.612 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 73' ' ' HIS . 32.3 mmmt -67.13 -50.24 62.07 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.814 0.446 . . . . 0.0 110.46 175.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 56.6 mt -70.66 -67.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.762 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.2 pt -108.83 20.63 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -170.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.25 172.15 45.04 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 119.018 0.826 . . . . 0.0 112.92 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.97 144.18 26.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.18 0.592 . . . . 0.0 111.314 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -154.45 167.56 29.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.748 1.219 . . . . 0.0 108.25 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.02 127.27 23.37 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.074 0.95 . . . . 0.0 111.853 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.4 -116.3 2.5 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.371 0.419 . . . . 0.0 112.533 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -88.93 107.39 18.99 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.661 0.785 . . . . 0.0 109.373 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 16' ' ' ILE . 15.8 m -135.7 167.98 23.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-O 121.912 0.863 . . . . 0.0 111.976 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 69.9 m -119.02 117.58 29.17 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.375 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 tp -100.04 123.48 44.34 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.272 0.629 . . . . 0.0 109.326 -175.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 28' ' ' GLN . 30.3 mt -109.34 137.21 42.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.195 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.741 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 26.5 p -156.84 157.69 35.41 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.578 0.751 . . . . 0.0 109.288 171.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -88.77 -28.2 20.64 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.872 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.498 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 23.8 m-20 -124.83 139.74 53.56 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.218 1.007 . . . . 0.0 110.962 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.14 -24.38 64.66 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.94 0.896 . . . . 0.0 112.435 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.498 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 11.2 pt-20 -68.31 -44.1 76.15 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.3 m -68.01 -35.87 79.02 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.599 0.76 . . . . 0.0 111.345 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.741 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 11.0 t80 -58.25 -48.05 81.66 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 122.889 0.476 . . . . 0.0 109.826 173.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -57.85 -47.58 82.29 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.298 0.999 . . . . 0.0 110.514 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 42.1 mmtm -53.83 -48.36 70.0 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 124.191 0.932 . . . . 0.0 111.469 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' A' ' 20' ' ' ILE . 44.1 mm -71.68 -44.72 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.065 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -55.05 -44.52 74.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.499 1.119 . . . . 0.0 112.851 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -60.07 -42.5 94.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.584 0.754 . . . . 0.0 110.248 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 98' ' ' LYS . 4.5 mm? -65.89 -51.67 56.74 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.0 pt -73.61 -42.56 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 117.915 0.325 . . . . 0.0 111.671 -167.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.13 103.32 0.03 OUTLIER Glycine 0 C--N 1.347 1.162 0 O-C-N 123.262 0.352 . . . . 0.0 113.584 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.31 -174.54 39.11 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.35 126.31 45.2 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.727 0.811 . . . . 0.0 109.334 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.6 mm -68.51 122.48 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.426 ' O ' HG12 ' A' ' 111' ' ' VAL . 12.5 t70 -135.24 98.68 4.04 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.718 1.207 . . . . 0.0 108.216 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -68.24 -31.15 70.43 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.975 0.51 . . . . 0.0 111.887 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.716 ' HA ' ' HG2' ' A' ' 113' ' ' GLU . 46.9 t -52.73 -31.45 37.89 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.673 HG23 ' HE3' ' A' ' 118' ' ' LYS . 2.6 p -69.31 -29.62 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 122.7 0.4 . . . . 0.0 110.28 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 28.5 mt -95.15 9.89 37.96 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.8 0.84 . . . . 0.0 112.153 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.716 ' HG2' ' HA ' ' A' ' 110' ' ' SER . 8.4 pt-20 -120.76 4.11 10.57 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.96 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.267 0.5 OUTLIER 76.15 138.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.092 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 172.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 26.6 p-10 -136.89 171.5 14.4 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 113.154 -1.839 . . . . 0.0 108.036 170.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.97 -31.36 70.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.173 0.589 . . . . 0.0 112.223 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.416 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 19.3 t70 -60.27 -53.14 61.22 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.113 0.965 . . . . 0.0 112.31 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HE3' HG23 ' A' ' 111' ' ' VAL . 63.7 mttm -74.88 -20.69 59.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.324 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.496 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 42.8 tt0 -72.82 -43.73 62.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.332 0.653 . . . . 0.0 111.522 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -72.07 -33.97 68.34 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.095 0.558 . . . . 0.0 110.588 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.1 -49.58 76.44 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.461 1.104 . . . . 0.0 111.143 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 36' ' ' ALA . 24.4 mt -57.35 -40.67 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.353 1.061 . . . . 0.0 112.051 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -74.66 -23.34 58.64 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 119.156 -0.45 . . . . 0.0 111.167 -176.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 127' ' ' LYS . 48.5 mt-10 -73.42 -55.14 6.76 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 169.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.42 -31.76 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 CA-C-N 120.573 1.533 . . . . 0.0 112.777 -176.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -88.72 -30.29 19.21 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 124' ' ' GLU . 38.9 mmtm 63.42 75.51 0.39 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.386 1.075 . . . . 0.0 112.484 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.515 HG21 ' HG3' ' A' ' 137' ' ' ARG . 14.2 mt -109.68 109.33 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -76.61 -37.62 56.13 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.83 0.852 . . . . 0.0 110.81 -173.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -91.36 124.42 7.59 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -149.54 113.82 5.21 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.686 1.243 . . . . 0.0 112.182 -170.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -103.03 -83.61 1.73 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 161.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.567 HD21 ' HB2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -96.58 158.93 15.2 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 166.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.496 ' HB ' ' HG3' ' A' ' 119' ' ' GLU . 13.6 p -76.4 -33.85 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.425 ' O ' HD13 ' A' ' 139' ' ' LEU . 60.4 t -65.37 -59.8 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.565 0.746 . . . . 0.0 112.153 -164.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.567 ' HB2' HD21 ' A' ' 133' ' ' ASN . 37.7 mt-10 -73.2 -28.73 62.35 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.81 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.515 ' HG3' HG21 ' A' ' 128' ' ' ILE . 20.2 tpt180 -77.35 -32.48 55.11 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.502 -170.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 36' ' ' ALA . 14.2 p -72.24 -33.87 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 40' ' ' HIS . 2.5 mp -54.76 -38.89 67.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.254 1.021 . . . . 0.0 111.044 170.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -67.61 -37.86 83.12 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.643 0.777 . . . . 0.0 111.171 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -68.58 -48.7 63.51 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 111.503 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 26.6 pt -78.53 -10.53 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.816 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.74 -20.63 29.01 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.743 171.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.79 10.33 1.17 Allowed 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.849 0.859 . . . . 0.0 112.416 -170.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.8 mp -91.96 -46.37 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -122.73 -14.23 7.75 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.11 0.964 . . . . 0.0 111.822 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.18 42.75 2.15 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -40.31 122.27 1.53 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.433 1.493 . . . . 0.0 113.295 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -93.76 -3.46 52.12 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.902 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.249 1.033 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.536 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.415 ' SD ' ' HG2' ' A' ' 91' ' ' GLU . 24.3 mmt . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.9 mt -101.39 103.56 15.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.1 mp -109.72 121.39 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -131.81 145.46 51.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.78 0.832 . . . . 0.0 109.084 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.38 124.63 8.18 Favored Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.2 tt -130.68 138.89 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 122.801 0.44 . . . . 0.0 109.869 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -129.3 124.14 33.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.839 0.855 . . . . 0.0 108.798 -172.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.41 2.36 56.64 Favored Glycine 0 N--CA 1.467 0.762 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.997 -170.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -74.44 98.17 3.25 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 123.792 0.837 . . . . 0.0 111.188 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.542 ' HA ' ' HB2' ' A' ' 83' ' ' ASP . 70.7 mtp180 -73.81 107.36 6.0 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.956 0.502 . . . . 0.0 110.616 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.548 HD11 HG11 ' A' ' 86' ' ' VAL . 49.6 mm -69.49 122.96 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.891 0.877 . . . . 0.0 110.79 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.27 165.64 18.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.519 0.728 . . . . 0.0 109.352 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -73.2 -17.0 61.41 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.39 -31.62 68.93 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.503 0.721 . . . . 0.0 111.795 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.567 HD12 HD12 ' A' ' 29' ' ' ILE . 16.0 pt -52.13 -28.35 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -90.11 -20.07 23.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.55 0.34 . . . . 0.0 111.303 -176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -76.81 -12.46 59.98 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.503 0.721 . . . . 0.0 111.83 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -81.0 -8.59 59.81 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.679 0.391 . . . . 0.0 111.776 176.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.48 19.08 17.16 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 23' ' ' LEU . 98.5 mt -81.66 174.74 11.09 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.493 0.646 . . . . 0.0 110.394 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -90.18 96.49 10.69 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.228 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -147.68 157.59 43.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.702 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.576 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -138.26 147.1 43.3 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 167.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.567 HD12 HD12 ' A' ' 20' ' ' ILE . 35.6 mt -132.29 121.6 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.567 ' HB3' HE22 ' A' ' 28' ' ' GLN . 4.2 pp -121.57 177.8 5.08 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' HB3' HG22 ' A' ' 34' ' ' VAL . 38.6 t-20 -75.71 119.46 19.76 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.654 0.782 . . . . 0.0 110.038 -173.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.42 -1.52 41.81 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.571 ' HA ' ' NZ ' ' A' ' 118' ' ' LYS . 37.8 t70 -79.67 -32.41 41.52 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.495 0.188 . . . . 0.0 110.522 176.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.522 HG21 HG22 ' A' ' 79' ' ' ILE . 27.7 m -98.75 -2.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.873 0.869 . . . . 0.0 112.538 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.486 HG11 HD23 ' A' ' 112' ' ' LEU . 10.5 p -78.69 139.96 17.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.401 ' HA ' HG12 ' A' ' 114' ' ' ILE . . . -76.1 -72.25 0.33 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 40.3 p -147.15 -177.35 5.63 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.823 0.849 . . . . 0.0 110.401 176.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.528 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -52.03 -39.77 60.06 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.168 167.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HD2' HD11 ' A' ' 42' ' ' LEU . 22.9 tptm -56.07 -29.94 61.25 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.676 0.79 . . . . 0.0 111.504 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.527 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.6 t-80 -68.44 -50.85 49.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.425 0.69 . . . . 0.0 111.015 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.408 HG11 HG12 ' A' ' 89' ' ' ILE . 93.0 t -68.37 -54.75 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HA ' HD12 ' A' ' 45' ' ' ILE . 4.2 pp -56.16 -33.16 64.96 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.664 0.786 . . . . 0.0 111.835 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.559 ' NE2' ' HB2' ' A' ' 143' ' ' ALA . 79.5 t60 -62.45 -45.28 93.78 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.061 173.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.17 87.51 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.383 0.673 . . . . 0.0 111.367 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.6 HG12 HD13 ' A' ' 62' ' ' ILE . 48.2 mt -56.96 -48.53 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.965 0.906 . . . . 0.0 109.815 170.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.523 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 62.1 t30 -64.95 -30.36 71.34 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.388 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 10.2 mm-40 -68.66 -39.96 80.39 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.952 0.501 . . . . 0.0 109.824 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -66.99 -26.33 66.75 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.464 0.706 . . . . 0.0 112.352 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' HE3' ' HA ' ' A' ' 46' ' ' ASN . 10.1 mtmp? -78.92 -31.94 45.44 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.631 0.372 . . . . 0.0 111.847 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.501 HG23 ' HG2' ' A' ' 51' ' ' LYS . 8.6 t -95.26 -45.17 7.28 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.68 0.392 . . . . 0.0 111.954 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.662 ' HB2' HH22 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -121.13 120.04 34.12 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.002 0.921 . . . . 0.0 109.183 -175.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -103.84 99.66 17.08 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 123.016 0.526 . . . . 0.0 110.229 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.61 -81.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.858 2.372 . . . . 0.0 113.935 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.4 pt -150.67 11.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.813 0.845 . . . . 0.0 111.83 -168.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.58 160.54 27.54 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -169.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -68.59 -50.14 53.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.783 0.833 . . . . 0.0 111.125 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -146.08 171.44 14.89 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.56 0.744 . . . . 0.0 110.197 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.93 -58.7 6.92 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.855 0.862 . . . . 0.0 111.897 -174.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.576 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 91.4 m95 -63.85 -33.81 76.53 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.756 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.8 mmm -73.53 -18.98 61.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.827 0.451 . . . . 0.0 110.674 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.612 ' HG2' HH11 ' A' ' 65' ' ' ARG . 22.3 tt0 -77.68 -38.84 46.65 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.072 0.949 . . . . 0.0 110.984 173.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.6 HD13 HG12 ' A' ' 45' ' ' ILE . 82.8 mt -55.0 -53.51 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.673 0.789 . . . . 0.0 111.27 -177.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.46 ' O ' HD11 ' A' ' 79' ' ' ILE . 4.3 pp -52.74 -31.29 37.23 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.189 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 61' ' ' GLU . 1.9 m -78.78 -32.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 112.005 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.662 HH22 ' HB2' ' A' ' 51' ' ' LYS . 11.8 mmm-85 -68.12 -45.14 74.5 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 122.954 0.502 . . . . 0.0 110.866 -175.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.41 -20.15 64.19 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.892 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -97.14 12.65 32.0 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.28 41.9 7.24 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 118.349 0.522 . . . . 0.0 113.481 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 57.37 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.193 1.797 . . . . 0.0 111.152 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -121.18 -160.97 0.88 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.328 1.051 . . . . 0.0 109.354 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -120.7 162.01 20.44 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.64 -49.97 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.264 1.026 . . . . 0.0 112.137 -170.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.443 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 33.6 m170 -61.45 -55.21 33.81 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.751 0.657 . . . . 0.0 110.623 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.41 -56.61 16.92 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.055 0.847 . . . . 0.0 111.789 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 -30.4 69.35 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.5 mt -68.22 -38.38 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.49 0.316 . . . . 0.0 111.012 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 73' ' ' HIS . 60.4 mttm -68.9 -45.66 70.35 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.685 HG22 HG23 ' A' ' 79' ' ' ILE . 59.4 mt -71.22 -66.11 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.206 1.003 . . . . 0.0 111.373 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.685 HG23 HG22 ' A' ' 78' ' ' ILE . 29.8 pt -122.7 26.83 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.64 179.75 48.69 Favored Glycine 0 N--CA 1.48 1.596 0 CA-C-N 118.821 0.737 . . . . 0.0 113.402 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.1 144.37 47.03 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.779 0.432 . . . . 0.0 111.323 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -151.28 149.24 29.15 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 15' ' ' ARG . 6.2 p-10 -65.79 151.33 46.87 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.459 0.572 . . . . 0.0 111.559 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.61 -118.36 6.08 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.481 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -85.27 103.78 14.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.548 HG11 HD11 ' A' ' 16' ' ' ILE . 1.1 p -137.72 156.07 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.116 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.2 t -106.85 122.87 47.27 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.504 1.122 . . . . 0.0 109.388 -170.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -95.68 128.6 42.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 28' ' ' GLN . 7.7 mt -120.27 117.92 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.701 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 42.3 t -145.91 161.94 38.89 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.874 0.369 . . . . 0.0 111.712 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.415 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 43.6 mt-10 -91.89 -47.91 7.06 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.591 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -111.7 136.3 51.12 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.171 0.588 . . . . 0.0 110.362 -171.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -57.63 -27.39 62.75 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.517 0.727 . . . . 0.0 112.403 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.79 -42.71 69.99 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.701 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 60.5 m -65.75 -37.58 86.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.749 0.82 . . . . 0.0 111.466 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -61.85 -43.1 99.53 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.538 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -62.37 -40.96 98.16 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 123.893 0.745 . . . . 0.0 110.055 177.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 34.5 mmtp -57.35 -51.82 67.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.454 0.702 . . . . 0.0 110.58 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.48 HD13 HD21 ' A' ' 23' ' ' LEU . 43.8 mm -66.15 -44.31 91.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.372 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.97 -40.31 29.93 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.499 1.119 . . . . 0.0 112.955 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 22.6 mm-40 -59.58 -46.86 87.68 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.509 0.506 . . . . 0.0 111.66 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.82 -36.43 64.95 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.469 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 20.3 pt -80.35 -47.71 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 118.639 0.654 . . . . 0.0 110.995 -173.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.07 95.17 0.02 OUTLIER Glycine 0 C--N 1.349 1.276 0 O-C-N 123.602 0.564 . . . . 0.0 113.517 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -158.11 -169.4 21.65 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -109.66 135.14 51.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.434 0.617 . . . . 0.0 109.728 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.7 mm -78.43 122.39 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -144.14 96.5 2.89 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -67.42 -17.12 64.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.578 0.751 . . . . 0.0 111.758 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.0 t -60.04 -26.66 66.31 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.12 -22.12 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.21 0.529 . . . . 0.0 110.252 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.486 HD23 HG11 ' A' ' 35' ' ' VAL . 56.2 mt -103.02 17.43 24.09 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.455 1.102 . . . . 0.0 111.953 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -113.44 -1.97 14.04 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 120.176 1.353 . . . . 0.0 112.942 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.401 HG12 ' HA ' ' A' ' 36' ' ' ALA 0.25 0.3 OUTLIER 76.97 139.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 124.812 1.245 . . . . 0.0 113.313 177.903 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.4 HD21 ' HB2' ' A' ' 117' ' ' ASP . 26.7 p-10 -154.24 -173.38 4.55 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.851 172.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.12 -34.12 70.75 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.4 ' HB2' HD21 ' A' ' 115' ' ' ASN . 44.6 m-20 -64.05 -47.09 81.52 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.624 0.37 . . . . 0.0 111.733 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.571 ' NZ ' ' HA ' ' A' ' 33' ' ' ASP . 4.8 mptp? -62.16 -34.18 75.91 Favored 'General case' 0 C--O 1.209 -1.049 0 O-C-N 123.46 0.475 . . . . 0.0 109.826 173.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.24 -51.9 65.89 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.66 0.6 . . . . 0.0 111.148 -172.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -70.45 -39.12 74.52 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.78 -33.06 66.05 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 122.108 -0.37 . . . . 0.0 110.833 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' A' ' 126' ' ' PHE . 6.3 mt -61.09 -38.65 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.656 0.782 . . . . 0.0 110.805 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 7.8 ptp180 -73.9 -23.86 59.62 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.025 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.604 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 13.0 tp10 -64.11 -58.53 6.37 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 170.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -35.9 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 118.68 0.673 . . . . 0.0 112.777 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.472 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.9 m-85 -87.99 -30.89 19.67 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 119.126 -0.464 . . . . 0.0 111.77 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 124' ' ' GLU . 21.4 mmtp 59.05 76.09 0.37 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.046 0.938 . . . . 0.0 111.744 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.526 HG12 ' HD3' ' A' ' 141' ' ' LYS . 25.6 mt . . . . . 0 C--O 1.242 0.673 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.77 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 44.9 t30 . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 120.685 0.279 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.07 -26.25 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.527 1.131 . . . . 0.0 112.288 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.04 -46.67 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.484 0.659 . . . . 0.0 109.745 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.72 -40.61 88.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.855 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -67.95 -38.27 82.62 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.595 0.559 . . . . 0.0 112.344 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.42 ' HA ' HD13 ' A' ' 128' ' ' ILE . 14.4 p -70.15 -42.79 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 40' ' ' HIS . 9.6 mp -62.09 -42.99 99.78 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 122.77 0.428 . . . . 0.0 111.692 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -57.1 -44.5 83.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.528 0.331 . . . . 0.0 111.626 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.526 ' HD3' HG12 ' A' ' 128' ' ' ILE . 8.4 ttpt -71.97 -46.87 55.8 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.185 0.303 . . . . 0.0 111.202 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.0 pt -75.84 -33.72 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.401 -171.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.559 ' HB2' ' NE2' ' A' ' 43' ' ' HIS . . . . . . . . 0 C--O 1.246 0.876 0 C-N-CA 123.585 0.754 . . . . 0.0 112.823 -173.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.504 ' HG2' HG21 ' A' ' 45' ' ' ILE . 1.5 mpt? . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.3 mt -106.08 103.43 15.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.4 mm -107.71 122.99 62.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.69 144.86 51.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.751 0.705 . . . . 0.0 110.627 -173.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.452 ' N ' HD11 ' A' ' 112' ' ' LEU . . . -104.85 127.47 9.07 Favored Glycine 0 CA--C 1.502 -0.78 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 tt -141.64 145.71 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.072 0.549 . . . . 0.0 110.679 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -123.22 130.78 53.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.581 1.152 . . . . 0.0 109.616 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.15 7.73 69.7 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.839 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.12 94.76 1.16 Allowed 'General case' 0 C--N 1.349 0.547 0 C-N-CA 123.938 0.895 . . . . 0.0 111.131 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.478 ' HA ' ' HB2' ' A' ' 83' ' ' ASP . 51.0 mtt180 -73.07 103.44 3.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.123 0.569 . . . . 0.0 109.803 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.99 108.93 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.701 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.407 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -114.08 165.56 12.51 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.597 0.759 . . . . 0.0 110.604 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -71.49 -16.4 62.35 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.89 -36.74 84.24 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 118.251 0.478 . . . . 0.0 111.671 -173.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.459 ' HA ' HD12 ' A' ' 102' ' ' LEU . 18.1 pt -50.47 -20.83 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -93.14 -26.55 17.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.422 0.689 . . . . 0.0 111.233 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -72.72 -16.92 61.66 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.641 0.776 . . . . 0.0 112.149 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.498 HD21 HD13 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -80.89 -10.21 59.74 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.883 0.473 . . . . 0.0 111.817 179.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.46 21.31 26.91 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 116.37 1.308 . . . . 0.0 116.37 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB2' HD13 ' A' ' 23' ' ' LEU . 92.4 mt -87.34 176.52 7.49 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.244 0.618 . . . . 0.0 111.468 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.468 ' HB3' ' HZ2' ' A' ' 59' ' ' TRP . 2.9 mptp? -85.69 98.33 10.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.859 0.864 . . . . 0.0 109.758 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -146.97 160.58 42.18 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.114 0.566 . . . . 0.0 110.331 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.415 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 19.1 tm0? -144.39 149.71 36.55 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 161.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.1 mt -131.29 127.22 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 pp -125.64 173.22 9.14 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.197 0.599 . . . . 0.0 109.979 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 33' ' ' ASP . 61.3 t30 -77.03 138.8 39.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.353 0.661 . . . . 0.0 110.738 -171.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.549 ' HA ' ' SG ' ' A' ' 87' ' ' CYS . . . -80.37 0.1 34.57 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.528 ' HB3' HD21 ' A' ' 121' ' ' LEU . 21.4 m-20 -82.75 -23.1 34.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.257 0.623 . . . . 0.0 111.128 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 79' ' ' ILE . 32.5 m -113.97 -3.73 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.692 0.797 . . . . 0.0 111.718 -171.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -59.41 -32.71 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.734 0.814 . . . . 0.0 112.38 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 59.79 -84.61 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.447 1.099 . . . . 0.0 109.372 -170.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 40.9 p -139.14 174.41 10.54 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.92 0.888 . . . . 0.0 109.353 171.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.91 -45.23 50.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.05 165.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -51.5 -34.41 35.84 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.335 1.054 . . . . 0.0 112.592 -178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.558 ' HA ' HD11 ' A' ' 139' ' ' LEU . 11.2 t-80 -66.55 -54.53 22.73 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.696 0.623 . . . . 0.0 111.028 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -70.69 -47.78 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 122.696 0.399 . . . . 0.0 112.074 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.45 -30.39 69.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.191 0.596 . . . . 0.0 111.556 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.46 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 71.2 t60 -61.6 -46.74 88.57 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 169.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . . . -61.86 -44.99 95.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.959 0.504 . . . . 0.0 111.407 -176.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.514 HG22 ' HE3' ' A' ' 49' ' ' LYS . 36.0 mt -65.98 -49.77 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.322 1.049 . . . . 0.0 111.081 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -51.6 -47.42 63.61 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.291 1.036 . . . . 0.0 110.991 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 17.9 mm100 -66.77 -35.48 80.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.327 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.09 63.25 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 122.672 0.389 . . . . 0.0 111.545 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HE3' HG22 ' A' ' 45' ' ' ILE . 98.4 mttt -86.31 -36.92 19.01 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.439 0.696 . . . . 0.0 112.06 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 47' ' ' GLN . 10.3 t -88.14 -37.28 16.31 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.909 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 47' ' ' GLN . 39.6 mtmt -85.53 157.54 20.39 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.683 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -102.64 103.31 31.57 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.18 177.43 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 124.154 3.236 . . . . 0.0 115.466 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.31 5.02 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.266 165.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.59 179.29 2.17 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.524 1.13 . . . . 0.0 111.749 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -62.33 -47.66 83.27 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.029 0.532 . . . . 0.0 110.326 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.4 m -157.85 -172.81 4.08 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.239 1.015 . . . . 0.0 110.185 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -62.01 -59.3 5.29 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.635 1.174 . . . . 0.0 112.919 -176.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.468 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 87.8 m95 -63.42 -28.71 70.16 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 120.753 0.311 . . . . 0.0 110.848 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.6 mmt -74.81 -21.22 59.42 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.687 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -75.84 -43.05 47.76 Favored 'General case' 0 C--O 1.209 -1.039 0 C-N-CA 122.398 0.279 . . . . 0.0 110.373 170.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.469 HD13 HG12 ' A' ' 45' ' ' ILE . 86.8 mt -56.47 -39.28 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.676 0.79 . . . . 0.0 112.173 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.407 ' O ' HD11 ' A' ' 79' ' ' ILE . 3.6 pp -71.06 -30.91 67.19 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.333 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -83.17 -29.05 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.337 -0.852 . . . . 0.0 110.922 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.5 ' HD2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.2 -45.75 62.71 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.548 1.139 . . . . 0.0 109.937 -172.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.22 -24.65 67.4 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.488 0.715 . . . . 0.0 112.031 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.2 p -100.18 23.67 9.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.241 0.616 . . . . 0.0 110.568 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.07 -88.54 1.54 Allowed Glycine 0 C--N 1.36 1.913 0 O-C-N 122.182 -0.324 . . . . 0.0 113.442 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.15 121.35 1.02 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -173.25 163.59 4.62 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 124.691 1.244 . . . . 0.0 109.053 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -57.39 149.69 20.06 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.136 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.32 -41.04 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.708 1.203 . . . . 0.0 111.845 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -57.21 -49.77 74.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.395 0.678 . . . . 0.0 111.096 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.524 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 49.9 mm-40 -57.0 -48.73 77.75 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.621 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.42 -36.81 83.53 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.666 0.786 . . . . 0.0 112.824 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.51 -37.55 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.041 0.536 . . . . 0.0 110.891 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 74' ' ' GLU . 53.2 mtmt -67.72 -48.65 65.91 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.798 0.333 . . . . 0.0 110.205 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.453 HG23 ' HB ' ' A' ' 125' ' ' ILE . 78.0 mt -74.21 -65.18 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.649 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.608 ' HB ' HG21 ' A' ' 34' ' ' VAL . 7.7 pt -109.41 14.3 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.61 168.55 46.07 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 119.433 1.015 . . . . 0.0 112.423 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.98 121.74 26.41 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.832 0.453 . . . . 0.0 111.323 -175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -116.95 162.36 17.89 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 165.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 15' ' ' ARG . 7.5 p-10 -65.35 153.91 39.83 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.293 0.637 . . . . 0.0 112.158 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.57 -119.46 5.81 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.358 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.467 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -87.45 104.6 16.61 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.8 p -136.92 168.74 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.562 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 32' ' ' ALA . 88.3 m -122.45 123.64 41.77 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.389 1.075 . . . . 0.0 110.238 -175.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.477 HD21 ' HB ' ' A' ' 99' ' ' ILE . 11.4 tp -102.91 125.5 49.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.281 0.632 . . . . 0.0 109.625 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mt -108.3 132.74 55.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.632 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.7 t -155.37 154.72 32.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.157 0.503 . . . . 0.0 111.225 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -87.17 -40.44 14.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.923 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.55 137.94 51.99 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.11 0.964 . . . . 0.0 110.482 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 39.6 tt0 -66.64 -35.93 81.34 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -170.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.74 -26.64 57.64 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.779 0.718 . . . . 0.0 110.348 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 96.9 m -67.88 -42.58 81.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.228 0.611 . . . . 0.0 111.167 165.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.418 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 2.3 t80 -56.97 -49.65 75.08 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.998 0.919 . . . . 0.0 110.817 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 76.7 ttt180 -65.27 -36.95 85.69 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 123.569 0.543 . . . . 0.0 110.441 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -56.2 -40.32 73.83 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.771 0.428 . . . . 0.0 111.674 176.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.498 HD13 HD21 ' A' ' 23' ' ' LEU . 29.1 mm -69.47 -45.83 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -53.69 -40.3 65.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.561 1.145 . . . . 0.0 112.564 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 70.7 mm-40 -59.47 -47.23 86.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.27 0.628 . . . . 0.0 110.847 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 20' ' ' ILE . 57.5 mt -72.75 -38.39 67.38 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.3 pt -74.63 -37.74 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 118.366 0.53 . . . . 0.0 110.768 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.98 93.41 0.03 OUTLIER Glycine 0 C--N 1.351 1.402 0 O-C-N 123.623 0.577 . . . . 0.0 114.312 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.27 -167.65 22.02 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -113.33 140.65 47.85 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.79 123.24 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.18 95.35 4.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.15 -42.03 85.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.898 0.479 . . . . 0.0 111.463 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.0 p -54.21 -29.91 48.01 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.6 p -67.32 -24.03 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 CA-C-N 118.565 0.621 . . . . 0.0 110.941 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 37' ' ' THR . 81.2 mt -86.28 -19.41 29.93 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.748 0.819 . . . . 0.0 112.009 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -93.37 -1.83 55.42 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 118.462 -0.78 . . . . 0.0 113.038 -165.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 114' ' ' ILE 0.26 0.5 OUTLIER 78.83 133.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 124.557 1.143 . . . . 0.0 112.89 -178.446 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 117' ' ' ASP . 4.4 p-10 -146.79 168.33 21.66 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.506 167.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.5 -34.13 76.26 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.906 0.482 . . . . 0.0 111.829 -169.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.422 ' HB2' ' ND2' ' A' ' 115' ' ' ASN . 14.2 m-20 -59.7 -48.95 79.65 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.928 0.491 . . . . 0.0 111.469 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -67.29 -27.25 67.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.448 0.468 . . . . 0.0 110.741 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.466 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 30.3 tt0 -72.62 -44.98 61.24 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.017 0.527 . . . . 0.0 110.998 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -73.69 -40.53 63.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.655 0.782 . . . . 0.0 109.993 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 33' ' ' ASP . 62.5 tp -53.78 -53.77 47.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.262 1.425 . . . . 0.0 112.317 170.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.1 mt -53.25 -30.64 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.621 1.169 . . . . 0.0 111.755 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.0 ttp85 -72.24 -33.62 67.67 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.045 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.72 -56.09 13.89 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 173.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.453 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -74.24 -36.24 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -90.38 -33.39 16.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 119.447 -0.311 . . . . 0.0 111.706 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 3.0 mmmp? 63.78 72.38 0.47 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.043 0.937 . . . . 0.0 111.765 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.566 HG21 ' HB3' ' A' ' 137' ' ' ARG . 9.2 mt . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.2 t30 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HB ' ' HG3' ' A' ' 119' ' ' GLU . 7.2 p -54.59 -34.19 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.369 1.068 . . . . 0.0 113.652 -176.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.4 t -71.41 -45.74 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.349 0.595 . . . . 0.0 109.759 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 40.3 mt-10 -68.52 -34.33 75.68 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.182 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.566 ' HB3' HG21 ' A' ' 128' ' ' ILE . 52.7 mtm180 -72.22 -39.05 68.8 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.863 0.865 . . . . 0.0 112.073 -176.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.04 -33.94 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.558 HD11 ' HA ' ' A' ' 40' ' ' HIS . 4.6 mp -62.98 -39.57 95.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.218 0.607 . . . . 0.0 111.148 173.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 35.0 mm-40 -59.66 -47.29 86.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 117.775 0.261 . . . . 0.0 111.009 173.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -63.87 -48.4 76.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.112 0.565 . . . . 0.0 111.973 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.6 pt -76.68 -25.33 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.746 0 C-N-CA 122.235 0.214 . . . . 0.0 110.54 173.293 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.544 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 76.2 mt -85.96 104.78 13.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.5 mm -101.19 120.82 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -127.27 146.92 50.26 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.19 140.42 14.86 Favored Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.473 HG23 HG12 ' A' ' 86' ' ' VAL . 10.1 tt -143.01 124.9 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.777 0.799 . . . . 0.0 111.081 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.431 ' HA ' HD22 ' A' ' 85' ' ' ASN . 7.2 ptm180 -90.11 133.2 35.01 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.196 175.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.45 8.76 80.32 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.832 174.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.04 100.76 0.23 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.033 0.933 . . . . 0.0 111.085 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -74.0 103.23 4.41 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.524 HD11 HG11 ' A' ' 86' ' ' VAL . 50.3 mm -74.05 114.91 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.354 0.597 . . . . 0.0 110.207 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' A' ' 20' ' ' ILE . 2.5 p-10 -103.92 134.63 46.89 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -74.08 -1.7 21.28 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.793 0.437 . . . . 0.0 111.779 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -75.68 -20.32 58.51 Favored 'General case' 0 C--O 1.217 -0.606 0 C-N-CA 124.414 1.086 . . . . 0.0 111.027 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.479 HG23 ' ND2' ' A' ' 17' ' ' ASN . 9.4 pt -49.77 -22.36 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -83.52 -0.1 48.81 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -71.4 -28.04 63.74 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.123 0.569 . . . . 0.0 112.005 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.65 -6.69 57.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.679 0.791 . . . . 0.0 111.512 -176.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.46 14.89 9.86 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB2' HD13 ' A' ' 23' ' ' LEU . 95.8 mt -74.73 157.77 34.69 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.159 0.584 . . . . 0.0 110.461 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -82.67 102.51 11.54 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.273 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -149.49 160.31 43.57 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.77 1.228 . . . . 0.0 108.823 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.511 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -142.22 150.43 40.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 173.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.7 mt -134.4 125.1 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.497 HD21 HG22 ' A' ' 41' ' ' VAL . 4.2 pp -118.97 172.47 7.53 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 47.6 t30 -87.93 131.34 34.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.52 1.128 . . . . 0.0 111.133 -167.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 111' ' ' VAL . . . -83.6 -3.84 58.04 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.682 ' HB3' HD21 ' A' ' 121' ' ' LEU . 76.9 m-20 -63.74 -44.82 92.38 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.358 0.599 . . . . 0.0 109.817 171.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.06 -1.95 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.871 -166.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 32' ' ' ALA . 9.9 p -85.71 129.87 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.78 -68.13 0.57 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 113' ' ' GLU . 30.8 p -128.85 166.59 18.77 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.465 1.106 . . . . 0.0 108.431 169.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -22.26 34.17 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.59 0.356 . . . . 0.0 111.493 169.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.13 -30.31 66.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.266 1.026 . . . . 0.0 112.081 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.571 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.2 t-80 -61.23 -44.82 96.65 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.806 0.842 . . . . 0.0 110.377 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 30' ' ' LEU . 40.4 t -65.76 -54.13 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.708 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.492 ' HA ' HD12 ' A' ' 45' ' ' ILE . 3.2 pp -63.55 -32.12 73.49 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.442 ' HD2' HD11 ' A' ' 142' ' ' ILE . 68.9 t60 -61.03 -37.48 82.73 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.196 0.999 . . . . 0.0 110.886 174.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.79 -35.36 67.38 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.079 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.498 HG12 HD13 ' A' ' 62' ' ' ILE . 53.4 mt -63.56 -47.07 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.461 0.704 . . . . 0.0 110.914 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -57.83 -37.26 73.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.776 0.831 . . . . 0.0 111.01 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.461 ' HA ' HG22 ' A' ' 50' ' ' THR . 79.7 mm-40 -67.56 -40.12 84.92 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.499 174.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.31 -27.6 68.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.979 0.512 . . . . 0.0 111.629 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -79.13 -34.3 43.48 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.978 0.511 . . . . 0.0 111.591 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.461 HG22 ' HA ' ' A' ' 47' ' ' GLN . 11.8 t -87.48 -28.23 22.18 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.436 0.294 . . . . 0.0 110.894 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -98.8 135.26 40.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.671 0.788 . . . . 0.0 111.547 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 105.5 2.28 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 162.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 41.1 Cg_endo -64.73 166.2 18.68 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.795 2.33 . . . . 0.0 114.801 -161.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 mm -108.7 -5.15 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 173.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.01 -179.5 6.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.048 1.339 . . . . 0.0 111.472 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HB2' ' HG2' ' A' ' 60' ' ' MET . 75.6 mmtt -73.22 -25.02 60.58 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.513 0.725 . . . . 0.0 112.262 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.691 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 29.0 t -165.28 -178.69 5.16 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.479 0.711 . . . . 0.0 110.327 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -57.48 -54.57 45.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.687 1.195 . . . . 0.0 111.42 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.511 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 86.5 m95 -62.14 -32.48 73.09 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.828 0.851 . . . . 0.0 111.58 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.691 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.1 mpt? -72.99 -26.47 61.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.876 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.573 ' HA ' HG22 ' A' ' 64' ' ' VAL . 19.8 tp10 -74.67 -31.59 61.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.282 0.233 . . . . 0.0 110.587 175.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.498 HD13 HG12 ' A' ' 45' ' ' ILE . 66.8 mt -61.52 -47.63 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.017 0.527 . . . . 0.0 110.183 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' O ' HD11 ' A' ' 79' ' ' ILE . 4.1 pp -71.9 -34.33 69.03 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.699 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 61' ' ' GLU . 23.5 m -76.98 -34.05 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 118.783 0.72 . . . . 0.0 111.558 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.41 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 5.3 tpp180 -68.95 -46.48 68.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.757 0.423 . . . . 0.0 111.11 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.7 -18.95 64.35 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 123.458 0.474 . . . . 0.0 112.157 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.8 p -90.03 18.88 5.35 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.431 0.692 . . . . 0.0 112.501 175.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 142' ' ' ILE . . . 95.29 26.22 12.66 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.385 -0.675 . . . . 0.0 113.193 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 57.78 97.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.837 1.255 . . . . 0.0 109.869 -174.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -137.84 -158.11 0.83 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.725 0.81 . . . . 0.0 110.862 -168.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -120.66 164.61 16.26 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.653 1.181 . . . . 0.0 108.985 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.442 HG13 ' HG2' ' A' ' 56' ' ' LYS . 51.4 mm -47.41 -47.6 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 125.659 1.583 . . . . 0.0 112.99 -171.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 m170 -56.74 -53.37 58.52 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.856 0.863 . . . . 0.0 111.572 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.38 -58.06 10.1 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 123.519 0.512 . . . . 0.0 110.75 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . . . -54.61 -54.99 34.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.428 1.091 . . . . 0.0 113.844 -170.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.3 mt -63.68 -31.24 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.49 0.716 . . . . 0.0 112.117 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.69 -39.62 19.94 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.1 mt -76.73 -66.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.83 0.452 . . . . 0.0 110.626 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.43 HD11 ' O ' ' A' ' 63' ' ' LEU . 9.0 pt -104.8 8.76 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.519 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 31' ' ' ASN . . . -81.83 173.95 53.8 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 119.364 0.984 . . . . 0.0 111.853 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.11 137.67 58.31 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.97 156.64 37.81 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -53.66 151.3 6.22 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.84 -115.51 5.18 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.123 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' A' ' 12' ' ' ARG . 13.6 m120 -85.5 108.55 17.97 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.524 HG11 HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -135.1 171.25 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.337 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 32' ' ' ALA . 61.0 m -131.64 121.46 24.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.841 1.256 . . . . 0.0 108.823 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.464 HD11 ' HB ' ' A' ' 99' ' ' ILE . 4.8 tt -99.47 128.77 45.6 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -174.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.456 HG22 ' HZ3' ' A' ' 59' ' ' TRP . 22.0 mt -113.75 114.28 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 20.8 p -138.26 156.88 47.25 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.836 0.454 . . . . 0.0 110.568 -176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.34 -51.98 15.52 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.866 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -128.75 158.39 38.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.121 0.968 . . . . 0.0 110.068 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 43.4 mt-10 -64.87 -16.15 62.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.885 0.874 . . . . 0.0 112.266 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 13.4 pt-20 -74.58 -46.59 37.73 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.0 m -61.56 -40.4 94.57 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 123.738 0.815 . . . . 0.0 110.505 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.745 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 19.4 t80 -56.74 -51.46 68.78 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 123.819 0.699 . . . . 0.0 110.84 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -61.39 -42.72 99.17 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.822 0.701 . . . . 0.0 111.005 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 74.8 mmtt -57.58 -50.14 74.09 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.654 0.596 . . . . 0.0 110.899 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.464 ' HB ' HD11 ' A' ' 88' ' ' LEU . 45.8 mm -69.82 -45.45 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.835 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.405 ' HD1' HD12 ' A' ' 11' ' ' ILE . 14.7 t80 -54.01 -45.7 71.57 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.257 1.423 . . . . 0.0 113.2 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.95 -30.34 68.76 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 119.463 -0.303 . . . . 0.0 111.667 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.24 -46.03 71.62 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.932 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.1 pt -75.62 -41.01 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 118.103 0.41 . . . . 0.0 110.799 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.56 109.11 0.09 OUTLIER Glycine 0 C--N 1.345 1.072 0 O-C-N 123.347 0.405 . . . . 0.0 113.706 170.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.44 -171.88 44.63 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -105.25 147.46 28.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.238 0.615 . . . . 0.0 109.568 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.36 129.29 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.248 0.619 . . . . 0.0 109.561 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -132.77 100.84 5.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.289 1.036 . . . . 0.0 108.906 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -69.88 -33.18 71.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.896 0.478 . . . . 0.0 111.622 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.516 ' HA ' ' HG2' ' A' ' 113' ' ' GLU . 18.4 m -50.6 -36.82 36.81 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 16.2 m -66.64 -22.52 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.8 mt -100.75 17.83 20.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.808 0.843 . . . . 0.0 111.856 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.593 ' HA ' HG22 ' A' ' 37' ' ' THR . 7.4 pt-20 -134.79 8.06 3.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 78.71 131.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.202 1.001 . . . . 0.0 111.615 173.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 117' ' ' ASP . 4.0 p-10 -156.87 174.44 15.5 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.219 1.407 . . . . 0.0 107.915 172.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -69.4 -32.23 71.09 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.46 ' HB2' ' ND2' ' A' ' 115' ' ' ASN . 2.2 m-20 -57.34 -50.68 72.19 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.541 0.736 . . . . 0.0 110.352 171.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -40.98 76.86 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.124 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.463 ' HG3' HG21 ' A' ' 134' ' ' VAL . 42.5 tt0 -72.32 -49.19 36.31 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.404 0.682 . . . . 0.0 112.485 -162.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 12.5 ptm180 -70.16 -36.95 75.06 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.678 0.752 . . . . 0.0 110.741 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.682 HD21 ' HB3' ' A' ' 33' ' ' ASP . 37.4 tp -59.64 -47.8 84.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.778 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.4 HG23 ' HD2' ' A' ' 126' ' ' PHE . 31.5 mt -63.5 -38.04 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.289 1.035 . . . . 0.0 110.645 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.2 ptp180 -74.36 -26.51 60.17 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 118.983 -0.532 . . . . 0.0 110.086 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -71.47 -57.49 4.38 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -31.27 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 119.014 0.825 . . . . 0.0 112.487 -172.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.4 ' HD2' HG23 ' A' ' 122' ' ' ILE . 23.0 m-30 -92.5 -33.59 14.42 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 119.593 -0.241 . . . . 0.0 111.553 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 12.4 mmmm 66.13 82.53 0.18 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.971 0.908 . . . . 0.0 112.419 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 137' ' ' ARG . 36.9 mt . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' A' ' 136' ' ' GLU . 54.0 t30 . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 120.847 0.356 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.463 HG21 ' HG3' ' A' ' 119' ' ' GLU . 84.2 t -64.19 -29.4 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.152 1.381 . . . . 0.0 112.324 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.8 -49.75 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.213 0.605 . . . . 0.0 110.469 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.414 ' HG3' HD22 ' A' ' 133' ' ' ASN . 41.1 mt-10 -64.99 -32.1 73.66 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.097 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.537 ' HB3' HG21 ' A' ' 128' ' ' ILE . 8.5 mmm180 -76.01 -35.48 59.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.115 0.566 . . . . 0.0 112.205 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.51 -41.33 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.823 -0.548 . . . . 0.0 110.973 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.5 mp -57.12 -40.16 76.54 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.508 1.123 . . . . 0.0 112.786 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.37 -35.52 68.5 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.024 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -64.96 -46.08 83.05 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.426 0.69 . . . . 0.0 111.281 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.442 HD11 ' HD2' ' A' ' 43' ' ' HIS . 19.5 pt -72.48 -8.48 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.403 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 0.561 0 C-N-CA 124.386 1.074 . . . . 0.0 111.267 171.497 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.508 ' SD ' ' HB2' ' A' ' 42' ' ' LEU . 2.0 mpt? . . . . . 0 N--CA 1.473 0.724 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -103.55 104.94 17.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mm -111.83 120.31 61.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.434 HH21 HG21 ' A' ' 107' ' ' ILE . 28.0 mmm180 -133.18 145.33 50.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.876 0.471 . . . . 0.0 109.869 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.564 ' H ' HD11 ' A' ' 112' ' ' LEU . . . -107.14 118.04 5.46 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.3 tt -124.28 124.97 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.566 0.746 . . . . 0.0 111.165 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.417 ' HA ' HD22 ' A' ' 85' ' ' ASN . 8.7 ptp180 -85.11 137.74 32.85 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.156 170.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.29 79.51 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.211 172.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.25 109.98 4.98 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.833 0.853 . . . . 0.0 111.815 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -76.76 103.15 6.57 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.546 HD11 HG11 ' A' ' 86' ' ' VAL . 50.9 mm -70.69 93.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.519 HD21 HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -102.01 153.59 19.75 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.625 -177.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -68.53 -13.26 62.21 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.39 -36.75 79.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.656 0.782 . . . . 0.0 112.013 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 17' ' ' ASN . 6.9 pt -56.72 -22.62 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -87.25 -16.78 34.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 118.231 0.469 . . . . 0.0 111.368 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -75.31 -19.52 59.61 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.381 0.673 . . . . 0.0 112.093 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -82.65 -9.76 59.23 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.944 0.498 . . . . 0.0 111.765 -177.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.73 8.39 2.85 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB2' HD13 ' A' ' 23' ' ' LEU . 86.2 mt -68.57 168.69 12.44 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.977 0.888 . . . . 0.0 112.131 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -77.78 92.21 4.18 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.09 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -148.81 162.3 40.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.984 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.648 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -146.1 159.82 42.76 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 164.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.8 mt -134.08 129.68 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 121.704 -0.623 . . . . 0.0 109.39 173.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.7 pt? -119.84 179.7 4.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.072 0.949 . . . . 0.0 108.456 172.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.467 ' HB3' HG22 ' A' ' 34' ' ' VAL . 51.0 t-20 -74.51 143.16 44.68 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.557 ' HB1' HG21 ' A' ' 111' ' ' VAL . . . -68.87 -49.67 56.28 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.038 0.447 . . . . 0.0 110.585 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HB3' HD21 ' A' ' 121' ' ' LEU . 40.9 m-20 -52.38 -16.66 0.92 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 31' ' ' ASN . 24.9 m -110.82 2.09 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.585 0.754 . . . . 0.0 111.906 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.13 -30.74 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.201 0.6 . . . . 0.0 111.95 -171.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.427 ' O ' HG12 ' A' ' 114' ' ' ILE . . . 58.29 -84.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.34 1.056 . . . . 0.0 109.35 -166.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 16.8 p -127.07 161.69 27.83 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.939 0.896 . . . . 0.0 111.081 172.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -53.56 -40.68 65.79 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.379 163.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.507 ' HD2' HD11 ' A' ' 42' ' ' LEU . 50.8 tptt -56.19 -35.76 67.61 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 124.994 1.318 . . . . 0.0 111.554 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -63.02 -52.6 62.27 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.889 0.743 . . . . 0.0 111.28 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 45' ' ' ILE . 40.4 t -72.66 -42.49 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 119.427 -0.321 . . . . 0.0 111.85 -175.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.508 ' HB2' ' SD ' ' A' ' 6' ' ' MET . 4.1 pp -64.6 -29.52 70.53 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.015 0.371 . . . . 0.0 111.209 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.455 ' HD2' HD11 ' A' ' 142' ' ' ILE . 49.4 t60 -62.6 -40.22 96.23 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.019 0.928 . . . . 0.0 110.546 169.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.27 82.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.571 0.748 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.467 ' HA ' HG12 ' A' ' 62' ' ' ILE . 41.7 mt -65.49 -45.8 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.099 0.96 . . . . 0.0 110.709 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -51.69 -48.77 63.37 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.568 1.147 . . . . 0.0 110.366 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -64.6 -31.82 73.21 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.987 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.46 -21.78 48.54 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.914 0.485 . . . . 0.0 112.025 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HE3' HG22 ' A' ' 45' ' ' ILE . 96.7 mttt -82.0 -31.75 30.91 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.973 0.509 . . . . 0.0 111.622 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.478 HG23 ' HG2' ' A' ' 51' ' ' LYS . 9.7 t -100.31 -35.98 9.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.478 ' HG2' HG23 ' A' ' 50' ' ' THR . 10.9 mmpt? -119.63 153.57 35.31 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.275 0.63 . . . . 0.0 111.877 -176.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.86 124.74 9.48 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.506 1.122 . . . . 0.0 109.766 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -90.57 -115.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 123.85 3.034 . . . . 0.0 110.468 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 mm -123.63 35.26 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . . . -85.83 156.54 20.52 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.878 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.554 ' HG2' HG13 ' A' ' 72' ' ' ILE . 74.3 mmtt -62.23 -53.83 49.56 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.207 0.603 . . . . 0.0 111.945 -171.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.539 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 10.6 t -156.33 -176.94 6.23 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.039 0.536 . . . . 0.0 109.678 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -58.55 -60.33 3.97 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.407 1.083 . . . . 0.0 113.244 -173.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.518 ' CE3' ' HB2' ' A' ' 28' ' ' GLN . 92.1 m95 -66.16 -23.5 66.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.747 0.419 . . . . 0.0 112.044 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.5 mpt? -77.19 -26.09 52.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.864 0.866 . . . . 0.0 110.599 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.524 ' HG2' ' HB3' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -74.92 -41.26 60.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.967 0.907 . . . . 0.0 109.389 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 45' ' ' ILE . 81.8 mt -61.54 -39.46 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.726 0.811 . . . . 0.0 112.455 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.455 HD12 HG13 ' A' ' 64' ' ' VAL . 3.6 pp -72.65 -33.47 66.62 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.007 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.455 HG13 HD12 ' A' ' 63' ' ' LEU . 25.0 m -77.07 -27.0 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.973 -0.454 . . . . 0.0 111.949 174.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.444 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 35.4 mmt180 -64.56 -62.76 1.39 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.205 0.602 . . . . 0.0 110.442 172.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.79 -27.72 68.23 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.608 0.763 . . . . 0.0 112.695 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 p -79.57 -59.07 2.89 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.37 6.6 29.16 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.722 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -78.83 -25.13 44.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.498 1.119 . . . . 0.0 111.763 -172.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.44 ' NH1' HG23 ' A' ' 64' ' ' VAL . 1.1 mpt_? 66.58 -10.61 0.27 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -173.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -99.45 118.5 36.2 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.94 0.896 . . . . 0.0 109.125 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.554 HG13 ' HG2' ' A' ' 56' ' ' LYS . 24.8 mm -53.45 -59.73 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.264 1.025 . . . . 0.0 112.353 -172.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -61.76 -45.14 95.17 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.152 0.907 . . . . 0.0 110.589 -172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -58.02 -47.86 81.79 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.858 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.92 80.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.52 0.728 . . . . 0.0 112.397 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.9 mt -68.08 -33.79 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.185 0.594 . . . . 0.0 111.035 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -68.71 -49.33 59.76 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.804 0.335 . . . . 0.0 110.698 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.518 HG23 ' HB ' ' A' ' 125' ' ' ILE . 74.2 mt -64.8 -64.22 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 124.004 0.922 . . . . 0.0 111.15 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.45 ' HB ' HG21 ' A' ' 34' ' ' VAL . 24.0 pt -110.4 15.36 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -172.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.58 173.29 44.16 Favored Glycine 0 N--CA 1.479 1.52 0 CA-C-N 120.389 1.449 . . . . 0.0 113.21 -174.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.44 146.59 32.68 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.189 0.595 . . . . 0.0 111.39 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -153.18 155.53 36.84 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.417 1.087 . . . . 0.0 108.104 171.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.25 151.98 44.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.927 0.491 . . . . 0.0 111.433 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.79 -120.78 7.01 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.205 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 12' ' ' ARG . 12.0 m120 -79.61 105.89 11.24 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG11 HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -135.74 164.53 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.647 -177.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 43.7 t -125.55 121.25 33.12 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.371 1.068 . . . . 0.0 108.959 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.41 HD21 ' HB ' ' A' ' 99' ' ' ILE . 10.0 tp -102.35 125.75 49.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.853 0.861 . . . . 0.0 109.865 -171.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 28' ' ' GLN . 68.4 mt -99.79 128.52 51.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 113.698 -1.592 . . . . 0.0 107.521 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.547 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 35.1 t -150.32 149.19 29.78 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 111.589 177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -86.02 -41.67 14.63 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.59 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -119.78 146.69 45.44 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.195 0.598 . . . . 0.0 110.994 -174.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -54.79 -38.31 67.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.71 0.804 . . . . 0.0 112.613 172.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -69.75 -46.51 65.7 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.547 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 28.7 m -61.21 -35.21 76.57 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.005 0.922 . . . . 0.0 110.948 178.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -63.83 -46.76 83.62 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.404 0.682 . . . . 0.0 110.152 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.58 -34.71 78.41 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.759 0.662 . . . . 0.0 110.574 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.79 -45.9 80.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.464 0.706 . . . . 0.0 111.638 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.474 HD13 HD21 ' A' ' 23' ' ' LEU . 40.2 mm -71.39 -46.72 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 122.43 -0.169 . . . . 0.0 110.766 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -54.76 -33.81 61.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.161 1.384 . . . . 0.0 112.086 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.8 -50.46 70.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.864 0.866 . . . . 0.0 111.769 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.67 -25.84 49.84 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 20' ' ' ILE . 17.7 pt -80.24 -50.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 118.584 0.629 . . . . 0.0 109.575 174.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.92 124.43 0.05 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 123.443 0.464 . . . . 0.0 113.796 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.43 -153.15 20.59 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 117.028 0.414 . . . . 0.0 112.159 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -123.91 143.79 50.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.938 0.895 . . . . 0.0 109.164 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.434 HG21 HH21 ' A' ' 9' ' ' ARG . 49.3 mm -86.89 136.73 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -135.66 108.97 7.8 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.15 -25.22 66.86 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.541 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.2 m -46.54 -39.68 11.36 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.557 HG21 ' HB1' ' A' ' 32' ' ' ALA . 12.6 p -71.29 -41.62 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-O 120.846 0.355 . . . . 0.0 110.399 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 37' ' ' THR . 86.3 mt -67.78 -31.17 70.88 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.551 1.141 . . . . 0.0 112.623 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.3 1.54 54.48 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 118.15 -0.929 . . . . 0.0 112.924 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.433 HD13 ' HA ' ' A' ' 114' ' ' ILE 0.253 1.5 mm 73.07 127.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.29 0 CA-C-N 119.296 0.953 . . . . 0.0 113.094 177.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.438 HD21 ' HD3' ' A' ' 118' ' ' LYS . 6.3 p30 -147.89 -176.68 5.36 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.024 1.329 . . . . 0.0 108.584 173.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -57.42 -49.61 75.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.493 0.717 . . . . 0.0 112.142 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.8 -51.39 69.93 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.53 1.132 . . . . 0.0 112.466 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.438 ' HD3' HD21 ' A' ' 115' ' ' ASN . 4.3 mptp? -70.6 -37.23 73.86 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.849 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -71.38 -39.22 71.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.976 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -72.2 -42.89 65.29 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.866 0.466 . . . . 0.0 112.046 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 33' ' ' ASP . 0.7 OUTLIER -66.14 -34.1 77.28 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.487 HG23 ' HD2' ' A' ' 126' ' ' PHE . 13.5 mt -58.33 -30.02 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.948 0.899 . . . . 0.0 110.782 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -69.44 -36.79 76.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 118.839 -0.6 . . . . 0.0 109.534 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.13 -55.71 30.5 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.518 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -75.57 -45.07 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 118.863 0.756 . . . . 0.0 112.693 -178.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.582 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 21.7 m-30 -81.87 -33.1 30.75 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? 63.6 76.32 0.36 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.151 0.98 . . . . 0.0 112.318 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.685 HG21 ' HB3' ' A' ' 137' ' ' ARG . 2.5 mt . . . . . 0 C--O 1.245 0.822 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.657 0.265 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.45 -16.53 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.083 0.553 . . . . 0.0 112.445 -171.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.476 ' O ' HD13 ' A' ' 139' ' ' LEU . 86.6 t -68.63 -49.29 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -174.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -52.75 -45.54 67.07 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.495 174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.685 ' HB3' HG21 ' A' ' 128' ' ' ILE . 37.4 mmt180 -73.55 -38.85 65.09 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 113.693 -1.594 . . . . 0.0 112.346 -168.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.55 -41.15 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 123.181 0.301 . . . . 0.0 110.485 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 135' ' ' VAL . 9.9 mp -55.74 -44.16 77.32 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.741 0.816 . . . . 0.0 110.509 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -74.33 -37.94 63.41 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 123.887 0.742 . . . . 0.0 111.929 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.633 ' HD3' HG12 ' A' ' 128' ' ' ILE . 16.5 ttpp -66.25 -40.01 89.91 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.086 0.47 . . . . 0.0 111.537 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.455 HD11 ' HD2' ' A' ' 43' ' ' HIS . 22.2 pt -73.29 -18.92 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.017 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.875 0 C-N-CA 124.3 1.04 . . . . 0.0 110.801 174.045 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 121.523 0.678 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 72.5 mt -98.75 103.81 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 108.359 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.57 122.28 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.7 mmt-85 -127.84 150.9 49.64 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.79 0.836 . . . . 0.0 109.723 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.31 126.26 8.67 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 tt -132.63 132.68 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.416 0.627 . . . . 0.0 110.452 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.417 ' HA ' HD22 ' A' ' 85' ' ' ASN . 15.4 ptm180 -107.83 133.68 51.86 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.27 1.028 . . . . 0.0 109.955 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.79 -6.27 79.62 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.534 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.57 112.77 2.12 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.112 0.965 . . . . 0.0 112.826 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -73.28 108.52 6.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.469 0.708 . . . . 0.0 110.288 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 86' ' ' VAL . 49.4 mm -70.76 94.17 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.272 1.034 . . . . 0.0 109.837 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.45 150.38 20.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.002 177.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -82.26 -4.57 57.39 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.974 0.51 . . . . 0.0 111.23 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' HA ' HD21 ' A' ' 22' ' ' ASN . 12.4 mm-40 -65.94 -40.09 91.07 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.076 0.95 . . . . 0.0 111.154 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.8 pt -70.62 -7.87 9.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.767 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -93.46 -34.32 13.46 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.226 0.921 . . . . 0.0 110.998 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' A' ' 19' ' ' GLU . 10.4 p30 -86.28 0.67 53.31 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -172.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.74 -3.94 55.04 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.365 0.666 . . . . 0.0 112.213 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.96 -11.8 2.43 Favored Glycine 0 CA--C 1.54 1.595 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.501 HD13 HG23 ' A' ' 95' ' ' THR . 85.2 mt -64.42 159.8 20.54 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.273 1.037 . . . . 0.0 112.217 -176.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -86.58 100.71 12.61 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.884 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -149.03 162.55 39.71 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.496 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.451 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 24.7 tt0 -139.02 145.55 39.76 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 166.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.0 mt -130.02 126.45 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 pp -122.39 174.28 7.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.068 0.947 . . . . 0.0 108.688 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -82.07 135.41 35.33 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -85.93 3.41 42.06 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -175.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -84.28 -34.66 23.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.271 0.629 . . . . 0.0 110.195 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 79' ' ' ILE . 14.8 p -93.88 -4.47 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 123.934 0.894 . . . . 0.0 111.229 -172.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG11 ' SG ' ' A' ' 87' ' ' CYS . 8.6 p -96.41 134.42 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.59 -64.09 1.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.1 p -135.24 168.89 18.34 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.465 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.595 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -56.6 -23.96 44.39 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 168.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 39.1 ttmt -63.02 -28.68 70.26 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 122.717 0.407 . . . . 0.0 111.947 174.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.485 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.8 t-80 -59.3 -44.82 92.5 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.853 0.461 . . . . 0.0 110.021 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.04 -52.14 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.742 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.632 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 3.8 pp -65.57 -36.42 83.71 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.764 0.256 . . . . 0.0 111.648 -171.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.458 ' CG ' ' HG ' ' A' ' 139' ' ' LEU . 57.5 t60 -57.68 -41.31 81.35 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.181 0.592 . . . . 0.0 110.71 169.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.29 -34.42 77.35 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.647 0.592 . . . . 0.0 111.13 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 42' ' ' LEU . 62.9 mt -65.78 -46.08 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.925 0.89 . . . . 0.0 110.641 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.411 ' O ' HG22 ' A' ' 50' ' ' THR . 67.4 m-20 -59.39 -46.93 87.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.424 0.69 . . . . 0.0 110.247 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -61.68 -36.14 80.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.448 1.099 . . . . 0.0 111.166 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.15 95.92 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.565 0.746 . . . . 0.0 111.859 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -76.96 -20.35 56.22 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 51' ' ' LYS . 5.1 t -105.25 -38.8 6.4 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.757 0.423 . . . . 0.0 110.757 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HG2' HG23 ' A' ' 50' ' ' THR . 45.2 mmtm -114.52 136.2 53.29 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.591 0.756 . . . . 0.0 110.602 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.603 ' HD3' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -109.56 116.53 54.35 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.856 -178.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.19 -142.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.126 2.551 . . . . 0.0 110.593 168.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.55 41.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 72' ' ' ILE . . . -77.68 150.94 34.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.534 -174.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -84.96 -23.14 28.89 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.85 0.86 . . . . 0.0 111.15 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -161.07 173.83 14.61 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.054 0.941 . . . . 0.0 109.399 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -66.89 -44.32 81.17 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.693 0.797 . . . . 0.0 111.177 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.451 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 94.0 m95 -76.39 -18.9 58.63 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.409 0.283 . . . . 0.0 111.589 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.5 mmt -79.15 -25.45 42.88 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.002 0.521 . . . . 0.0 110.779 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 29.8 tt0 -76.03 -37.59 58.2 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.177 0.991 . . . . 0.0 111.544 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.448 HD13 HG12 ' A' ' 45' ' ' ILE . 78.6 mt -68.25 -39.9 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.129 0.572 . . . . 0.0 111.33 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.413 HD12 HG13 ' A' ' 64' ' ' VAL . 3.9 pp -72.06 -34.68 68.93 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 123.214 0.321 . . . . 0.0 111.466 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.413 HG13 HD12 ' A' ' 63' ' ' LEU . 21.9 m -74.34 -35.48 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 121.971 -0.456 . . . . 0.0 110.745 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 16.7 tpt85 -68.42 -42.56 78.75 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.161 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.01 66.57 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.451 0.7 . . . . 0.0 111.573 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -82.93 -5.32 59.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.578 0.751 . . . . 0.0 111.947 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.9 -73.46 2.12 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -44.32 136.49 4.03 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.326 1.45 . . . . 0.0 112.365 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -96.59 5.86 49.89 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.941 0.896 . . . . 0.0 111.482 -165.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.48 126.21 43.94 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.707 1.203 . . . . 0.0 110.997 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 55' ' ' ALA . 1.7 mp -53.12 -59.15 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 124.957 1.303 . . . . 0.0 112.55 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.491 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 63.0 m80 -60.36 -46.79 88.68 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.781 0.676 . . . . 0.0 110.702 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -57.2 -51.83 67.77 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.415 1.072 . . . . 0.0 111.187 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.62 72.33 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.376 0.671 . . . . 0.0 112.681 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.55 -32.6 55.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 122.918 0.487 . . . . 0.0 111.217 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 73' ' ' HIS . 32.6 mmtp -70.14 -49.38 51.28 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 175.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 52.6 mt -68.82 -67.56 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.095 0.958 . . . . 0.0 111.881 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 34' ' ' VAL . 6.9 pt -103.85 8.91 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.92 168.59 54.75 Favored Glycine 0 C--N 1.352 1.459 0 CA-C-N 119.457 1.026 . . . . 0.0 113.11 -171.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.86 144.82 48.93 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.54 0.736 . . . . 0.0 112.755 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -147.1 151.51 36.96 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -58.77 149.94 25.1 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 119.659 1.118 . . . . 0.0 112.062 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.78 -114.52 4.39 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.083 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 12' ' ' ARG . 14.7 m120 -89.2 109.05 19.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.136 0.575 . . . . 0.0 110.223 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG21 HD11 ' A' ' 16' ' ' ILE . 4.2 m -137.44 175.11 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.749 0.82 . . . . 0.0 112.034 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.507 ' SG ' HG11 ' A' ' 35' ' ' VAL . 57.9 m -122.82 120.88 34.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.411 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD21 ' HB ' ' A' ' 99' ' ' ILE . 9.2 tp -104.1 120.19 40.56 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.765 0.793 . . . . 0.0 109.344 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 12.1 mt -119.12 129.48 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.074 -170.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.565 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 47.9 t -157.69 164.48 37.12 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -78.27 -53.11 7.67 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.357 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -119.86 149.84 41.43 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.193 0.597 . . . . 0.0 110.18 -173.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.14 -35.67 69.79 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.382 1.073 . . . . 0.0 113.143 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 12.8 pt-20 -73.67 -40.68 63.49 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.565 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 34.9 m -66.07 -36.24 82.68 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.137 0.575 . . . . 0.0 110.938 176.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.16 -47.36 83.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.308 0.643 . . . . 0.0 109.383 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -67.46 -34.97 78.26 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.927 -175.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 30.6 mmmt -63.52 -36.66 84.51 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.39 0.676 . . . . 0.0 111.698 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.431 ' HB ' HD21 ' A' ' 88' ' ' LEU . 38.1 mm -76.25 -44.68 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 N-CA-C 110.464 -0.198 . . . . 0.0 110.464 175.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.46 -45.02 76.94 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.962 1.305 . . . . 0.0 113.221 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.675 ' HG3' HD22 ' A' ' 102' ' ' LEU . 8.0 pt-20 -62.35 -35.75 80.08 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.475 0.484 . . . . 0.0 111.959 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.675 HD22 ' HG3' ' A' ' 101' ' ' GLU . 3.5 mm? -75.83 -39.15 57.28 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 119.102 -0.475 . . . . 0.0 112.012 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.3 pt -74.73 -42.94 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 118.604 0.638 . . . . 0.0 110.639 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.27 113.81 0.06 OUTLIER Glycine 0 C--N 1.35 1.308 0 O-C-N 123.545 0.528 . . . . 0.0 113.838 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.83 -162.74 29.31 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -116.92 134.98 54.08 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.56 0.744 . . . . 0.0 109.974 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.8 mm -75.43 123.67 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -143.03 95.94 2.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.099 1.36 . . . . 0.0 107.694 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.4 -18.55 63.77 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.8 0.44 . . . . 0.0 112.157 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.5 m -57.38 -25.34 59.35 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -70.71 -25.23 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 CA-C-O 120.893 0.378 . . . . 0.0 110.159 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.564 HD13 ' HB3' ' A' ' 38' ' ' LYS . 38.6 mt -107.81 16.52 23.49 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.634 1.174 . . . . 0.0 112.051 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -103.69 -4.91 23.12 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 119.743 1.156 . . . . 0.0 112.428 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.528 HD11 HG12 ' A' ' 134' ' ' VAL 0.294 0.5 OUTLIER 93.57 123.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.803 2.041 . . . . 0.0 109.401 -176.43 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.552 ' HB2' ' HD3' ' A' ' 118' ' ' LYS . 3.7 m-80 -139.58 157.59 45.55 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 124.525 1.13 . . . . 0.0 108.328 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.72 -38.56 91.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.412 0.685 . . . . 0.0 110.733 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.79 -48.56 80.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.126 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' A' ' 115' ' ' ASN . 4.2 mptp? -63.02 -42.18 99.74 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.83 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 29.1 tt0 -65.61 -44.17 87.38 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.757 -166.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -69.38 -39.02 78.25 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.54 -33.05 62.65 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 119.485 -0.293 . . . . 0.0 110.718 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.1 mt -59.14 -41.89 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.88 0.872 . . . . 0.0 110.538 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -74.53 -23.41 58.8 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.611 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -65.92 -57.65 7.37 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.519 HD11 HG23 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -78.36 -24.61 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 119.262 0.937 . . . . 0.0 112.977 -175.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -97.1 -32.42 11.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.15 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 57.88 79.11 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.062 0.945 . . . . 0.0 111.2 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.454 HD21 ' HB ' ' A' ' 135' ' ' VAL . 10.5 t30 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.528 HG12 HD11 ' A' ' 114' ' ' ILE . 3.8 p -69.73 -15.86 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.124 0.57 . . . . 0.0 112.453 -171.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.454 ' HB ' HD21 ' A' ' 133' ' ' ASN . 21.4 t -70.34 -53.13 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -56.57 -39.37 73.38 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.41 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -68.17 -42.21 80.34 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.451 -173.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.9 p -76.23 -37.83 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 122.817 0.447 . . . . 0.0 110.892 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.5 mp -60.46 -37.24 80.38 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.015 0.926 . . . . 0.0 111.388 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -73.23 -40.96 64.25 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.499 0.499 . . . . 0.0 111.618 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -72.61 -29.54 63.58 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.396 0.278 . . . . 0.0 111.438 -171.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.406 HD11 ' HD2' ' A' ' 43' ' ' HIS . 22.2 pt -84.75 -18.55 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.212 0 C-N-CA 123.008 0.523 . . . . 0.0 110.334 172.554 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.9 mt -93.01 102.17 13.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.4 mm -112.69 118.92 59.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -135.08 149.05 50.01 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.26 151.52 17.9 Favored Glycine 0 C--O 1.239 0.42 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.91 127.65 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.61 0.719 . . . . 0.0 112.874 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.534 ' HA ' HD22 ' A' ' 85' ' ' ASN . 11.5 ptp85 -91.72 133.17 35.84 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.823 1.249 . . . . 0.0 110.31 175.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.94 24.37 72.11 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.192 -0.458 . . . . 0.0 114.101 170.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.497 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -80.21 111.79 16.91 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.673 0.789 . . . . 0.0 110.974 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 110.17 8.42 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.409 HD11 HG21 ' A' ' 86' ' ' VAL . 49.6 mm -69.02 92.41 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.72 0.771 . . . . 0.0 109.34 175.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -105.01 148.58 26.58 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.486 -176.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -56.53 -24.41 46.53 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.4 -34.17 76.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.394 0.678 . . . . 0.0 112.38 -172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.621 HG21 HG23 ' A' ' 103' ' ' ILE . 7.2 pt -62.66 -15.14 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -106.82 -17.85 14.09 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 118.525 0.602 . . . . 0.0 109.845 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -69.39 -25.44 64.15 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.08 0.952 . . . . 0.0 111.16 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -76.57 -8.94 58.21 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.196 -174.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.11 17.22 9.92 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 116.737 1.455 . . . . 0.0 116.737 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.468 ' HB2' HD13 ' A' ' 23' ' ' LEU . 93.3 mt -81.93 170.5 15.55 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.426 0.69 . . . . 0.0 110.833 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -84.58 99.41 10.74 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.643 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -149.9 162.25 40.69 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.852 0.861 . . . . 0.0 109.421 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.433 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -140.09 145.89 38.21 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.6 mt -130.98 127.48 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 172.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -120.31 176.63 5.37 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 34' ' ' VAL . 44.4 t30 -81.17 138.07 35.87 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.541 ' HB1' ' HB ' ' A' ' 111' ' ' VAL . . . -83.74 -2.45 56.3 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.507 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 61.3 m-20 -89.87 -30.22 18.05 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 122.854 0.462 . . . . 0.0 110.387 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.469 HG23 HG13 ' A' ' 125' ' ' ILE . 9.4 p -87.52 -16.29 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 123.309 0.644 . . . . 0.0 111.234 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 32' ' ' ALA . 13.4 p -93.86 136.13 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.77 -66.93 0.64 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.681 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.4 p -138.49 167.78 21.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.595 1.158 . . . . 0.0 109.362 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB3' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -58.26 -22.94 54.43 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 174.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 87.4 tttt -58.95 -34.68 72.04 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.021 0.528 . . . . 0.0 111.677 174.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.509 ' HA ' HD11 ' A' ' 139' ' ' LEU . 18.1 t-80 -60.58 -44.57 96.07 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.204 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.57 -52.83 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.036 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 4.1 pp -64.57 -28.37 69.59 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -172.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.441 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 79.4 t60 -68.63 -33.48 74.09 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.226 0.61 . . . . 0.0 110.985 171.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 -40.82 69.58 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.024 0.53 . . . . 0.0 110.914 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.504 HG12 HD13 ' A' ' 62' ' ' ILE . 55.9 mt -61.3 -43.79 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.163 0.985 . . . . 0.0 109.915 172.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 50' ' ' THR . 25.8 t-20 -53.13 -48.39 67.93 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.634 1.173 . . . . 0.0 110.69 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 26.7 mm-40 -63.82 -34.62 78.34 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.231 0.957 . . . . 0.0 110.583 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.452 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . . . -73.35 -25.66 60.69 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -83.71 -46.19 12.55 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.376 0.67 . . . . 0.0 111.23 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.537 HG23 ' HG3' ' A' ' 51' ' ' LYS . 15.1 t -93.9 -32.35 13.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.75 0.42 . . . . 0.0 111.827 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.537 ' HG3' HG23 ' A' ' 50' ' ' THR . 42.3 mtpt -109.51 160.97 15.78 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.925 0.49 . . . . 0.0 111.239 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -142.36 98.82 5.95 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 124.066 0.947 . . . . 0.0 110.248 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.41 -119.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.549 2.832 . . . . 0.0 112.036 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.3 mt -132.99 34.73 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.39 158.59 23.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.548 -175.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -60.24 -60.37 3.92 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.9 0.88 . . . . 0.0 112.416 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.543 ' HB2' ' SD ' ' A' ' 60' ' ' MET . 70.0 m -148.65 179.17 8.03 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.512 0.725 . . . . 0.0 109.818 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.402 ' O ' HG13 ' A' ' 62' ' ' ILE . 58.1 t80 -53.56 -56.97 12.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.324 1.049 . . . . 0.0 111.852 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.515 ' HZ3' HG22 ' A' ' 89' ' ' ILE . 75.7 m95 -65.54 -35.18 80.09 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.491 0.716 . . . . 0.0 111.473 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 57' ' ' SER . 1.1 mpt? -76.34 -19.81 57.85 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 22.9 tt0 -78.53 -38.94 39.37 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.442 0.697 . . . . 0.0 110.627 173.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.504 HD13 HG12 ' A' ' 45' ' ' ILE . 90.2 mt -57.01 -41.28 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.491 0.716 . . . . 0.0 111.036 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.403 HD12 HG13 ' A' ' 64' ' ' VAL . 3.9 pp -72.0 -32.88 67.63 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.21 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.713 HG23 ' HE ' ' A' ' 65' ' ' ARG . 12.0 m -78.38 -34.21 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 121.771 -0.581 . . . . 0.0 111.729 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.713 ' HE ' HG23 ' A' ' 64' ' ' VAL . 5.8 mmp_? -70.39 -38.98 74.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.651 0.38 . . . . 0.0 110.919 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.81 68.84 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.34 0.656 . . . . 0.0 112.199 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.0 p -92.44 -3.53 55.08 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.764 0.426 . . . . 0.0 111.933 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.48 16.04 48.52 Favored Glycine 0 C--N 1.358 1.77 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -170.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.605 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.7 tp-100 -105.76 151.57 24.29 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.5 ptt-85 -85.19 -27.2 26.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.072 0.549 . . . . 0.0 111.361 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.605 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 5.8 mm-40 -90.04 125.45 35.41 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.357 1.063 . . . . 0.0 111.195 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.499 HD12 HG11 ' A' ' 64' ' ' VAL . 1.8 mp -58.76 -44.95 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.343 1.057 . . . . 0.0 110.357 172.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -60.94 -51.09 70.76 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.351 0.661 . . . . 0.0 111.348 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.408 ' HB2' ' HG2' ' A' ' 69' ' ' GLN . 16.8 mm-40 -56.47 -55.52 32.63 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.316 0.385 . . . . 0.0 110.983 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.71 -38.78 75.86 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.3 mt -68.99 -31.1 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 120.661 0.267 . . . . 0.0 111.178 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -74.05 -43.63 57.15 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 122.098 -0.376 . . . . 0.0 110.675 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 79.4 mt -68.55 -65.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.83 0.852 . . . . 0.0 111.825 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.462 HG22 HG21 ' A' ' 34' ' ' VAL . 7.7 pt -105.91 6.06 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.15 176.13 47.4 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 119.094 0.861 . . . . 0.0 114.025 -166.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.33 140.31 42.99 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.613 0.765 . . . . 0.0 111.803 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -145.64 143.22 29.71 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.44 141.3 58.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.297 0.953 . . . . 0.0 111.41 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.07 -119.41 4.45 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.534 HD22 ' HA ' ' A' ' 12' ' ' ARG . 12.6 m120 -82.83 110.29 17.71 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.252 0.526 . . . . 0.0 109.913 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.409 HG21 HD11 ' A' ' 16' ' ' ILE . 3.6 m -134.79 174.06 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.627 0.727 . . . . 0.0 111.519 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.1 t -130.94 121.81 25.81 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.709 -173.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.515 HD21 ' HB ' ' A' ' 99' ' ' ILE . 8.3 tp -102.1 122.22 43.7 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.774 0.797 . . . . 0.0 109.503 -172.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.515 HG22 ' HZ3' ' A' ' 59' ' ' TRP . 32.0 mt -111.03 122.19 65.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 113.35 -1.75 . . . . 0.0 107.692 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.609 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 40.1 t -154.56 168.0 28.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.953 0.342 . . . . 0.0 111.028 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -95.96 -48.13 5.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.356 0.663 . . . . 0.0 110.827 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -111.66 138.15 48.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.428 0.691 . . . . 0.0 109.26 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 41.4 tt0 -63.49 -24.14 67.7 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.278 0.631 . . . . 0.0 111.902 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.15 -45.82 72.49 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.609 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 28.3 m -70.88 -34.45 71.6 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.929 0.892 . . . . 0.0 111.001 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 5.5 t80 -61.54 -52.31 64.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.553 0.741 . . . . 0.0 109.667 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 30.7 mtp180 -68.58 -33.62 74.37 Favored 'General case' 0 C--O 1.213 -0.855 0 O-C-N 123.685 0.616 . . . . 0.0 110.343 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.415 ' O ' HD13 ' A' ' 102' ' ' LEU . 50.4 tptt -56.46 -40.49 74.94 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.024 0.529 . . . . 0.0 110.663 175.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.515 ' HB ' HD21 ' A' ' 88' ' ' LEU . 43.2 mm -73.67 -48.64 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.6 174.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -54.54 -43.37 71.9 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 124.826 1.251 . . . . 0.0 113.702 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 56.6 mm-40 -60.88 -40.33 92.61 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.624 0.37 . . . . 0.0 110.776 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 98' ' ' LYS . 6.8 mp -72.97 -42.08 63.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.533 0.733 . . . . 0.0 112.082 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.621 HG23 HG21 ' A' ' 20' ' ' ILE . 8.2 pt -74.66 -32.59 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 118.229 0.468 . . . . 0.0 110.019 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.38 27.14 73.92 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 163.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.38 -170.58 43.72 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 172.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -111.62 146.38 37.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.35 124.54 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 121.003 0.43 . . . . 0.0 110.087 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -118.93 101.0 7.73 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.37 -41.82 76.01 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 50.4 m -56.82 -24.93 54.5 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -175.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.541 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 13.5 m -70.36 -17.75 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 118.583 0.629 . . . . 0.0 111.605 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 38' ' ' LYS . 21.2 mt -107.05 17.6 22.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.791 0.836 . . . . 0.0 111.136 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 110' ' ' SER . 8.0 pt-20 -114.46 -10.64 12.57 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.044 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 78.63 127.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 C-N-CA 124.527 1.131 . . . . 0.0 110.451 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -158.88 -172.39 3.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.554 1.142 . . . . 0.0 109.408 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.38 -47.58 83.53 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.284 0.634 . . . . 0.0 111.362 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.08 -44.04 95.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.187 0.595 . . . . 0.0 110.967 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -59.97 -43.92 94.78 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.128 0.893 . . . . 0.0 110.389 177.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.01 -50.05 31.91 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.353 -167.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -64.96 -54.5 29.51 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -172.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 33' ' ' ASP . 1.2 pp -64.44 -33.09 75.06 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.14 0.275 . . . . 0.0 111.17 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.526 ' HA ' HD11 ' A' ' 125' ' ' ILE . 1.9 mt -53.84 -32.66 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 124.052 0.941 . . . . 0.0 112.048 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -64.51 -36.5 84.38 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.498 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.62 -56.69 18.73 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.526 HD11 ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -70.0 -52.92 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.328 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.424 ' HD2' HG23 ' A' ' 122' ' ' ILE . 23.6 m-85 -83.58 -33.07 25.48 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -170.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? 61.53 69.55 0.64 Allowed 'General case' 0 C--N 1.35 0.592 0 O-C-N 124.403 1.064 . . . . 0.0 110.586 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.9 mm . . . . . 0 CA--C 1.541 0.602 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.573 -174.212 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.521 HD22 ' HG2' ' A' ' 136' ' ' GLU . 37.0 t30 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.06 -32.12 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.892 0.877 . . . . 0.0 111.861 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.67 -53.48 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.178 0.514 . . . . 0.0 109.971 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.521 ' HG2' HD22 ' A' ' 133' ' ' ASN . 28.5 mm-40 -70.04 -37.14 75.49 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.83 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -76.91 -29.44 55.7 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 123.561 0.538 . . . . 0.0 111.817 -172.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.56 -36.15 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 172.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.9 mp -60.49 -38.11 83.25 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.423 0.689 . . . . 0.0 110.646 172.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 31.4 mm-40 -59.65 -51.41 69.93 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.136 0.574 . . . . 0.0 110.955 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -49.19 78.2 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.557 0.743 . . . . 0.0 112.249 -175.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.9 pt -70.18 -27.59 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 122.972 0.509 . . . . 0.0 110.683 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.233 0 C-N-CA 122.848 0.459 . . . . 0.0 110.531 175.203 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.517 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 63.0 mt -101.77 106.15 19.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -171.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.516 HG12 ' HB ' ' A' ' 41' ' ' VAL . 3.7 mp -103.29 122.63 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 170.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.427 HH11 HG23 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -124.19 149.61 46.14 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -174.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' N ' HD11 ' A' ' 112' ' ' LEU . . . -104.8 137.32 13.58 Favored Glycine 0 CA--C 1.501 -0.792 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.0 tt -146.83 142.94 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.291 0.567 . . . . 0.0 111.093 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -122.56 132.28 54.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.352 1.461 . . . . 0.0 108.906 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.07 1.33 70.05 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.624 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.87 106.42 1.54 Allowed 'General case' 0 C--N 1.351 0.66 0 C-N-CA 124.287 1.035 . . . . 0.0 111.352 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -74.78 104.08 5.28 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.198 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.483 HD11 HG21 ' A' ' 86' ' ' VAL . 49.9 mm -71.25 98.2 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.687 0.756 . . . . 0.0 109.253 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -112.26 153.05 27.74 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.453 -178.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -67.15 -12.12 59.13 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.561 0.744 . . . . 0.0 112.349 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -67.03 -33.26 75.16 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.014 0.926 . . . . 0.0 111.83 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.413 HG23 ' ND2' ' A' ' 17' ' ' ASN . 12.6 pt -55.23 -22.57 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -87.36 -21.82 25.44 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.448 0.567 . . . . 0.0 111.409 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -77.35 -16.21 59.01 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.22 0.608 . . . . 0.0 112.025 -170.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 99' ' ' ILE . 1.2 pp -80.3 -8.92 59.69 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.974 0.51 . . . . 0.0 111.814 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.7 14.92 10.53 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.854 1.501 . . . . 0.0 116.854 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.56 159.27 32.4 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.577 0.688 . . . . 0.0 110.33 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -83.3 100.68 10.79 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -145.12 166.45 25.37 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.555 1.142 . . . . 0.0 108.7 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -149.95 151.78 33.91 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 162.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.415 HG12 HD13 ' A' ' 88' ' ' LEU . 27.3 mt -128.15 127.51 67.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.616 HD22 HD11 ' A' ' 89' ' ' ILE . 2.7 pt? -115.35 172.35 7.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -81.41 142.91 32.53 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.151 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 111' ' ' VAL . . . -78.61 0.64 25.6 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.16 -28.58 57.42 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.17 0.588 . . . . 0.0 111.082 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 HG11 HG22 ' A' ' 79' ' ' ILE . 32.4 m -107.46 -2.74 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.122 0.569 . . . . 0.0 112.484 -170.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.515 HG11 ' SG ' ' A' ' 87' ' ' CYS . 7.4 p -78.45 104.53 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.277 0.56 . . . . 0.0 109.557 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.5 -66.61 0.53 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.565 HG22 ' HA ' ' A' ' 113' ' ' GLU . 19.1 p -137.78 173.07 12.04 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.677 169.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' A' ' 112' ' ' LEU . 51.3 mtpt -53.98 -25.29 20.14 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.055 0.542 . . . . 0.0 111.678 165.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 10.7 mptt -57.74 -36.74 72.47 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.317 1.047 . . . . 0.0 111.959 172.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.409 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.2 t-80 -60.18 -49.82 76.12 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.211 0.945 . . . . 0.0 110.553 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.516 ' HB ' HG12 ' A' ' 8' ' ' ILE . 59.1 t -69.53 -54.04 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.271 177.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 45' ' ' ILE . 1.8 pp -60.64 -36.8 79.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.001 0.521 . . . . 0.0 111.556 -172.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.547 ' HD2' HD11 ' A' ' 142' ' ' ILE . 75.6 t60 -58.92 -39.82 82.71 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.781 0.832 . . . . 0.0 111.454 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.04 -33.45 70.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.266 0.626 . . . . 0.0 110.693 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.537 HG12 HD13 ' A' ' 62' ' ' ILE . 43.0 mt -65.16 -44.28 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.386 0.675 . . . . 0.0 110.426 170.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -55.45 -40.42 71.55 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.797 0.839 . . . . 0.0 110.538 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -60.3 -43.79 95.98 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.519 1.137 . . . . 0.0 110.601 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.61 -28.13 66.64 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.55 0.74 . . . . 0.0 112.462 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -76.54 -42.1 44.23 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.572 0.349 . . . . 0.0 111.038 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.572 HG23 ' HG3' ' A' ' 51' ' ' LYS . 12.8 t -88.25 -31.69 18.9 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.392 0.277 . . . . 0.0 111.479 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.572 ' HG3' HG23 ' A' ' 50' ' ' THR . 39.9 mtmt -109.53 152.95 24.79 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.911 0.863 . . . . 0.0 112.752 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -139.23 81.84 20.27 Favored Pre-proline 0 CA--C 1.553 1.087 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.627 160.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -87.73 -78.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.278 2.652 . . . . 0.0 113.017 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.3 mt -123.89 -10.82 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 124.275 1.03 . . . . 0.0 108.939 -172.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HA ' HD11 ' A' ' 72' ' ' ILE . . . -65.06 147.34 53.64 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.954 0.902 . . . . 0.0 112.508 -172.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.654 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 75.9 mmtt -66.83 -33.44 75.61 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.566 0.747 . . . . 0.0 110.108 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.406 ' H ' ' HB2' ' A' ' 60' ' ' MET . 28.0 t -163.41 178.15 8.32 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.641 -175.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -51.94 -60.33 3.31 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.691 1.596 . . . . 0.0 111.481 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.402 ' HA ' HD12 ' A' ' 62' ' ' ILE . 78.6 m95 -66.83 -20.73 65.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.294 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.654 ' HG3' ' HB2' ' A' ' 56' ' ' LYS . 22.8 mmt -76.73 -28.55 55.84 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.349 0.66 . . . . 0.0 111.534 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 64' ' ' VAL . 51.6 tp10 -74.95 -32.08 61.65 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 120.641 0.257 . . . . 0.0 110.498 174.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.537 HD13 HG12 ' A' ' 45' ' ' ILE . 60.5 mt -62.01 -46.49 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.903 0.481 . . . . 0.0 110.833 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.492 HD21 ' SD ' ' A' ' 60' ' ' MET . 4.0 pp -71.91 -34.89 69.46 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.932 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 61' ' ' GLU . 36.0 m -73.94 -31.55 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 118.291 0.496 . . . . 0.0 111.811 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 65' ' ' ARG . 12.6 mmp_? -77.28 -42.23 37.81 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.629 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.11 71.74 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.434 0.561 . . . . 0.0 111.048 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.1 p -86.57 -13.82 44.68 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 59.37 20.75 52.06 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 114.42 0.528 . . . . 0.0 114.42 -164.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -117.44 93.44 4.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.056 0.942 . . . . 0.0 108.929 -177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -59.35 -10.76 3.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -174.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -85.15 121.27 27.66 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 55' ' ' ALA . 27.6 mm -52.95 -54.88 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.696 1.198 . . . . 0.0 112.27 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -58.71 -50.96 71.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.73 0.812 . . . . 0.0 110.967 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.525 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 39.9 mm-40 -61.92 -40.0 93.96 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.053 0.846 . . . . 0.0 112.242 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.45 80.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.489 0.715 . . . . 0.0 111.788 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.1 -30.17 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 123.398 0.679 . . . . 0.0 110.808 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 58.5 mtpt -64.77 -49.12 71.98 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 122.108 -0.37 . . . . 0.0 110.781 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.84 -65.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.636 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.617 HG22 HG11 ' A' ' 34' ' ' VAL . 23.0 pt -104.36 11.21 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -169.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.13 155.15 50.33 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 118.921 0.782 . . . . 0.0 112.03 -172.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.09 54.5 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.676 0.791 . . . . 0.0 112.976 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -132.2 158.45 41.72 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -53.32 145.63 13.76 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 119.043 0.838 . . . . 0.0 112.611 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.17 -111.19 4.18 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.23 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.422 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.9 OUTLIER -91.17 111.47 22.96 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.26 0.624 . . . . 0.0 109.85 -173.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 16' ' ' ILE . 3.7 m -138.75 -179.84 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.819 1.248 . . . . 0.0 111.426 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.515 ' SG ' HG11 ' A' ' 35' ' ' VAL . 78.0 m -133.89 125.35 28.13 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.495 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.455 HD21 ' HB ' ' A' ' 99' ' ' ILE . 11.7 tp -104.72 126.09 51.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.232 1.013 . . . . 0.0 109.686 -170.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.616 HD11 HD22 ' A' ' 30' ' ' LEU . 7.0 mt -109.45 122.78 64.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 114.302 -1.317 . . . . 0.0 107.45 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 9.4 p -143.43 152.15 41.21 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 122.776 0.43 . . . . 0.0 109.902 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.15 -46.35 84.48 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.283 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.401 ' OD2' ' HG2' ' A' ' 94' ' ' GLU . 1.5 p-10 -148.46 171.15 16.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.411 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -69.0 -22.58 64.07 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -168.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HG2' ' OD2' ' A' ' 92' ' ' ASP . 10.1 pt-20 -74.46 -41.73 60.28 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.098 0.863 . . . . 0.0 109.281 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m -58.49 -39.69 80.74 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.605 0.762 . . . . 0.0 110.819 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.697 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 14.1 t80 -56.55 -51.23 69.34 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 123.364 0.666 . . . . 0.0 110.719 175.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -63.93 -35.21 79.92 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.75 0.656 . . . . 0.0 110.822 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 98' ' ' LYS . 10.7 mmpt? -64.59 -45.94 84.82 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.586 0.554 . . . . 0.0 111.571 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.487 HD13 HD21 ' A' ' 23' ' ' LEU . 44.4 mm -69.06 -44.57 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.395 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -53.31 -34.37 57.11 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.041 1.336 . . . . 0.0 112.182 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -60.25 -51.35 69.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.588 0.755 . . . . 0.0 111.561 174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.429 ' HB3' HD21 ' A' ' 17' ' ' ASN . 4.1 mm? -69.66 -41.43 75.53 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.8 pt -77.89 -50.2 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 118.35 0.523 . . . . 0.0 110.775 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.04 114.33 0.04 OUTLIER Glycine 0 C--N 1.35 1.353 0 N-CA-C 113.883 0.313 . . . . 0.0 113.883 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.46 -159.88 24.81 Favored Glycine 0 C--O 1.241 0.589 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.2 143.18 49.27 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.3 0.55 . . . . 0.0 109.829 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.5 mm -71.22 129.1 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 122.928 0.491 . . . . 0.0 110.18 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -116.5 101.79 8.93 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -68.12 -53.5 24.89 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.1 0.56 . . . . 0.0 111.747 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.1 p -53.06 -30.03 33.5 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.546 HG21 ' HB1' ' A' ' 32' ' ' ALA . 10.3 p -65.3 -27.26 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 118.401 0.546 . . . . 0.0 111.44 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.459 HD11 ' N ' ' A' ' 10' ' ' GLY . 93.4 mt -80.46 -3.2 48.99 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.372 1.069 . . . . 0.0 112.503 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 37' ' ' THR . 12.8 pt-20 -135.95 23.57 3.31 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -169.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 118' ' ' LYS . 0.4 OUTLIER 77.74 138.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 124.242 1.017 . . . . 0.0 112.46 165.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 5.2 p-10 -151.16 -179.93 7.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.527 1.131 . . . . 0.0 109.517 170.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.81 -41.61 97.85 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.315 0.646 . . . . 0.0 111.943 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.514 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 0.1 OUTLIER -62.17 -41.72 98.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.592 1.157 . . . . 0.0 109.928 176.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -62.62 -40.01 95.62 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.047 0.842 . . . . 0.0 110.691 177.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.6 -48.41 48.3 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.345 -166.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -73.55 -39.45 64.69 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.172 0.589 . . . . 0.0 110.697 -174.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.8 tp -53.88 -53.15 56.65 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.278 1.431 . . . . 0.0 111.971 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.443 HG23 ' HD2' ' A' ' 126' ' ' PHE . 43.6 mt -62.44 -29.72 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.753 1.221 . . . . 0.0 111.309 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 5.4 tmm_? -72.41 -35.94 68.51 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.992 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.62 -55.99 12.75 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.63 -35.75 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 118.916 0.78 . . . . 0.0 113.075 -174.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.443 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.7 m-30 -88.39 -32.21 18.47 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 29.1 mmtp 63.84 75.86 0.37 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.176 0.99 . . . . 0.0 112.213 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.2 mt . . . . . 0 CA--C 1.537 0.447 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.524 -179.548 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.2 t30 . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.24 -25.87 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 123.474 0.71 . . . . 0.0 111.516 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.436 ' O ' HD13 ' A' ' 139' ' ' LEU . 85.1 t -68.64 -58.35 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.45 0.7 . . . . 0.0 111.667 -174.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -63.05 -29.05 70.51 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 117.742 0.246 . . . . 0.0 111.042 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.46 ' HA ' ' HG2' ' A' ' 140' ' ' GLU . 77.6 mtt-85 -75.97 -32.76 59.63 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 123.736 0.648 . . . . 0.0 112.187 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.0 p -73.82 -41.05 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 CA-C-N 118.218 0.463 . . . . 0.0 110.142 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 135' ' ' VAL . 11.2 mp -57.29 -42.4 81.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.535 0.734 . . . . 0.0 112.565 175.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 137' ' ' ARG . 13.5 pt-20 -80.73 -28.57 36.54 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.054 0.141 . . . . 0.0 110.971 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -59.82 -52.55 64.99 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.694 0.797 . . . . 0.0 110.679 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.547 HD11 ' HD2' ' A' ' 43' ' ' HIS . 13.6 pt -73.59 -17.12 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.056 -171.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.809 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.327 167.743 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.759 ' SD ' ' HG2' ' A' ' 91' ' ' GLU . 5.1 mmt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.548 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 41.9 mt -96.95 102.98 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.27 122.65 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -124.65 145.87 49.41 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.039 0.935 . . . . 0.0 109.549 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.72 139.19 14.52 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.247 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.0 tt -152.48 144.07 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 122.849 0.46 . . . . 0.0 110.992 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -116.85 142.7 46.59 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.84 0.856 . . . . 0.0 109.308 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.34 11.24 85.7 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.56 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.59 95.21 1.06 Allowed 'General case' 0 C--N 1.351 0.639 0 C-N-CA 123.899 0.879 . . . . 0.0 110.604 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 51.8 mtm-85 -70.79 101.65 2.16 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.805 0.69 . . . . 0.0 109.599 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.585 HD11 HG11 ' A' ' 86' ' ' VAL . 48.2 mm -67.39 121.13 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.419 0.687 . . . . 0.0 110.377 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.43 HD21 HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -112.29 159.34 18.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.794 0.837 . . . . 0.0 109.855 175.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -77.28 -16.55 58.93 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.539 0.735 . . . . 0.0 112.213 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.95 -30.18 63.66 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.386 0.674 . . . . 0.0 112.685 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.43 HG23 HD21 ' A' ' 17' ' ' ASN . 8.3 pt -60.48 -12.47 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.15 0.23 56.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.993 0.517 . . . . 0.0 112.19 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -79.4 -25.09 42.16 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.221 0.464 . . . . 0.0 111.551 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pp -85.15 -14.44 47.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.996 0.518 . . . . 0.0 111.682 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.53 16.37 7.03 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 116.616 1.406 . . . . 0.0 116.616 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.7 mt -73.82 175.17 7.51 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 117.501 0.651 . . . . 0.0 111.457 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.93 81.21 2.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.048 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -139.7 145.95 39.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.002 0.921 . . . . 0.0 108.719 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.418 ' NE2' ' HB3' ' A' ' 63' ' ' LEU . 1.6 tm0? -142.15 136.68 30.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 171.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 86' ' ' VAL . 3.9 mt -127.21 129.74 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.404 ' H ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -131.34 171.05 13.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.748 0.819 . . . . 0.0 110.443 176.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -76.38 116.37 17.0 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.805 0.842 . . . . 0.0 109.906 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.27 3.47 51.95 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.08 -35.69 49.1 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 79' ' ' ILE . 26.8 m -97.88 5.86 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 122.902 0.481 . . . . 0.0 111.729 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.48 139.14 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.81 -69.34 0.53 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.4 p -136.63 172.88 12.36 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.719 0.808 . . . . 0.0 110.065 174.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -26.34 12.33 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.506 0.722 . . . . 0.0 112.311 170.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -54.73 -32.93 60.39 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.446 1.098 . . . . 0.0 112.202 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.582 ' HA ' HD11 ' A' ' 139' ' ' LEU . 30.2 t-80 -65.44 -47.48 76.05 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.728 0.811 . . . . 0.0 110.878 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.507 HG21 ' SG ' ' A' ' 87' ' ' CYS . 38.8 t -67.3 -50.92 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.029 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -61.32 -34.6 75.52 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.039 0.535 . . . . 0.0 111.54 -175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -55.21 -43.95 74.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.043 0.937 . . . . 0.0 110.734 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.8 78.39 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.796 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.512 HG12 HD13 ' A' ' 62' ' ' ILE . 63.5 mt -65.02 -53.38 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.028 0.931 . . . . 0.0 112.192 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -49.28 -44.66 44.14 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.923 0.889 . . . . 0.0 110.628 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -73.44 -31.62 63.92 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.293 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.84 -21.22 60.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.244 0.618 . . . . 0.0 112.323 174.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -78.11 -48.14 16.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.869 0.468 . . . . 0.0 110.332 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.53 HG23 ' HG3' ' A' ' 51' ' ' LYS . 10.9 t -88.98 -29.12 19.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.023 0.529 . . . . 0.0 112.268 -171.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.53 ' HG3' HG23 ' A' ' 50' ' ' THR . 49.1 mtmt -114.45 155.41 26.42 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.571 0.701 . . . . 0.0 112.229 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -140.06 73.13 32.93 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.336 167.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.23 -78.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.206 2.604 . . . . 0.0 114.164 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.69 -26.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.066 0.546 . . . . 0.0 111.645 -166.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.21 174.09 4.21 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -169.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -73.75 -53.62 9.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.447 0.699 . . . . 0.0 112.193 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.614 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 21.4 t -157.03 -171.73 3.76 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.408 0.683 . . . . 0.0 109.453 -174.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -53.95 -60.92 2.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.497 1.119 . . . . 0.0 113.268 -174.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.403 ' CE3' ' HB2' ' A' ' 28' ' ' GLN . 79.8 m95 -64.76 -29.62 70.6 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.014 0.435 . . . . 0.0 111.144 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.614 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.3 mpt? -77.18 -27.51 53.68 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.926 0.891 . . . . 0.0 110.455 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 11.3 tp10 -74.43 -34.08 63.12 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.893 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.512 HD13 HG12 ' A' ' 45' ' ' ILE . 72.9 mt -64.38 -47.07 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.145 0.578 . . . . 0.0 111.061 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.443 ' O ' HD11 ' A' ' 79' ' ' ILE . 3.4 pp -68.34 -33.39 74.22 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.215 0.322 . . . . 0.0 111.607 -175.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.438 HG13 HD12 ' A' ' 63' ' ' LEU . 35.0 m -77.16 -40.5 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 118.094 0.406 . . . . 0.0 110.986 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -70.0 -32.63 70.9 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.035 0.534 . . . . 0.0 111.709 -170.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.64 -30.87 70.55 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.186 0.594 . . . . 0.0 112.109 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.2 p -104.37 9.32 35.82 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.85 0.46 . . . . 0.0 112.225 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.72 23.7 65.55 Favored Glycine 0 C--N 1.358 1.787 0 CA-C-O 121.328 0.404 . . . . 0.0 113.965 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HB3' ' H ' ' A' ' 70' ' ' ARG . 88.2 mm-40 -89.8 -163.23 0.98 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.509 1.124 . . . . 0.0 112.512 -177.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -165.18 -34.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.628 1.571 . . . . 0.0 108.523 -165.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -101.98 121.98 43.18 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.928 0.891 . . . . 0.0 108.653 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 76' ' ' ILE . 1.8 mp -51.34 -45.78 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.587 1.179 . . . . 0.0 111.697 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -66.13 -40.58 90.77 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.265 0.626 . . . . 0.0 110.928 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.03 -47.39 81.01 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.311 0.644 . . . . 0.0 111.478 173.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.85 -35.47 74.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.209 0.604 . . . . 0.0 112.619 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 72' ' ' ILE . 71.4 mt -71.49 -29.89 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 122.991 0.516 . . . . 0.0 110.981 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -63.88 -54.88 27.9 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.012 0.434 . . . . 0.0 109.918 173.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.9 mt -73.29 -65.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.262 -173.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.455 HG22 HG21 ' A' ' 34' ' ' VAL . 23.2 pt -111.0 32.64 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.47 159.47 53.09 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 113.504 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.58 98.99 2.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.41 0.684 . . . . 0.0 110.961 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -109.97 153.15 24.96 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.94 0.896 . . . . 0.0 108.835 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.24 150.69 38.34 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.56 0.744 . . . . 0.0 112.492 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.34 -120.02 6.02 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.75 104.69 14.06 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.585 HG11 HD11 ' A' ' 16' ' ' ILE . 1.3 p -134.11 151.42 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.355 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.507 ' SG ' HG21 ' A' ' 41' ' ' VAL . 41.4 t -109.81 118.88 37.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.426 1.091 . . . . 0.0 108.99 -172.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.84 120.95 43.7 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.46 0.704 . . . . 0.0 110.153 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -107.12 137.21 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 21.8 p -152.42 151.78 31.21 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.985 0.514 . . . . 0.0 109.919 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.759 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 51.3 mt-10 -86.45 -32.23 20.95 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.31 128.89 56.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.003 0.921 . . . . 0.0 108.761 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -67.37 -21.38 65.62 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.315 0.646 . . . . 0.0 111.332 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 8.3 pt-20 -69.66 -40.02 76.7 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.667 0.387 . . . . 0.0 110.031 173.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 99' ' ' ILE . 99.0 m -63.55 -38.44 91.15 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.876 0.87 . . . . 0.0 109.878 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.688 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 11.6 t80 -56.96 -47.85 79.74 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.84 0.856 . . . . 0.0 110.973 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -61.54 -42.99 99.65 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.73 0.644 . . . . 0.0 110.34 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 45.6 mmtm -56.13 -45.9 79.4 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.171 0.92 . . . . 0.0 111.04 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 95' ' ' THR . 32.9 mm -69.84 -45.66 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.322 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -52.62 -43.41 65.37 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.88 1.272 . . . . 0.0 113.171 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.15 -48.27 80.78 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.777 0.673 . . . . 0.0 111.511 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.05 -36.18 56.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 pt -74.83 -39.83 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 118.311 0.505 . . . . 0.0 109.897 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.16 96.79 0.04 OUTLIER Glycine 0 C--N 1.351 1.368 0 O-C-N 123.635 0.585 . . . . 0.0 113.14 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.37 -171.36 25.09 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.16 131.03 55.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.6 mm -62.99 112.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -129.69 92.47 3.34 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 4.6 p-10 -60.27 -34.08 73.22 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.531 0.732 . . . . 0.0 111.81 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 23.8 m -52.86 -24.62 9.46 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -176.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.5 m -66.75 -32.19 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-N 118.204 0.457 . . . . 0.0 110.131 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.0 mt -95.72 -1.92 48.95 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.768 1.227 . . . . 0.0 112.253 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 110' ' ' SER . 76.0 mm-40 -103.78 -9.29 19.16 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 118.148 -0.93 . . . . 0.0 112.459 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.257 0.4 OUTLIER 84.82 135.64 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.983 1.313 . . . . 0.0 111.105 177.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 4.3 p-10 -159.77 170.77 20.8 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.832 1.253 . . . . 0.0 108.799 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.79 -37.62 85.02 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.59 0.756 . . . . 0.0 112.372 -168.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.507 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 16.1 t70 -54.87 -54.1 46.79 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.444 1.098 . . . . 0.0 112.219 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -63.1 -34.13 76.94 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.716 0.635 . . . . 0.0 110.881 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.85 -49.0 32.83 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.416 0.686 . . . . 0.0 112.159 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 67.6 mtp180 -75.22 -30.8 60.67 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.519 0.676 . . . . 0.0 110.942 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.5 tp -55.7 -48.03 75.81 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.219 165.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.422 HG23 ' HD2' ' A' ' 126' ' ' PHE . 25.2 mt -55.7 -35.11 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.229 1.012 . . . . 0.0 112.556 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -74.56 -26.53 60.01 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.951 -178.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -69.45 -58.47 3.95 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 171.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -29.49 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 119.192 0.906 . . . . 0.0 112.968 -174.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.422 ' HD2' HG23 ' A' ' 122' ' ' ILE . 23.2 m-85 -99.51 -26.24 14.17 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 68.3 mmtt 62.03 66.6 0.8 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.138 0.975 . . . . 0.0 112.506 171.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.507 HG21 ' HB3' ' A' ' 137' ' ' ARG . 16.9 mt . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.495 HD22 ' HG3' ' A' ' 136' ' ' GLU . 31.3 t30 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.98 -31.41 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 119.124 0.875 . . . . 0.0 112.21 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.16 -53.94 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.798 0.839 . . . . 0.0 110.415 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.495 ' HG3' HD22 ' A' ' 133' ' ' ASN . 40.8 mt-10 -59.23 -42.6 91.4 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.333 0.396 . . . . 0.0 111.074 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.507 ' HB3' HG21 ' A' ' 128' ' ' ILE . 8.7 mpt_? -73.0 -31.67 64.65 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.949 0.781 . . . . 0.0 112.074 -167.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 139' ' ' LEU . 11.1 p -70.56 -42.56 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 117.706 0.23 . . . . 0.0 110.501 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 40' ' ' HIS . 10.9 mp -60.75 -39.67 89.61 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.567 0.542 . . . . 0.0 111.625 172.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.73 -44.43 93.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.618 0.767 . . . . 0.0 111.117 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -63.87 -45.99 86.97 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.018 0.527 . . . . 0.0 111.286 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 11.5 pt -75.6 -22.23 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.019 0.2 . . . . 0.0 110.62 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 0.884 0 C-N-CA 123.569 0.748 . . . . 0.0 111.089 172.467 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.6 mt -101.2 111.03 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.918 1.287 . . . . 0.0 109.271 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -107.08 127.26 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 9' ' ' ARG . 2.9 mmp_? -128.15 149.89 50.23 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.718 0.807 . . . . 0.0 110.553 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.66 129.94 10.0 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.622 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 tt -141.18 147.04 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.148 0.579 . . . . 0.0 110.597 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -122.97 136.9 55.03 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.349 1.059 . . . . 0.0 109.419 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.36 7.91 87.01 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.36 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.508 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -76.03 104.03 6.37 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.547 0.739 . . . . 0.0 110.218 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -70.81 123.86 22.95 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.365 0.415 . . . . 0.0 110.148 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.8 mm -73.53 91.03 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.887 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.559 ' ND2' HG23 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -91.11 151.23 21.07 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.021 -177.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -63.92 -21.64 66.56 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -64.84 -29.85 70.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.405 0.682 . . . . 0.0 112.103 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.559 HG23 ' ND2' ' A' ' 17' ' ' ASN . 19.1 pt -54.37 -23.82 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -90.07 -19.45 24.33 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.284 0.493 . . . . 0.0 111.32 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.19 -22.23 63.91 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.976 0.91 . . . . 0.0 111.609 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.481 HD21 HD13 ' A' ' 99' ' ' ILE . 1.5 pp -81.95 -10.17 59.35 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.282 0.633 . . . . 0.0 111.965 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.16 16.96 9.65 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 23' ' ' LEU . 86.1 mt -82.39 176.57 9.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.283 0.633 . . . . 0.0 112.197 -174.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -87.56 93.44 9.42 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.102 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -145.66 160.32 41.87 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.111 0.964 . . . . 0.0 108.678 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 59' ' ' TRP . 6.6 tp-100 -148.64 153.23 38.01 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 166.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.85 137.98 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.424 HD22 HD11 ' A' ' 89' ' ' ILE . 2.2 pt? -128.16 -175.06 3.38 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.65 0.78 . . . . 0.0 109.389 170.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -89.22 120.1 30.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.784 0.834 . . . . 0.0 109.78 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.72 -5.27 56.84 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.886 0.874 . . . . 0.0 113.168 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -76.19 -33.63 59.31 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.408 HG21 HG22 ' A' ' 79' ' ' ILE . 3.3 m -105.19 9.5 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.321 0.649 . . . . 0.0 112.264 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.4 p -85.13 140.71 15.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.16 -62.16 1.57 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 113' ' ' GLU . 21.5 p -145.59 169.92 17.46 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.931 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HB3' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -53.71 -31.98 50.17 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.131 0.572 . . . . 0.0 110.649 162.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.539 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 85.5 tttt -66.99 -30.57 70.73 Favored 'General case' 0 C--N 1.36 1.059 0 C-N-CA 123.909 0.883 . . . . 0.0 111.52 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.554 ' HA ' HD11 ' A' ' 139' ' ' LEU . 16.8 t-80 -60.88 -46.75 89.38 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.091 0.556 . . . . 0.0 110.305 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 45' ' ' ILE . 38.8 t -67.64 -51.2 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 O-C-N 123.77 0.669 . . . . 0.0 111.671 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 3.2 pp -64.83 -30.13 71.12 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.516 ' NE2' ' HB2' ' A' ' 143' ' ' ALA . 35.7 t60 -65.39 -35.38 80.76 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.789 0.836 . . . . 0.0 111.119 172.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 65' ' ' ARG . . . -67.44 -34.79 77.93 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.592 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.424 HG12 HD13 ' A' ' 62' ' ' ILE . 19.8 mt -69.79 -35.94 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.931 0.892 . . . . 0.0 110.967 175.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.33 -53.98 51.93 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.246 0.618 . . . . 0.0 109.594 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.445 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 29.1 mm-40 -60.46 -30.47 69.68 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.672 1.189 . . . . 0.0 112.079 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.5 -27.32 66.03 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -89.24 -16.81 30.38 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.443 0.64 . . . . 0.0 109.831 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.0 m -91.49 -43.92 9.41 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.393 1.477 . . . . 0.0 111.041 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . 10.3 mmpt? -114.23 141.94 46.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.133 0.973 . . . . 0.0 112.533 -174.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -123.64 88.65 51.81 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 124.834 1.254 . . . . 0.0 107.988 165.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HG3' ' NE2' ' A' ' 69' ' ' GLN . 67.0 Cg_endo -79.15 -107.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.643 2.229 . . . . 0.0 111.941 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.1 mt -126.21 13.18 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.33 146.45 53.46 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.595 0.758 . . . . 0.0 111.688 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.67 -47.39 86.49 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.594 0.757 . . . . 0.0 111.291 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.1 m -147.63 172.18 14.45 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.856 0.863 . . . . 0.0 110.201 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.72 -52.73 64.25 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.453 1.101 . . . . 0.0 110.944 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 28' ' ' GLN . 83.8 m95 -67.43 -29.09 68.48 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.118 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.444 ' SD ' HD21 ' A' ' 63' ' ' LEU . 23.3 mmt -71.72 -28.45 63.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.153 0.581 . . . . 0.0 111.665 174.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 64' ' ' VAL . 44.8 tp10 -71.05 -27.93 64.01 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.757 0.423 . . . . 0.0 110.398 174.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 HG12 ' A' ' 45' ' ' ILE . 67.5 mt -66.25 -45.64 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.657 0.383 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.451 HD23 ' NE2' ' A' ' 28' ' ' GLN . 4.4 pp -69.77 -32.76 71.44 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.156 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.675 ' HB ' ' H ' ' A' ' 70' ' ' ARG . 10.0 m -78.33 -40.78 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 122.498 -0.126 . . . . 0.0 111.294 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.471 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 6.6 tpt180 -67.9 -39.99 83.53 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 122.494 0.318 . . . . 0.0 111.025 -169.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.03 -14.28 60.03 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 124.036 0.835 . . . . 0.0 112.308 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 p -108.85 26.78 10.18 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.464 0.706 . . . . 0.0 111.546 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 26.13 53.29 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-O 119.619 -0.545 . . . . 0.0 114.297 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' NE2' ' HG3' ' A' ' 53' ' ' PRO . 34.9 tt0 55.99 113.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.269 1.427 . . . . 0.0 113.104 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.675 ' H ' ' HB ' ' A' ' 64' ' ' VAL . 2.8 mpt_? -140.04 172.54 12.62 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.973 1.709 . . . . 0.0 109.256 -173.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -57.13 135.99 56.38 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.97 159.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.14 -49.94 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.404 1.082 . . . . 0.0 111.957 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.77 -37.36 86.11 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.482 0.489 . . . . 0.0 110.52 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -63.28 -46.91 84.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.771 0.428 . . . . 0.0 112.084 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.53 71.54 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.883 0.473 . . . . 0.0 112.114 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.51 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 84.9 mt -64.51 -32.31 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.464 0.706 . . . . 0.0 110.554 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -72.49 -50.87 22.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.697 0.399 . . . . 0.0 110.066 174.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.576 HG22 HG23 ' A' ' 79' ' ' ILE . 43.9 mt -66.69 -65.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.8 0.84 . . . . 0.0 111.791 -173.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.576 HG23 HG22 ' A' ' 78' ' ' ILE . 38.6 pt -124.0 21.15 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 76' ' ' ILE . . . -76.36 156.78 47.22 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.09 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.26 113.97 1.46 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.82 0.848 . . . . 0.0 112.602 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -135.55 153.16 51.79 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.92 124.59 15.88 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.589 1.156 . . . . 0.0 112.755 -170.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.32 -118.26 1.58 Allowed Glycine 0 C--N 1.352 1.432 0 O-C-N 123.434 0.459 . . . . 0.0 112.379 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -84.25 108.14 16.95 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.26 159.98 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.959 0.885 . . . . 0.0 112.674 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.8 m -112.51 118.44 35.14 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.811 -1.54 . . . . 0.0 108.265 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.541 HD21 ' HB ' ' A' ' 99' ' ' ILE . 10.4 tp -102.63 121.19 41.91 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.32 0.648 . . . . 0.0 109.328 -174.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 28' ' ' GLN . 4.8 mt -111.48 125.6 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.902 1.281 . . . . 0.0 108.242 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 74.3 m -148.79 145.95 27.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.158 0.583 . . . . 0.0 109.746 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 -27.36 59.32 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.43 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 28.7 m-20 -131.27 148.92 52.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.287 0.635 . . . . 0.0 111.683 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.09 -25.17 65.21 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.944 1.298 . . . . 0.0 112.764 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 11.2 pt-20 -69.2 -43.27 74.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.788 0.435 . . . . 0.0 110.089 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 m -70.21 -33.08 71.25 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.708 0.803 . . . . 0.0 110.598 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -60.99 -50.96 71.28 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 45.0 ttp180 -59.86 -45.08 93.58 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.886 0.741 . . . . 0.0 109.862 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -59.44 -42.21 91.4 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.097 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.541 ' HB ' HD21 ' A' ' 88' ' ' LEU . 35.6 mm -71.9 -43.66 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -55.18 -37.83 67.55 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 124.596 1.158 . . . . 0.0 112.509 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 46.5 mt-10 -61.26 -39.25 89.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.684 0.794 . . . . 0.0 111.204 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.13 -47.46 35.96 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.691 0.797 . . . . 0.0 112.272 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.508 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 18.2 pt -79.91 -28.95 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 122.068 0.147 . . . . 0.0 110.992 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.32 25.73 70.08 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.044 1.177 . . . . 0.0 116.044 160.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.32 -170.16 46.3 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 117.047 0.423 . . . . 0.0 112.513 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -104.71 140.45 38.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.604 0.762 . . . . 0.0 108.996 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mm -73.04 119.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.162 0.506 . . . . 0.0 109.79 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 111' ' ' VAL . 14.7 t70 -131.54 91.49 3.01 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.87 -32.61 73.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.958 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.591 ' HA ' ' HG3' ' A' ' 113' ' ' GLU . 12.1 p -58.34 -15.4 10.32 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 108' ' ' ASP . 35.4 m -66.42 -24.69 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 118.709 0.686 . . . . 0.0 110.888 171.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 38' ' ' LYS . 67.1 mt -99.65 18.23 18.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.827 1.251 . . . . 0.0 112.593 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.591 ' HG3' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -138.48 12.67 2.76 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 76.02 124.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.825 0.85 . . . . 0.0 112.375 168.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 3.3 p-10 -142.87 177.16 8.53 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.197 173.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -61.88 -42.1 98.66 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.071 0.948 . . . . 0.0 111.52 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 24.8 t70 -59.08 -47.37 85.5 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.048 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -67.01 -31.75 72.52 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.33 0.652 . . . . 0.0 111.142 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.76 -51.28 28.15 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.068 0.547 . . . . 0.0 111.364 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.33 -39.08 71.58 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.494 0.664 . . . . 0.0 110.131 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.1 tp -54.22 -52.87 59.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.315 1.446 . . . . 0.0 112.415 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.42 HG23 ' HD2' ' A' ' 126' ' ' PHE . 15.6 mt -57.96 -30.14 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.566 1.146 . . . . 0.0 111.282 177.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.4 ttm180 -72.05 -33.68 68.16 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.39 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 127' ' ' LYS . 12.4 mm-40 -73.67 -56.51 4.92 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 173.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 pp -78.38 -30.52 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.42 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.1 m-30 -95.85 -30.5 13.63 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 119.358 -0.354 . . . . 0.0 111.539 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 26.2 mmmt 61.97 74.66 0.43 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.746 0.818 . . . . 0.0 111.848 176.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.5 mt . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 123.637 0.775 . . . . 0.0 109.463 -175.499 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 137' ' ' ARG . 39.3 t30 . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.02 -29.14 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.389 1.076 . . . . 0.0 112.476 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.12 -51.51 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.219 0.608 . . . . 0.0 110.592 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -63.55 -30.46 71.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.633 0.373 . . . . 0.0 111.441 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 133' ' ' ASN . 4.2 mmp_? -69.61 -47.7 62.55 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.107 0.563 . . . . 0.0 110.975 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.8 p -72.66 -36.59 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.82 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.554 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.0 mp -58.59 -37.21 75.33 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.149 0.98 . . . . 0.0 111.88 173.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -67.31 -41.59 85.09 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.3 0.375 . . . . 0.0 111.341 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -72.84 -42.52 63.69 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 120.876 0.37 . . . . 0.0 111.834 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 29.9 pt -74.77 -24.04 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.516 ' HB2' ' NE2' ' A' ' 43' ' ' HIS . . . . . . . . 0 C--O 1.212 -0.894 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.168 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.51 ' HG2' HG21 ' A' ' 45' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 74.3 mt -109.1 101.4 12.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.3 mm -110.21 124.11 66.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -121.58 145.12 48.3 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.79 137.62 13.49 Favored Glycine 0 CA--C 1.5 -0.875 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.4 tt -148.85 138.64 16.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.336 0.588 . . . . 0.0 110.357 -173.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -125.34 126.82 45.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.813 1.245 . . . . 0.0 108.714 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.96 -0.11 57.5 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 123.377 0.423 . . . . 0.0 112.565 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.8 94.37 0.45 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.22 1.008 . . . . 0.0 110.823 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -68.89 104.18 2.0 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.577 HD11 HG21 ' A' ' 86' ' ' VAL . 44.6 mm -72.61 120.78 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -176.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.47 ' ND2' HG23 ' A' ' 20' ' ' ILE . 3.4 p-10 -104.08 156.1 18.15 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -81.8 -14.58 56.18 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.099 0.559 . . . . 0.0 111.63 -174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -76.5 -17.21 59.39 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.161 0.984 . . . . 0.0 111.45 -172.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.47 HG23 ' ND2' ' A' ' 17' ' ' ASN . 30.3 pt -53.91 -19.81 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 172.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -83.32 -17.93 40.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.082 0.553 . . . . 0.0 111.94 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -91.35 47.05 1.34 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.074 0.94 . . . . 0.0 109.716 -169.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -139.29 -11.99 1.21 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.311 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.67 33.32 55.0 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 114.513 0.565 . . . . 0.0 114.513 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' HB2' HD13 ' A' ' 23' ' ' LEU . 67.2 mt -102.97 167.38 9.88 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.423 0.689 . . . . 0.0 110.715 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HB3' ' HZ2' ' A' ' 59' ' ' TRP . 60.2 mttp -81.87 91.49 6.55 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.935 0.894 . . . . 0.0 111.31 -176.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.53 158.36 43.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.068 0.547 . . . . 0.0 109.92 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.512 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.6 tm0? -149.26 149.81 31.55 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 165.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 99' ' ' ILE . 16.3 mt -132.18 131.8 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.35 -176.12 3.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.825 0.85 . . . . 0.0 109.447 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -80.68 141.78 34.57 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.844 0.858 . . . . 0.0 109.732 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.23 7.8 45.52 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.3 0.64 . . . . 0.0 112.706 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -88.83 -19.89 25.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.316 0.647 . . . . 0.0 110.855 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 m -111.91 7.31 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.061 0.945 . . . . 0.0 111.641 -176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.2 102.55 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 121.91 0.862 . . . . 0.0 109.971 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.597 ' HB3' HG11 ' A' ' 138' ' ' VAL . . . -79.17 74.83 5.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p 62.69 162.25 0.09 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.63 1.972 . . . . 0.0 111.677 -166.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . 25.3 pttm -53.17 -22.49 6.59 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.506 0.723 . . . . 0.0 111.542 169.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.568 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 56.8 tttp -64.45 -28.42 69.66 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 123.187 0.595 . . . . 0.0 111.541 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.506 ' HA ' HD11 ' A' ' 139' ' ' LEU . 11.7 t-160 -62.73 -45.53 92.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.021 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 45' ' ' ILE . 42.3 t -67.68 -55.17 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 123.735 0.647 . . . . 0.0 111.195 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 4.1 pp -60.02 -32.69 71.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.095 0.558 . . . . 0.0 112.395 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.467 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 36.9 t60 -65.75 -40.77 92.45 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.372 0.669 . . . . 0.0 110.479 173.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.91 87.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.954 0.502 . . . . 0.0 110.789 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.552 HG12 HD13 ' A' ' 62' ' ' ILE . 33.8 mt -64.9 -46.59 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.232 1.013 . . . . 0.0 110.76 175.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -49.0 -48.39 43.58 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.44 1.496 . . . . 0.0 111.084 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 25.8 mm-40 -63.67 -47.24 82.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.089 176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.79 -28.71 69.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.462 0.705 . . . . 0.0 112.556 -175.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HE2' HG22 ' A' ' 45' ' ' ILE . 68.2 mttm -66.11 -43.69 86.49 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.279 0.632 . . . . 0.0 110.925 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.1 t -80.17 -16.82 54.01 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.799 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 51.3 mtpt -99.28 146.95 25.68 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.999 0.92 . . . . 0.0 112.27 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -142.96 72.86 18.67 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.577 161.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 51' ' ' LYS . 56.2 Cg_endo -84.25 -177.04 2.82 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.657 2.238 . . . . 0.0 111.852 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.5 mt -37.04 -22.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.464 ' HA ' HD11 ' A' ' 72' ' ' ILE . . . -53.21 125.42 17.51 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.446 0.698 . . . . 0.0 110.787 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -57.02 -22.26 37.34 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -167.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.623 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 41.9 t -157.36 167.29 30.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.214 0.606 . . . . 0.0 110.114 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -58.73 -50.16 74.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.589 1.156 . . . . 0.0 110.467 170.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.466 ' HA ' HD12 ' A' ' 62' ' ' ILE . 81.7 m95 -64.54 -30.99 72.02 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.651 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.753 ' HB3' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -78.81 -21.03 48.35 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.907 0.883 . . . . 0.0 111.316 176.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -35.52 64.25 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 173.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 HG12 ' A' ' 45' ' ' ILE . 77.5 mt -65.58 -42.36 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.722 0.809 . . . . 0.0 112.344 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.5 ' HB3' ' NE2' ' A' ' 28' ' ' GLN . 3.2 pp -71.53 -34.03 69.69 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 122.998 0.186 . . . . 0.0 110.879 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.97 -38.11 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.414 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.531 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 0.3 OUTLIER -66.48 -50.22 64.02 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 122.816 0.447 . . . . 0.0 110.659 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.29 68.51 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.225 0.61 . . . . 0.0 112.06 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 t -88.68 -0.2 57.05 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.712 0.805 . . . . 0.0 112.506 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.89 17.76 65.65 Favored Glycine 0 C--N 1.354 1.564 0 N-CA-C 114.485 0.554 . . . . 0.0 114.485 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.774 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 46.5 tp60 -107.91 164.96 11.82 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.609 1.164 . . . . 0.0 109.63 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -114.36 -6.2 12.92 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 123.038 0.535 . . . . 0.0 111.508 167.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.774 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 17.0 mm-40 -103.94 119.03 38.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.427 1.091 . . . . 0.0 110.684 -173.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.753 HD12 ' HB3' ' A' ' 60' ' ' MET . 34.7 mm -52.92 -53.02 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 124.736 1.273 . . . . 0.0 112.386 -173.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.4 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 73.7 m80 -61.09 -50.17 74.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.59 -173.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.27 -44.56 84.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.227 0.611 . . . . 0.0 112.091 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.03 94.19 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.68 -31.84 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 122.918 0.487 . . . . 0.0 110.612 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 73' ' ' HIS . 32.3 mmmt -67.13 -50.24 62.07 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.814 0.446 . . . . 0.0 110.46 175.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 56.6 mt -70.66 -67.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.762 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.2 pt -108.83 20.63 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -170.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.25 172.15 45.04 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 119.018 0.826 . . . . 0.0 112.92 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.97 144.18 26.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.18 0.592 . . . . 0.0 111.314 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -154.45 167.56 29.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.748 1.219 . . . . 0.0 108.25 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.02 127.27 23.37 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.074 0.95 . . . . 0.0 111.853 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.4 -116.3 2.5 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.371 0.419 . . . . 0.0 112.533 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.402 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -88.93 107.39 18.99 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.661 0.785 . . . . 0.0 109.373 -176.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 16' ' ' ILE . 15.8 m -135.7 167.98 23.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-O 121.912 0.863 . . . . 0.0 111.976 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 69.9 m -119.02 117.58 29.17 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.375 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 tp -100.04 123.48 44.34 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.272 0.629 . . . . 0.0 109.326 -175.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 28' ' ' GLN . 30.3 mt -109.34 137.21 42.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.195 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.741 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 26.5 p -156.84 157.69 35.41 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.578 0.751 . . . . 0.0 109.288 171.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -88.77 -28.2 20.64 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.872 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.498 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 23.8 m-20 -124.83 139.74 53.56 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.218 1.007 . . . . 0.0 110.962 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.14 -24.38 64.66 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.94 0.896 . . . . 0.0 112.435 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.498 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 11.2 pt-20 -68.31 -44.1 76.15 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.3 m -68.01 -35.87 79.02 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.599 0.76 . . . . 0.0 111.345 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.741 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 11.0 t80 -58.25 -48.05 81.66 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 122.889 0.476 . . . . 0.0 109.826 173.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -57.85 -47.58 82.29 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.298 0.999 . . . . 0.0 110.514 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 42.1 mmtm -53.83 -48.36 70.0 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 124.191 0.932 . . . . 0.0 111.469 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' A' ' 20' ' ' ILE . 44.1 mm -71.68 -44.72 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.065 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -55.05 -44.52 74.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.499 1.119 . . . . 0.0 112.851 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -60.07 -42.5 94.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.584 0.754 . . . . 0.0 110.248 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 98' ' ' LYS . 4.5 mm? -65.89 -51.67 56.74 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.0 pt -73.61 -42.56 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 117.915 0.325 . . . . 0.0 111.671 -167.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.13 103.32 0.03 OUTLIER Glycine 0 C--N 1.347 1.162 0 O-C-N 123.262 0.352 . . . . 0.0 113.584 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.31 -174.54 39.11 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.35 126.31 45.2 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.727 0.811 . . . . 0.0 109.334 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.6 mm -68.51 122.48 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.426 ' O ' HG12 ' A' ' 111' ' ' VAL . 12.5 t70 -135.24 98.68 4.04 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.718 1.207 . . . . 0.0 108.216 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -68.24 -31.15 70.43 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.975 0.51 . . . . 0.0 111.887 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.716 ' HA ' ' HG2' ' A' ' 113' ' ' GLU . 46.9 t -52.73 -31.45 37.89 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.673 HG23 ' HE3' ' A' ' 118' ' ' LYS . 2.6 p -69.31 -29.62 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 122.7 0.4 . . . . 0.0 110.28 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 28.5 mt -95.15 9.89 37.96 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.8 0.84 . . . . 0.0 112.153 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.716 ' HG2' ' HA ' ' A' ' 110' ' ' SER . 8.4 pt-20 -120.76 4.11 10.57 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.96 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.267 0.5 OUTLIER 76.15 138.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.092 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 172.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 26.6 p-10 -136.89 171.5 14.4 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 113.154 -1.839 . . . . 0.0 108.036 170.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.97 -31.36 70.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.173 0.589 . . . . 0.0 112.223 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.416 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 19.3 t70 -60.27 -53.14 61.22 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.113 0.965 . . . . 0.0 112.31 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HE3' HG23 ' A' ' 111' ' ' VAL . 63.7 mttm -74.88 -20.69 59.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.324 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.496 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 42.8 tt0 -72.82 -43.73 62.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.332 0.653 . . . . 0.0 111.522 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -72.07 -33.97 68.34 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.095 0.558 . . . . 0.0 110.588 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.1 -49.58 76.44 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.461 1.104 . . . . 0.0 111.143 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 36' ' ' ALA . 24.4 mt -57.35 -40.67 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.353 1.061 . . . . 0.0 112.051 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -74.66 -23.34 58.64 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 119.156 -0.45 . . . . 0.0 111.167 -176.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 127' ' ' LYS . 48.5 mt-10 -73.42 -55.14 6.76 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 169.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.42 -31.76 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 CA-C-N 120.573 1.533 . . . . 0.0 112.777 -176.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -88.72 -30.29 19.21 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 124' ' ' GLU . 38.9 mmtm 63.42 75.51 0.39 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.386 1.075 . . . . 0.0 112.484 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.515 HG21 ' HG3' ' A' ' 137' ' ' ARG . 14.2 mt . . . . . 0 CA--C 1.55 0.951 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.567 HD21 ' HB2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.496 ' HB ' ' HG3' ' A' ' 119' ' ' GLU . 13.6 p -76.4 -33.85 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.425 ' O ' HD13 ' A' ' 139' ' ' LEU . 60.4 t -65.37 -59.8 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.565 0.746 . . . . 0.0 112.153 -164.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.567 ' HB2' HD21 ' A' ' 133' ' ' ASN . 37.7 mt-10 -73.2 -28.73 62.35 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.81 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.515 ' HG3' HG21 ' A' ' 128' ' ' ILE . 20.2 tpt180 -77.35 -32.48 55.11 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.502 -170.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 36' ' ' ALA . 14.2 p -72.24 -33.87 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 40' ' ' HIS . 2.5 mp -54.76 -38.89 67.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.254 1.021 . . . . 0.0 111.044 170.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -67.61 -37.86 83.12 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.643 0.777 . . . . 0.0 111.171 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -68.58 -48.7 63.51 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 111.503 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 26.6 pt -78.53 -10.53 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.816 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.813 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.743 171.019 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.395 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.51 159.64 42.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.558 0.743 . . . . 0.0 110.791 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.3 mtt -130.47 30.45 4.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.291 1.037 . . . . 0.0 109.575 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.485 ' HA ' HD22 ' A' ' 42' ' ' LEU . 5.3 m-20 57.24 74.36 0.67 Allowed Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 124.694 1.197 . . . . 0.0 110.555 -171.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.446 ' HD2' HD22 ' A' ' 42' ' ' LEU . 34.2 Cg_endo -61.21 -53.42 2.48 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 122.974 2.449 . . . . 0.0 112.658 -175.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.415 ' SD ' ' HG2' ' A' ' 91' ' ' GLU . 24.3 mmt -95.12 177.48 5.86 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.595 0.758 . . . . 0.0 109.553 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.9 mt -101.39 103.56 15.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 88' ' ' LEU . 4.1 mp -109.72 121.39 62.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 174.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -131.81 145.46 51.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.78 0.832 . . . . 0.0 109.084 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.38 124.63 8.18 Favored Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.2 tt -130.68 138.89 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 122.801 0.44 . . . . 0.0 109.869 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -129.3 124.14 33.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.839 0.855 . . . . 0.0 108.798 -172.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.41 2.36 56.64 Favored Glycine 0 N--CA 1.467 0.762 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.997 -170.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -74.44 98.17 3.25 Favored 'General case' 0 C--N 1.347 0.473 0 C-N-CA 123.792 0.837 . . . . 0.0 111.188 -177.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.542 ' HA ' ' HB2' ' A' ' 83' ' ' ASP . 70.7 mtp180 -73.81 107.36 6.0 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.956 0.502 . . . . 0.0 110.616 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.548 HD11 HG11 ' A' ' 86' ' ' VAL . 49.6 mm -69.49 122.96 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.891 0.877 . . . . 0.0 110.79 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.27 165.64 18.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.519 0.728 . . . . 0.0 109.352 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -73.2 -17.0 61.41 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.39 -31.62 68.93 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.503 0.721 . . . . 0.0 111.795 -173.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.567 HD12 HD12 ' A' ' 29' ' ' ILE . 16.0 pt -52.13 -28.35 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -90.11 -20.07 23.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.55 0.34 . . . . 0.0 111.303 -176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -76.81 -12.46 59.98 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.503 0.721 . . . . 0.0 111.83 -171.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.48 HD21 HD13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -81.0 -8.59 59.81 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.679 0.391 . . . . 0.0 111.776 176.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.48 19.08 17.16 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 116.52 1.368 . . . . 0.0 116.52 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 23' ' ' LEU . 98.5 mt -81.66 174.74 11.09 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 117.493 0.646 . . . . 0.0 110.394 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -90.18 96.49 10.69 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.228 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -147.68 157.59 43.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.702 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.576 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -138.26 147.1 43.3 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 167.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.567 HD12 HD12 ' A' ' 20' ' ' ILE . 35.6 mt -132.29 121.6 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.567 ' HB3' HE22 ' A' ' 28' ' ' GLN . 4.2 pp -121.57 177.8 5.08 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' HB3' HG22 ' A' ' 34' ' ' VAL . 38.6 t-20 -75.71 119.46 19.76 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.654 0.782 . . . . 0.0 110.038 -173.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.42 -1.52 41.81 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.571 ' HA ' ' NZ ' ' A' ' 118' ' ' LYS . 37.8 t70 -79.67 -32.41 41.52 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.495 0.188 . . . . 0.0 110.522 176.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.522 HG21 HG22 ' A' ' 79' ' ' ILE . 27.7 m -98.75 -2.25 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.873 0.869 . . . . 0.0 112.538 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.486 HG11 HD23 ' A' ' 112' ' ' LEU . 10.5 p -78.69 139.96 17.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.401 ' HA ' HG12 ' A' ' 114' ' ' ILE . . . -76.1 -72.25 0.33 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 40.3 p -147.15 -177.35 5.63 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.823 0.849 . . . . 0.0 110.401 176.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.528 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -52.03 -39.77 60.06 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.168 167.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' HD2' HD11 ' A' ' 42' ' ' LEU . 22.9 tptm -56.07 -29.94 61.25 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.676 0.79 . . . . 0.0 111.504 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.527 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.6 t-80 -68.44 -50.85 49.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.425 0.69 . . . . 0.0 111.015 176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.408 HG11 HG12 ' A' ' 89' ' ' ILE . 93.0 t -68.37 -54.75 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HA ' HD12 ' A' ' 45' ' ' ILE . 4.2 pp -56.16 -33.16 64.96 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.664 0.786 . . . . 0.0 111.835 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.559 ' NE2' ' HB2' ' A' ' 143' ' ' ALA . 79.5 t60 -62.45 -45.28 93.78 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.061 173.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.12 -38.17 87.51 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.383 0.673 . . . . 0.0 111.367 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.6 HG12 HD13 ' A' ' 62' ' ' ILE . 48.2 mt -56.96 -48.53 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.965 0.906 . . . . 0.0 109.815 170.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.523 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 62.1 t30 -64.95 -30.36 71.34 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.388 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 10.2 mm-40 -68.66 -39.96 80.39 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.952 0.501 . . . . 0.0 109.824 174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . . . -66.99 -26.33 66.75 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.464 0.706 . . . . 0.0 112.352 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' HE3' ' HA ' ' A' ' 46' ' ' ASN . 10.1 mtmp? -78.92 -31.94 45.44 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.631 0.372 . . . . 0.0 111.847 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.501 HG23 ' HG2' ' A' ' 51' ' ' LYS . 8.6 t -95.26 -45.17 7.28 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.68 0.392 . . . . 0.0 111.954 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.662 ' HB2' HH22 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -121.13 120.04 34.12 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.002 0.921 . . . . 0.0 109.183 -175.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -103.84 99.66 17.08 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 123.016 0.526 . . . . 0.0 110.229 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.61 -81.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 122.858 2.372 . . . . 0.0 113.935 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.4 pt -150.67 11.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.813 0.845 . . . . 0.0 111.83 -168.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.58 160.54 27.54 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -169.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -68.59 -50.14 53.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.783 0.833 . . . . 0.0 111.125 -176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -146.08 171.44 14.89 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.56 0.744 . . . . 0.0 110.197 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -61.93 -58.7 6.92 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.855 0.862 . . . . 0.0 111.897 -174.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.576 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 91.4 m95 -63.85 -33.81 76.53 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.756 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 90.8 mmm -73.53 -18.98 61.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.827 0.451 . . . . 0.0 110.674 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.612 ' HG2' HH11 ' A' ' 65' ' ' ARG . 22.3 tt0 -77.68 -38.84 46.65 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.072 0.949 . . . . 0.0 110.984 173.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.6 HD13 HG12 ' A' ' 45' ' ' ILE . 82.8 mt -55.0 -53.51 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.673 0.789 . . . . 0.0 111.27 -177.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.46 ' O ' HD11 ' A' ' 79' ' ' ILE . 4.3 pp -52.74 -31.29 37.23 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.189 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 61' ' ' GLU . 1.9 m -78.78 -32.52 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 112.005 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.662 HH22 ' HB2' ' A' ' 51' ' ' LYS . 11.8 mmm-85 -68.12 -45.14 74.5 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 122.954 0.502 . . . . 0.0 110.866 -175.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.41 -20.15 64.19 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.892 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -97.14 12.65 32.0 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.28 41.9 7.24 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 118.349 0.522 . . . . 0.0 113.481 -176.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 57.37 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 126.193 1.797 . . . . 0.0 111.152 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -121.18 -160.97 0.88 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.328 1.051 . . . . 0.0 109.354 -177.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -120.7 162.01 20.44 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -50.64 -49.97 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.264 1.026 . . . . 0.0 112.137 -170.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.443 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 33.6 m170 -61.45 -55.21 33.81 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.751 0.657 . . . . 0.0 110.623 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -54.41 -56.61 16.92 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.055 0.847 . . . . 0.0 111.789 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 -30.4 69.35 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.5 mt -68.22 -38.38 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 122.49 0.316 . . . . 0.0 111.012 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 73' ' ' HIS . 60.4 mttm -68.9 -45.66 70.35 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.685 HG22 HG23 ' A' ' 79' ' ' ILE . 59.4 mt -71.22 -66.11 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.206 1.003 . . . . 0.0 111.373 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.685 HG23 HG22 ' A' ' 78' ' ' ILE . 29.8 pt -122.7 26.83 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.64 179.75 48.69 Favored Glycine 0 N--CA 1.48 1.596 0 CA-C-N 118.821 0.737 . . . . 0.0 113.402 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.1 144.37 47.03 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.779 0.432 . . . . 0.0 111.323 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -151.28 149.24 29.15 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 15' ' ' ARG . 6.2 p-10 -65.79 151.33 46.87 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.459 0.572 . . . . 0.0 111.559 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.61 -118.36 6.08 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.481 -177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -85.27 103.78 14.53 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -178.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.548 HG11 HD11 ' A' ' 16' ' ' ILE . 1.1 p -137.72 156.07 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.116 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.2 t -106.85 122.87 47.27 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.504 1.122 . . . . 0.0 109.388 -170.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 8' ' ' ILE . 0.1 OUTLIER -95.68 128.6 42.69 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 28' ' ' GLN . 7.7 mt -120.27 117.92 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 175.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.701 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 42.3 t -145.91 161.94 38.89 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.874 0.369 . . . . 0.0 111.712 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.415 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 43.6 mt-10 -91.89 -47.91 7.06 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.591 174.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -111.7 136.3 51.12 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.171 0.588 . . . . 0.0 110.362 -171.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -57.63 -27.39 62.75 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.517 0.727 . . . . 0.0 112.403 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.79 -42.71 69.99 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.701 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 60.5 m -65.75 -37.58 86.76 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.749 0.82 . . . . 0.0 111.466 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -61.85 -43.1 99.53 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.538 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -62.37 -40.96 98.16 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 123.893 0.745 . . . . 0.0 110.055 177.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 34.5 mmtp -57.35 -51.82 67.83 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.454 0.702 . . . . 0.0 110.58 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.48 HD13 HD21 ' A' ' 23' ' ' LEU . 43.8 mm -66.15 -44.31 91.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.372 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -48.97 -40.31 29.93 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.499 1.119 . . . . 0.0 112.955 174.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 22.6 mm-40 -59.58 -46.86 87.68 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.509 0.506 . . . . 0.0 111.66 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.82 -36.43 64.95 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.469 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 20.3 pt -80.35 -47.71 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 CA-C-N 118.639 0.654 . . . . 0.0 110.995 -173.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 65.07 95.17 0.02 OUTLIER Glycine 0 C--N 1.349 1.276 0 O-C-N 123.602 0.564 . . . . 0.0 113.517 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -158.11 -169.4 21.65 Favored Glycine 0 N--CA 1.468 0.768 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -109.66 135.14 51.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.434 0.617 . . . . 0.0 109.728 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.7 mm -78.43 122.39 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -144.14 96.5 2.89 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -67.42 -17.12 64.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.578 0.751 . . . . 0.0 111.758 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.0 t -60.04 -26.66 66.31 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.12 -22.12 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.21 0.529 . . . . 0.0 110.252 174.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.486 HD23 HG11 ' A' ' 35' ' ' VAL . 56.2 mt -103.02 17.43 24.09 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.455 1.102 . . . . 0.0 111.953 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -113.44 -1.97 14.04 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 120.176 1.353 . . . . 0.0 112.942 -177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.401 HG12 ' HA ' ' A' ' 36' ' ' ALA 0.25 0.3 OUTLIER 76.97 139.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 124.812 1.245 . . . . 0.0 113.313 177.903 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.4 HD21 ' HB2' ' A' ' 117' ' ' ASP . 26.7 p-10 -154.24 -173.38 4.55 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.851 172.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -71.12 -34.12 70.75 Favored 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.4 ' HB2' HD21 ' A' ' 115' ' ' ASN . 44.6 m-20 -64.05 -47.09 81.52 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 122.624 0.37 . . . . 0.0 111.733 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.571 ' NZ ' ' HA ' ' A' ' 33' ' ' ASP . 4.8 mptp? -62.16 -34.18 75.91 Favored 'General case' 0 C--O 1.209 -1.049 0 O-C-N 123.46 0.475 . . . . 0.0 109.826 173.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.24 -51.9 65.89 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 123.66 0.6 . . . . 0.0 111.148 -172.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -70.45 -39.12 74.52 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.78 -33.06 66.05 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 122.108 -0.37 . . . . 0.0 110.833 177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' A' ' 126' ' ' PHE . 6.3 mt -61.09 -38.65 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 123.656 0.782 . . . . 0.0 110.805 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 7.8 ptp180 -73.9 -23.86 59.62 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.025 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.604 ' HA ' ' HE3' ' A' ' 127' ' ' LYS . 13.0 tp10 -64.11 -58.53 6.37 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 170.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.27 -35.9 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 118.68 0.673 . . . . 0.0 112.777 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.472 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.9 m-85 -87.99 -30.89 19.67 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 119.126 -0.464 . . . . 0.0 111.77 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 124' ' ' GLU . 21.4 mmtp 59.05 76.09 0.37 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.046 0.938 . . . . 0.0 111.744 175.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.526 HG12 ' HD3' ' A' ' 141' ' ' LYS . 25.6 mt -120.99 127.69 75.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.77 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.7 tpp180 -86.43 105.82 17.02 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 167.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 179.57 138.69 3.4 Favored Glycine 0 C--N 1.343 0.931 0 O-C-N 123.239 0.337 . . . . 0.0 112.29 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -107.62 -169.72 1.58 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.765 1.226 . . . . 0.0 109.561 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.49 -123.74 6.25 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.79 -0.45 . . . . 0.0 111.993 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -96.8 119.49 35.38 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.403 0.681 . . . . 0.0 110.468 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 70.4 t -65.07 -26.25 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.527 1.131 . . . . 0.0 112.288 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 58.8 t -67.04 -46.67 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.484 0.659 . . . . 0.0 109.745 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.72 -40.61 88.49 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.855 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -67.95 -38.27 82.62 Favored 'General case' 0 N--CA 1.48 1.03 0 O-C-N 123.595 0.559 . . . . 0.0 112.344 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.42 ' HA ' HD13 ' A' ' 128' ' ' ILE . 14.4 p -70.15 -42.79 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 40' ' ' HIS . 9.6 mp -62.09 -42.99 99.78 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 122.77 0.428 . . . . 0.0 111.692 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 144' ' ' LEU . 46.4 mt-10 -57.1 -44.5 83.26 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.528 0.331 . . . . 0.0 111.626 177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.526 ' HD3' HG12 ' A' ' 128' ' ' ILE . 8.4 ttpt -71.97 -46.87 55.8 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.185 0.303 . . . . 0.0 111.202 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 24.0 pt -75.84 -33.72 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.401 -171.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.559 ' HB2' ' NE2' ' A' ' 43' ' ' HIS . . . -95.58 -4.52 44.47 Favored 'General case' 0 C--O 1.246 0.876 0 C-N-CA 123.585 0.754 . . . . 0.0 112.823 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 18.7 tp -60.97 -48.94 79.52 Favored 'General case' 0 C--N 1.346 0.429 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.9 mt -70.07 -35.73 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.495 0.718 . . . . 0.0 111.61 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -65.15 -7.49 12.75 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.786 0.834 . . . . 0.0 112.718 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.6 mt 81.59 18.79 0.41 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.094 1.357 . . . . 0.0 111.774 167.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.408 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 21.0 pttp 171.91 128.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.801 0.84 . . . . 0.0 110.482 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -77.46 35.83 0.19 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.099 0.959 . . . . 0.0 112.254 175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 C--O 1.253 1.279 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -168.097 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.534 -0.626 . . . . 0.0 111.534 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.16 167.53 21.74 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.794 0.837 . . . . 0.0 111.291 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.66 -46.12 77.57 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.08 0.952 . . . . 0.0 109.661 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -109.13 96.69 22.03 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 165.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.673 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 56.5 Cg_endo -68.86 -36.85 12.58 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.562 2.175 . . . . 0.0 111.988 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.673 ' SD ' ' HG2' ' A' ' 5' ' ' PRO . 1.5 mpt? -105.58 174.2 5.98 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 170.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.3 mt -106.08 103.43 15.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.4 mm -107.71 122.99 62.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.69 144.86 51.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.751 0.705 . . . . 0.0 110.627 -173.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.452 ' N ' HD11 ' A' ' 112' ' ' LEU . . . -104.85 127.47 9.07 Favored Glycine 0 CA--C 1.502 -0.78 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.8 tt -141.64 145.71 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.072 0.549 . . . . 0.0 110.679 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -123.22 130.78 53.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.581 1.152 . . . . 0.0 109.616 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.15 7.73 69.7 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.839 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.12 94.76 1.16 Allowed 'General case' 0 C--N 1.349 0.547 0 C-N-CA 123.938 0.895 . . . . 0.0 111.131 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.478 ' HA ' ' HB2' ' A' ' 83' ' ' ASP . 51.0 mtt180 -73.07 103.44 3.83 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.123 0.569 . . . . 0.0 109.803 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.99 108.93 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.701 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.407 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -114.08 165.56 12.51 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.597 0.759 . . . . 0.0 110.604 179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -71.49 -16.4 62.35 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.89 -36.74 84.24 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 118.251 0.478 . . . . 0.0 111.671 -173.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.459 ' HA ' HD12 ' A' ' 102' ' ' LEU . 18.1 pt -50.47 -20.83 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -93.14 -26.55 17.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.422 0.689 . . . . 0.0 111.233 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -72.72 -16.92 61.66 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.641 0.776 . . . . 0.0 112.149 -169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.498 HD21 HD13 ' A' ' 99' ' ' ILE . 0.8 OUTLIER -80.89 -10.21 59.74 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.883 0.473 . . . . 0.0 111.817 179.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.46 21.31 26.91 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 116.37 1.308 . . . . 0.0 116.37 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB2' HD13 ' A' ' 23' ' ' LEU . 92.4 mt -87.34 176.52 7.49 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.244 0.618 . . . . 0.0 111.468 -175.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.468 ' HB3' ' HZ2' ' A' ' 59' ' ' TRP . 2.9 mptp? -85.69 98.33 10.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.859 0.864 . . . . 0.0 109.758 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -146.97 160.58 42.18 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.114 0.566 . . . . 0.0 110.331 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.415 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 19.1 tm0? -144.39 149.71 36.55 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 161.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.1 mt -131.29 127.22 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 pp -125.64 173.22 9.14 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.197 0.599 . . . . 0.0 109.979 175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 33' ' ' ASP . 61.3 t30 -77.03 138.8 39.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.353 0.661 . . . . 0.0 110.738 -171.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.549 ' HA ' ' SG ' ' A' ' 87' ' ' CYS . . . -80.37 0.1 34.57 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.528 ' HB3' HD21 ' A' ' 121' ' ' LEU . 21.4 m-20 -82.75 -23.1 34.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.257 0.623 . . . . 0.0 111.128 176.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 79' ' ' ILE . 32.5 m -113.97 -3.73 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.692 0.797 . . . . 0.0 111.718 -171.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -59.41 -32.71 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.734 0.814 . . . . 0.0 112.38 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 59.79 -84.61 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.447 1.099 . . . . 0.0 109.372 -170.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 40.9 p -139.14 174.41 10.54 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.92 0.888 . . . . 0.0 109.353 171.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.91 -45.23 50.7 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.05 165.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -51.5 -34.41 35.84 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.335 1.054 . . . . 0.0 112.592 -178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.558 ' HA ' HD11 ' A' ' 139' ' ' LEU . 11.2 t-80 -66.55 -54.53 22.73 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.696 0.623 . . . . 0.0 111.028 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -70.69 -47.78 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 122.696 0.399 . . . . 0.0 112.074 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.567 HD22 ' HD2' ' A' ' 5' ' ' PRO . 3.9 pp -60.45 -30.39 69.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.191 0.596 . . . . 0.0 111.556 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.46 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 71.2 t60 -61.6 -46.74 88.57 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 169.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.5 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . . . -61.86 -44.99 95.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.959 0.504 . . . . 0.0 111.407 -176.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.514 HG22 ' HE3' ' A' ' 49' ' ' LYS . 36.0 mt -65.98 -49.77 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 124.322 1.049 . . . . 0.0 111.081 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -51.6 -47.42 63.61 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.291 1.036 . . . . 0.0 110.991 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 17.9 mm100 -66.77 -35.48 80.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.327 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.09 63.25 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 122.672 0.389 . . . . 0.0 111.545 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HE3' HG22 ' A' ' 45' ' ' ILE . 98.4 mttt -86.31 -36.92 19.01 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.439 0.696 . . . . 0.0 112.06 178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 47' ' ' GLN . 10.3 t -88.14 -37.28 16.31 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.909 -175.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 47' ' ' GLN . 39.6 mtmt -85.53 157.54 20.39 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.683 175.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -102.64 103.31 31.57 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.18 177.43 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.288 0 C-N-CA 124.154 3.236 . . . . 0.0 115.466 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.7 pp -121.31 5.02 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.266 165.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.59 179.29 2.17 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.524 1.13 . . . . 0.0 111.749 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -62.33 -47.66 83.27 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.029 0.532 . . . . 0.0 110.326 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.4 m -157.85 -172.81 4.08 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.239 1.015 . . . . 0.0 110.185 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -62.01 -59.3 5.29 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.635 1.174 . . . . 0.0 112.919 -176.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.468 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 87.8 m95 -63.42 -28.71 70.16 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 120.753 0.311 . . . . 0.0 110.848 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 25.6 mmt -74.81 -21.22 59.42 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.687 176.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -75.84 -43.05 47.76 Favored 'General case' 0 C--O 1.209 -1.039 0 C-N-CA 122.398 0.279 . . . . 0.0 110.373 170.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.469 HD13 HG12 ' A' ' 45' ' ' ILE . 86.8 mt -56.47 -39.28 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 123.676 0.79 . . . . 0.0 112.173 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.407 ' O ' HD11 ' A' ' 79' ' ' ILE . 3.6 pp -71.06 -30.91 67.19 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.333 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -83.17 -29.05 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.337 -0.852 . . . . 0.0 110.922 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.5 ' HD2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -71.2 -45.75 62.71 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.548 1.139 . . . . 0.0 109.937 -172.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.22 -24.65 67.4 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.488 0.715 . . . . 0.0 112.031 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.2 p -100.18 23.67 9.7 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.241 0.616 . . . . 0.0 110.568 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.07 -88.54 1.54 Allowed Glycine 0 C--N 1.36 1.913 0 O-C-N 122.182 -0.324 . . . . 0.0 113.442 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.706 ' HB2' HG12 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -167.15 121.35 1.02 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -173.25 163.59 4.62 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 124.691 1.244 . . . . 0.0 109.053 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -57.39 149.69 20.06 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.136 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.8 mp -52.32 -41.04 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.708 1.203 . . . . 0.0 111.845 -175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -57.21 -49.77 74.94 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.395 0.678 . . . . 0.0 111.096 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.524 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 49.9 mm-40 -57.0 -48.73 77.75 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.621 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.42 -36.81 83.53 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.666 0.786 . . . . 0.0 112.824 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.6 mt -64.51 -37.55 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.041 0.536 . . . . 0.0 110.891 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.524 ' HE2' ' HA ' ' A' ' 74' ' ' GLU . 53.2 mtmt -67.72 -48.65 65.91 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.798 0.333 . . . . 0.0 110.205 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.453 HG23 ' HB ' ' A' ' 125' ' ' ILE . 78.0 mt -74.21 -65.18 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.649 -175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.608 ' HB ' HG21 ' A' ' 34' ' ' VAL . 7.7 pt -109.41 14.3 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -172.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.61 168.55 46.07 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 119.433 1.015 . . . . 0.0 112.423 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -80.98 121.74 26.41 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.832 0.453 . . . . 0.0 111.323 -175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -116.95 162.36 17.89 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 165.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 15' ' ' ARG . 7.5 p-10 -65.35 153.91 39.83 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.293 0.637 . . . . 0.0 112.158 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.57 -119.46 5.81 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.358 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.467 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -87.45 104.6 16.61 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.557 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.8 p -136.92 168.74 21.11 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.562 -173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.549 ' SG ' ' HA ' ' A' ' 32' ' ' ALA . 88.3 m -122.45 123.64 41.77 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.389 1.075 . . . . 0.0 110.238 -175.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.477 HD21 ' HB ' ' A' ' 99' ' ' ILE . 11.4 tp -102.91 125.5 49.69 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.281 0.632 . . . . 0.0 109.625 -176.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 mt -108.3 132.74 55.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.632 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 14.7 t -155.37 154.72 32.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.157 0.503 . . . . 0.0 111.225 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -87.17 -40.44 14.59 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.923 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -128.55 137.94 51.99 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.11 0.964 . . . . 0.0 110.482 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 39.6 tt0 -66.64 -35.93 81.34 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -170.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.74 -26.64 57.64 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.779 0.718 . . . . 0.0 110.348 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 96.9 m -67.88 -42.58 81.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.228 0.611 . . . . 0.0 111.167 165.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.418 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 2.3 t80 -56.97 -49.65 75.08 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.998 0.919 . . . . 0.0 110.817 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 76.7 ttt180 -65.27 -36.95 85.69 Favored 'General case' 0 C--O 1.214 -0.774 0 O-C-N 123.569 0.543 . . . . 0.0 110.441 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -56.2 -40.32 73.83 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 122.771 0.428 . . . . 0.0 111.674 176.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.498 HD13 HD21 ' A' ' 23' ' ' LEU . 29.1 mm -69.47 -45.83 77.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -53.69 -40.3 65.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.561 1.145 . . . . 0.0 112.564 174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 70.7 mm-40 -59.47 -47.23 86.28 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.27 0.628 . . . . 0.0 110.847 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 20' ' ' ILE . 57.5 mt -72.75 -38.39 67.38 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.3 pt -74.63 -37.74 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 118.366 0.53 . . . . 0.0 110.768 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.98 93.41 0.03 OUTLIER Glycine 0 C--N 1.351 1.402 0 O-C-N 123.623 0.577 . . . . 0.0 114.312 170.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.27 -167.65 22.02 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 175.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -113.33 140.65 47.85 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.79 123.24 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -121.18 95.35 4.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -67.15 -42.03 85.05 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.898 0.479 . . . . 0.0 111.463 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.0 p -54.21 -29.91 48.01 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.6 p -67.32 -24.03 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 CA-C-N 118.565 0.621 . . . . 0.0 110.941 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 37' ' ' THR . 81.2 mt -86.28 -19.41 29.93 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.748 0.819 . . . . 0.0 112.009 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -93.37 -1.83 55.42 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 118.462 -0.78 . . . . 0.0 113.038 -165.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 114' ' ' ILE 0.26 0.5 OUTLIER 78.83 133.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 124.557 1.143 . . . . 0.0 112.89 -178.446 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.422 ' ND2' ' HB2' ' A' ' 117' ' ' ASP . 4.4 p-10 -146.79 168.33 21.66 Favored 'General case' 0 C--O 1.246 0.92 0 CA-C-N 113.625 -1.625 . . . . 0.0 107.506 167.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -62.5 -34.13 76.26 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.906 0.482 . . . . 0.0 111.829 -169.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.422 ' HB2' ' ND2' ' A' ' 115' ' ' ASN . 14.2 m-20 -59.7 -48.95 79.65 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.928 0.491 . . . . 0.0 111.469 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -67.29 -27.25 67.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 123.448 0.468 . . . . 0.0 110.741 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.466 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 30.3 tt0 -72.62 -44.98 61.24 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.017 0.527 . . . . 0.0 110.998 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -73.69 -40.53 63.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.655 0.782 . . . . 0.0 109.993 -177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 33' ' ' ASP . 62.5 tp -53.78 -53.77 47.61 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.262 1.425 . . . . 0.0 112.317 170.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 20.1 mt -53.25 -30.64 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 124.621 1.169 . . . . 0.0 111.755 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.0 ttp85 -72.24 -33.62 67.67 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.045 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.72 -56.09 13.89 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 173.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.453 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -74.24 -36.24 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -90.38 -33.39 16.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 119.447 -0.311 . . . . 0.0 111.706 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 3.0 mmmp? 63.78 72.38 0.47 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.043 0.937 . . . . 0.0 111.765 177.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.566 HG21 ' HB3' ' A' ' 137' ' ' ARG . 9.2 mt -100.49 130.61 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -174.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.95 156.16 20.81 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.203 0.601 . . . . 0.0 110.349 171.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 125.06 -147.91 16.62 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.872 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -136.29 163.69 29.83 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.391 1.076 . . . . 0.0 109.264 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.0 -152.11 17.08 Favored Glycine 0 C--N 1.346 1.088 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 171.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -94.22 137.86 32.91 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.339 1.056 . . . . 0.0 109.851 -173.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.466 ' HB ' ' HG3' ' A' ' 119' ' ' GLU . 7.2 p -54.59 -34.19 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 124.369 1.068 . . . . 0.0 113.652 -176.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 87.4 t -71.41 -45.74 67.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-O 121.349 0.595 . . . . 0.0 109.759 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 40.3 mt-10 -68.52 -34.33 75.68 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.182 177.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.566 ' HB3' HG21 ' A' ' 128' ' ' ILE . 52.7 mtm180 -72.22 -39.05 68.8 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.863 0.865 . . . . 0.0 112.073 -176.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.04 -33.94 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.558 HD11 ' HA ' ' A' ' 40' ' ' HIS . 4.6 mp -62.98 -39.57 95.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.218 0.607 . . . . 0.0 111.148 173.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 35.0 mm-40 -59.66 -47.29 86.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 117.775 0.261 . . . . 0.0 111.009 173.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -63.87 -48.4 76.86 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.112 0.565 . . . . 0.0 111.973 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 15.6 pt -76.68 -25.33 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.95 -16.12 55.9 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 122.235 0.214 . . . . 0.0 110.54 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.95 10.26 0.75 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.681 0.793 . . . . 0.0 111.971 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.706 HG12 ' HB2' ' A' ' 69' ' ' GLN . 3.9 mp -107.22 -44.17 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.349 1.06 . . . . 0.0 108.437 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -94.8 -21.71 18.53 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.061 -170.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tt -90.74 -33.11 15.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.079 0.951 . . . . 0.0 108.753 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -76.58 134.12 39.48 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.873 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -79.71 -23.44 42.36 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.757 0.823 . . . . 0.0 110.644 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 . . . . . 0 N--CA 1.487 1.393 0 C-N-CA 126.197 1.799 . . . . 0.0 108.624 174.157 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.74 142.82 19.14 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.915 0.886 . . . . 0.0 109.865 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.8 ttt -113.66 -56.51 2.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.858 0.863 . . . . 0.0 110.57 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.28 94.52 0.05 OUTLIER Pre-proline 0 N--CA 1.488 1.464 0 C-N-CA 124.656 1.183 . . . . 0.0 109.979 -173.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 42' ' ' LEU . 19.2 Cg_endo -56.09 -45.06 41.08 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.892 3.061 . . . . 0.0 113.031 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.0 mmt -109.69 163.66 13.28 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.302 0.641 . . . . 0.0 109.405 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.544 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 76.2 mt -85.96 104.78 13.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.755 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.5 mm -101.19 120.82 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.0 mmt-85 -127.27 146.92 50.26 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.19 140.42 14.86 Favored Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.473 HG23 HG12 ' A' ' 86' ' ' VAL . 10.1 tt -143.01 124.9 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.777 0.799 . . . . 0.0 111.081 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.431 ' HA ' HD22 ' A' ' 85' ' ' ASN . 7.2 ptm180 -90.11 133.2 35.01 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.196 175.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.45 8.76 80.32 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.832 174.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.04 100.76 0.23 Allowed 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.033 0.933 . . . . 0.0 111.085 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -74.0 103.23 4.41 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.524 HD11 HG11 ' A' ' 86' ' ' VAL . 50.3 mm -74.05 114.91 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.354 0.597 . . . . 0.0 110.207 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' A' ' 20' ' ' ILE . 2.5 p-10 -103.92 134.63 46.89 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 174.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -74.08 -1.7 21.28 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.793 0.437 . . . . 0.0 111.779 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -75.68 -20.32 58.51 Favored 'General case' 0 C--O 1.217 -0.606 0 C-N-CA 124.414 1.086 . . . . 0.0 111.027 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.479 HG23 ' ND2' ' A' ' 17' ' ' ASN . 9.4 pt -49.77 -22.36 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -83.52 -0.1 48.81 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 37.9 p30 -71.4 -28.04 63.74 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.123 0.569 . . . . 0.0 112.005 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -79.65 -6.69 57.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.679 0.791 . . . . 0.0 111.512 -176.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.46 14.89 9.86 Favored Glycine 0 C--N 1.355 1.593 0 N-CA-C 116.178 1.231 . . . . 0.0 116.178 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB2' HD13 ' A' ' 23' ' ' LEU . 95.8 mt -74.73 157.77 34.69 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.159 0.584 . . . . 0.0 110.461 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -82.67 102.51 11.54 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.273 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -149.49 160.31 43.57 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.77 1.228 . . . . 0.0 108.823 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.511 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -142.22 150.43 40.95 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 173.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.7 mt -134.4 125.1 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 172.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.497 HD21 HG22 ' A' ' 41' ' ' VAL . 4.2 pp -118.97 172.47 7.53 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 174.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 80' ' ' GLY . 47.6 t30 -87.93 131.34 34.63 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.52 1.128 . . . . 0.0 111.133 -167.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 111' ' ' VAL . . . -83.6 -3.84 58.04 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.682 ' HB3' HD21 ' A' ' 121' ' ' LEU . 76.9 m-20 -63.74 -44.82 92.38 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.358 0.599 . . . . 0.0 109.817 171.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.8 m -104.06 -1.95 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.871 -166.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 32' ' ' ALA . 9.9 p -85.71 129.87 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.78 -68.13 0.57 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 113' ' ' GLU . 30.8 p -128.85 166.59 18.77 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.465 1.106 . . . . 0.0 108.431 169.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -22.26 34.17 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.59 0.356 . . . . 0.0 111.493 169.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.13 -30.31 66.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.266 1.026 . . . . 0.0 112.081 172.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.571 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.2 t-80 -61.23 -44.82 96.65 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.806 0.842 . . . . 0.0 110.377 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 30' ' ' LEU . 40.4 t -65.76 -54.13 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.708 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.684 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 3.2 pp -63.55 -32.12 73.49 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -172.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.442 ' HD2' HD11 ' A' ' 142' ' ' ILE . 68.9 t60 -61.03 -37.48 82.73 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.196 0.999 . . . . 0.0 110.886 174.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.79 -35.36 67.38 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.079 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.498 HG12 HD13 ' A' ' 62' ' ' ILE . 53.4 mt -63.56 -47.07 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.461 0.704 . . . . 0.0 110.914 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -57.83 -37.26 73.52 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.776 0.831 . . . . 0.0 111.01 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.461 ' HA ' HG22 ' A' ' 50' ' ' THR . 79.7 mm-40 -67.56 -40.12 84.92 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.499 174.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.31 -27.6 68.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.979 0.512 . . . . 0.0 111.629 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -79.13 -34.3 43.48 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.978 0.511 . . . . 0.0 111.591 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.461 HG22 ' HA ' ' A' ' 47' ' ' GLN . 11.8 t -87.48 -28.23 22.18 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.436 0.294 . . . . 0.0 110.894 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -98.8 135.26 40.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.671 0.788 . . . . 0.0 111.547 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.13 105.5 2.28 Favored Pre-proline 0 CA--C 1.552 1.031 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 162.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 41.1 Cg_endo -64.73 166.2 18.68 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.795 2.33 . . . . 0.0 114.801 -161.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.3 mm -108.7 -5.15 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 173.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.01 -179.5 6.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.048 1.339 . . . . 0.0 111.472 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HB2' ' HG2' ' A' ' 60' ' ' MET . 75.6 mmtt -73.22 -25.02 60.58 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.513 0.725 . . . . 0.0 112.262 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.691 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 29.0 t -165.28 -178.69 5.16 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.479 0.711 . . . . 0.0 110.327 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -57.48 -54.57 45.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.687 1.195 . . . . 0.0 111.42 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.511 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 86.5 m95 -62.14 -32.48 73.09 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.828 0.851 . . . . 0.0 111.58 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.691 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.1 mpt? -72.99 -26.47 61.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.876 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.573 ' HA ' HG22 ' A' ' 64' ' ' VAL . 19.8 tp10 -74.67 -31.59 61.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.282 0.233 . . . . 0.0 110.587 175.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.498 HD13 HG12 ' A' ' 45' ' ' ILE . 66.8 mt -61.52 -47.63 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 123.017 0.527 . . . . 0.0 110.183 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' O ' HD11 ' A' ' 79' ' ' ILE . 4.1 pp -71.9 -34.33 69.03 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.699 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.573 HG22 ' HA ' ' A' ' 61' ' ' GLU . 23.5 m -76.98 -34.05 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 118.783 0.72 . . . . 0.0 111.558 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.41 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 5.3 tpp180 -68.95 -46.48 68.05 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 122.757 0.423 . . . . 0.0 111.11 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.7 -18.95 64.35 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 123.458 0.474 . . . . 0.0 112.157 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.8 p -90.03 18.88 5.35 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.431 0.692 . . . . 0.0 112.501 175.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 142' ' ' ILE . . . 95.29 26.22 12.66 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.385 -0.675 . . . . 0.0 113.193 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.513 ' HB3' HG13 ' A' ' 145' ' ' ILE . 17.2 tt0 57.78 97.5 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.837 1.255 . . . . 0.0 109.869 -174.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -137.84 -158.11 0.83 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.725 0.81 . . . . 0.0 110.862 -168.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -120.66 164.61 16.26 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.653 1.181 . . . . 0.0 108.985 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.442 HG13 ' HG2' ' A' ' 56' ' ' LYS . 51.4 mm -47.41 -47.6 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 125.659 1.583 . . . . 0.0 112.99 -171.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 m170 -56.74 -53.37 58.52 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.856 0.863 . . . . 0.0 111.572 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.38 -58.06 10.1 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 123.519 0.512 . . . . 0.0 110.75 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . . . -54.61 -54.99 34.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.428 1.091 . . . . 0.0 113.844 -170.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.3 mt -63.68 -31.24 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.49 0.716 . . . . 0.0 112.117 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.69 -39.62 19.94 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 80.1 mt -76.73 -66.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.83 0.452 . . . . 0.0 110.626 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.43 HD11 ' O ' ' A' ' 63' ' ' LEU . 9.0 pt -104.8 8.76 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 118.687 -0.673 . . . . 0.0 112.519 -175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 31' ' ' ASN . . . -81.83 173.95 53.8 Favored Glycine 0 N--CA 1.475 1.253 0 CA-C-N 119.364 0.984 . . . . 0.0 111.853 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.11 137.67 58.31 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -174.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.97 156.64 37.81 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -53.66 151.3 6.22 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.84 -115.51 5.18 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.119 -0.946 . . . . 0.0 112.123 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' A' ' 12' ' ' ARG . 13.6 m120 -85.5 108.55 17.97 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.524 HG11 HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -135.1 171.25 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.337 -178.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.453 ' SG ' ' HB2' ' A' ' 32' ' ' ALA . 61.0 m -131.64 121.46 24.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.841 1.256 . . . . 0.0 108.823 -174.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.464 HD11 ' HB ' ' A' ' 99' ' ' ILE . 4.8 tt -99.47 128.77 45.6 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -174.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.456 HG22 ' HZ3' ' A' ' 59' ' ' TRP . 22.0 mt -113.75 114.28 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 20.8 p -138.26 156.88 47.25 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.836 0.454 . . . . 0.0 110.568 -176.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.34 -51.98 15.52 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.866 175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -128.75 158.39 38.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.121 0.968 . . . . 0.0 110.068 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 43.4 mt-10 -64.87 -16.15 62.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.885 0.874 . . . . 0.0 112.266 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 13.4 pt-20 -74.58 -46.59 37.73 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 34.0 m -61.56 -40.4 94.57 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 123.738 0.815 . . . . 0.0 110.505 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.745 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 19.4 t80 -56.74 -51.46 68.78 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 123.819 0.699 . . . . 0.0 110.84 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -61.39 -42.72 99.17 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.822 0.701 . . . . 0.0 111.005 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 74.8 mmtt -57.58 -50.14 74.09 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.654 0.596 . . . . 0.0 110.899 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.464 ' HB ' HD11 ' A' ' 88' ' ' LEU . 45.8 mm -69.82 -45.45 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.835 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.405 ' HD1' HD12 ' A' ' 11' ' ' ILE . 14.7 t80 -54.01 -45.7 71.57 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.257 1.423 . . . . 0.0 113.2 176.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -68.95 -30.34 68.76 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 119.463 -0.303 . . . . 0.0 111.667 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.24 -46.03 71.62 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 119.217 -0.42 . . . . 0.0 111.932 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.1 pt -75.62 -41.01 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 118.103 0.41 . . . . 0.0 110.799 -172.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.56 109.11 0.09 OUTLIER Glycine 0 C--N 1.345 1.072 0 O-C-N 123.347 0.405 . . . . 0.0 113.706 170.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 177.44 -171.88 44.63 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -105.25 147.46 28.04 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.238 0.615 . . . . 0.0 109.568 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.9 mm -71.36 129.29 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 123.248 0.619 . . . . 0.0 109.561 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -132.77 100.84 5.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.289 1.036 . . . . 0.0 108.906 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -69.88 -33.18 71.89 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.896 0.478 . . . . 0.0 111.622 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.516 ' HA ' ' HG2' ' A' ' 113' ' ' GLU . 18.4 m -50.6 -36.82 36.81 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 16.2 m -66.64 -22.52 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.8 mt -100.75 17.83 20.97 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.808 0.843 . . . . 0.0 111.856 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.593 ' HA ' HG22 ' A' ' 37' ' ' THR . 7.4 pt-20 -134.79 8.06 3.53 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 78.71 131.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 124.202 1.001 . . . . 0.0 111.615 173.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.46 ' ND2' ' HB2' ' A' ' 117' ' ' ASP . 4.0 p-10 -156.87 174.44 15.5 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.219 1.407 . . . . 0.0 107.915 172.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -69.4 -32.23 71.09 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -170.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.46 ' HB2' ' ND2' ' A' ' 115' ' ' ASN . 2.2 m-20 -57.34 -50.68 72.19 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.541 0.736 . . . . 0.0 110.352 171.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.78 -40.98 76.86 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.124 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.463 ' HG3' HG21 ' A' ' 134' ' ' VAL . 42.5 tt0 -72.32 -49.19 36.31 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.404 0.682 . . . . 0.0 112.485 -162.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 123' ' ' ARG . 12.5 ptm180 -70.16 -36.95 75.06 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.678 0.752 . . . . 0.0 110.741 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.682 HD21 ' HB3' ' A' ' 33' ' ' ASP . 37.4 tp -59.64 -47.8 84.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.778 172.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.4 HG23 ' HD2' ' A' ' 126' ' ' PHE . 31.5 mt -63.5 -38.04 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.289 1.035 . . . . 0.0 110.645 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.2 ptp180 -74.36 -26.51 60.17 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-O 118.983 -0.532 . . . . 0.0 110.086 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -71.47 -57.49 4.38 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -31.27 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-N 119.014 0.825 . . . . 0.0 112.487 -172.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.4 ' HD2' HG23 ' A' ' 122' ' ' ILE . 23.0 m-30 -92.5 -33.59 14.42 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 119.593 -0.241 . . . . 0.0 111.553 177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 12.4 mmmm 66.13 82.53 0.18 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.971 0.908 . . . . 0.0 112.419 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 137' ' ' ARG . 36.9 mt -124.01 156.73 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -42.06 -55.23 3.27 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.86 0.464 . . . . 0.0 111.045 165.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.93 33.9 7.55 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -114.78 152.3 32.35 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 124.293 1.037 . . . . 0.0 109.117 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 71.37 -132.99 21.38 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.623 0.577 . . . . 0.0 112.138 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' A' ' 136' ' ' GLU . 54.0 t30 -96.22 116.79 29.56 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.654 0.381 . . . . 0.0 110.638 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.463 HG21 ' HG3' ' A' ' 119' ' ' GLU . 84.2 t -64.19 -29.4 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.152 1.381 . . . . 0.0 112.324 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.8 -49.75 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.213 0.605 . . . . 0.0 110.469 -174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.414 ' HG3' HD22 ' A' ' 133' ' ' ASN . 41.1 mt-10 -64.99 -32.1 73.66 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.097 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.537 ' HB3' HG21 ' A' ' 128' ' ' ILE . 8.5 mmm180 -76.01 -35.48 59.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.115 0.566 . . . . 0.0 112.205 -176.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.51 -41.33 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.823 -0.548 . . . . 0.0 110.973 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.5 mp -57.12 -40.16 76.54 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.508 1.123 . . . . 0.0 112.786 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.37 -35.52 68.5 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.024 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -64.96 -46.08 83.05 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.426 0.69 . . . . 0.0 111.281 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.442 HD11 ' HD2' ' A' ' 43' ' ' HIS . 19.5 pt -72.48 -8.48 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.403 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.75 -29.22 13.13 Favored 'General case' 0 C--N 1.349 0.561 0 C-N-CA 124.386 1.074 . . . . 0.0 111.267 171.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.89 3.97 0.95 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.16 1.384 . . . . 0.0 113.724 -165.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.513 HG13 ' HB3' ' A' ' 69' ' ' GLN . 19.1 mm -82.15 -38.06 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -98.39 -33.79 10.91 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.102 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.76 31.74 0.6 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.524 1.13 . . . . 0.0 110.007 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -102.27 -40.14 6.9 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? 66.99 76.18 0.3 Allowed 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.449 1.499 . . . . 0.0 110.027 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 124.729 1.212 . . . . 0.0 111.145 170.04 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.524 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.95 175.52 6.68 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.607 0.763 . . . . 0.0 110.955 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 3' ' ' MET . 1.3 mpt? -56.91 -33.49 66.98 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.899 0.88 . . . . 0.0 110.638 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.97 93.0 7.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 162.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.719 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 67.5 Cg_endo -71.72 -33.34 10.47 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.357 2.038 . . . . 0.0 112.732 -177.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.719 ' SD ' ' HG2' ' A' ' 5' ' ' PRO . 2.0 mpt? -106.94 161.45 14.71 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 173.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -103.55 104.94 17.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.0 mm -111.83 120.31 61.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.434 HH21 HG21 ' A' ' 107' ' ' ILE . 28.0 mmm180 -133.18 145.33 50.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.876 0.471 . . . . 0.0 109.869 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.564 ' H ' HD11 ' A' ' 112' ' ' LEU . . . -107.14 118.04 5.46 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 -177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.3 tt -124.28 124.97 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.566 0.746 . . . . 0.0 111.165 -175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.417 ' HA ' HD22 ' A' ' 85' ' ' ASN . 8.7 ptp180 -85.11 137.74 32.85 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.156 170.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.29 79.51 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.211 172.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.25 109.98 4.98 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.833 0.853 . . . . 0.0 111.815 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -76.76 103.15 6.57 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.546 HD11 HG11 ' A' ' 86' ' ' VAL . 50.9 mm -70.69 93.26 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.519 HD21 HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -102.01 153.59 19.75 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.625 -177.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -68.53 -13.26 62.21 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.39 -36.75 79.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.656 0.782 . . . . 0.0 112.013 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 17' ' ' ASN . 6.9 pt -56.72 -22.62 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -87.25 -16.78 34.23 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 118.231 0.469 . . . . 0.0 111.368 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -75.31 -19.52 59.61 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.381 0.673 . . . . 0.0 112.093 -173.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -82.65 -9.76 59.23 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.944 0.498 . . . . 0.0 111.765 -177.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.73 8.39 2.85 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 117.312 1.685 . . . . 0.0 117.312 177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB2' HD13 ' A' ' 23' ' ' LEU . 86.2 mt -68.57 168.69 12.44 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 117.977 0.888 . . . . 0.0 112.131 -177.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -77.78 92.21 4.18 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.09 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -148.81 162.3 40.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.984 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.648 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -146.1 159.82 42.76 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 164.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.8 mt -134.08 129.68 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 121.704 -0.623 . . . . 0.0 109.39 173.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.7 pt? -119.84 179.7 4.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.072 0.949 . . . . 0.0 108.456 172.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.467 ' HB3' HG22 ' A' ' 34' ' ' VAL . 51.0 t-20 -74.51 143.16 44.68 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.557 ' HB1' HG21 ' A' ' 111' ' ' VAL . . . -68.87 -49.67 56.28 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.038 0.447 . . . . 0.0 110.585 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HB3' HD21 ' A' ' 121' ' ' LEU . 40.9 m-20 -52.38 -16.66 0.92 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 31' ' ' ASN . 24.9 m -110.82 2.09 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.585 0.754 . . . . 0.0 111.906 -178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.0 p -65.13 -30.74 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.201 0.6 . . . . 0.0 111.95 -171.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.427 ' O ' HG12 ' A' ' 114' ' ' ILE . . . 58.29 -84.99 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.34 1.056 . . . . 0.0 109.35 -166.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 16.8 p -127.07 161.69 27.83 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.939 0.896 . . . . 0.0 111.081 172.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -53.56 -40.68 65.79 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.379 163.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.507 ' HD2' HD11 ' A' ' 42' ' ' LEU . 50.8 tptt -56.19 -35.76 67.61 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 124.994 1.318 . . . . 0.0 111.554 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -63.02 -52.6 62.27 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.889 0.743 . . . . 0.0 111.28 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 45' ' ' ILE . 40.4 t -72.66 -42.49 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-O 119.427 -0.321 . . . . 0.0 111.85 -175.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.508 ' HB2' ' SD ' ' A' ' 6' ' ' MET . 4.1 pp -64.6 -29.52 70.53 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 118.015 0.371 . . . . 0.0 111.209 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.455 ' HD2' HD11 ' A' ' 142' ' ' ILE . 49.4 t60 -62.6 -40.22 96.23 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.019 0.928 . . . . 0.0 110.546 169.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 -44.27 82.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.571 0.748 . . . . 0.0 111.101 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.467 ' HA ' HG12 ' A' ' 62' ' ' ILE . 41.7 mt -65.49 -45.8 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.099 0.96 . . . . 0.0 110.709 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -51.69 -48.77 63.37 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.568 1.147 . . . . 0.0 110.366 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -64.6 -31.82 73.21 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.987 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.46 -21.78 48.54 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.914 0.485 . . . . 0.0 112.025 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HE3' HG22 ' A' ' 45' ' ' ILE . 96.7 mttt -82.0 -31.75 30.91 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.973 0.509 . . . . 0.0 111.622 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.478 HG23 ' HG2' ' A' ' 51' ' ' LYS . 9.7 t -100.31 -35.98 9.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.478 ' HG2' HG23 ' A' ' 50' ' ' THR . 10.9 mmpt? -119.63 153.57 35.31 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.275 0.63 . . . . 0.0 111.877 -176.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.86 124.74 9.48 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.506 1.122 . . . . 0.0 109.766 173.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -90.57 -115.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 123.85 3.034 . . . . 0.0 110.468 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 25.8 mm -123.63 35.26 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HB3' ' HG2' ' A' ' 61' ' ' GLU . . . -85.83 156.54 20.52 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.878 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.554 ' HG2' HG13 ' A' ' 72' ' ' ILE . 74.3 mmtt -62.23 -53.83 49.56 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.207 0.603 . . . . 0.0 111.945 -171.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.539 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 10.6 t -156.33 -176.94 6.23 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.039 0.536 . . . . 0.0 109.678 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -58.55 -60.33 3.97 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.407 1.083 . . . . 0.0 113.244 -173.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.518 ' CE3' ' HB2' ' A' ' 28' ' ' GLN . 92.1 m95 -66.16 -23.5 66.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.747 0.419 . . . . 0.0 112.044 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.5 mpt? -77.19 -26.09 52.49 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.864 0.866 . . . . 0.0 110.599 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.524 ' HG2' ' HB3' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -74.92 -41.26 60.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.967 0.907 . . . . 0.0 109.389 179.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 45' ' ' ILE . 81.8 mt -61.54 -39.46 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.726 0.811 . . . . 0.0 112.455 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.455 HD12 HG13 ' A' ' 64' ' ' VAL . 3.6 pp -72.65 -33.47 66.62 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.007 -178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.455 HG13 HD12 ' A' ' 63' ' ' LEU . 25.0 m -77.07 -27.0 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.973 -0.454 . . . . 0.0 111.949 174.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.444 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 35.4 mmt180 -64.56 -62.76 1.39 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.205 0.602 . . . . 0.0 110.442 172.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.79 -27.72 68.23 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.608 0.763 . . . . 0.0 112.695 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 p -79.57 -59.07 2.89 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 170.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.37 6.6 29.16 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.722 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -78.83 -25.13 44.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.498 1.119 . . . . 0.0 111.763 -172.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' NH1' HG23 ' A' ' 64' ' ' VAL . 1.1 mpt_? 66.58 -10.61 0.27 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -173.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -99.45 118.5 36.2 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.94 0.896 . . . . 0.0 109.125 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.554 HG13 ' HG2' ' A' ' 56' ' ' LYS . 24.8 mm -53.45 -59.73 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 124.264 1.025 . . . . 0.0 112.353 -172.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -61.76 -45.14 95.17 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 124.152 0.907 . . . . 0.0 110.589 -172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -58.02 -47.86 81.79 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.858 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.92 80.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.52 0.728 . . . . 0.0 112.397 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.9 mt -68.08 -33.79 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.185 0.594 . . . . 0.0 111.035 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -68.71 -49.33 59.76 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.804 0.335 . . . . 0.0 110.698 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.518 HG23 ' HB ' ' A' ' 125' ' ' ILE . 74.2 mt -64.8 -64.22 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 124.004 0.922 . . . . 0.0 111.15 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.45 ' HB ' HG21 ' A' ' 34' ' ' VAL . 24.0 pt -110.4 15.36 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -172.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.58 173.29 44.16 Favored Glycine 0 N--CA 1.479 1.52 0 CA-C-N 120.389 1.449 . . . . 0.0 113.21 -174.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.44 146.59 32.68 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.189 0.595 . . . . 0.0 111.39 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -153.18 155.53 36.84 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.417 1.087 . . . . 0.0 108.104 171.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -65.25 151.98 44.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.927 0.491 . . . . 0.0 111.433 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.79 -120.78 7.01 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.205 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 12' ' ' ARG . 12.0 m120 -79.61 105.89 11.24 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG11 HD11 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -135.74 164.53 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.647 -177.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 32' ' ' ALA . 43.7 t -125.55 121.25 33.12 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.371 1.068 . . . . 0.0 108.959 -174.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.41 HD21 ' HB ' ' A' ' 99' ' ' ILE . 10.0 tp -102.35 125.75 49.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.853 0.861 . . . . 0.0 109.865 -171.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 28' ' ' GLN . 68.4 mt -99.79 128.52 51.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 CA-C-N 113.698 -1.592 . . . . 0.0 107.521 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.547 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 35.1 t -150.32 149.19 29.78 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 111.589 177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -86.02 -41.67 14.63 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.59 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -119.78 146.69 45.44 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 123.195 0.598 . . . . 0.0 110.994 -174.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -54.79 -38.31 67.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.71 0.804 . . . . 0.0 112.613 172.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -69.75 -46.51 65.7 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.547 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 28.7 m -61.21 -35.21 76.57 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.005 0.922 . . . . 0.0 110.948 178.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -63.83 -46.76 83.62 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.404 0.682 . . . . 0.0 110.152 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -63.58 -34.71 78.41 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.759 0.662 . . . . 0.0 110.574 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.79 -45.9 80.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.464 0.706 . . . . 0.0 111.638 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.474 HD13 HD21 ' A' ' 23' ' ' LEU . 40.2 mm -71.39 -46.72 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 122.43 -0.169 . . . . 0.0 110.766 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -54.76 -33.81 61.77 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.161 1.384 . . . . 0.0 112.086 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -62.8 -50.46 70.91 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.864 0.866 . . . . 0.0 111.769 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.67 -25.84 49.84 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -174.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.409 HG23 HG21 ' A' ' 20' ' ' ILE . 17.7 pt -80.24 -50.49 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 118.584 0.629 . . . . 0.0 109.575 174.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.92 124.43 0.05 OUTLIER Glycine 0 C--N 1.352 1.418 0 O-C-N 123.443 0.464 . . . . 0.0 113.796 176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.43 -153.15 20.59 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 117.028 0.414 . . . . 0.0 112.159 175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -123.91 143.79 50.16 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.938 0.895 . . . . 0.0 109.164 -177.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.434 HG21 HH21 ' A' ' 9' ' ' ARG . 49.3 mm -86.89 136.73 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -135.66 108.97 7.8 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 172.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.15 -25.22 66.86 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.541 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.2 m -46.54 -39.68 11.36 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.557 HG21 ' HB1' ' A' ' 32' ' ' ALA . 12.6 p -71.29 -41.62 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-O 120.846 0.355 . . . . 0.0 110.399 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 37' ' ' THR . 86.3 mt -67.78 -31.17 70.88 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.551 1.141 . . . . 0.0 112.623 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.3 1.54 54.48 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 118.15 -0.929 . . . . 0.0 112.924 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.433 HD13 ' HA ' ' A' ' 114' ' ' ILE 0.253 1.5 mm 73.07 127.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.29 0 CA-C-N 119.296 0.953 . . . . 0.0 113.094 177.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.438 HD21 ' HD3' ' A' ' 118' ' ' LYS . 6.3 p30 -147.89 -176.68 5.36 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.024 1.329 . . . . 0.0 108.584 173.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -57.42 -49.61 75.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.493 0.717 . . . . 0.0 112.142 -171.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.8 -51.39 69.93 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.53 1.132 . . . . 0.0 112.466 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.438 ' HD3' HD21 ' A' ' 115' ' ' ASN . 4.3 mptp? -70.6 -37.23 73.86 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.849 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -71.38 -39.22 71.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.976 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -72.2 -42.89 65.29 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.866 0.466 . . . . 0.0 112.046 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.54 HD21 ' HB3' ' A' ' 33' ' ' ASP . 0.7 OUTLIER -66.14 -34.1 77.28 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.487 HG23 ' HD2' ' A' ' 126' ' ' PHE . 13.5 mt -58.33 -30.02 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 123.948 0.899 . . . . 0.0 110.782 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -69.44 -36.79 76.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 118.839 -0.6 . . . . 0.0 109.534 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.13 -55.71 30.5 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.518 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -75.57 -45.07 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-N 118.863 0.756 . . . . 0.0 112.693 -178.026 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.582 ' HB3' ' HE2' ' A' ' 141' ' ' LYS . 21.7 m-30 -81.87 -33.1 30.75 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? 63.6 76.32 0.36 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.151 0.98 . . . . 0.0 112.318 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.685 HG21 ' HB3' ' A' ' 137' ' ' ARG . 2.5 mt -124.49 151.13 29.58 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -61.72 -90.82 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.619 176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 173.66 -120.38 0.8 Allowed Glycine 0 C--N 1.35 1.337 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.1 t80 67.0 101.21 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.017 1.327 . . . . 0.0 111.242 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.4 -125.46 8.58 Favored Glycine 0 N--CA 1.469 0.879 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.62 165.49 19.87 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.425 0.612 . . . . 0.0 110.383 167.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.45 -16.53 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.083 0.553 . . . . 0.0 112.445 -171.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.476 ' O ' HD13 ' A' ' 139' ' ' LEU . 86.6 t -68.63 -49.29 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -174.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -52.75 -45.54 67.07 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.495 174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.685 ' HB3' HG21 ' A' ' 128' ' ' ILE . 37.4 mmt180 -73.55 -38.85 65.09 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 113.693 -1.594 . . . . 0.0 112.346 -168.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.55 -41.15 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 123.181 0.301 . . . . 0.0 110.485 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 135' ' ' VAL . 9.9 mp -55.74 -44.16 77.32 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.741 0.816 . . . . 0.0 110.509 175.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -74.33 -37.94 63.41 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 123.887 0.742 . . . . 0.0 111.929 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.633 ' HD3' HG12 ' A' ' 128' ' ' ILE . 16.5 ttpp -66.25 -40.01 89.91 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.086 0.47 . . . . 0.0 111.537 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.455 HD11 ' HD2' ' A' ' 43' ' ' HIS . 22.2 pt -73.29 -18.92 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.017 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -106.82 15.24 25.75 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.3 1.04 . . . . 0.0 110.801 174.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 tt -85.33 19.15 2.38 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 123.977 0.911 . . . . 0.0 109.987 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 12.3 mm -72.33 -30.21 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.83 -17.27 64.45 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.824 1.25 . . . . 0.0 111.824 173.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.9 mt 81.36 67.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.255 1.822 . . . . 0.0 110.596 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -71.65 -178.3 2.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.494 0.718 . . . . 0.0 111.685 175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -116.83 33.17 5.74 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.242 1.017 . . . . 0.0 109.878 -175.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 . . . . . 0 N--CA 1.481 1.105 0 C-N-CA 123.103 0.561 . . . . 0.0 110.279 -170.535 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.906 -0.478 . . . . 0.0 111.906 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.49 118.23 1.9 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.936 0.894 . . . . 0.0 109.79 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.8 mtt -144.83 87.62 1.85 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.923 0.889 . . . . 0.0 110.028 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.5 t70 60.1 91.68 0.07 OUTLIER Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 125.349 1.46 . . . . 0.0 112.295 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 42' ' ' LEU . 96.1 Cg_endo -83.41 -43.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.512 2.141 . . . . 0.0 113.319 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.4 mmt -110.64 175.97 5.22 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.782 0.833 . . . . 0.0 110.927 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 72.5 mt -98.75 103.81 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 108.359 176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.57 122.28 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.7 mmt-85 -127.84 150.9 49.64 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.79 0.836 . . . . 0.0 109.723 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.31 126.26 8.67 Favored Glycine 0 CA--C 1.506 -0.489 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.7 tt -132.63 132.68 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.416 0.627 . . . . 0.0 110.452 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.417 ' HA ' HD22 ' A' ' 85' ' ' ASN . 15.4 ptm180 -107.83 133.68 51.86 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.27 1.028 . . . . 0.0 109.955 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.79 -6.27 79.62 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.534 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.57 112.77 2.12 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.112 0.965 . . . . 0.0 112.826 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -73.28 108.52 6.2 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.469 0.708 . . . . 0.0 110.288 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 86' ' ' VAL . 49.4 mm -70.76 94.17 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 122.272 1.034 . . . . 0.0 109.837 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.45 150.38 20.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.002 177.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -82.26 -4.57 57.39 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.974 0.51 . . . . 0.0 111.23 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' HA ' HD21 ' A' ' 22' ' ' ASN . 12.4 mm-40 -65.94 -40.09 91.07 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.076 0.95 . . . . 0.0 111.154 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.8 pt -70.62 -7.87 9.73 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.766 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.767 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -93.46 -34.32 13.46 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.226 0.921 . . . . 0.0 110.998 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' A' ' 19' ' ' GLU . 10.4 p30 -86.28 0.67 53.31 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -172.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -81.74 -3.94 55.04 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.365 0.666 . . . . 0.0 112.213 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.96 -11.8 2.43 Favored Glycine 0 CA--C 1.54 1.595 0 N-CA-C 117.073 1.589 . . . . 0.0 117.073 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.501 HD13 HG23 ' A' ' 95' ' ' THR . 85.2 mt -64.42 159.8 20.54 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.273 1.037 . . . . 0.0 112.217 -176.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -86.58 100.71 12.61 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.884 -175.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -149.03 162.55 39.71 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.496 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.451 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 24.7 tt0 -139.02 145.55 39.76 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 166.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.0 mt -130.02 126.45 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 pp -122.39 174.28 7.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.068 0.947 . . . . 0.0 108.688 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -82.07 135.41 35.33 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HA ' HG12 ' A' ' 35' ' ' VAL . . . -85.93 3.41 42.06 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -175.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -84.28 -34.66 23.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.271 0.629 . . . . 0.0 110.195 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 79' ' ' ILE . 14.8 p -93.88 -4.47 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 C-N-CA 123.934 0.894 . . . . 0.0 111.229 -172.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG11 ' SG ' ' A' ' 87' ' ' CYS . 8.6 p -96.41 134.42 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.59 -64.09 1.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.1 p -135.24 168.89 18.34 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.465 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.595 ' HD3' ' H ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -56.6 -23.96 44.39 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 168.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 39.1 ttmt -63.02 -28.68 70.26 Favored 'General case' 0 C--N 1.363 1.163 0 C-N-CA 122.717 0.407 . . . . 0.0 111.947 174.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.485 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.8 t-80 -59.3 -44.82 92.5 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.853 0.461 . . . . 0.0 110.021 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.04 -52.14 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.742 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.632 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 3.8 pp -65.57 -36.42 83.71 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.764 0.256 . . . . 0.0 111.648 -171.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.458 ' CG ' ' HG ' ' A' ' 139' ' ' LEU . 57.5 t60 -57.68 -41.31 81.35 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.181 0.592 . . . . 0.0 110.71 169.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.29 -34.42 77.35 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.647 0.592 . . . . 0.0 111.13 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 42' ' ' LEU . 62.9 mt -65.78 -46.08 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.925 0.89 . . . . 0.0 110.641 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' O ' HG22 ' A' ' 50' ' ' THR . 67.4 m-20 -59.39 -46.93 87.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.424 0.69 . . . . 0.0 110.247 176.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -61.68 -36.14 80.01 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.448 1.099 . . . . 0.0 111.166 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.15 95.92 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.565 0.746 . . . . 0.0 111.859 175.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -76.96 -20.35 56.22 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 51' ' ' LYS . 5.1 t -105.25 -38.8 6.4 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.757 0.423 . . . . 0.0 110.757 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HG2' HG23 ' A' ' 50' ' ' THR . 45.2 mmtm -114.52 136.2 53.29 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.591 0.756 . . . . 0.0 110.602 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.603 ' HD3' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -109.56 116.53 54.35 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.856 -178.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.19 -142.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.126 2.551 . . . . 0.0 110.593 168.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.2 mt -110.55 41.52 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.523 ' HA ' HD11 ' A' ' 72' ' ' ILE . . . -77.68 150.94 34.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.534 -174.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -84.96 -23.14 28.89 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.85 0.86 . . . . 0.0 111.15 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.0 t -161.07 173.83 14.61 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.054 0.941 . . . . 0.0 109.399 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -66.89 -44.32 81.17 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.693 0.797 . . . . 0.0 111.177 177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.451 ' HE3' ' HB2' ' A' ' 28' ' ' GLN . 94.0 m95 -76.39 -18.9 58.63 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.409 0.283 . . . . 0.0 111.589 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 24.5 mmt -79.15 -25.45 42.88 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.002 0.521 . . . . 0.0 110.779 166.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 29.8 tt0 -76.03 -37.59 58.2 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.177 0.991 . . . . 0.0 111.544 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.448 HD13 HG12 ' A' ' 45' ' ' ILE . 78.6 mt -68.25 -39.9 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.129 0.572 . . . . 0.0 111.33 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.413 HD12 HG13 ' A' ' 64' ' ' VAL . 3.9 pp -72.06 -34.68 68.93 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 123.214 0.321 . . . . 0.0 111.466 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.413 HG13 HD12 ' A' ' 63' ' ' LEU . 21.9 m -74.34 -35.48 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 O-C-N 121.971 -0.456 . . . . 0.0 110.745 175.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 16.7 tpt85 -68.42 -42.56 78.75 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.161 -175.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.01 66.57 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.451 0.7 . . . . 0.0 111.573 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -82.93 -5.32 59.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.578 0.751 . . . . 0.0 111.947 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.9 -73.46 2.12 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -44.32 136.49 4.03 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.326 1.45 . . . . 0.0 112.365 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -96.59 5.86 49.89 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.941 0.896 . . . . 0.0 111.482 -165.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -98.48 126.21 43.94 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.707 1.203 . . . . 0.0 110.997 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' A' ' 55' ' ' ALA . 1.7 mp -53.12 -59.15 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 124.957 1.303 . . . . 0.0 112.55 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.491 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 63.0 m80 -60.36 -46.79 88.68 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.781 0.676 . . . . 0.0 110.702 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -57.2 -51.83 67.77 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 124.415 1.072 . . . . 0.0 111.187 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.75 -36.62 72.33 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.376 0.671 . . . . 0.0 112.681 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.55 -32.6 55.89 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 122.918 0.487 . . . . 0.0 111.217 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 73' ' ' HIS . 32.6 mmtp -70.14 -49.38 51.28 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 175.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 52.6 mt -68.82 -67.56 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.095 0.958 . . . . 0.0 111.881 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 34' ' ' VAL . 6.9 pt -103.85 8.91 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -173.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.92 168.59 54.75 Favored Glycine 0 C--N 1.352 1.459 0 CA-C-N 119.457 1.026 . . . . 0.0 113.11 -171.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.86 144.82 48.93 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.54 0.736 . . . . 0.0 112.755 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -147.1 151.51 36.96 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -58.77 149.94 25.1 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 119.659 1.118 . . . . 0.0 112.062 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.78 -114.52 4.39 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.083 -177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 12' ' ' ARG . 14.7 m120 -89.2 109.05 19.97 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.136 0.575 . . . . 0.0 110.223 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG21 HD11 ' A' ' 16' ' ' ILE . 4.2 m -137.44 175.11 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.749 0.82 . . . . 0.0 112.034 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.507 ' SG ' HG11 ' A' ' 35' ' ' VAL . 57.9 m -122.82 120.88 34.85 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.411 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD21 ' HB ' ' A' ' 99' ' ' ILE . 9.2 tp -104.1 120.19 40.56 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.765 0.793 . . . . 0.0 109.344 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 12.1 mt -119.12 129.48 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.074 -170.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.565 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 47.9 t -157.69 164.48 37.12 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -78.27 -53.11 7.67 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.357 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -119.86 149.84 41.43 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.193 0.597 . . . . 0.0 110.18 -173.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.14 -35.67 69.79 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.382 1.073 . . . . 0.0 113.143 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 12.8 pt-20 -73.67 -40.68 63.49 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -175.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.565 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 34.9 m -66.07 -36.24 82.68 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.137 0.575 . . . . 0.0 110.938 176.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -58.16 -47.36 83.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.308 0.643 . . . . 0.0 109.383 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -67.46 -34.97 78.26 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.927 -175.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 30.6 mmmt -63.52 -36.66 84.51 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.39 0.676 . . . . 0.0 111.698 176.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.431 ' HB ' HD21 ' A' ' 88' ' ' LEU . 38.1 mm -76.25 -44.68 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 N-CA-C 110.464 -0.198 . . . . 0.0 110.464 175.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -55.46 -45.02 76.94 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.962 1.305 . . . . 0.0 113.221 -178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.675 ' HG3' HD22 ' A' ' 102' ' ' LEU . 8.0 pt-20 -62.35 -35.75 80.08 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 123.475 0.484 . . . . 0.0 111.959 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.675 HD22 ' HG3' ' A' ' 101' ' ' GLU . 3.5 mm? -75.83 -39.15 57.28 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 119.102 -0.475 . . . . 0.0 112.012 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 12.3 pt -74.73 -42.94 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 118.604 0.638 . . . . 0.0 110.639 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.27 113.81 0.06 OUTLIER Glycine 0 C--N 1.35 1.308 0 O-C-N 123.545 0.528 . . . . 0.0 113.838 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -179.83 -162.74 29.31 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -116.92 134.98 54.08 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.56 0.744 . . . . 0.0 109.974 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.8 mm -75.43 123.67 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -143.03 95.94 2.85 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.099 1.36 . . . . 0.0 107.694 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.4 -18.55 63.77 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.8 0.44 . . . . 0.0 112.157 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.5 m -57.38 -25.34 59.35 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.3 p -70.71 -25.23 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.195 0 CA-C-O 120.893 0.378 . . . . 0.0 110.159 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.564 HD13 ' HB3' ' A' ' 38' ' ' LYS . 38.6 mt -107.81 16.52 23.49 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.634 1.174 . . . . 0.0 112.051 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -103.69 -4.91 23.12 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 119.743 1.156 . . . . 0.0 112.428 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.528 HD11 HG12 ' A' ' 134' ' ' VAL 0.294 0.5 OUTLIER 93.57 123.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 126.803 2.041 . . . . 0.0 109.401 -176.43 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.552 ' HB2' ' HD3' ' A' ' 118' ' ' LYS . 3.7 m-80 -139.58 157.59 45.55 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 124.525 1.13 . . . . 0.0 108.328 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.72 -38.56 91.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.412 0.685 . . . . 0.0 110.733 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.79 -48.56 80.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.126 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' A' ' 115' ' ' ASN . 4.2 mptp? -63.02 -42.18 99.74 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.83 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.428 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 29.1 tt0 -65.61 -44.17 87.38 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.757 -166.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -69.38 -39.02 78.25 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.54 -33.05 62.65 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 119.485 -0.293 . . . . 0.0 110.718 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.1 mt -59.14 -41.89 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.88 0.872 . . . . 0.0 110.538 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -74.53 -23.41 58.8 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.611 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -65.92 -57.65 7.37 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.519 HD11 HG23 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -78.36 -24.61 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 119.262 0.937 . . . . 0.0 112.977 -175.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -97.1 -32.42 11.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.15 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 57.88 79.11 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.062 0.945 . . . . 0.0 111.2 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.23 117.01 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -177.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -81.45 105.99 13.05 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 156.47 120.77 0.67 Allowed Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -79.7 -172.15 3.17 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 123.997 0.919 . . . . 0.0 108.928 174.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 105.39 -125.61 8.33 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 121.628 -0.67 . . . . 0.0 111.629 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.454 HD21 ' HB ' ' A' ' 135' ' ' VAL . 10.5 t30 -108.96 119.28 39.08 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.865 0.866 . . . . 0.0 109.371 176.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.528 HG12 HD11 ' A' ' 114' ' ' ILE . 3.8 p -69.73 -15.86 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.124 0.57 . . . . 0.0 112.453 -171.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.454 ' HB ' HD21 ' A' ' 133' ' ' ASN . 21.4 t -70.34 -53.13 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -56.57 -39.37 73.38 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.41 173.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -68.17 -42.21 80.34 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.451 -173.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.9 p -76.23 -37.83 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 122.817 0.447 . . . . 0.0 110.892 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.5 mp -60.46 -37.24 80.38 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.015 0.926 . . . . 0.0 111.388 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -73.23 -40.96 64.25 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.499 0.499 . . . . 0.0 111.618 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -72.61 -29.54 63.58 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.396 0.278 . . . . 0.0 111.438 -171.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.406 HD11 ' HD2' ' A' ' 43' ' ' HIS . 22.2 pt -84.75 -18.55 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.87 -15.64 41.16 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.008 0.523 . . . . 0.0 110.334 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 149' ' ' LYS . 32.0 tp -71.28 -2.73 17.16 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.587 1.555 . . . . 0.0 112.076 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 80.6 mt -92.48 -53.63 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.487 1.115 . . . . 0.0 109.2 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.46 -17.53 19.58 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.066 -174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.0 mt -135.55 63.74 1.59 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -43.88 125.89 4.48 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.529 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.452 ' H ' HD12 ' A' ' 144' ' ' LEU . 1.5 tppp? -98.48 17.44 18.96 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.932 0.893 . . . . 0.0 110.061 -174.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 C--O 1.25 1.126 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.096 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.37 0 N-CA-C 112.258 -0.337 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.78 97.47 2.74 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.238 0.615 . . . . 0.0 110.325 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.2 ptm 115.29 12.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.53 0 C-N-CA 129.04 2.936 . . . . 0.0 109.797 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -166.01 68.24 1.13 Allowed Pre-proline 0 CA--C 1.56 1.364 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.76 -60.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.143 2.562 . . . . 0.0 113.315 -170.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.7 mmt -83.92 173.53 11.13 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.239 0.616 . . . . 0.0 109.513 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.9 mt -93.01 102.17 13.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.4 mm -112.69 118.92 59.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 177.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -135.08 149.05 50.01 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.26 151.52 17.9 Favored Glycine 0 C--O 1.239 0.42 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.91 127.65 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.61 0.719 . . . . 0.0 112.874 -176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.534 ' HA ' HD22 ' A' ' 85' ' ' ASN . 11.5 ptp85 -91.72 133.17 35.84 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.823 1.249 . . . . 0.0 110.31 175.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.94 24.37 72.11 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.192 -0.458 . . . . 0.0 114.101 170.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.497 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -80.21 111.79 16.91 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.673 0.789 . . . . 0.0 110.974 177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 110.17 8.42 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.409 HD11 HG21 ' A' ' 86' ' ' VAL . 49.6 mm -69.02 92.41 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.72 0.771 . . . . 0.0 109.34 175.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.488 ' O ' HG12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -105.01 148.58 26.58 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.486 -176.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -56.53 -24.41 46.53 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.4 -34.17 76.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.394 0.678 . . . . 0.0 112.38 -172.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.621 HG21 HG23 ' A' ' 103' ' ' ILE . 7.2 pt -62.66 -15.14 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -106.82 -17.85 14.09 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 118.525 0.602 . . . . 0.0 109.845 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -69.39 -25.44 64.15 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.08 0.952 . . . . 0.0 111.16 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -76.57 -8.94 58.21 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.196 -174.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.11 17.22 9.92 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 116.737 1.455 . . . . 0.0 116.737 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.468 ' HB2' HD13 ' A' ' 23' ' ' LEU . 93.3 mt -81.93 170.5 15.55 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.426 0.69 . . . . 0.0 110.833 -177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -84.58 99.41 10.74 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.643 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -149.9 162.25 40.69 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.852 0.861 . . . . 0.0 109.421 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.433 ' HB2' ' HE3' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -140.09 145.89 38.21 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.6 mt -130.98 127.48 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 172.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 pp -120.31 176.63 5.37 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 34' ' ' VAL . 44.4 t30 -81.17 138.07 35.87 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.541 ' HB1' ' HB ' ' A' ' 111' ' ' VAL . . . -83.74 -2.45 56.3 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.507 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 61.3 m-20 -89.87 -30.22 18.05 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 122.854 0.462 . . . . 0.0 110.387 176.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.469 HG23 HG13 ' A' ' 125' ' ' ILE . 9.4 p -87.52 -16.29 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 123.309 0.644 . . . . 0.0 111.234 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 32' ' ' ALA . 13.4 p -93.86 136.13 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.77 -66.93 0.64 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.681 175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.4 p -138.49 167.78 21.19 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.595 1.158 . . . . 0.0 109.362 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HB3' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -58.26 -22.94 54.43 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 174.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 87.4 tttt -58.95 -34.68 72.04 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.021 0.528 . . . . 0.0 111.677 174.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.509 ' HA ' HD11 ' A' ' 139' ' ' LEU . 18.1 t-80 -60.58 -44.57 96.07 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.204 177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.57 -52.83 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.036 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 4.1 pp -64.57 -28.37 69.59 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -172.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.441 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 79.4 t60 -68.63 -33.48 74.09 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.226 0.61 . . . . 0.0 110.985 171.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 -40.82 69.58 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.024 0.53 . . . . 0.0 110.914 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.504 HG12 HD13 ' A' ' 62' ' ' ILE . 55.9 mt -61.3 -43.79 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.163 0.985 . . . . 0.0 109.915 172.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 50' ' ' THR . 25.8 t-20 -53.13 -48.39 67.93 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.634 1.173 . . . . 0.0 110.69 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 26.7 mm-40 -63.82 -34.62 78.34 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.231 0.957 . . . . 0.0 110.583 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.452 ' HA ' ' OE2' ' A' ' 61' ' ' GLU . . . -73.35 -25.66 60.69 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 176.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -83.71 -46.19 12.55 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.376 0.67 . . . . 0.0 111.23 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.537 HG23 ' HG3' ' A' ' 51' ' ' LYS . 15.1 t -93.9 -32.35 13.94 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.75 0.42 . . . . 0.0 111.827 -173.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.537 ' HG3' HG23 ' A' ' 50' ' ' THR . 42.3 mtpt -109.51 160.97 15.78 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.925 0.49 . . . . 0.0 111.239 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -142.36 98.82 5.95 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 124.066 0.947 . . . . 0.0 110.248 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.41 -119.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 123.549 2.832 . . . . 0.0 112.036 169.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 30.3 mt -132.99 34.73 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.39 158.59 23.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.548 -175.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -60.24 -60.37 3.92 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.9 0.88 . . . . 0.0 112.416 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.543 ' HB2' ' SD ' ' A' ' 60' ' ' MET . 70.0 m -148.65 179.17 8.03 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.512 0.725 . . . . 0.0 109.818 -177.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.402 ' O ' HG13 ' A' ' 62' ' ' ILE . 58.1 t80 -53.56 -56.97 12.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.324 1.049 . . . . 0.0 111.852 -178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.515 ' HZ3' HG22 ' A' ' 89' ' ' ILE . 75.7 m95 -65.54 -35.18 80.09 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.491 0.716 . . . . 0.0 111.473 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 57' ' ' SER . 1.1 mpt? -76.34 -19.81 57.85 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.371 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 22.9 tt0 -78.53 -38.94 39.37 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.442 0.697 . . . . 0.0 110.627 173.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.504 HD13 HG12 ' A' ' 45' ' ' ILE . 90.2 mt -57.01 -41.28 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 123.491 0.716 . . . . 0.0 111.036 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.403 HD12 HG13 ' A' ' 64' ' ' VAL . 3.9 pp -72.0 -32.88 67.63 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.21 -177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.713 HG23 ' HE ' ' A' ' 65' ' ' ARG . 12.0 m -78.38 -34.21 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 O-C-N 121.771 -0.581 . . . . 0.0 111.729 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.713 ' HE ' HG23 ' A' ' 64' ' ' VAL . 5.8 mmp_? -70.39 -38.98 74.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.651 0.38 . . . . 0.0 110.919 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.52 -28.81 68.84 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.34 0.656 . . . . 0.0 112.199 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.0 p -92.44 -3.53 55.08 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.764 0.426 . . . . 0.0 111.933 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.48 16.04 48.52 Favored Glycine 0 C--N 1.358 1.77 0 N-CA-C 114.939 0.735 . . . . 0.0 114.939 -170.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.605 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.7 tp-100 -105.76 151.57 24.29 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 30.5 ptt-85 -85.19 -27.2 26.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.072 0.549 . . . . 0.0 111.361 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.605 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 5.8 mm-40 -90.04 125.45 35.41 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.357 1.063 . . . . 0.0 111.195 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.499 HD12 HG11 ' A' ' 64' ' ' VAL . 1.8 mp -58.76 -44.95 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 124.343 1.057 . . . . 0.0 110.357 172.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -60.94 -51.09 70.76 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.351 0.661 . . . . 0.0 111.348 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.408 ' HB2' ' HG2' ' A' ' 69' ' ' GLN . 16.8 mm-40 -56.47 -55.52 32.63 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.316 0.385 . . . . 0.0 110.983 174.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.71 -38.78 75.86 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.3 mt -68.99 -31.1 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 120.661 0.267 . . . . 0.0 111.178 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -74.05 -43.63 57.15 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 122.098 -0.376 . . . . 0.0 110.675 174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 79.4 mt -68.55 -65.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.83 0.852 . . . . 0.0 111.825 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.462 HG22 HG21 ' A' ' 34' ' ' VAL . 7.7 pt -105.91 6.06 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.15 176.13 47.4 Favored Glycine 0 N--CA 1.477 1.394 0 CA-C-N 119.094 0.861 . . . . 0.0 114.025 -166.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.33 140.31 42.99 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.613 0.765 . . . . 0.0 111.803 -172.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -145.64 143.22 29.71 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.44 141.3 58.43 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.297 0.953 . . . . 0.0 111.41 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 117.07 -119.41 4.45 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 -171.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.534 HD22 ' HA ' ' A' ' 12' ' ' ARG . 12.6 m120 -82.83 110.29 17.71 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 117.252 0.526 . . . . 0.0 109.913 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.409 HG21 HD11 ' A' ' 16' ' ' ILE . 3.6 m -134.79 174.06 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.627 0.727 . . . . 0.0 111.519 173.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 44.1 t -130.94 121.81 25.81 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.301 -1.318 . . . . 0.0 107.709 -173.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.515 HD21 ' HB ' ' A' ' 99' ' ' ILE . 8.3 tp -102.1 122.22 43.7 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.774 0.797 . . . . 0.0 109.503 -172.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.515 HG22 ' HZ3' ' A' ' 59' ' ' TRP . 32.0 mt -111.03 122.19 65.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 113.35 -1.75 . . . . 0.0 107.692 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.609 ' SG ' ' HB ' ' A' ' 95' ' ' THR . 40.1 t -154.56 168.0 28.21 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 117.953 0.342 . . . . 0.0 111.028 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 64.6 mt-10 -95.96 -48.13 5.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.356 0.663 . . . . 0.0 110.827 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -111.66 138.15 48.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.428 0.691 . . . . 0.0 109.26 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 96' ' ' PHE . 41.4 tt0 -63.49 -24.14 67.7 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.278 0.631 . . . . 0.0 111.902 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.15 -45.82 72.49 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.609 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 28.3 m -70.88 -34.45 71.6 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.929 0.892 . . . . 0.0 111.001 177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.477 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 5.5 t80 -61.54 -52.31 64.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.553 0.741 . . . . 0.0 109.667 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.542 ' O ' ' HG2' ' A' ' 101' ' ' GLU . 30.7 mtp180 -68.58 -33.62 74.37 Favored 'General case' 0 C--O 1.213 -0.855 0 O-C-N 123.685 0.616 . . . . 0.0 110.343 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.415 ' O ' HD13 ' A' ' 102' ' ' LEU . 50.4 tptt -56.46 -40.49 74.94 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.024 0.529 . . . . 0.0 110.663 175.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.515 ' HB ' HD21 ' A' ' 88' ' ' LEU . 43.2 mm -73.67 -48.64 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.6 174.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -54.54 -43.37 71.9 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 124.826 1.251 . . . . 0.0 113.702 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 97' ' ' ARG . 56.6 mm-40 -60.88 -40.33 92.61 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.624 0.37 . . . . 0.0 110.776 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.415 HD13 ' O ' ' A' ' 98' ' ' LYS . 6.8 mp -72.97 -42.08 63.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.533 0.733 . . . . 0.0 112.082 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.621 HG23 HG21 ' A' ' 20' ' ' ILE . 8.2 pt -74.66 -32.59 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 118.229 0.468 . . . . 0.0 110.019 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.38 27.14 73.92 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 163.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -90.38 -170.58 43.72 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.869 -0.492 . . . . 0.0 111.869 172.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -111.62 146.38 37.53 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 44.8 mm -69.35 124.54 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 121.003 0.43 . . . . 0.0 110.087 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -118.93 101.0 7.73 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -69.37 -41.82 76.01 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 50.4 m -56.82 -24.93 54.5 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -175.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.541 ' HB ' ' HB1' ' A' ' 32' ' ' ALA . 13.5 m -70.36 -17.75 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 118.583 0.629 . . . . 0.0 111.605 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 38' ' ' LYS . 21.2 mt -107.05 17.6 22.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.791 0.836 . . . . 0.0 111.136 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 110' ' ' SER . 8.0 pt-20 -114.46 -10.64 12.57 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 117.954 -1.022 . . . . 0.0 113.044 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 78.63 127.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 C-N-CA 124.527 1.131 . . . . 0.0 110.451 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -158.88 -172.39 3.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.554 1.142 . . . . 0.0 109.408 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -62.38 -47.58 83.53 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.284 0.634 . . . . 0.0 111.362 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.08 -44.04 95.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.187 0.595 . . . . 0.0 110.967 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -59.97 -43.92 94.78 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.128 0.893 . . . . 0.0 110.389 177.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -72.01 -50.05 31.91 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.353 -167.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -64.96 -54.5 29.51 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -172.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 33' ' ' ASP . 1.2 pp -64.44 -33.09 75.06 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.14 0.275 . . . . 0.0 111.17 -174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.526 ' HA ' HD11 ' A' ' 125' ' ' ILE . 1.9 mt -53.84 -32.66 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 124.052 0.941 . . . . 0.0 112.048 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -64.51 -36.5 84.38 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 119.388 -0.339 . . . . 0.0 110.498 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.62 -56.69 18.73 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.526 HD11 ' HA ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -70.0 -52.92 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.328 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.424 ' HD2' HG23 ' A' ' 122' ' ' ILE . 23.6 m-85 -83.58 -33.07 25.48 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -170.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? 61.53 69.55 0.64 Allowed 'General case' 0 C--N 1.35 0.592 0 O-C-N 124.403 1.064 . . . . 0.0 110.586 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.42 115.07 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.573 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 53.8 mmm-85 -86.35 39.0 0.8 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.603 0.761 . . . . 0.0 111.74 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -167.38 139.73 5.88 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -94.83 -175.0 3.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.46 0.704 . . . . 0.0 110.582 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.13 -138.54 14.33 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -173.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.521 HD22 ' HG2' ' A' ' 136' ' ' GLU . 37.0 t30 -91.33 125.09 35.98 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.06 -32.12 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.892 0.877 . . . . 0.0 111.861 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.67 -53.48 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 121.178 0.514 . . . . 0.0 109.971 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.521 ' HG2' HD22 ' A' ' 133' ' ' ASN . 28.5 mm-40 -70.04 -37.14 75.49 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.83 -178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -76.91 -29.44 55.7 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 123.561 0.538 . . . . 0.0 111.817 -172.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.56 -36.15 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 172.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.509 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.9 mp -60.49 -38.11 83.25 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.423 0.689 . . . . 0.0 110.646 172.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 136' ' ' GLU . 31.4 mm-40 -59.65 -51.41 69.93 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.136 0.574 . . . . 0.0 110.955 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.17 -49.19 78.2 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.557 0.743 . . . . 0.0 112.249 -175.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.9 pt -70.18 -27.59 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 122.972 0.509 . . . . 0.0 110.683 -174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.92 -31.94 34.86 Favored 'General case' 0 C--O 1.206 -1.233 0 C-N-CA 122.848 0.459 . . . . 0.0 110.531 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.8 tp -72.37 3.06 5.13 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 124.092 0.957 . . . . 0.0 112.177 -173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.4 mt -103.14 -50.65 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.154 0.982 . . . . 0.0 109.188 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -93.23 -3.35 53.91 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.656 0.741 . . . . 0.0 111.169 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 49.2 tp -144.08 60.66 1.36 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -57.74 163.75 2.42 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 113.664 -1.607 . . . . 0.0 112.784 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -109.53 -2.81 17.37 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.514 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.249 1.067 0 C-N-CA 123.801 0.84 . . . . 0.0 109.71 177.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.44 174.14 14.24 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.298 1.039 . . . . 0.0 109.053 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -57.91 -39.84 78.93 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.305 0.378 . . . . 0.0 110.141 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.593 ' HA ' HD22 ' A' ' 42' ' ' LEU . 14.4 m-20 -132.18 93.99 24.83 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 167.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.643 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 35.9 Cg_endo -59.81 -53.46 3.22 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.912 2.408 . . . . 0.0 112.859 -173.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.643 ' SD ' ' HG2' ' A' ' 5' ' ' PRO . 1.4 mpt? -89.63 168.53 12.06 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.517 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 63.0 mt -101.77 106.15 19.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -171.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.516 HG12 ' HB ' ' A' ' 41' ' ' VAL . 3.7 mp -103.29 122.63 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 170.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.427 HH11 HG23 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -124.19 149.61 46.14 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -174.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' N ' HD11 ' A' ' 112' ' ' LEU . . . -104.8 137.32 13.58 Favored Glycine 0 CA--C 1.501 -0.792 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.0 tt -146.83 142.94 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.291 0.567 . . . . 0.0 111.093 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -122.56 132.28 54.23 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.352 1.461 . . . . 0.0 108.906 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.07 1.33 70.05 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.624 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.87 106.42 1.54 Allowed 'General case' 0 C--N 1.351 0.66 0 C-N-CA 124.287 1.035 . . . . 0.0 111.352 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -74.78 104.08 5.28 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.198 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.483 HD11 HG21 ' A' ' 86' ' ' VAL . 49.9 mm -71.25 98.2 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.579 0 CA-C-O 121.687 0.756 . . . . 0.0 109.253 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -112.26 153.05 27.74 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.144 -1.389 . . . . 0.0 109.453 -178.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -67.15 -12.12 59.13 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.561 0.744 . . . . 0.0 112.349 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -67.03 -33.26 75.16 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.014 0.926 . . . . 0.0 111.83 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.413 HG23 ' ND2' ' A' ' 17' ' ' ASN . 12.6 pt -55.23 -22.57 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -87.36 -21.82 25.44 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.448 0.567 . . . . 0.0 111.409 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -77.35 -16.21 59.01 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.22 0.608 . . . . 0.0 112.025 -170.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.487 HD21 HD13 ' A' ' 99' ' ' ILE . 1.2 pp -80.3 -8.92 59.69 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.974 0.51 . . . . 0.0 111.814 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 56.7 14.92 10.53 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 116.854 1.501 . . . . 0.0 116.854 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.56 159.27 32.4 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 117.577 0.688 . . . . 0.0 110.33 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -83.3 100.68 10.79 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -145.12 166.45 25.37 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.555 1.142 . . . . 0.0 108.7 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -149.95 151.78 33.91 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 162.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.415 HG12 HD13 ' A' ' 88' ' ' LEU . 27.3 mt -128.15 127.51 67.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.616 HD22 HD11 ' A' ' 89' ' ' ILE . 2.7 pt? -115.35 172.35 7.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -81.41 142.91 32.53 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.151 -176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.546 ' HB1' HG21 ' A' ' 111' ' ' VAL . . . -78.61 0.64 25.6 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.16 -28.58 57.42 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.17 0.588 . . . . 0.0 111.082 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 HG11 HG22 ' A' ' 79' ' ' ILE . 32.4 m -107.46 -2.74 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.122 0.569 . . . . 0.0 112.484 -170.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.515 HG11 ' SG ' ' A' ' 87' ' ' CYS . 7.4 p -78.45 104.53 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.277 0.56 . . . . 0.0 109.557 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.5 -66.61 0.53 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.565 HG22 ' HA ' ' A' ' 113' ' ' GLU . 19.1 p -137.78 173.07 12.04 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.677 169.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' A' ' 112' ' ' LEU . 51.3 mtpt -53.98 -25.29 20.14 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.055 0.542 . . . . 0.0 111.678 165.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HB2' ' OG1' ' A' ' 37' ' ' THR . 10.7 mptt -57.74 -36.74 72.47 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.317 1.047 . . . . 0.0 111.959 172.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.409 ' HA ' HD11 ' A' ' 139' ' ' LEU . 12.2 t-80 -60.18 -49.82 76.12 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.211 0.945 . . . . 0.0 110.553 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.516 ' HB ' HG12 ' A' ' 8' ' ' ILE . 59.1 t -69.53 -54.04 21.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.271 177.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.593 HD22 ' HA ' ' A' ' 4' ' ' ASP . 1.8 pp -60.64 -36.8 79.55 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.001 0.521 . . . . 0.0 111.556 -172.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.547 ' HD2' HD11 ' A' ' 142' ' ' ILE . 75.6 t60 -58.92 -39.82 82.71 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.781 0.832 . . . . 0.0 111.454 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.04 -33.45 70.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.266 0.626 . . . . 0.0 110.693 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.537 HG12 HD13 ' A' ' 62' ' ' ILE . 43.0 mt -65.16 -44.28 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.386 0.675 . . . . 0.0 110.426 170.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -55.45 -40.42 71.55 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.797 0.839 . . . . 0.0 110.538 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -60.3 -43.79 95.98 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.519 1.137 . . . . 0.0 110.601 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.61 -28.13 66.64 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.55 0.74 . . . . 0.0 112.462 177.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -76.54 -42.1 44.23 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.572 0.349 . . . . 0.0 111.038 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.572 HG23 ' HG3' ' A' ' 51' ' ' LYS . 12.8 t -88.25 -31.69 18.9 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.392 0.277 . . . . 0.0 111.479 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.572 ' HG3' HG23 ' A' ' 50' ' ' THR . 39.9 mtmt -109.53 152.95 24.79 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.911 0.863 . . . . 0.0 112.752 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -139.23 81.84 20.27 Favored Pre-proline 0 CA--C 1.553 1.087 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.627 160.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -87.73 -78.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.278 2.652 . . . . 0.0 113.017 -171.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.3 mt -123.89 -10.82 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 C-N-CA 124.275 1.03 . . . . 0.0 108.939 -172.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HA ' HD11 ' A' ' 72' ' ' ILE . . . -65.06 147.34 53.64 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.954 0.902 . . . . 0.0 112.508 -172.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.654 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 75.9 mmtt -66.83 -33.44 75.61 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.566 0.747 . . . . 0.0 110.108 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.406 ' H ' ' HB2' ' A' ' 60' ' ' MET . 28.0 t -163.41 178.15 8.32 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.641 -175.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -51.94 -60.33 3.31 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.691 1.596 . . . . 0.0 111.481 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.402 ' HA ' HD12 ' A' ' 62' ' ' ILE . 78.6 m95 -66.83 -20.73 65.99 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.294 -177.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.654 ' HG3' ' HB2' ' A' ' 56' ' ' LYS . 22.8 mmt -76.73 -28.55 55.84 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.349 0.66 . . . . 0.0 111.534 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 64' ' ' VAL . 51.6 tp10 -74.95 -32.08 61.65 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 120.641 0.257 . . . . 0.0 110.498 174.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.537 HD13 HG12 ' A' ' 45' ' ' ILE . 60.5 mt -62.01 -46.49 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 122.903 0.481 . . . . 0.0 110.833 178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.492 HD21 ' SD ' ' A' ' 60' ' ' MET . 4.0 pp -71.91 -34.89 69.46 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.932 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 61' ' ' GLU . 36.0 m -73.94 -31.55 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 118.291 0.496 . . . . 0.0 111.811 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.513 ' NE ' ' HA ' ' A' ' 65' ' ' ARG . 12.6 mmp_? -77.28 -42.23 37.81 Favored 'General case' 0 C--O 1.208 -1.097 0 CA-C-O 118.925 -0.559 . . . . 0.0 111.629 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.11 71.74 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-N 118.434 0.561 . . . . 0.0 111.048 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 71.1 p -86.57 -13.82 44.68 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 59.37 20.75 52.06 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 114.42 0.528 . . . . 0.0 114.42 -164.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -117.44 93.44 4.17 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.056 0.942 . . . . 0.0 108.929 -177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.439 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -59.35 -10.76 3.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -174.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -85.15 121.27 27.66 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 55' ' ' ALA . 27.6 mm -52.95 -54.88 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.696 1.198 . . . . 0.0 112.27 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -58.71 -50.96 71.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.73 0.812 . . . . 0.0 110.967 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.525 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 39.9 mm-40 -61.92 -40.0 93.96 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.053 0.846 . . . . 0.0 112.242 -178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.45 80.41 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.489 0.715 . . . . 0.0 111.788 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.1 -30.17 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 123.398 0.679 . . . . 0.0 110.808 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 58.5 mtpt -64.77 -49.12 71.98 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 122.108 -0.37 . . . . 0.0 110.781 175.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.84 -65.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.636 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.617 HG22 HG11 ' A' ' 34' ' ' VAL . 23.0 pt -104.36 11.21 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -169.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.13 155.15 50.33 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 118.921 0.782 . . . . 0.0 112.03 -172.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.09 54.5 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.676 0.791 . . . . 0.0 112.976 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -132.2 158.45 41.72 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -53.32 145.63 13.76 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 119.043 0.838 . . . . 0.0 112.611 174.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.17 -111.19 4.18 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.23 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.422 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.9 OUTLIER -91.17 111.47 22.96 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.26 0.624 . . . . 0.0 109.85 -173.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 16' ' ' ILE . 3.7 m -138.75 -179.84 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 124.819 1.248 . . . . 0.0 111.426 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.515 ' SG ' HG11 ' A' ' 35' ' ' VAL . 78.0 m -133.89 125.35 28.13 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.495 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.455 HD21 ' HB ' ' A' ' 99' ' ' ILE . 11.7 tp -104.72 126.09 51.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.232 1.013 . . . . 0.0 109.686 -170.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.616 HD11 HD22 ' A' ' 30' ' ' LEU . 7.0 mt -109.45 122.78 64.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 114.302 -1.317 . . . . 0.0 107.45 -177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 9.4 p -143.43 152.15 41.21 Favored 'General case' 0 C--O 1.244 0.798 0 C-N-CA 122.776 0.43 . . . . 0.0 109.902 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.15 -46.35 84.48 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.283 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.401 ' OD2' ' HG2' ' A' ' 94' ' ' GLU . 1.5 p-10 -148.46 171.15 16.54 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.411 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -69.0 -22.58 64.07 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -168.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HG2' ' OD2' ' A' ' 92' ' ' ASP . 10.1 pt-20 -74.46 -41.73 60.28 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.098 0.863 . . . . 0.0 109.281 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.3 m -58.49 -39.69 80.74 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.605 0.762 . . . . 0.0 110.819 171.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.697 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 14.1 t80 -56.55 -51.23 69.34 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 123.364 0.666 . . . . 0.0 110.719 175.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.6 ttt180 -63.93 -35.21 79.92 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.75 0.656 . . . . 0.0 110.822 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 98' ' ' LYS . 10.7 mmpt? -64.59 -45.94 84.82 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.586 0.554 . . . . 0.0 111.571 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.487 HD13 HD21 ' A' ' 23' ' ' LEU . 44.4 mm -69.06 -44.57 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.395 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -53.31 -34.37 57.11 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.041 1.336 . . . . 0.0 112.182 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -60.25 -51.35 69.93 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.588 0.755 . . . . 0.0 111.561 174.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.429 ' HB3' HD21 ' A' ' 17' ' ' ASN . 4.1 mm? -69.66 -41.43 75.53 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.8 pt -77.89 -50.2 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 118.35 0.523 . . . . 0.0 110.775 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.04 114.33 0.04 OUTLIER Glycine 0 C--N 1.35 1.353 0 N-CA-C 113.883 0.313 . . . . 0.0 113.883 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 179.46 -159.88 24.81 Favored Glycine 0 C--O 1.241 0.589 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.2 143.18 49.27 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.3 0.55 . . . . 0.0 109.829 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 49.5 mm -71.22 129.1 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 122.928 0.491 . . . . 0.0 110.18 -176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -116.5 101.79 8.93 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -68.12 -53.5 24.89 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.1 0.56 . . . . 0.0 111.747 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 25.1 p -53.06 -30.03 33.5 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.546 HG21 ' HB1' ' A' ' 32' ' ' ALA . 10.3 p -65.3 -27.26 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 118.401 0.546 . . . . 0.0 111.44 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.459 HD11 ' N ' ' A' ' 10' ' ' GLY . 93.4 mt -80.46 -3.2 48.99 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.372 1.069 . . . . 0.0 112.503 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 37' ' ' THR . 12.8 pt-20 -135.95 23.57 3.31 Favored 'General case' 0 C--O 1.246 0.897 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -169.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 118' ' ' LYS . 0.4 OUTLIER 77.74 138.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 124.242 1.017 . . . . 0.0 112.46 165.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 5.2 p-10 -151.16 -179.93 7.75 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.527 1.131 . . . . 0.0 109.517 170.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.81 -41.61 97.85 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.315 0.646 . . . . 0.0 111.943 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.514 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 0.1 OUTLIER -62.17 -41.72 98.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.592 1.157 . . . . 0.0 109.928 176.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -62.62 -40.01 95.62 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.047 0.842 . . . . 0.0 110.691 177.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.6 -48.41 48.3 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.345 -166.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -73.55 -39.45 64.69 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.172 0.589 . . . . 0.0 110.697 -174.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.8 tp -53.88 -53.15 56.65 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.278 1.431 . . . . 0.0 111.971 170.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.443 HG23 ' HD2' ' A' ' 126' ' ' PHE . 43.6 mt -62.44 -29.72 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.753 1.221 . . . . 0.0 111.309 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 5.4 tmm_? -72.41 -35.94 68.51 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.992 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.62 -55.99 12.75 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.63 -35.75 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-N 118.916 0.78 . . . . 0.0 113.075 -174.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.443 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.7 m-30 -88.39 -32.21 18.47 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 29.1 mmtp 63.84 75.86 0.37 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.176 0.99 . . . . 0.0 112.213 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 66.2 mt -98.26 121.19 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.524 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -91.86 99.13 12.04 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 141.59 120.14 1.6 Allowed Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -86.65 -160.83 0.6 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.156 0.982 . . . . 0.0 109.533 173.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.66 -68.1 2.91 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -138.6 114.31 9.86 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.24 -25.87 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 123.474 0.71 . . . . 0.0 111.516 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.436 ' O ' HD13 ' A' ' 139' ' ' LEU . 85.1 t -68.64 -58.35 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.45 0.7 . . . . 0.0 111.667 -174.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -63.05 -29.05 70.51 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 117.742 0.246 . . . . 0.0 111.042 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.46 ' HA ' ' HG2' ' A' ' 140' ' ' GLU . 77.6 mtt-85 -75.97 -32.76 59.63 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 123.736 0.648 . . . . 0.0 112.187 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.0 p -73.82 -41.05 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 CA-C-N 118.218 0.463 . . . . 0.0 110.142 174.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.436 HD13 ' O ' ' A' ' 135' ' ' VAL . 11.2 mp -57.29 -42.4 81.67 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.535 0.734 . . . . 0.0 112.565 175.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 137' ' ' ARG . 13.5 pt-20 -80.73 -28.57 36.54 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.054 0.141 . . . . 0.0 110.971 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -59.82 -52.55 64.99 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.694 0.797 . . . . 0.0 110.679 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.547 HD11 ' HD2' ' A' ' 43' ' ' HIS . 13.6 pt -73.59 -17.12 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.056 -171.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.8 57.26 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.327 167.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.2 tp -75.5 -6.04 48.19 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.802 0.841 . . . . 0.0 111.822 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.464 HG22 ' HB2' ' A' ' 146' ' ' GLU . 1.7 mp -92.29 -55.81 5.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 173.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.464 ' HB2' HG22 ' A' ' 145' ' ' ILE . 1.6 tm-20 -146.72 78.95 1.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -173.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.5 HD13 ' HD3' ' A' ' 51' ' ' LYS . 57.2 tp -170.73 -60.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.009 164.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt 14.48 -145.0 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 C-N-CA 126.012 1.725 . . . . 0.0 113.584 -158.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -135.98 74.0 1.49 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 149.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.25 1.095 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.271 -174.555 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 N-CA-C 112.131 -0.388 . . . . 0.0 112.131 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.17 94.85 7.36 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.533 0.733 . . . . 0.0 109.826 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -69.47 -69.08 0.36 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.733 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.44 64.82 6.37 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.386 1.074 . . . . 0.0 109.68 -169.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.576 ' HD2' ' HB2' ' A' ' 42' ' ' LEU . 45.8 Cg_endo -64.01 -50.58 2.86 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 123.19 2.593 . . . . 0.0 113.335 -168.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.759 ' SD ' ' HG2' ' A' ' 91' ' ' GLU . 5.1 mmt -97.52 -175.48 3.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.547 0.739 . . . . 0.0 109.201 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.548 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 41.9 mt -96.95 102.98 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.27 122.65 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -124.65 145.87 49.41 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.039 0.935 . . . . 0.0 109.549 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.72 139.19 14.52 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.247 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.0 tt -152.48 144.07 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 122.849 0.46 . . . . 0.0 110.992 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -116.85 142.7 46.59 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.84 0.856 . . . . 0.0 109.308 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.34 11.24 85.7 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.56 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.59 95.21 1.06 Allowed 'General case' 0 C--N 1.351 0.639 0 C-N-CA 123.899 0.879 . . . . 0.0 110.604 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 51.8 mtm-85 -70.79 101.65 2.16 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.805 0.69 . . . . 0.0 109.599 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.585 HD11 HG11 ' A' ' 86' ' ' VAL . 48.2 mm -67.39 121.13 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 123.419 0.687 . . . . 0.0 110.377 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.43 HD21 HG23 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -112.29 159.34 18.73 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.794 0.837 . . . . 0.0 109.855 175.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -77.28 -16.55 58.93 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.539 0.735 . . . . 0.0 112.213 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.95 -30.18 63.66 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.386 0.674 . . . . 0.0 112.685 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.43 HG23 HD21 ' A' ' 17' ' ' ASN . 8.3 pt -60.48 -12.47 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -89.15 0.23 56.9 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.993 0.517 . . . . 0.0 112.19 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -79.4 -25.09 42.16 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 118.221 0.464 . . . . 0.0 111.551 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pp -85.15 -14.44 47.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.996 0.518 . . . . 0.0 111.682 -173.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.53 16.37 7.03 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 116.616 1.406 . . . . 0.0 116.616 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.7 mt -73.82 175.17 7.51 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 117.501 0.651 . . . . 0.0 111.457 -175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -75.93 81.21 2.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.048 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -139.7 145.95 39.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.002 0.921 . . . . 0.0 108.719 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.418 ' NE2' ' HB3' ' A' ' 63' ' ' LEU . 1.6 tm0? -142.15 136.68 30.25 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 171.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 86' ' ' VAL . 3.9 mt -127.21 129.74 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' H ' HD13 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -131.34 171.05 13.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.748 0.819 . . . . 0.0 110.443 176.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -76.38 116.37 17.0 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.805 0.842 . . . . 0.0 109.906 -172.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.27 3.47 51.95 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -78.08 -35.69 49.1 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 170.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 79' ' ' ILE . 26.8 m -97.88 5.86 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 122.902 0.481 . . . . 0.0 111.729 -177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.48 139.14 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.81 -69.34 0.53 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.4 p -136.63 172.88 12.36 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.719 0.808 . . . . 0.0 110.065 174.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -26.34 12.33 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.506 0.722 . . . . 0.0 112.311 170.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -54.73 -32.93 60.39 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.446 1.098 . . . . 0.0 112.202 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.582 ' HA ' HD11 ' A' ' 139' ' ' LEU . 30.2 t-80 -65.44 -47.48 76.05 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.728 0.811 . . . . 0.0 110.878 177.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.507 HG21 ' SG ' ' A' ' 87' ' ' CYS . 38.8 t -67.3 -50.92 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.701 -0.682 . . . . 0.0 112.029 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.576 ' HB2' ' HD2' ' A' ' 5' ' ' PRO . 3.1 pp -61.32 -34.6 75.52 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.039 0.535 . . . . 0.0 111.54 -175.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -55.21 -43.95 74.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.043 0.937 . . . . 0.0 110.734 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.8 78.39 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.796 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.512 HG12 HD13 ' A' ' 62' ' ' ILE . 63.5 mt -65.02 -53.38 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.028 0.931 . . . . 0.0 112.192 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -49.28 -44.66 44.14 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.923 0.889 . . . . 0.0 110.628 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -73.44 -31.62 63.92 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 113.999 -1.455 . . . . 0.0 112.293 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.84 -21.22 60.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.244 0.618 . . . . 0.0 112.323 174.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -78.11 -48.14 16.67 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.869 0.468 . . . . 0.0 110.332 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.53 HG23 ' HG3' ' A' ' 51' ' ' LYS . 10.9 t -88.98 -29.12 19.76 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.023 0.529 . . . . 0.0 112.268 -171.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.53 ' HG3' HG23 ' A' ' 50' ' ' THR . 49.1 mtmt -114.45 155.41 26.42 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.571 0.701 . . . . 0.0 112.229 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -140.06 73.13 32.93 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.336 167.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -57.23 -78.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.206 2.604 . . . . 0.0 114.164 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 58.4 mt -131.69 -26.02 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.066 0.546 . . . . 0.0 111.645 -166.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.21 174.09 4.21 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -169.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -73.75 -53.62 9.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.447 0.699 . . . . 0.0 112.193 -173.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.614 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 21.4 t -157.03 -171.73 3.76 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.408 0.683 . . . . 0.0 109.453 -174.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -53.95 -60.92 2.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.497 1.119 . . . . 0.0 113.268 -174.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.403 ' CE3' ' HB2' ' A' ' 28' ' ' GLN . 79.8 m95 -64.76 -29.62 70.6 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.014 0.435 . . . . 0.0 111.144 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.614 ' SD ' ' HB3' ' A' ' 57' ' ' SER . 1.3 mpt? -77.18 -27.51 53.68 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.926 0.891 . . . . 0.0 110.455 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 11.3 tp10 -74.43 -34.08 63.12 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.893 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.512 HD13 HG12 ' A' ' 45' ' ' ILE . 72.9 mt -64.38 -47.07 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.145 0.578 . . . . 0.0 111.061 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.443 ' O ' HD11 ' A' ' 79' ' ' ILE . 3.4 pp -68.34 -33.39 74.22 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 123.215 0.322 . . . . 0.0 111.607 -175.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.438 HG13 HD12 ' A' ' 63' ' ' LEU . 35.0 m -77.16 -40.5 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 118.094 0.406 . . . . 0.0 110.986 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.5 OUTLIER -70.0 -32.63 70.9 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.035 0.534 . . . . 0.0 111.709 -170.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.64 -30.87 70.55 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.186 0.594 . . . . 0.0 112.109 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.2 p -104.37 9.32 35.82 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.85 0.46 . . . . 0.0 112.225 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.72 23.7 65.55 Favored Glycine 0 C--N 1.358 1.787 0 CA-C-O 121.328 0.404 . . . . 0.0 113.965 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HB3' ' H ' ' A' ' 70' ' ' ARG . 88.2 mm-40 -89.8 -163.23 0.98 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.509 1.124 . . . . 0.0 112.512 -177.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -165.18 -34.06 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.628 1.571 . . . . 0.0 108.523 -165.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -101.98 121.98 43.18 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.928 0.891 . . . . 0.0 108.653 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.405 ' O ' HG13 ' A' ' 76' ' ' ILE . 1.8 mp -51.34 -45.78 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 124.587 1.179 . . . . 0.0 111.697 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -66.13 -40.58 90.77 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.265 0.626 . . . . 0.0 110.928 -174.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.03 -47.39 81.01 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.311 0.644 . . . . 0.0 111.478 173.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.85 -35.47 74.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.209 0.604 . . . . 0.0 112.619 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 72' ' ' ILE . 71.4 mt -71.49 -29.89 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 122.991 0.516 . . . . 0.0 110.981 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -63.88 -54.88 27.9 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.012 0.434 . . . . 0.0 109.918 173.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 46.9 mt -73.29 -65.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.262 -173.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.455 HG22 HG21 ' A' ' 34' ' ' VAL . 23.2 pt -111.0 32.64 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.47 159.47 53.09 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 113.504 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.58 98.99 2.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.41 0.684 . . . . 0.0 110.961 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -109.97 153.15 24.96 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.94 0.896 . . . . 0.0 108.835 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.24 150.69 38.34 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.56 0.744 . . . . 0.0 112.492 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.34 -120.02 6.02 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -83.75 104.69 14.06 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.585 HG11 HD11 ' A' ' 16' ' ' ILE . 1.3 p -134.11 151.42 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.355 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.507 ' SG ' HG21 ' A' ' 41' ' ' VAL . 41.4 t -109.81 118.88 37.66 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.426 1.091 . . . . 0.0 108.99 -172.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.84 120.95 43.7 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.46 0.704 . . . . 0.0 110.153 -172.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.9 mt -107.12 137.21 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 21.8 p -152.42 151.78 31.21 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.985 0.514 . . . . 0.0 109.919 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.759 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 51.3 mt-10 -86.45 -32.23 20.95 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 171.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.31 128.89 56.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.003 0.921 . . . . 0.0 108.761 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -67.37 -21.38 65.62 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.315 0.646 . . . . 0.0 111.332 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 8.3 pt-20 -69.66 -40.02 76.7 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.667 0.387 . . . . 0.0 110.031 173.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 99' ' ' ILE . 99.0 m -63.55 -38.44 91.15 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.876 0.87 . . . . 0.0 109.878 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.688 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 11.6 t80 -56.96 -47.85 79.74 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 123.84 0.856 . . . . 0.0 110.973 177.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -61.54 -42.99 99.65 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 123.73 0.644 . . . . 0.0 110.34 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 45.6 mmtm -56.13 -45.9 79.4 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.171 0.92 . . . . 0.0 111.04 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 95' ' ' THR . 32.9 mm -69.84 -45.66 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.322 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -52.62 -43.41 65.37 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.88 1.272 . . . . 0.0 113.171 177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -58.15 -48.27 80.78 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.777 0.673 . . . . 0.0 111.511 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.05 -36.18 56.18 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 14.3 pt -74.83 -39.83 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 118.311 0.505 . . . . 0.0 109.897 -177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.16 96.79 0.04 OUTLIER Glycine 0 C--N 1.351 1.368 0 O-C-N 123.635 0.585 . . . . 0.0 113.14 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.37 -171.36 25.09 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.16 131.03 55.07 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 47.6 mm -62.99 112.15 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -129.69 92.47 3.34 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -170.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 4.6 p-10 -60.27 -34.08 73.22 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.531 0.732 . . . . 0.0 111.81 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 113' ' ' GLU . 23.8 m -52.86 -24.62 9.46 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -176.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.5 m -66.75 -32.19 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 CA-C-N 118.204 0.457 . . . . 0.0 110.131 174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 45.0 mt -95.72 -1.92 48.95 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.768 1.227 . . . . 0.0 112.253 174.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 110' ' ' SER . 76.0 mm-40 -103.78 -9.29 19.16 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 118.148 -0.93 . . . . 0.0 112.459 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.257 0.4 OUTLIER 84.82 135.64 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.983 1.313 . . . . 0.0 111.105 177.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 4.3 p-10 -159.77 170.77 20.8 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.832 1.253 . . . . 0.0 108.799 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.79 -37.62 85.02 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.59 0.756 . . . . 0.0 112.372 -168.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.507 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 16.1 t70 -54.87 -54.1 46.79 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.444 1.098 . . . . 0.0 112.219 177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -63.1 -34.13 76.94 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.716 0.635 . . . . 0.0 110.881 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -72.85 -49.0 32.83 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.416 0.686 . . . . 0.0 112.159 -166.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' A' ' 123' ' ' ARG . 67.6 mtp180 -75.22 -30.8 60.67 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.519 0.676 . . . . 0.0 110.942 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 55.5 tp -55.7 -48.03 75.81 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.219 165.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.422 HG23 ' HD2' ' A' ' 126' ' ' PHE . 25.2 mt -55.7 -35.11 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.229 1.012 . . . . 0.0 112.556 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -74.56 -26.53 60.01 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.951 -178.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -69.45 -58.47 3.95 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 171.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.26 -29.49 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 119.192 0.906 . . . . 0.0 112.968 -174.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.422 ' HD2' HG23 ' A' ' 122' ' ' ILE . 23.2 m-85 -99.51 -26.24 14.17 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 68.3 mmtt 62.03 66.6 0.8 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.138 0.975 . . . . 0.0 112.506 171.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.507 HG21 ' HB3' ' A' ' 137' ' ' ARG . 16.9 mt -116.56 143.52 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 -176.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -34.75 -51.94 0.51 Allowed 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 125.285 1.434 . . . . 0.0 114.319 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.29 32.46 4.28 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -121.77 145.39 48.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.171 0.988 . . . . 0.0 110.03 -177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.97 -98.73 2.43 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.474 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.495 HD22 ' HG3' ' A' ' 136' ' ' GLU . 31.3 t30 -140.18 117.3 11.19 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.98 -31.41 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 119.124 0.875 . . . . 0.0 112.21 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.16 -53.94 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.798 0.839 . . . . 0.0 110.415 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.495 ' HG3' HD22 ' A' ' 133' ' ' ASN . 40.8 mt-10 -59.23 -42.6 91.4 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.333 0.396 . . . . 0.0 111.074 176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.507 ' HB3' HG21 ' A' ' 128' ' ' ILE . 8.7 mpt_? -73.0 -31.67 64.65 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.949 0.781 . . . . 0.0 112.074 -167.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.493 HG13 HD12 ' A' ' 139' ' ' LEU . 11.1 p -70.56 -42.56 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 117.706 0.23 . . . . 0.0 110.501 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 40' ' ' HIS . 10.9 mp -60.75 -39.67 89.61 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.567 0.542 . . . . 0.0 111.625 172.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.73 -44.43 93.57 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.618 0.767 . . . . 0.0 111.117 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -63.87 -45.99 86.97 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.018 0.527 . . . . 0.0 111.286 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 11.5 pt -75.6 -22.23 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 O-C-N 123.019 0.2 . . . . 0.0 110.62 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 148' ' ' LYS . . . -74.78 -20.09 59.94 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.569 0.748 . . . . 0.0 111.089 172.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.86 5.47 9.54 Favored 'General case' 0 CA--C 1.566 1.568 0 C-N-CA 123.499 0.72 . . . . 0.0 110.228 174.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.4 mp -108.6 -37.65 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 165.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -71.56 -13.11 61.69 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.356 1.063 . . . . 0.0 113.212 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.1 mt 71.27 49.79 0.31 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.451 1.101 . . . . 0.0 108.077 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.558 ' HB3' ' HB1' ' A' ' 143' ' ' ALA . 22.6 ttmm -137.62 159.83 40.88 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.646 -169.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -149.82 110.34 4.24 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 166.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 . . . . . 0 CA--C 1.558 1.282 0 CA-C-O 119.282 -0.39 . . . . 0.0 110.219 -177.764 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.305 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.19 153.44 33.83 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.182 0.993 . . . . 0.0 109.377 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.7 mtm -78.09 -48.16 16.65 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -145.8 86.11 7.4 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.04 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 42' ' ' LEU . 49.3 Cg_endo -67.04 -39.32 14.0 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.496 2.131 . . . . 0.0 111.3 172.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.8 mmt -138.88 176.03 9.04 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.937 0.895 . . . . 0.0 109.568 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.6 mt -101.2 111.03 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.918 1.287 . . . . 0.0 109.271 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 3.7 mp -107.08 127.26 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 9' ' ' ARG . 2.9 mmp_? -128.15 149.89 50.23 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.718 0.807 . . . . 0.0 110.553 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.66 129.94 10.0 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.622 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.3 tt -141.18 147.04 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 123.148 0.579 . . . . 0.0 110.597 -175.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -122.97 136.9 55.03 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.349 1.059 . . . . 0.0 109.419 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.36 7.91 87.01 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.36 178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.508 ' HB1' ' HB ' ' A' ' 103' ' ' ILE . . . -76.03 104.03 6.37 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.547 0.739 . . . . 0.0 110.218 178.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.7 mtt-85 -70.81 123.86 22.95 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.365 0.415 . . . . 0.0 110.148 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.8 mm -73.53 91.03 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.887 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.559 ' ND2' HG23 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -91.11 151.23 21.07 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.551 -1.204 . . . . 0.0 109.021 -177.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 -63.92 -21.64 66.56 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -64.84 -29.85 70.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.405 0.682 . . . . 0.0 112.103 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.559 HG23 ' ND2' ' A' ' 17' ' ' ASN . 19.1 pt -54.37 -23.82 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 177.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -90.07 -19.45 24.33 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 118.284 0.493 . . . . 0.0 111.32 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -69.19 -22.23 63.91 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.976 0.91 . . . . 0.0 111.609 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.481 HD21 HD13 ' A' ' 99' ' ' ILE . 1.5 pp -81.95 -10.17 59.35 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.282 0.633 . . . . 0.0 111.965 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 55.16 16.96 9.65 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 117.113 1.605 . . . . 0.0 117.113 175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 23' ' ' LEU . 86.1 mt -82.39 176.57 9.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.283 0.633 . . . . 0.0 112.197 -174.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -87.56 93.44 9.42 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.102 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -145.66 160.32 41.87 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.111 0.964 . . . . 0.0 108.678 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 59' ' ' TRP . 6.6 tp-100 -148.64 153.23 38.01 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 166.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.85 137.98 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 175.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.424 HD22 HD11 ' A' ' 89' ' ' ILE . 2.2 pt? -128.16 -175.06 3.38 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.65 0.78 . . . . 0.0 109.389 170.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -89.22 120.1 30.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.784 0.834 . . . . 0.0 109.78 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.72 -5.27 56.84 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.886 0.874 . . . . 0.0 113.168 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -76.19 -33.63 59.31 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.408 HG21 HG22 ' A' ' 79' ' ' ILE . 3.3 m -105.19 9.5 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.321 0.649 . . . . 0.0 112.264 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.4 p -85.13 140.71 15.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.16 -62.16 1.57 Allowed 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 113' ' ' GLU . 21.5 p -145.59 169.92 17.46 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.552 -1.203 . . . . 0.0 110.931 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HB3' HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -53.71 -31.98 50.17 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.131 0.572 . . . . 0.0 110.649 162.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.539 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 85.5 tttt -66.99 -30.57 70.73 Favored 'General case' 0 C--N 1.36 1.059 0 C-N-CA 123.909 0.883 . . . . 0.0 111.52 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.554 ' HA ' HD11 ' A' ' 139' ' ' LEU . 16.8 t-80 -60.88 -46.75 89.38 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.091 0.556 . . . . 0.0 110.305 175.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 45' ' ' ILE . 38.8 t -67.64 -51.2 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 O-C-N 123.77 0.669 . . . . 0.0 111.671 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 3.2 pp -64.83 -30.13 71.12 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.516 ' NE2' ' HB2' ' A' ' 143' ' ' ALA . 35.7 t60 -65.39 -35.38 80.76 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.789 0.836 . . . . 0.0 111.119 172.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 65' ' ' ARG . . . -67.44 -34.79 77.93 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.592 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.424 HG12 HD13 ' A' ' 62' ' ' ILE . 19.8 mt -69.79 -35.94 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.931 0.892 . . . . 0.0 110.967 175.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.33 -53.98 51.93 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.246 0.618 . . . . 0.0 109.594 172.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.445 ' HB2' ' HG2' ' A' ' 65' ' ' ARG . 29.1 mm-40 -60.46 -30.47 69.68 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.672 1.189 . . . . 0.0 112.079 175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.5 -27.32 66.03 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -89.24 -16.81 30.38 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.443 0.64 . . . . 0.0 109.831 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.0 m -91.49 -43.92 9.41 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.393 1.477 . . . . 0.0 111.041 -176.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . 10.3 mmpt? -114.23 141.94 46.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.133 0.973 . . . . 0.0 112.533 -174.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -123.64 88.65 51.81 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 124.834 1.254 . . . . 0.0 107.988 165.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HG3' ' NE2' ' A' ' 69' ' ' GLN . 67.0 Cg_endo -79.15 -107.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 122.643 2.229 . . . . 0.0 111.941 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 28.1 mt -126.21 13.18 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.33 146.45 53.46 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.595 0.758 . . . . 0.0 111.688 -176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -60.67 -47.39 86.49 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.594 0.757 . . . . 0.0 111.291 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.1 m -147.63 172.18 14.45 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.856 0.863 . . . . 0.0 110.201 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.72 -52.73 64.25 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.453 1.101 . . . . 0.0 110.944 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 28' ' ' GLN . 83.8 m95 -67.43 -29.09 68.48 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.118 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.444 ' SD ' HD21 ' A' ' 63' ' ' LEU . 23.3 mmt -71.72 -28.45 63.7 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.153 0.581 . . . . 0.0 111.665 174.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 64' ' ' VAL . 44.8 tp10 -71.05 -27.93 64.01 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.757 0.423 . . . . 0.0 110.398 174.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.424 HD13 HG12 ' A' ' 45' ' ' ILE . 67.5 mt -66.25 -45.64 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.657 0.383 . . . . 0.0 110.789 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.451 HD23 ' NE2' ' A' ' 28' ' ' GLN . 4.4 pp -69.77 -32.76 71.44 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.156 -177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.675 ' HB ' ' H ' ' A' ' 70' ' ' ARG . 10.0 m -78.33 -40.78 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 122.498 -0.126 . . . . 0.0 111.294 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.471 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 6.6 tpt180 -67.9 -39.99 83.53 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 122.494 0.318 . . . . 0.0 111.025 -169.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.03 -14.28 60.03 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 124.036 0.835 . . . . 0.0 112.308 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.7 p -108.85 26.78 10.18 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.464 0.706 . . . . 0.0 111.546 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.17 26.13 53.29 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-O 119.619 -0.545 . . . . 0.0 114.297 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' NE2' ' HG3' ' A' ' 53' ' ' PRO . 34.9 tt0 55.99 113.91 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.269 1.427 . . . . 0.0 113.104 -176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.675 ' H ' ' HB ' ' A' ' 64' ' ' VAL . 2.8 mpt_? -140.04 172.54 12.62 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.973 1.709 . . . . 0.0 109.256 -173.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -57.13 135.99 56.38 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.97 159.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.14 -49.94 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.404 1.082 . . . . 0.0 111.957 -174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.77 -37.36 86.11 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 123.482 0.489 . . . . 0.0 110.52 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -63.28 -46.91 84.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.771 0.428 . . . . 0.0 112.084 174.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.53 71.54 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.883 0.473 . . . . 0.0 112.114 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.51 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 84.9 mt -64.51 -32.31 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.464 0.706 . . . . 0.0 110.554 172.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -72.49 -50.87 22.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.697 0.399 . . . . 0.0 110.066 174.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.576 HG22 HG23 ' A' ' 79' ' ' ILE . 43.9 mt -66.69 -65.3 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.8 0.84 . . . . 0.0 111.791 -173.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.576 HG23 HG22 ' A' ' 78' ' ' ILE . 38.6 pt -124.0 21.15 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 76' ' ' ILE . . . -76.36 156.78 47.22 Favored Glycine 0 N--CA 1.471 0.971 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.09 -175.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.26 113.97 1.46 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.82 0.848 . . . . 0.0 112.602 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -135.55 153.16 51.79 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.92 124.59 15.88 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.589 1.156 . . . . 0.0 112.755 -170.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.32 -118.26 1.58 Allowed Glycine 0 C--N 1.352 1.432 0 O-C-N 123.434 0.459 . . . . 0.0 112.379 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -84.25 108.14 16.95 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.26 159.98 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.959 0.885 . . . . 0.0 112.674 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 87.8 m -112.51 118.44 35.14 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.811 -1.54 . . . . 0.0 108.265 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.541 HD21 ' HB ' ' A' ' 99' ' ' ILE . 10.4 tp -102.63 121.19 41.91 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.32 0.648 . . . . 0.0 109.328 -174.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 28' ' ' GLN . 4.8 mt -111.48 125.6 68.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.902 1.281 . . . . 0.0 108.242 -174.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . . . . . . . . . 74.3 m -148.79 145.95 27.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.158 0.583 . . . . 0.0 109.746 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 -27.36 59.32 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.43 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 28.7 m-20 -131.27 148.92 52.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.287 0.635 . . . . 0.0 111.683 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.09 -25.17 65.21 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.944 1.298 . . . . 0.0 112.764 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.43 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 11.2 pt-20 -69.2 -43.27 74.49 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.788 0.435 . . . . 0.0 110.089 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.7 m -70.21 -33.08 71.25 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.708 0.803 . . . . 0.0 110.598 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -60.99 -50.96 71.28 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 45.0 ttp180 -59.86 -45.08 93.58 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.886 0.741 . . . . 0.0 109.862 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -59.44 -42.21 91.4 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.097 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.541 ' HB ' HD21 ' A' ' 88' ' ' LEU . 35.6 mm -71.9 -43.66 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -55.18 -37.83 67.55 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 124.596 1.158 . . . . 0.0 112.509 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 97' ' ' ARG . 46.5 mt-10 -61.26 -39.25 89.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.684 0.794 . . . . 0.0 111.204 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.13 -47.46 35.96 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.691 0.797 . . . . 0.0 112.272 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.508 ' HB ' ' HB1' ' A' ' 14' ' ' ALA . 18.2 pt -79.91 -28.95 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 122.068 0.147 . . . . 0.0 110.992 -171.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.32 25.73 70.08 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.044 1.177 . . . . 0.0 116.044 160.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -87.32 -170.16 46.3 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 117.047 0.423 . . . . 0.0 112.513 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -104.71 140.45 38.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.604 0.762 . . . . 0.0 108.996 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 42.5 mm -73.04 119.98 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 121.162 0.506 . . . . 0.0 109.79 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 111' ' ' VAL . 14.7 t70 -131.54 91.49 3.01 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.87 -32.61 73.99 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.958 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.591 ' HA ' ' HG3' ' A' ' 113' ' ' GLU . 12.1 p -58.34 -15.4 10.32 Favored 'General case' 0 CA--C 1.555 1.15 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 108' ' ' ASP . 35.4 m -66.42 -24.69 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 CA-C-N 118.709 0.686 . . . . 0.0 110.888 171.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 38' ' ' LYS . 67.1 mt -99.65 18.23 18.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.827 1.251 . . . . 0.0 112.593 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.591 ' HG3' ' HA ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -138.48 12.67 2.76 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -177.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 76.02 124.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.825 0.85 . . . . 0.0 112.375 168.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 3.3 p-10 -142.87 177.16 8.53 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.197 173.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -61.88 -42.1 98.66 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.071 0.948 . . . . 0.0 111.52 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 24.8 t70 -59.08 -47.37 85.5 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.048 176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -67.01 -31.75 72.52 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.33 0.652 . . . . 0.0 111.142 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.76 -51.28 28.15 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.068 0.547 . . . . 0.0 111.364 -171.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -71.33 -39.08 71.58 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.494 0.664 . . . . 0.0 110.131 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.1 tp -54.22 -52.87 59.91 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.315 1.446 . . . . 0.0 112.415 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.42 HG23 ' HD2' ' A' ' 126' ' ' PHE . 15.6 mt -57.96 -30.14 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.566 1.146 . . . . 0.0 111.282 177.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 10.4 ttm180 -72.05 -33.68 68.16 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.39 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 127' ' ' LYS . 12.4 mm-40 -73.67 -56.51 4.92 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 173.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 pp -78.38 -30.52 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.42 ' HD2' HG23 ' A' ' 122' ' ' ILE . 22.1 m-30 -95.85 -30.5 13.63 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 119.358 -0.354 . . . . 0.0 111.539 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 26.2 mmmt 61.97 74.66 0.43 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.746 0.818 . . . . 0.0 111.848 176.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.5 mt -124.92 127.75 72.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.637 0.775 . . . . 0.0 109.463 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -77.83 101.93 6.98 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 167.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -88.59 -173.84 47.06 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.651 -0.25 . . . . 0.0 112.969 -173.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -136.72 -61.58 0.67 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.442 0.697 . . . . 0.0 109.774 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -141.93 -68.1 0.03 OUTLIER Glycine 0 N--CA 1.471 1.01 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.081 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 137' ' ' ARG . 39.3 t30 -94.42 115.28 27.45 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.109 0.564 . . . . 0.0 109.971 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.02 -29.14 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.389 1.076 . . . . 0.0 112.476 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.12 -51.51 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.219 0.608 . . . . 0.0 110.592 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -63.55 -30.46 71.57 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.633 0.373 . . . . 0.0 111.441 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 133' ' ' ASN . 4.2 mmp_? -69.61 -47.7 62.55 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.107 0.563 . . . . 0.0 110.975 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 12.8 p -72.66 -36.59 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.82 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.554 HD11 ' HA ' ' A' ' 40' ' ' HIS . 5.0 mp -58.59 -37.21 75.33 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.149 0.98 . . . . 0.0 111.88 173.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -67.31 -41.59 85.09 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.3 0.375 . . . . 0.0 111.341 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -72.84 -42.52 63.69 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 120.876 0.37 . . . . 0.0 111.834 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.471 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 29.9 pt -74.77 -24.04 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -177.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.516 ' HB2' ' NE2' ' A' ' 43' ' ' HIS . . . -93.29 -15.48 25.75 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 118.044 -0.979 . . . . 0.0 112.168 175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -47.28 -45.7 24.26 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.584 1.154 . . . . 0.0 112.256 -165.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 64.8 mt -49.02 -41.69 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.581 1.153 . . . . 0.0 113.162 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.404 ' HB2' HH22 ' A' ' 65' ' ' ARG . 5.5 tm-20 -93.91 -61.74 1.48 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.577 0.751 . . . . 0.0 109.574 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 31.4 tp -91.31 36.08 0.93 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.082 1.353 . . . . 0.0 111.847 -167.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -67.04 160.28 26.91 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.405 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -92.67 31.94 1.3 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.19 0.519 . . . . 0.0 110.593 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 C--O 1.252 1.237 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 -179.41 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.674 -0.17 . . . . 0.0 112.674 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.93 104.27 5.46 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.362 0.665 . . . . 0.0 109.329 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mpp? 95.97 21.57 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 126.58 1.952 . . . . 0.0 108.276 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -153.61 81.59 4.84 Favored Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.583 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 60.2 Cg_endo -69.27 -63.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.616 2.211 . . . . 0.0 113.187 -169.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.583 ' SD ' ' HG2' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -95.9 175.14 6.61 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 178.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' HB ' ' SG ' ' A' ' 90' ' ' CYS . 74.3 mt -109.1 101.4 12.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.3 mm -110.21 124.11 66.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -121.58 145.12 48.3 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 173.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.79 137.62 13.49 Favored Glycine 0 CA--C 1.5 -0.875 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.4 tt -148.85 138.64 16.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.336 0.588 . . . . 0.0 110.357 -173.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -125.34 126.82 45.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.813 1.245 . . . . 0.0 108.714 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.96 -0.11 57.5 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 123.377 0.423 . . . . 0.0 112.565 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.8 94.37 0.45 Allowed 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.22 1.008 . . . . 0.0 110.823 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -68.89 104.18 2.0 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.577 HD11 HG21 ' A' ' 86' ' ' VAL . 44.6 mm -72.61 120.78 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -176.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.47 ' ND2' HG23 ' A' ' 20' ' ' ILE . 3.4 p-10 -104.08 156.1 18.15 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -81.8 -14.58 56.18 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.099 0.559 . . . . 0.0 111.63 -174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -76.5 -17.21 59.39 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.161 0.984 . . . . 0.0 111.45 -172.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.47 HG23 ' ND2' ' A' ' 17' ' ' ASN . 30.3 pt -53.91 -19.81 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 172.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -83.32 -17.93 40.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.082 0.553 . . . . 0.0 111.94 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -91.35 47.05 1.34 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.074 0.94 . . . . 0.0 109.716 -169.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -139.29 -11.99 1.21 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.311 176.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.67 33.32 55.0 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 114.513 0.565 . . . . 0.0 114.513 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' HB2' HD13 ' A' ' 23' ' ' LEU . 67.2 mt -102.97 167.38 9.88 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.423 0.689 . . . . 0.0 110.715 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HB3' ' HZ2' ' A' ' 59' ' ' TRP . 60.2 mttp -81.87 91.49 6.55 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.935 0.894 . . . . 0.0 111.31 -176.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.53 158.36 43.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.068 0.547 . . . . 0.0 109.92 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.512 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.6 tm0? -149.26 149.81 31.55 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 165.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 99' ' ' ILE . 16.3 mt -132.18 131.8 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.35 -176.12 3.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.825 0.85 . . . . 0.0 109.447 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -80.68 141.78 34.57 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.844 0.858 . . . . 0.0 109.732 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.23 7.8 45.52 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.3 0.64 . . . . 0.0 112.706 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -88.83 -19.89 25.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.316 0.647 . . . . 0.0 110.855 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 m -111.91 7.31 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.061 0.945 . . . . 0.0 111.641 -176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 p -88.2 102.55 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 121.91 0.862 . . . . 0.0 109.971 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.597 ' HB3' HG11 ' A' ' 138' ' ' VAL . . . -79.17 74.83 5.73 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p 62.69 162.25 0.09 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.63 1.972 . . . . 0.0 111.677 -166.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . 25.3 pttm -53.17 -22.49 6.59 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.506 0.723 . . . . 0.0 111.542 169.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.568 ' HA ' ' HG ' ' A' ' 42' ' ' LEU . 56.8 tttp -64.45 -28.42 69.66 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 123.187 0.595 . . . . 0.0 111.541 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.506 ' HA ' HD11 ' A' ' 139' ' ' LEU . 11.7 t-160 -62.73 -45.53 92.3 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.021 174.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 45' ' ' ILE . 42.3 t -67.68 -55.17 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 O-C-N 123.735 0.647 . . . . 0.0 111.195 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 39' ' ' LYS . 4.1 pp -60.02 -32.69 71.12 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.095 0.558 . . . . 0.0 112.395 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.467 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 36.9 t60 -65.75 -40.77 92.45 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.372 0.669 . . . . 0.0 110.479 173.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.58 -41.91 87.83 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.954 0.502 . . . . 0.0 110.789 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.552 HG12 HD13 ' A' ' 62' ' ' ILE . 33.8 mt -64.9 -46.59 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.232 1.013 . . . . 0.0 110.76 175.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -49.0 -48.39 43.58 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.44 1.496 . . . . 0.0 111.084 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 43' ' ' HIS . 25.8 mm-40 -63.67 -47.24 82.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.089 176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.79 -28.71 69.75 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.462 0.705 . . . . 0.0 112.556 -175.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HE2' HG22 ' A' ' 45' ' ' ILE . 68.2 mttm -66.11 -43.69 86.49 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.279 0.632 . . . . 0.0 110.925 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.1 t -80.17 -16.82 54.01 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.799 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 51.3 mtpt -99.28 146.95 25.68 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.999 0.92 . . . . 0.0 112.27 -177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -142.96 72.86 18.67 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.577 161.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 51' ' ' LYS . 56.2 Cg_endo -84.25 -177.04 2.82 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.657 2.238 . . . . 0.0 111.852 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.5 mt -37.04 -22.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.464 ' HA ' HD11 ' A' ' 72' ' ' ILE . . . -53.21 125.42 17.51 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.446 0.698 . . . . 0.0 110.787 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -57.02 -22.26 37.34 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -167.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.623 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 41.9 t -157.36 167.29 30.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.214 0.606 . . . . 0.0 110.114 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -58.73 -50.16 74.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.589 1.156 . . . . 0.0 110.467 170.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.466 ' HA ' HD12 ' A' ' 62' ' ' ILE . 81.7 m95 -64.54 -30.99 72.02 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.651 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.753 ' HB3' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -78.81 -21.03 48.35 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.907 0.883 . . . . 0.0 111.316 176.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.07 -35.52 64.25 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 173.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 HG12 ' A' ' 45' ' ' ILE . 77.5 mt -65.58 -42.36 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.722 0.809 . . . . 0.0 112.344 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.5 ' HB3' ' NE2' ' A' ' 28' ' ' GLN . 3.2 pp -71.53 -34.03 69.69 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 122.998 0.186 . . . . 0.0 110.879 -177.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.97 -38.11 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.414 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.531 ' O ' ' HB ' ' A' ' 142' ' ' ILE . 0.3 OUTLIER -66.48 -50.22 64.02 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 122.816 0.447 . . . . 0.0 110.659 -174.011 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.99 -26.29 68.51 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.225 0.61 . . . . 0.0 112.06 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 t -88.68 -0.2 57.05 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.712 0.805 . . . . 0.0 112.506 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.89 17.76 65.65 Favored Glycine 0 C--N 1.354 1.564 0 N-CA-C 114.485 0.554 . . . . 0.0 114.485 -173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.774 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 46.5 tp60 -107.91 164.96 11.82 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.609 1.164 . . . . 0.0 109.63 -177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -114.36 -6.2 12.92 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 123.038 0.535 . . . . 0.0 111.508 167.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.774 ' H ' ' HG3' ' A' ' 69' ' ' GLN . 17.0 mm-40 -103.94 119.03 38.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.427 1.091 . . . . 0.0 110.684 -173.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.753 HD12 ' HB3' ' A' ' 60' ' ' MET . 34.7 mm -52.92 -53.02 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 124.736 1.273 . . . . 0.0 112.386 -173.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' O ' ' HG2' ' A' ' 77' ' ' LYS . 73.7 m80 -61.09 -50.17 74.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.59 -173.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.27 -44.56 84.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.227 0.611 . . . . 0.0 112.091 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.03 94.19 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.68 -31.84 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 122.918 0.487 . . . . 0.0 110.612 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 73' ' ' HIS . 32.3 mmmt -67.13 -50.24 62.07 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.814 0.446 . . . . 0.0 110.46 175.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 56.6 mt -70.66 -67.2 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.762 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.2 pt -108.83 20.63 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -170.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.25 172.15 45.04 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 119.018 0.826 . . . . 0.0 112.92 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.97 144.18 26.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.18 0.592 . . . . 0.0 111.314 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -154.45 167.56 29.63 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.748 1.219 . . . . 0.0 108.25 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.02 127.27 23.37 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.074 0.95 . . . . 0.0 111.853 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 126.4 -116.3 2.5 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.371 0.419 . . . . 0.0 112.533 174.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.402 HD22 ' N ' ' A' ' 85' ' ' ASN . 0.8 OUTLIER -88.93 107.39 18.99 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.661 0.785 . . . . 0.0 109.373 -176.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.577 HG21 HD11 ' A' ' 16' ' ' ILE . 15.8 m -135.7 167.98 23.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 CA-C-O 121.912 0.863 . . . . 0.0 111.976 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 69.9 m -119.02 117.58 29.17 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.408 -1.724 . . . . 0.0 107.375 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.2 tp -100.04 123.48 44.34 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.272 0.629 . . . . 0.0 109.326 -175.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 28' ' ' GLN . 30.3 mt -109.34 137.21 42.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.195 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.741 ' SG ' ' HB2' ' A' ' 96' ' ' PHE . 26.5 p -156.84 157.69 35.41 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.578 0.751 . . . . 0.0 109.288 171.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -88.77 -28.2 20.64 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.872 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.498 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 23.8 m-20 -124.83 139.74 53.56 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.218 1.007 . . . . 0.0 110.962 -177.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.14 -24.38 64.66 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.94 0.896 . . . . 0.0 112.435 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.498 ' HG2' ' HB3' ' A' ' 92' ' ' ASP . 11.2 pt-20 -68.31 -44.1 76.15 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.3 m -68.01 -35.87 79.02 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.599 0.76 . . . . 0.0 111.345 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.741 ' HB2' ' SG ' ' A' ' 90' ' ' CYS . 11.0 t80 -58.25 -48.05 81.66 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 122.889 0.476 . . . . 0.0 109.826 173.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -57.85 -47.58 82.29 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.298 0.999 . . . . 0.0 110.514 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 42.1 mmtm -53.83 -48.36 70.0 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 124.191 0.932 . . . . 0.0 111.469 -178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' A' ' 20' ' ' ILE . 44.1 mm -71.68 -44.72 68.91 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.065 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -55.05 -44.52 74.8 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.499 1.119 . . . . 0.0 112.851 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -60.07 -42.5 94.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.584 0.754 . . . . 0.0 110.248 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 98' ' ' LYS . 4.5 mm? -65.89 -51.67 56.74 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 15.0 pt -73.61 -42.56 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 117.915 0.325 . . . . 0.0 111.671 -167.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 69.13 103.32 0.03 OUTLIER Glycine 0 C--N 1.347 1.162 0 O-C-N 123.262 0.352 . . . . 0.0 113.584 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -171.31 -174.54 39.11 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.491 -0.643 . . . . 0.0 111.491 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -99.35 126.31 45.2 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.727 0.811 . . . . 0.0 109.334 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.6 mm -68.51 122.48 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.426 ' O ' HG12 ' A' ' 111' ' ' VAL . 12.5 t70 -135.24 98.68 4.04 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.718 1.207 . . . . 0.0 108.216 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -68.24 -31.15 70.43 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.975 0.51 . . . . 0.0 111.887 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.716 ' HA ' ' HG2' ' A' ' 113' ' ' GLU . 46.9 t -52.73 -31.45 37.89 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.673 HG23 ' HE3' ' A' ' 118' ' ' LYS . 2.6 p -69.31 -29.62 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.167 0 C-N-CA 122.7 0.4 . . . . 0.0 110.28 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 28.5 mt -95.15 9.89 37.96 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.8 0.84 . . . . 0.0 112.153 177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.716 ' HG2' ' HA ' ' A' ' 110' ' ' SER . 8.4 pt-20 -120.76 4.11 10.57 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.96 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . 0.267 0.5 OUTLIER 76.15 138.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.092 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 172.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 117' ' ' ASP . 26.6 p-10 -136.89 171.5 14.4 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 113.154 -1.839 . . . . 0.0 108.036 170.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.97 -31.36 70.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.173 0.589 . . . . 0.0 112.223 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.416 ' HB3' ' ND2' ' A' ' 115' ' ' ASN . 19.3 t70 -60.27 -53.14 61.22 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.113 0.965 . . . . 0.0 112.31 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HE3' HG23 ' A' ' 111' ' ' VAL . 63.7 mttm -74.88 -20.69 59.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.324 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.496 ' HG3' ' HB ' ' A' ' 134' ' ' VAL . 42.8 tt0 -72.82 -43.73 62.33 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.332 0.653 . . . . 0.0 111.522 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -72.07 -33.97 68.34 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.095 0.558 . . . . 0.0 110.588 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 53.4 tp -58.1 -49.58 76.44 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.461 1.104 . . . . 0.0 111.143 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 36' ' ' ALA . 24.4 mt -57.35 -40.67 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.353 1.061 . . . . 0.0 112.051 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER -74.66 -23.34 58.64 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 119.156 -0.45 . . . . 0.0 111.167 -176.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 127' ' ' LYS . 48.5 mt-10 -73.42 -55.14 6.76 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 169.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.42 -31.76 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 CA-C-N 120.573 1.533 . . . . 0.0 112.777 -176.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 22.4 m-30 -88.72 -30.29 19.21 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 124' ' ' GLU . 38.9 mmtm 63.42 75.51 0.39 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.386 1.075 . . . . 0.0 112.484 174.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.515 HG21 ' HG3' ' A' ' 137' ' ' ARG . 14.2 mt -109.68 109.33 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -76.61 -37.62 56.13 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.83 0.852 . . . . 0.0 110.81 -173.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -91.36 124.42 7.59 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -149.54 113.82 5.21 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.686 1.243 . . . . 0.0 112.182 -170.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -103.03 -83.61 1.73 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 161.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.567 HD21 ' HB2' ' A' ' 136' ' ' GLU . 0.1 OUTLIER -96.58 158.93 15.2 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 166.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.496 ' HB ' ' HG3' ' A' ' 119' ' ' GLU . 13.6 p -76.4 -33.85 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.425 ' O ' HD13 ' A' ' 139' ' ' LEU . 60.4 t -65.37 -59.8 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.565 0.746 . . . . 0.0 112.153 -164.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.567 ' HB2' HD21 ' A' ' 133' ' ' ASN . 37.7 mt-10 -73.2 -28.73 62.35 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.81 -177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.515 ' HG3' HG21 ' A' ' 128' ' ' ILE . 20.2 tpt180 -77.35 -32.48 55.11 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.502 -170.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.597 HG11 ' HB3' ' A' ' 36' ' ' ALA . 14.2 p -72.24 -33.87 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.506 HD11 ' HA ' ' A' ' 40' ' ' HIS . 2.5 mp -54.76 -38.89 67.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.254 1.021 . . . . 0.0 111.044 170.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -67.61 -37.86 83.12 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.643 0.777 . . . . 0.0 111.171 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -68.58 -48.7 63.51 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 111.503 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 65' ' ' ARG . 26.6 pt -78.53 -10.53 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.816 -176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -85.74 -20.63 29.01 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.743 171.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.79 10.33 1.17 Allowed 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.849 0.859 . . . . 0.0 112.416 -170.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.8 mp -91.96 -46.37 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -122.73 -14.23 7.75 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.11 0.964 . . . . 0.0 111.822 -177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.18 42.75 2.15 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -40.31 122.27 1.53 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.433 1.493 . . . . 0.0 113.295 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -93.76 -3.46 52.12 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.902 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.249 1.033 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -174.536 . . . . . . . . 0 0 . 1 stop_ save_